An investigation into the role, recruitment, and regulation of PrimPol in DNA replication restart by Guilliam, Thomas A
   
 
A University of Sussex PhD thesis 
Available online via Sussex Research Online: 
http://sro.sussex.ac.uk/   
This thesis is protected by copyright which belongs to the author.   
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author   
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author   
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
Please visit Sussex Research Online for more information and further details   
An Investigation into the Role, 
Recruitment, and Regulation of PrimPol 
in DNA Replication Restart
A thesis submitted to the University of Sussex for the 
degree of Doctor of Philosophy
Thomas A. Guilliam
March 2017
DECLARATION
This thesis conforms to an article format in which the middle chapters consist of discrete 
articles which have been published in peer-reviewed journals. The first and final chapters 
present an overview and discussion of the field and the research undertaken, these 
chapters contain material already published in review articles.
The second half of Chapter 1 is published in Nucleic Acids Research as:
Guilliam, T.A., Keen, B.A., Brissett, N.C., Doherty, A.J., 2015. Primase-
polymerases are a functionally diverse superfamily of replication and repair 
enzymes. Nucleic Acids Res. 43, 66516664. doi:10.1093/nar/gkv625
Contributions: T.A.G. researched and wrote the majority of the paper and created 
four of the six figures presented. B.A.K. was involved in assisting with research 
and writing. N.C.B. created the crystallographic figures 1 and 5. A.J.D. was 
responsible for the initial concept of the review, in addition to co-writing the 
manuscript. 
Chapter 2 is published in Nucleic Acids Research as:
Guilliam, T.A., Jozwiakowski, S.K., Ehlinger, A., Barnes, R.P., Rudd, S.G., Bailey, 
L.J., Skehel, J.M., Eckert, K.A., Chazin, W.J., Doherty, A.J., 2015. Human PrimPol 
is a highly error-prone polymerase regulated by single-stranded DNA binding 
proteins. Nucleic Acids Res. 43, 10561068. doi:10.1093/nar/gku1321
Contributions: T.A.G. purified human PrimPol, RPA, and mtSSB, performed all 
gel-based biochemical experiments, generated the figures, assisted in pSJ4-lacZ
polymerase-fidelity assay analysis, developed the model, and wrote the 
manuscript. S.K.J. purified human Pol  and PCNA, developed and performed the 
pSJ4-lacZ fidelity assay, and assisted in development of the model. A.E. and
W.J.C. performed the nuclear magnetic resonance (NMR) experiments. R.P.B. and
K.A.E performed the HSV-tk forward mutation assay. S.G.R. performed the affinity 
purification of PrimPol for mass spectrometry (MS) and western blot validation. 
M.J.S. was responsible for MS analysis. A.J.D. was involved in experimental 
development and co-writing the manuscript. 
Chapter 3 is published in Nucleic Acids Research as:
Guilliam, T.A., Bailey, L.J., Brissett, N.C., Doherty, A.J., 2016. PolDIP2 interacts 
with human PrimPol and enhances its DNA polymerase activities. Nucleic Acids 
Res. 44, 33173329. doi:10.1093/nar/gkw175
Contributions: T.A.G. purified all proteins, developed and performed all 
experiments, analysed the data, generated the figures, and wrote the manuscript. 
L.J.B. was responsible for generating the PrimPol-/- MRC5 cells. N.C.B. was 
involved in technical assistance during MS analysis. A.J.D. oversaw the 
development of experiments and co-wrote the manuscript. 
The first half of Chapter 4 is in press at Methods in Enzymology as:
Guilliam, T.A., Doherty, A.J., 2017. Current and emerging assays for studying the 
primer synthesis activities of DNA primases. Methods Enzymol. 
Contributions: T.A.G. developed the fluorescence-based primase assay, wrote 
the manuscript, and produced the figures. A.J.D. developed the initial concept of 
the paper and co-wrote the manuscript. 
The majority of Chapter 5 is in press at Nature Communications as:
Guilliam, T.A., Brissett, N.C., Ehlinger, A., Keen, B.A., Kolesar, P., Taylor, E., 
Bailey, L.J., Lindsay, H., Chazin, W.J., Doherty, A.J. 2017. Molecular basis for 
PrimPol recruitment to replication forks by RPA. Nat. Commun. 
Contributions: T.A.G. purified human PrimPol, PrimPol C-terminal domain (CTD)
cancer mutants, and RPA, generated the HEK293 and DT40 stable cell lines, 
performed the in vitro primase assay, gel filtration chromatography (GFC) analysis 
of CTD cancer mutants, immunoprecipitation experiments, DNA fibre analysis, 
triton fractionation, generated the figures, developed the model, and wrote the 
manuscript. N.C.B. was responsible for crystallography and GFC analysis of RBM 
mutants. A.E. and W.J.C. performed the NMR, isothermal titration calorimetry 
(ITC), dynamic light scattering (DLS), and size exclusion chromatography with 
multi-angle light scattering (SEC-MALS) experiments. B.A.K. Assisted in 
crystallography and gel filtration chromatography studies, and performed circular 
dichroism (CD). P.K. performed the yeast 2-hybrid experiments. E.T. and H.L. 
performed the chromatin isolation from Xenopus egg extract. L.J.B. generated the 
wild-type human PrimPol stable DT40 cell line. A.J.D. was involved in experimental 
design and co-writing of the manuscript. 
The majority of Chapter 6 is published in genes as:
Guilliam, T.A., Doherty, A.J., 2017. PrimPolPrime Time to Reprime. Genes 8, 
20. doi:10.3390/genes8010020
Contributions: T.A.G. wrote the manuscript and generated the figures. A.J.D. 
developed the initial concept and co-wrote the manuscript. 
I hereby declare that this thesis has not been and will not be, submitted in whole or in 
part to another University for the award of any degree.
Thomas A. Guilliam 
University of Sussex 
Thomas A. Guilliam 
Doctor of Philosophy Genome Stability
An investigation into the role, recruitment, and regulation 
of PrimPol in DNA replication restart
Summary
DNA replication is one of lifes fundamental processes. This delicate task is performed 
by a complex of molecular machines, known collectively as the replisome. At the heart 
of the replisome lie the replicative DNA polymerases which catalyse synthesis of 
daughter DNA strands with astonishing accuracy and efficiency. Nevertheless, these 
enzymes are prone to stalling upon encountering DNA damage lesions and secondary 
structures. In order to restart replication, DNA damage tolerance mechanisms are 
required. This published article-format thesis focusses on a recently discovered primase-
polymerase, and member of the archaeo-eukaryotic primase (AEP) superfamily, 
involved in DNA damage tolerance, known as PrimPol. The work presented here builds 
on the initial characterisation of the enzyme, which identified potential roles in the bypass 
of DNA damage through translesion synthesis (TLS) and repriming of replication.
The first presented article consists of a review of the AEP superfamily, functionally 
repositioning the group under the category of primase-polymerases. In the second paper, 
evidence is presented to suggest that PrimPols activity is regulated by single-strand 
binding proteins, required due to the enzymes error-prone nature. In the third chapter, a 
novel PrimPol binding protein, polymerase delta-interacting protein 2 (PolDIP2), is 
identified and characterised as a stimulatory factor for PrimPols primer extension 
activities.  Chapter 4 focusses on the development and use of a gel-based fluorescent 
primase assay to assess PrimPols ability to reprime downstream of DNA damage 
lesions and secondary structures. The fifth presented paper identifies the molecular 
basis for PrimPols interaction with replication protein A (RPA). Using biophysical, 
biochemical, and cellular approaches, this paper identifies the mechanism by which 
PrimPol is recruited to reprime replication. Lastly, in Chapter 6, a review of the presented 
articles in the context of the wider literature is included. Together, this work supports a 
role for PrimPol in repriming and restarting DNA replication following stalling at 
impediments, as well as identifying mechanisms involved in the recruitment and 
regulation of the enzyme. 
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1Chapter 1
Introduction
21. Introduction 
In any system, replication, variation, and selection, given adequate time, facilitate the 
spontaneous emergence of organised complexity. In biology, these three pre-requisites 
form the fundamental basis which underpins the evolution of all life. At its core, biological 
replication is dependent upon the accurate and efficient duplication of the genome, with 
errors during this process generating the necessary variation for selection to occur. From 
a reductionist point of view, therefore, genome duplication, and more specifically DNA 
replication, is the underlying foundation for the emergence and evolution of all complex 
life. The introduction to this thesis provides a general background to the process of DNA 
replication, with a particular focus on the enzymes involved in the direct synthesis of 
DNA; primases and polymerases. Following a broad review of our current understanding 
of DNA replication, the strategies employed by the replisome to maintain progression 
and DNA synthesis in the presence of a range of obstacles will be discussed. Finally, the 
often under-appreciated role of archaeo-eukaryotic primases (AEPs) in DNA replication, 
repair, and damage tolerance will be highlighted, before moving on to introduce the focus 
of this thesis, a recently discovered vertebrate AEP termed PrimPol. 
1.1. The Double Helix 
In 1953, James Watson and Francis Crick published their now famous model for the 
structure of deoxyribose nucleic acid (DNA) (Watson and Crick, 1953). Based on 
unpublished X-ray data from Franklin, Gosling, and Wilkins, coupled with Chargaffs 
identification of base ratios, Watson and Crick proposed a right handed double-helical 
structure of DNA (Chargaff et al., 1952; Franklin et al., 1953; Wilkins et al., 1953; 
Zamenhof et al., 1952). Although previous work had identified DNA as the biological 
carrier of genetic information, the mechanism for how the molecule could store and 
transmit such information was not apparent until after the elucidation of its structure 
(Avery et al., 1944; Griffith, 1928; Hershey and Chase, 1952). 
The DNA double helix is composed of two anti-parallel polymers of deoxyribonucleotides. 
Each deoxyribonucleotide consists of a nitrogenous base bound to the 1 carbon of a 
deoxyribose sugar, and a phosphate group bound to the 5 carbon of the sugar. The 
nucleotide monomers bind together via their phosphate groups, which form 
phosphodiester bonds between the 3 and 5 carbons of the adjacent deoxyribose 
sugars. Importantly, the asymmetric nature of these bonds gives DNA directionality due 
to its 5 and 3 termini. Two antiparallel DNA strands bind together in a right-handed, 
helical fashion by virtue of non-covalent hydrogen bonding between purine (adenine and 
guanine) and pyrimidine (cytosine and thymine) bases. Here, adenine and thymine pair, 
3and cytosine and guanine pair, forming two and three complementary hydrogen bonds 
with each other, respectively (Watson and Crick, 1953). Consequently, each DNA strand 
is bound to another, which encodes the reverse complementary sequence of its bases. 
The formation and stabilisation of the double helix through these hydrogen bonds, 
produces a structure in which the inward-facing nitrogenous bases lie perpendicular to 
the alternating sugar-phosphate backbone of each DNA strand. 
The inherent complementary nature of the double helix structure of DNA, elucidated by 
Watson and Crick, immediately suggests a possible mechanism of duplication. Indeed 
the authors remarked that It has not escaped our notice that the specific pairing we have 
postulated immediately suggests a possible copying mechanism for the genetic material 
(Watson and Crick, 1953). The copying mechanism referred to by Watson and Crick was 
a semi-conservative DNA replication model. Here, each parental DNA strand would 
provide a template for the synthesis of a complementary daughter DNA strand. This 
semi-conservative mode of DNA replication, inferred from the very structure of the 
molecule itself, was later confirmed, adding further elegance to the structure and function 
of DNA (Meselson and Stahl, 1958). 
Subsequent studies were able to determine the nature of the genetic code stored in DNA
(Crick, 1970). It was found that DNA provides the information required for the production 
of proteins in the sequence of bases which it encodes. DNA is transcribed into mRNA, 
each three bases of which are known as a codon; with each codon encoding a specific 
amino acid (Crick et al., 1961; Nirenberg et al., 1965; Tsugita and Fraenkel-Conrat, 
1960). Thus, during the process of translation, each codon is read sequentially to 
produce a specific amino acid sequence and consequent protein. This linear flow of 
information in biological systems, from DNA and RNA to proteins, but never from protein 
to protein, or back to nucleic acid, was termed by Francis Crick the central dogma of 
molecular biology (Crick, 1970).
1.2. DNA Polymerases
Despite the, theoretically, relatively simple copying mechanism envisaged by Watson 
and Crick, the reality of duplicating the genome of any organism is a highly complicated
process, requiring a coordinated complex of molecular machines known collectively as 
the replisome. At the core of the replisome lie the enzymes responsible for template-
directed synthesis of the daughter DNA strands, these enzymes are known as DNA 
polymerases. In humans, DNA polymerases are tasked with accurately copying the ~6 
billion base pair diploid genome, packaged into 46 chromosomes and compacted around 
histones to form chromatin. 
41.2.1. A Brief History of DNA Polymerases
In 1956, only three years after the publication of the structure of DNA, the first enzyme 
capable of performing template-directed DNA synthesis was discovered in Escherichia 
coli (Kornberg et al., 1956). Two years later, this enzyme was purified and designated 
as polymerase, coining the term which would be used to describe the plethora of 
nucleotidyl transferase enzymes discovered thereafter (Lehman et al., 1958). These 
studies determined the requirement of deoxynucleotide triphosphates (dNTPs), a primed 
DNA template, and magnesium (Mg2+) ions as a cofactor, for DNA polymerase activity. 
Thus highlighting that, although a whole replisome is required for accurate and efficient 
genome replication in vivo, DNA synthesis in vitro can be performed by a single enzyme 
in a relatively simple reaction mixture. In 1959, Arthur Kornberg was awarded The Nobel 
Prize for his work in discovering the first DNA polymerase. However, the enzyme he 
discovered, now known as DNA Pol I, is not the polymerase responsible for bulk DNA 
replication in E. coli (De Lucia and Cairns, 1969). Remarkably, the honour of discovering 
that polymerase was left to Arthur Kornbergs son, Thomas Kornberg. In 1971, one year 
after identifying E. coli DNA Pol II, Thomas Kornberg and Malcolm Gefter discovered 
what would become DNA Pol III, the enzyme responsible for genome duplication in E. 
coli (Kornberg and Gefter, 1970, 1971). We now know that E. coli possess five DNA 
polymerases (Pols I, II, III, IV, V), with DNA Pol I playing a role in DNA damage repair 
and Okazaki fragment maturation (Lehman, 2003). 
After the initial identification of DNA polymerase activity by Kornberg et al. in 1956, the 
discovery of polymerase activity in eukaryotes followed closely behind. In 1957, Bollum 
and Potter identified the activity of DNA Polymerase  (Pol ) in rat liver homogenates 
(Bollum and Potter, 1957). In the sixty years since these discoveries an array of DNA 
polymerases have been identified and characterised from all domains of life. These 
studies have revealed that DNA polymerases are essential not only for genome 
duplication, but also for the tolerance and repair of DNA damage. We now know that the 
human genome alone encodes at least 15 DNA-dependent DNA polymerases, excluding 
PrimPol (Figure 1.1.) (Lange et al., 2011). DNA polymerases can be grouped into seven
distinct families based on their phylogenetic relationships with E. coli Pol I (A family), Pol 
II (B family), Pol III (C family), Euryarchaeotic Pol II (D family), human Pol  (X family), 
and E. coli UmuC/DinB and eukaryotic RAD30/xeroderma pigmentosum variant (Y
family). The 15 human DNA-dependent DNA polymerases can all be grouped into just 
four of these, the A, B, X, and Y families (Braithwaite and Ito, 1993; Burgers et al., 2001; 
Ito and Braithwaite, 1991; Zhao and Washington, 2017).  
5Figure 1.1. The domain architecture of the human DNA-dependent DNA polymerases.
The 15 human DNA-dependent DNA polymerases (excluding PrimPol) are arranged into their respective polymerase families, A-family (blue), B-family (red), 
X-family (green), and Y-family (purple). The predominant role and domain architecture of the catalytic subunit of each polymerase is indicated to the right, 
with the length in amino acids displayed below. Note that telomerase is omitted from this list as it is an RNA- not DNA- dependent DNA polymerase. Figure 
adapted from Lange et al., 2011.  
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61.2.2. The General Structure and Mechanism of DNA Polymerases 
The versatile array of DNA polymerases uncovered since 1956 all conform to a highly 
conserved general structure and common mechanism of DNA synthesis. Thus, the 
information gleaned from early mechanistic studies of Pol I has proved applicable to all 
DNA polymerases discovered thereafter (Kornberg et al., 1956; Lehman et al., 1958; 
Rothwell and Waksman, 2005). DNA polymerases utilise single-stranded (ss) DNA 
templates to extend the 3 end of a short DNA or RNA chain (known as a primer) already 
base-paired to the template. Importantly, the majority of these enzymes cannot initiate 
DNA synthesise de novo, rather they rely on DNA primases (see section 1.6.) to 
synthesise the initial primer and provide them with the 3 hydroxyl group required for 
further extension. Following binding to a primer-template substrate, DNA polymerases 
are able to catalyse the addition of successive incoming dNTPs to the 3 end of the primer 
in a repetitive fashion (Figure 1.2.A.) (Lujan et al., 2016). Here, an incoming dNTP first 
base pairs with its complementary partner in the template strand through hydrogen 
bonding. The polymerase is then able to catalyse nucleophilic attack of the 3 hydroxyl 
group of the primer terminus on the -phosphate group of the dNTP to be added. This 
releases two of the phosphate moieties from the incoming dNTP and provides the energy 
required to form a phosphodiester bond, thereby linking the incorporated dNTP with 
phosphate-sugar backbone of the primer strand (Rothwell and Waksman, 2005) (Figure 
1.2.A.). In this manner, DNA polymerases always synthesise DNA in a 5 to 3 direction, 
whilst moving 3 to 5 on the anti-parallel template strand. This is an important feature 
when considering duplication of the double helix. DNA replication occurs bi-directionally 
on each strand, producing a forked structure. Since the two template DNA stands are 
anti-parallel to each other, one will allow continuous synthesis of nascent DNA in a 5 to 
3 direction, this is known as the leading strand. However, since the complementary 
strand is anti-parallel it cannot permit continuous 5 to 3 synthesis and thus requires 
repeated repriming and discontinuous replication in segments termed Okazaki 
fragments. These fragments are subsequently processed and ligated together to form 
the lagging strand (Kainuma-Kuroda and Okazaki, 1975). 
As noted in early studies, metal ions, generally Mg2+, are required for DNA synthesis
(Lehman et al., 1958). Polymerases utilise a two-metal ion mechanism (metal ion A and 
B) to catalyse nucleotide incorporation (Figure 1.2.B.). Each metal ion is held in the 
correct position and orientation by the carboxylate groups of conserved aspartate 
residues. Metal ion A binds to the 3 hydroxyl group of the primer to facilitate its 
nucleophilic attack on the incoming dNTP. Whilst the metal ion B binds to the incoming 
dNTP to facilitate release of the  and  phosphate groups by stabilising their negative 
7Figure 1.2. The mechanism of DNA synthesis by polymerases.
(A) DNA polymerases catalyse the nucleophilic attack of the 3 hydroxyl group of the growing 
DNA strand (red) on the 5 phosphate of the incoming dNTP (purple). This reaction is driven 
by the chemical energy supplied by the triphosphate (yellow) of the incoming dNTP. This 
mechanism of polymerisation provides directionality to DNA synthesis by only permitting 
polymerases to extend the 3 end of DNA chains. Due to the antiparallel nature of duplex 
DNA, polymerases move 3 to 5 on the template DNA strand (blue). Polymerases are unable 
to initiate DNA synthesis de novo and require a DNA or RNA primer. Here an RNA primer is 
shown (green), identifiable from its 2-hydroxyl group. Figure adapted from Lujan et al., 2016. 
(B) The two-metal ion mechanism of DNA synthesis. The two magnesium ions (orange) are 
coordinated by catalytic amino acids of the polymerase (orange). Metal ion A activate the 3-
hydroxyl group of the nascent DNA chain (red) for nucleophilic attack of the -phosphate of 
the incoming dNTP (purple). Metal ion B interacts wth the - and -phosphates of the dNTP 
to facilitate their removal. Together these interactions stabilise the pentavalent transition state 
required for synthesis. 
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8charge. Together, the two metal ions stabilise the pentacovalent transition state to permit 
catalysis and dNTP incorporation into the growing primer strand (Brautigam and Steitz, 
1998).  
In order to achieve this synthesis all DNA polymerases conform to a common domain 
organisation and general overall structure. The first insights into this structure came from 
crystallographic resolution of the Klenow fragment of E. coli Pol I, the polymerase and 
exonuclease domains of the enzyme (Klenow and Overgaard-Hansen, 1970; Ollis et al., 
1985). These studies revealed that the polymerase domain of the enzyme resembles a
right hand, consisting of three subdomains termed the fingers, thumb, and palm
(Figure 1.3.A. and B.) (Beard and Wilson, 2001; Ollis et al., 1985). Independent of the 
detailed structural features of their distinct domains, all polymerase structures uncovered 
to date share this overall architecture (Steitz, 1999). Here, the DNA molecule sits within 
the palm and is enclosed by the fingers and thumb subdomains, creating a U shaped 
structure (Ollis et al., 1985). The palm subdomain contains the polymerase active site, 
harbouring the catalytic carboxylate groups required for metal ion coordination, which 
facilitate phosphoryl transfer. Whilst the fingers subdomain interacts with the incoming 
dNTP and the thumb subdomain coordinates the DNA template (Figure 1.3.C). 
During catalysis, conformational changes in these essential domains facilitate extension 
of the primer strand. Upon binding the primer-template substrate, a helix-loop-helix motif 
located in the thumb subdomain of the polymerase undergoes a conformational change 
to grip the DNA (Li et al., 1998a, 1998b). The fingers subdomain binds the incoming 
dNTP and subsequently undergoes a large conformational alteration involving an initial 
6° rotation in the core of the subdomain, followed by a large 40° inward rotation of the 
helices in the tip of the fingers towards the palm domain (Li and Waksman, 2001). This 
change causes a closing of the hand, bringing the incoming dNTP into close proximity 
of the active site and further coordinating the primer-template substrate. In addition to 
facilitating phosphoryl transfer, this step is also important in ensuring incorporation of the 
correct incoming nucleotide. The tight closed-conformation of the enzyme around the 
base-paired incoming dNTP sterically hinders incorrect base pairing and thus aids in 
preventing misincorporation (Li et al., 1998a; Li and Waksman, 2001). Following 
phosphodiester bond formation an additional conformational change in the enzyme 
permits release of the  and  phosphate groups from the incorporated dNTP as 
pyrophosphate. This is followed by either dissociation of the enzyme or the addition of 
another nucleotide. 
9Figure 1.3. The canonical right-hand structure of DNA polymerases.
(A) Cartoon schematic of the canonical DNA right-hand polymerase structure displaying the 
fingers (orange), thumb (yellow), palm (green), and exonuclease (grey, not present in all 
polymerases) domains. (B) The structure of the first DNA polymerase to be solved, E. coli 
DNA Pol I Klenow fragment (Ollis et al., 1985), showing the resemblance to a right-hand, with 
the corresponding domains indicated. Figure taken from Beard and Wilson, 2001. (C) 
Schematic of a DNA polymerase in combination with DNA. The DNA sits in the U-shaped cleft 
of the enzyme, the thumb domain coordinates the DNA template, whilst the fingers domain 
interacts with the incoming dNTP. The catalytic residues are located in the palm domain. 
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1.2.3. The Eukaryotic Nuclear Replicative DNA Polymerases
Despite having a plethora of DNA polymerases at their disposal, eukaryotes employ just 
three of these for the bulk of DNA synthesis during nuclear replication (Table 1.1.)
(Hübscher et al., 2002; McCulloch and Kunkel, 2008). These multi-subunit enzymes, 
Pols , , and , all belong to the B family (Lujan et al., 2016). All B family polymerases 
possess five distinct subdomains, these include an exonuclease domain and an N-
terminal domain (NTD), in addition to the familiar fingers, thumb, and palm domains
(Franklin et al., 2001; Xia and Konigsberg, 2014, p. 69). Whilst the exonuclease domain 
displays 3-5 proofreading activity, used to remove misincorporated nucleotides, the 
NTD is devoid of catalytic activity, although may play a role in increasing stability and 
fidelity (ratio of correct over incorrect nucleotide incorporation) (Li et al., 2010; Prindle et 
al., 2013). The eukaryotic replicative polymerases exhibit a number of distinct features 
which make them particularly suited to accurate and efficient DNA synthesis (Burgers, 
2009; Kunkel and Burgers, 2008). These include large thumb subdomains and tight 
active sites, in addition to the 3-5 exonuclease domains, which together act to increase 
the processivity (the number of nucleotides incorporated in a single binding event) and 
fidelity of the enzymes.
The first eukaryotic polymerase to be identified, Pol , is also the first of these 
polymerases to perform DNA synthesis during replication (Friedberg, 2006; Lujan et al., 
2016). The polymerase activity of this enzyme is coupled to the replicative primase, 
together they comprise a heterotetrameric complex containing: Prim1, Prim2, PolA1, and 
PolA2 (Muzi-Falconi et al., 2003) (Table 1.1.). During the initiation of replication, Prim1 
is responsible for the synthesis of a short RNA primer (7-12 ribonucleotides long), which 
is subsequently extended by PolA1 to generate a 30-35 nucleotide primer with an RNA 
5 end and DNA 3 end (Garg and Burgers, 2005b; Johansson and Dixon, 2013). The 
two remaining subunits, Prim2 and PolA2, associate with the primase and polymerase 
subunits, respectively, and are responsible for stabilisation and regulation of catalytic 
activity. Structural studies of the catalytic PolA1 subunit in three states (apo, binary, and 
ternary) have permitted insight into the conformational changes of Pol  during synthesis
(Perera et al., 2013). These studies reveal that the thumb subdomain makes multiple 
contacts with the RNA primer through hydrophobic and polar interactions. Interestingly, 
it was suggested that Pol  may recognise the shape of the RNA-DNA duplex, due to it 
being in the A-form, rather than typical B-form of DNA usually found in vivo. Extension 
of the RNA primer by Pol  is limited to 10-12 nucleotides, which is equal to one turn of 
the helix. This has led to speculation that synthesis may be terminated by Pol  upon 
loss of specific contacts between the thumb subdomain and RNA primer, thereby 
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Table 1.1. The subunit composition, role, and fidelity of the human replicative DNA polymerases.
The subunit composition and function, in addition to the polymerase function and fidelity of the three replicative nuclear DNA polymerases, Pol  (blue), Pol 
 (red), and Pol  (green), are displayed. For Pol  and Pol  the polymerase fidelity in both the absence and presence (+ Exo) of proofreading exonuclease 
activity is given. Information obtained from Hübscher et al., 2002; McCulloch and Kunkel, 2008.
Polymerase Subunit Composition (kDa) Subunit Function
Polymerase 
Function
Fidelity (x 10-5)
Sub. Indel
Pol 
180 / PolA1 Catalytic subunit (Pol)
Primer synthesis and 
extension, initiation 
of leading and 
lagging strand 
replication
9.6 3.1
68 / PolA2 Structural, Interactions
55 / Prim2 Accessory (Primase)
48 / Prim 2 Catalytic subunit (Primase)
Pol 
125 / PolD1 Catalytic subunit 
Bulk lagging strand 
replication, 
extension of primers 
on leading strand
1.3 5.7
66 / PolD3 Multimerisation, PCNA Interaction
50 / PolD2 Structural, Interactions
+ Exo: < 1.3 + Exo: 1.3
12 / PolD4 Regulation, TLS?
Pol 
261 / PolE1 Catalytic subunit
Bulk leading strand 
replication
24 5.659 / PolE2 Multimerisation
17 / PolE3 Structural, Interactions
+ Exo: < 0.2 + Exo: 0.0512 / PolE4 Structural, Interactions
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triggering disassociation of the enzyme and handover to Pol  (Perera et al., 2013).
However, a more recent crystallographic study of Pol  in complex with a DNA:DNA helix 
shows that contacts previously observed with the RNA:DNA duplex are preserved, 
suggesting that primer termination is not due to loss of specific contacts upon extension 
of the RNA primer (Coloma et al., 2016). Rather, this report identifies that the DNA duplex 
in contact with the enzyme is in the A-B form and the energetic cost of distorting B-DNA 
to A-B DNA may actually be the factor leading to termination of primer extension. 
In addition to well characterised conformational changes to the finger and thumb 
subdomains, the palm subdomain of Pol  also undergoes structural rearrangements 
during primer extension (Perera et al., 2013). It is thought that these changes permit the 
enzyme to translocate at and beyond the RNA/DNA duplex during synthesis. In contrast 
to Pols  and , Pol  lacks exonuclease activity due to the loss of four critical carboxylate 
groups and a -hairpin motif usually found in B-family polymerases (Hogg et al., 2007). 
Given that Pol  is responsible for the initiation of Okazaki fragment synthesis, and each 
Okazaki fragment is only ~ 165 nucleotides in length, the enzyme contributes
significantly to the total amount of DNA synthesis during replication (Johansson and 
Dixon, 2013). This significant contribution to replication, coupled with the enzymes lack 
of proofreading capabilities, necessitates compensation by Pol  and the mismatch 
repair system to remove and correct errors created by the enzyme (McElhinny et al., 
2010; Pavlov et al., 2006). 
Pol  was identified as the third mammalian DNA polymerase in 1976, following the 
discoveries of Pol  in 1957 and Pol  in 1971 (Byrnes et al., 1976; Friedberg, 2006). 
We now know that the enzyme is responsible for extending the primers synthesised by 
Pol , and therefore performs the majority of lagging strand synthesis (Lujan et al., 2016). 
Intriguing new evidence suggests that Pol  may also perform this role on the leading 
strand following initiation of replication, before handing over to Pol  (see section 1.3.4.)
(Daigaku et al., 2015; Yeeles et al., 2017). In humans, Pol  is composed of four subunits: 
p125/PolD1, p50/PolD2, p66/PolD3, and p12/PolD4. Here, p125 is the catalytic subunit, 
whilst p50 serves as a scaffold to mediate interactions with the p66 and p12 subunits
(Johansson and Dixon, 2013) (Table 1.1.). Pol  is adapted to its role as the lagging 
strand polymerase by displaying extremely high fidelity. The enzyme exhibits an error 
frequency of 1 in 22,000 incorporated nucleotides, with proofreading activity increasing 
this fidelity by one to two orders of magnitude (McCulloch and Kunkel, 2008; Prindle et 
al., 2013; Schmitt et al., 2009). This proofreading activity, enabled by the exonuclease 
domain, is able to sense mismatched base pairs through the loss of specific hydrogen 
bond contacts at the N3 and O2 positions of purines and pyrimidines, respectively
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(Doublié and Zahn, 2014). These contacts extend up to five base-pairs post-insertion, 
greatly contributing to the enzymes fidelity (Swan et al., 2009). Upon loss of the 
hydrogen bond contacts, a critical -hairpin segment in the exonuclease domain 
mediates switching from the polymerase to proofreading mode, which consequently 
facilitates removal of the incorrectly base-paired nucleotide (Doublié and Zahn, 2014).
The importance of this activity for both Pol  and Pol  is highlighted by the observation 
that most mutations of these enzymes involved in cancer development are located in the 
exonuclease domain (Church et al., 2013; Henninger and Pursell, 2014). 
In addition to high fidelity, Pol  is also suited to bulk DNA replication by its processive 
nature. In comparison to Pol , which only extends RNA primers by 10-12 nucleotides, 
Pol  from Saccharomyces cerevisiae has been shown to incorporate over 7000 
nucleotides per binding event in vitro (Burgers, 1991). This processivity is partly due to 
the structural features of the enzyme, such as the large thumb subdomain which 
mediates contact with the DNA template (Rothwell and Waksman, 2005; Sale et al., 
2012). However, processivity is also greatly influenced by interactions with accessory 
proteins, such as Proliferating Cell Nuclear Antigen (PCNA) and Replication Factor C 
(RFC). These two proteins, known as the sliding clamp and clamp loader, respectively, 
form a complex with the Pol  holoenzyme and greatly increase its processivity
(Hashimoto et al., 2003). Here, PCNA encircles the DNA template, after being loaded by 
RFC, and interacts with Pol , thus helping to tether the enzyme to the DNA and prevent 
dissociation. 
In 1989, Pol  became the fourth nuclear DNA polymerase to be identified in mammalian 
cells (Friedberg, 2006). Since its discovery, significant evidence has amounted to 
support a role for the enzyme as the predominant leading strand polymerase (Lujan et 
al., 2016). Pol  is a heterotetrameric complex, which in humans consists of: PolE1, 
PolE2, PolE3, and PolE4, in yeast these are labelled Pol2, Dpb2, Dpb3, and Dpb4. Here, 
PolE1 or Pol2, is the catalytic centre, possessing both polymerase and exonuclease 
activity, with the other three subunits performing accessory roles, including interacting 
with the ssDNA template to increase processivity (Table 1.1.) (Aksenova et al., 2010; 
Tsubota et al., 2003). Notably, unlike Pol , Pol  does not require interactions with PCNA 
to achieve high levels of processivity. Structural studies of yeast Pol  have revealed two 
key differences between the enzyme and typical B-family polymerases (Hogg et al., 
2014). Firstly, Pol  possesses a new functional domain not previously observed in B-
family polymerases. This domain, termed the P domain, is formed from two large 
insertions in the palm domain of the enzyme, which form an elongated structure that 
extends out of the palm and towards the dsDNA. This allows the enzyme to grip the 
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newly synthesised DNA as it leaves the active site and is likely responsible for its high 
intrinsic processivity (Hogg et al., 2014). Secondly, Pol  lacks the extended -hairpin 
loop found in other B-family polymerases, which is important for switching to the 
exonuclease active site. Here, it is thought that the novel P domain compensates for this 
short -hairpin loop by maintaining close contact between the polymerase and DNA 
whilst switching active sites (Hogg et al., 2014). Clearly, this compensation is sufficient, 
given that Pol  is reported to be the most accurate of all yeast DNA polymerases
(Fortune et al., 2005). 
1.3. DNA Replication 
Accurate and efficient DNA replication, prior to cell division, is dependent not only on the 
appropriate functioning of DNA polymerases, but of the replisome as a whole which 
together unpacks, unwinds, and duplicates the genome. Failure to perform this task 
appropriately risks genomic instability. Consequently, a discrete phase of the cell cycle 
is dedicated to the process, this is termed the DNA synthesis (S)-phase, which is 
coordinated to ensure complete genome duplication prior to mitosis and cytokinesis. 
DNA replication can be broadly partitioned into three main stages: initiation, elongation, 
and termination. After a discussion of DNA replication origins, each of these stages will 
be described drawing on recent insights from benchmark in vitro reconstitution studies
(Devbhandari et al., 2017; Kurat et al., 2017; Yeeles et al., 2017). 
1.3.1. DNA Replication Origins and Their Licensing
It has been estimated that a single bi-directional replication fork propagated from a single 
origin of replication would take more than 40 days to copy just human chromosome 1 
(MacAlpine, 2016). In 1966, Huberman and Riggs noted that in order to obviate this issue 
and complete DNA replication within S-phase, multiple origins of replication must be 
dispersed across each chromosome (Huberman and Riggs, 1966). 
In S. cerevisiae, replication origins are denoted by short autonomously replicating 
sequences (ARSs) which contain a consensus sequence (Leonard and Méchali, 2013). 
This sequence is bound by the origin recognition complex (ORC), a conserved 
heterohexameric replication initiation factor (Bell and Kaguni, 2013). However, in higher 
eukaryotes ORC does not display any sequence specificity, leading to speculation that 
alternative chromatin features, rather than consensus sequences, are required to specify 
origins (Remus et al., 2004; Vashee et al., 2003). Indeed, studies in both Drosophila and 
human cells have found that ORC localises in a sequence-independent manner to open 
chromatin and is frequently associated with promoters and enhancers, in addition to 
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regions occupied by transcription factors (MacAlpine et al., 2010; Miotto et al., 2016). In 
conjunction with this, recent reconstitution studies using purified yeast replication 
proteins and chromatinised templates, found that nucleosomes are able to suppress non-
specific ORC binding (Kurat et al., 2017). The authors suggest that this phenomenon 
may also limit ORC binding to only nucleosome free regions (NFRs) in mammalian cells
(Figure 1.4.A.). During S-phase mammalian genomes are divided into temporally distinct 
early- and late-replicating regions, depending on the density of replication origins and 
the timing of activation (Rhind and Gilbert, 2013). A recent study identified that ORC 
density may play a role in determining replication timing (Miotto et al., 2016). 
Remarkably, the authors were able to accurately model and predict replication timing 
based solely on the density of ORC binding sites. Interestingly, a lack of ORC binding 
was observed at common fragile sites, areas of chromosomes prone to breakage, 
demonstrating the significance of replication origins on genome integrity. 
Despite, the lack of a detailed understanding of the precise chromatin features governing 
origin selection and activation, much is known about events following ORC binding.
These events lead to the assembly of the pre-replication complex (pre-RC) in a process 
known as origin licensing (Siddiqui et al., 2013). Importantly, origin licensing is strictly 
regulated to ensure that all origins are licensed prior to the initiation of DNA replication 
and therefore before entering S-phase. In order to achieve this, origin licensing only 
occurs during late mitosis and G1-phase of the cell cycle. In S. cerevisiae, this regulation 
is instilled by the action of cyclin dependent kinase (CDK), which phosphorylates a 
number of initiation proteins to prevent pre-RC assembly (Figure 1.4.A.) (Siddiqui et al., 
2013). Upon exit from mitosis, CDK activity drops, removing this inhibition and permitting 
origin licensing. During G1-phase, ORC bound to replication origins recruits two 
additional factors, Cell Division Cycle 6 (CDC6) and CDC10 Target 1 (CDT1) (Remus et 
al., 2009). Together, these three licensing factors direct loading of the mini-chromosome 
maintenance (MCM) complex, MCM2-7, the replicative helicase, around dsDNA as an 
inactive double hexamer (Figure 1.4.B.) (Siddiqui et al., 2013). This completes the 
formation of the pre-RC, which subsequently requires the recruitment of other replication 
factors to form the pre-initiation complex (pre-IC) before DNA replication can proceed. 
1.3.2. Formation of the Pre-Initiation Complex
The formation of the pre-RC during G1-phase is the first step in preparing origins for 
firing. However, a second step is required before the initiation of replication can occur. 
Here, recruitment of additional factors just before and during S-phase forms the pre-IC,
leading to helicase activation and the recruitment of the replicative primase and 
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Figure 1.4. Formation of the Pre-RC and Pre-IC at DNA replication origins.
(A) In higher eukaryotes ORC binds to nucleosome free regions (NFRs) in the genome to 
mark origins of replication. High CDK activity phosphorylates a number of key initiation factors 
to inhibit Pre-RC assembly during mitosis. (B) Upon entry into G1-phase, CDK activity drops, 
permitting Pre-RC assembly. ORC recruits CDC6 and CDT1 which direct loading of MCM2-6 
onto dsDNA as an inactive double hexamer in an ATP-dependent fashion, forming the Pre-
RC. (C) In late G1 and early S-phase CDK and DDK activity increases. DDK phosphorylates 
MCM2, 4, and 6. (D) Phosphorylation of MCM stimulates recruitment of Sld3/7 and CDC45. 
(E) CDK phosphorylation of Sld2 and 3, further stimulates recruitment of Sld2, Dpb11, GINS, 
Pol , and MCM10. Together, these factors form the Pre-IC, with MCM, GINS, and CDC45 
forming the CMG complex. DNA replication is initiated following unwinding of DNA by CMG. 
Information obtained from Yeeles et al., 2015.
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polymerases (Tanaka and Araki, 2013). The model for the events leading up to and 
during origin firing, including the factors and regulatory mechanisms involved, was 
recently confirmed following the reconstitution of replication initiation using sixteen
purified yeast replication proteins (Yeeles et al., 2015). Here, it was determined that pre-
IC formation is regulated by the activity of CDK and Dbf4-Dependent Kinase (DDK). 
Immediately prior to S-phase, CDK and DDK levels rise, this prevents additional MCM 
loading and leads to the phosphorylation of a number of key replication factors. Firstly, 
DDK phosphorylates MCM2, 4, and 6, stimulating recruitment of synthetic lethality with 
dpb11 (Sld) 3/7 and CDC45 (Figure 1.4.C. and D.) (Deegan et al., 2016). The remaining 
firing factors, Sld2, DNA polymerase-binding protein 11 (Dpb11), GINS, Pol , and 
MCM10, are then recruited following CDK phosphorylation of Sld3 (Figure 1.4.E.) (Parker 
et al., 2017). Upon recruitment, CDC45 and GINS form a complex with MCM2-7, known 
as the CMG complex. Notably, Pol  also plays a non-catalytic, but critical, role in the 
assembly of this complex and is recruited to the CMG complex through a direct 
interaction with GINS (Georgescu et al., 2014). Although not required for stable complex 
formation, MCM10 is essential for activation of the CMG complex (Yeeles et al., 2015). 
Thus, this list represents the minimum set of factors required for pre-IC formation and 
CMG activation. Subsequently, each CMG complex is remodelled, forming a single-
stranded 3-5 DNA translocase responsible for unwinding the double helix, with each of 
the two MCM hexamers translocating in opposite directions (Figure 1.5.A.) (Fu et al., 
2011). Following origin firing in yeast, re-replication is prevented by CDK, which 
promotes the degradation of CDC6 and nuclear exclusion of CDT1 (Parker et al., 2017). 
In humans and other higher eukaryotes, Geminin prevents re-replication by binding to 
CDT1 at origins already licenced (Lutzmann et al., 2006). Importantly, not all licenced 
origins fire during replication, leaving behind dormant origins which may play a role in 
DNA damage tolerance (see section 1.5.1.). 
1.3.3. The Initiation of DNA Replication
Following the formation and activation of the pre-IC, MCM2-7 unwinds the DNA duplex, 
forming a bubble of ssDNA. This ssDNA is rapidly bound by Replication Protein A (RPA), 
a heterotrimeric single-strand binding protein (SSB) which prevents re-annealing, the 
generation of secondary structures, and degradation of DNA. A number of additional 
proteins are also recruited, which together form the replication progression complex
(RPC). These include Chromosome transmission fidelity protein 4 (Ctf4), Pol , 
Chromosome segregation in meiosis 3 (Csm3), Topoisomerase 1-associated factor 1 
(Tof1), Mediator of replication checkpoint protein 1 (Mrc1), Facilitates chromatin 
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Figure 1.5. The initiation of leading strand replication. 
(A) Following Pre-IC formation, the parental DNA duplex is unwound by MCM. This produces 
ssDNA which is bound by RPA. Pol , Ctf4, Csm3, Tof1, Mrc1, FACT, and Top1 are recruited 
to form the replication progression complex. Once recruited, Pol  initiates DNA synthesis on 
the ssDNA template. (B) Initiation of leading strand replication. (I) Slow unwinding of the DNA 
duplex by MCM permits recruitment and primer synthesis by Pol  on the leading strand 
template. (II) RFC loads PCNA onto the primer-template, displacing Pol  and stimulating Pol 
 recruitment. Pol  rapidly extends the primer. (III) Rapid synthesis continues until Pol  
reaches the advancing replisome, here synthesis slows as it is limited by the rate of unwinding 
by MCM. (IV) The nascent DNA chain and PCNA are transferred to Pol , which stimulates 
DNA unwinding and subsequently performs the bulk of leading strand synthesis. Figure B 
adapted from Yeeles et al., 2017. 
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transcription (FACT), and DNA topoisomerase I (Top1) (Figure 1.5.A) (Gambus et al., 
2006). 
Again through reconstitution studies, it was recently demonstrated that Mrc1 (Claspin in 
metazoans) and Csm3/Tof1 are essential for the establishment and maintenance of in 
vivo replication rates (Yeeles et al., 2017). In conjunction, these studies identified that 
FACT is critical for replication of chromatinised templates, but dispensable when 
replicating naked DNA (Kurat et al., 2017). Both MCM10 and Ctf4 have been proposed 
to link Pol  to CMG, however in reconstitution studies on naked DNA, Pol  functioned 
distributively, even in the presence of these two factors (Gambus et al., 2009; Ricke and 
Bielinsky, 2004; Yeeles et al., 2017). Interestingly, experiments using chromatinised 
templates identified that lagging-strand products became consistent over a range of Pol 
 concentrations, potentially suggesting that the polymerase is physically tethered to the 
replisome by interactions with FACT and nucleosomes (Kurat et al., 2017). Alternatively, 
regular priming may be enforced by pausing of Pol  at each nucleosome (Devbhandari 
et al., 2017; Kurat et al., 2017). Therefore, it is also possible that Pol  is simply recruited 
to the RPA bound ssDNA exposed by MCM unwinding, indeed the enzyme has been 
previously shown to share an interaction with RPA (Dornreiter et al., 1992).  
Regardless of the precise mechanism which localises Pol  to the exposed ssDNA, once 
in contact the primase subunit is able to facilitate RNA primer synthesis, before extension 
by the polymerase subunit (Figure 1.5.A.). Consequently, this provides the 3 hydroxyl 
utilised for further elongation by the replicative polymerases. In order for these 
polymerases to take over synthesis a polymerase switch mechanism is required. This 
occurs in two steps, firstly Pol  is competed from RPA by RFC. RFC is then able to load 
PCNA, which is subsequently bound by Pol  (Yuzhakov et al., 1999). This mechanism, 
which further acts to restrict Pol  activity to the generation of short primers, was recently 
confirmed in reconstitution experiments (Devbhandari et al., 2017). 
1.3.4. Elongation and the Progression of the Replisome 
The switch from Pol  to the replicative DNA polymerases  and , marks the transition 
from the initiation to elongation phase of replication. Notably, however, Pol  activity is 
still critical to prime Okazaki fragment synthesis throughout replication on the lagging 
strand. The prevailing model for polymerase usage during the elongation phase of DNA 
replication, is that Pol  is responsible for leading strand replication, whilst Pol 
synthesises Okazaki fragments on the lagging strand, which involves extension and 
displacement of the primers synthesised by Pol  (Figure 1.6.A.) (Kunkel and Burgers, 
2008). Indeed, accumulating evidence over the past decade has strongly supported this 
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model (Kunkel and Burgers, 2008). However, the Prakash laboratory recently challenged 
this view, presenting evidence to suggest that Pol  is responsible for synthesis of both 
the leading and lagging strands, with Pol s primary role being the proofreading of errors 
made by Pol  on the leading strand (Johnson et al., 2015). This model has now been 
largely discredited due to concerns over experimental procedures and the observation 
that Pol  is unable to proofread errors made by Pol  (Burgers et al., 2016; Flood et al., 
2015).
Whilst recent evidence generally supports the model that Pol  and Pol  perform leading 
and lagging strand synthesis, respectively, it also suggests that this model is not as
simple as first thought. Polymerase usage sequencing (Pu-seq) studies in yeast, which
use high-throughput sequencing to map ribonucleotides incorporated in the genome by 
Pol  and Pol  mutants during replication, have shed light on the genome wide subtleties 
of polymerase usage during this process (Clausen et al., 2015; Daigaku et al., 2015; Koh 
et al., 2015; Reijns et al., 2015). Here, it was found that Pol  and Pol  are consistently 
responsible for leading and lagging strand synthesis, respectively. However, there was 
a strong bias towards Pol  synthesis on the leading strand close to replication origins
(Daigaku et al., 2015). Recent replisome reconstitution studies by Yeeles et al. have now 
identified the role of Pol  in leading strand replication following primer synthesis (Figure 
1.5.B.). In this report, Pol  was required for efficient and uniform initiation of leading 
strand synthesis (Yeeles et al., 2017). Yeeles et al. propose a model whereby Pol  and 
PCNA take over the 3 end of the primer synthesised by Pol  on the leading strand
(Figure 1.5.B. I and II). Initially, as CMG-Pol  moves away from the primer, synthesis by 
Pol  will be rapid, until it catches up with the slow moving CMG (Figure 1.5.B. II). At this 
point Pol  will slow down due to an inability to accelerate unwinding by CMG (Figure 
1.5.B. III). Here, a polymerase switch occurs in which the 3 end and PCNA are 
transferred over to Pol , which can stimulate CMG unwinding, consequently promoting 
maximal leading strand replication rates for continued synthesis (Figure 1.5.B. IV). Mrc1 
also stimulates unwinding by CMG during replisome progression, with Csm3/Tof1 acting 
to promote functional association of Mrc1 with the replisome. Interestingly, in 
conjunction, it was discovered that PCNA plays an important role in promoting leading, 
as well as lagging, strand replication (Yeeles et al., 2017). This suggests that Pol  
utilises both CMG and PCNA as processivity factors during synthesis. It is likely that
CMG tethers the polymerase to the unwinding fork while PCNA promotes continued 
association with the 3 end of the leading strand (Figure 1.5.B. IV). 
On the lagging strand, discontinuous synthesis of Okazaki fragments by the concerted 
activities of Pol  and Pol  continues as the replisome progresses (Figure 1.6.A. and 
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Figure 1.6. DNA replication elongation and lagging strand synthesis. 
(A) The elongation phase of DNA replication. Following initiation, the replicative DNA 
polymerases  and  perform the bulk of DNA synthesis on the leading and lagging strands, 
respectively. Synthesis on the leading strand is predominantly continuous, whereas lagging 
strand synthesis is discontinuous and requires constant priming by Pol . Mrc1, Csm3, and 
Tof1 are required for the maintenance of maximal fork speeds, while FACT is required for 
nucleosome processing. Top1 works ahead of the replisome to relieve torsional stress caused 
by unwinding of the DNA duplex. (B) Lagging strand DNA synthesis. (I) Discontinuous 
generation of Okazaki fragments is initiated by Pol  mediated primer synthesis. (II) Pol  and 
PCNA replace Pol  and extend the Okazaki fragment primer, displacing RPA from the ssDNA 
template. (III) Extension continues until Pol  reaches the primer of the preceding Okazaki 
fragment downstream, the enzyme displaces the RNA primer generating a flap. (IV) The flap 
is removed by FEN1, (IV) and the two Okazaki fragments are ligated together by LIG1.
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B.), these fragments must be ligated together to produce an intact daughter lagging 
strand in a process known as Okazaki fragment maturation. Here Pol  displaces the 
RNA primer of the previous Okazaki fragment, producing a 5 flap which is subsequently 
cleaved by flap endonuclease 1 (FEN1) (Maga et al., 2001). The two Okazaki fragments 
are then ligated together by DNA ligase I (Figure 1.6.B.)(Barnes et al., 1990; 
Devbhandari et al., 2017; Lehman, 1974; Li et al., 1995; Pascal et al., 2004). 
Due to the double helical nature of DNA, unwinding of the two strands during CMG 
progression causes torsion to build up ahead of the replisome, resulting in positive 
supercoiling and topological stress (Keszthelyi et al., 2016). In order to release this 
torsion, specialised enzymes known as topoisomerases are required. During replication 
in eukaryotes, two such enzymes, Top1 and Top2, are employed to resolve topological 
stress. Top1 is a type IB topoisomerase which functions by nicking one of the DNA 
strands, while Top2, a type II topoisomerase, breaks both strands (Keszthelyi et al., 
2016; Wang, 1996, 1998). In each case, this activity allows topological stress to be 
released before re-ligation of the nicked strands. This is critical to relax the positive 
supercoiling produced ahead of the fork during replication and thus facilitate the 
continued progression of the replisome (Figure 1.6.A.) (Brill et al., 1987; Hiasa and 
Marians, 1994a, 1994b; Kim and Wang, 1989). Aside from acting ahead of the replisome, 
topoisomerases can also function behind the fork in a second pathway. Here the 
replication fork rotates relative to the unwound template DNA ahead, thereby transferring 
the DNA intertwines to the region behind the replisome (Keszthelyi et al., 2016). This 
transfer causes the replicated sister-chromatids to become intertwined, forming pre-
catenanes, which can progress to full catenanes upon completion of replication. Pre-
catenanes are removed by the action of type II topoisomerases behind the progressing 
replisome, allowing topological stress to be relieved when template DNA ahead of the 
fork is not accessible (Baxter, 2015). This pathway is of particular importance upon the 
convergence of two adjacent replisomes during the termination of replication (Keszthelyi 
et al., 2016).
1.3.5. The Termination of DNA Replication 
DNA replication terminates when adjacent replication forks moving towards each other 
meet. The location of termination is largely dependent upon the site of initiation and the 
rate of replication, rather than specific DNA sequences or chromatin features
(Greenfeder and Newlon, 1992). There are four main processes required to efficiently 
terminate replication. These include; the unwinding of the final portion of DNA between 
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the two replisomes, the filling in and ligation of daughter strands, the removal of dsDNA 
catenanes, and the disassembly of the replisome (Dewar et al., 2015). 
As replisomes converge during termination, topological stress builds up in the unwound 
DNA in between. However, this DNA is thought to be largely inaccessible to 
topoisomerases due to steric exclusion by the two replisomes (Keszthelyi et al., 2016). 
In order to proceed, fork rotation is employed, allowing the topological stress to be 
transferred behind the fork and unwinding of the final unreplicated DNA to occur (Sundin 
and Varshavsky, 1981). This rotation generates catenanes which are subsequently 
removed by Top2. Recent work in Xenopus extracts has revealed the mechanism which 
ensures complete replication at sites of termination in vertebrates (Dewar et al., 2015). 
Here it was determined that as replisomes converge on opposite strands, due to the 
CMGs encircling the leading strand, they efficiently pass each other without stalling. This 
allows the remaining gaps in the daughter strands to be filled in before the CMG contacts 
the 5 end of the opposing forks lagging strand. At this point the complex passes over 
the ssDNA-dsDNA junction and moves onto the dsDNA. Ligation of the daughter DNA 
strands then occurs and at the same catenanes are resolved. Lastly, the dsDNA bound 
CMG is ubiquitylated on MCM7, triggering removal by the ATPase p97 (Maric et al., 
2014; Moreno et al., 2014). 
1.3.6. Mitochondrial DNA Replication
In addition to the nuclear genome, eukaryotes also possess a second genome in the 
mitochondria. In mammals, around 1000 copies of this 16.5 Kb circular DNA molecule 
are housed in the mitochondria (Wilson et al., 1985). The mitochondrial replisome is 
distinct from the nuclear DNA replication machinery, and includes Pol , Twinkle DNA
helicase, mitochondrial single-strand binding protein (mtSSB), mitochondrial RNA 
polymerase (PolRMT), topoisomerases, mitochondrial transcription factor A (TFAM), 
DNA ligase III, RNase H1, and RNase mitochondrial RNA processing enzyme (RNase 
MRP) (Cerritelli et al., 2003; Hance et al., 2005; Simsek et al., 2011; Spelbrink et al., 
2001; Tyynismaa et al., 2004; Van Goethem et al., 2001). 
The mitochondrial genome has a single origin of replication on each strand. These are 
termed OH and OL on the heavy and light strands respectively, with OL located two-thirds 
of the way around the DNA molecular relative to OH (Falkenberg et al., 2007). Prior to 
the initiation of DNA synthesis, TFAM, a member of the high-mobility group (HMG) 
proteins, binds upstream of OH and unwinds the DNA duplex (Dairaghi et al., 1995; Fisher 
et al., 1987). This facilitates the recruitment of PolRMT which synthesis an RNA primer 
at the OH origin (Chang et al., 1985; Chang and Clayton, 1985). Importantly, this primer 
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is identical to the one used for the polycistronic transcription of mitochondrial genes and 
therefore requires processing by the endoribonuclease RNase MRP for replication to 
occur (Topper and Clayton, 1990). The resulting processed RNA primer can then be 
utilised by Pol  for extension (Ropp and Copeland, 1996). During replication, unwinding 
of the duplex parental DNA is facilitated by the replicative helicase Twinkle which acts 
as a hexamer without the need for a specialised protein to load it onto the circular mtDNA 
template (Jemt et al., 2011; Korhonen et al., 2003). Following unwinding, ssDNA is 
bound by mtSSB, a homotetramer with an analogous function to RPA. Pol , Twinkle, 
and mtSSB form a processive replication machinery and together make up the minimal 
mitochondrial replisome, capable of generating 16.5 Kb products in vitro (Falkenberg et 
al., 2007). 
DNA synthesis at OL is not initiated until it is exposed by replication of the leading heavy 
strand. Once in a ssDNA conformation, OL forms a stem loop structure which facilitates 
priming by PolRMT (Fusté et al., 2010). Interestingly, this stem loop structure is highly 
conserved and mutations affecting its structure are under-represented in the 
mitochondrial genome (Wanrooij et al., 2012). RNase H1 is also thought to play a key 
role in mtDNA replication, with RNaseh1-/- mice displaying significant mitochondrial 
defects (Cerritelli et al., 2003). Here, RNase H1 is likely involved in the removal of the 
RNA primers at each origin, likewise DNA ligase III may also be involved in ligation of 
the resulting nicks. 
1.4. Replication Stress
During its progression, the replisome faces numerous obstacles which it must overcome 
in order to accurately complete genome duplication (summarised in Figure 1.7.). These 
obstacles arise from a variety of intracellular and extracellular origins, however almost 
all cause a similar effect; the slowing or stalling of replication fork progression. In this 
section, the array of sources contributing to replication stress will be described, before 
focussing more closely on one of these, DNA damage, and the mechanisms employed 
for its repair. 
1.4.1. Sources of Replication Stress
Any factor which leads to the slowing or stalling of the replisome can be considered a 
source of replication stress (Zeman and Cimprich, 2014). Over recent years, the list of 
potential sources of replication stress has grown, highlighting the vulnerability of the core 
replisome to perturbations in its DNA template and the requirement for sufficient 
resources to maintain progression. In fact, the DNA template itself can act as a source 
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Figure 1.7. The sources of DNA replication stress. 
Various sources contribute to replication stress and can impede the completion of genome duplication including, DNA damage, ribonucleotide incorporation, 
repetitive DNA sequences, limiting pools of nucleotides, fragile sites, DNA secondary structures, and collisions between replication and transcription 
machinery. Potential pathways and factors involved in remediating each of these sources are highlighted in bold. Figure adapted from Zeman and Cimprich, 
2014. 
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of replication stress. Numerous DNA sequences pose a challenge to the progressing 
replisome due to their ability to form DNA secondary structures, these include hairpins 
and triplexes, formed by trinucleotide repeats, which can directly block the replisome or 
cause slippage (McMurray, 2010). This in turn leads to expansion or contraction of the 
repeats and can potentially further contribute to replication stress (Kim and Mirkin, 2013). 
In addition to trinucleotide repeats, G-rich sequences of DNA have the ability to form G-
quadruplex structures through hoogsteen base-pairing. These structures can cause the 
formation of double-strand breaks (DSBs) and deletions when incorrectly replicated and 
thus require specialised helicases for their unwinding (Bochman et al., 2012; Paeschke 
et al., 2013). Aside from DNA secondary structures, nicks and gaps present in the 
template can additionally stall the replisome or contribute to DSB formation. These nicks 
and gaps are often caused by DNA repair pathways or topoisomerases during 
processing (Zeman and Cimprich, 2014). 
Although extremely accurate when forming correct base-pairs, the replicative 
polymerases can themselves contribute to replication stress through misincorporation of 
ribonucleotides (rNTPs). Both Pol  and Pol  incorporate rNTPs at a high rate during 
replication, which must be removed through ribonucleotide excision repair (Dalgaard, 
2012). Loss of this pathway is lethal in mammals and causes damage sensitivity in yeast, 
highlighting the detrimental affect misincorporated rNTPs can have on the cell (Lazzaro 
et al., 2012; Reijns et al., 2012). The replicative polymerases are stalled upon 
encountering rNTPs in the template strand and aberrant processing of rNTPs by Top1 
can produce non-ligatable nicks, both contributing to replication stress (Kim et al., 2011; 
Nick McElhinny et al., 2010; Williams et al., 2013). 
Protein complexes bound to the DNA template during replication can also hinder fork 
progression. Perhaps the most significant of these is transcription machinery, due to 
replication and transcription sharing the same DNA template (Bermejo et al., 2012; 
Helmrich et al., 2013). Collisions between replication and transcription complexes can 
cause DSBs, this is a particular problem at early replicating fragile sites. These are highly 
transcribed regions of the genome which are replicated early in S-phase, thus increasing 
the chance of collision (Barlow et al., 2013). As well as direct collision, replication and 
transcription on the same DNA template can generate topological stress. Indeed, this is 
supported by studies in yeast which found that replication stress is produced by 
converging replication and transcription machinery even before they collide (Bermejo et 
al., 2011, 2012). Loss of RNA processing elements can further increase the risk of 
replication-transcription collision and topological stress by slowing the rate of 
transcription (Huertas and Aguilera, 2003; Li and Manley, 2005; Paulsen et al., 2009; 
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Stirling et al., 2012; Wahba et al., 2011). Additionally, this can promote the formation of 
unresolved R-loop structures, RNA-DNA duplexes with a displaced ssDNA strand, which 
can also stall progressing replisomes (Aguilera and García-Muse, 2012). RNA 
processing elements help to prevent this scenario by preventing rehybridisation of the 
RNA transcript, with specialised helicases assisting in unwinding RNA-DNA duplexes 
which do occur (Alzu et al., 2012; Yüce and West, 2013). Therefore, loss of these 
components contributes to replication stress. 
In addition to early replicating fragile sites, common fragile sites are prone to causing 
DSBs even at low levels of replication stress (Debatisse et al., 2012). Interestingly, the 
replication fork progresses through these sites at a normal rate, suggesting there is no 
direct block produced by secondary structures or specific template elements (Debatisse 
et al., 2012). Instead, it is thought that these regions are vulnerable to stress due to the 
lack of origins, which may impair the ability to overcome normal replication obstacles at 
these sites (Zeman and Cimprich, 2014). Improper control of replication initiation can 
also contribute to replication stress. Firing of too many origins can result in depletion of 
nucleotide pools and thereby slowed fork rates (Beck et al., 2012; Sørensen and 
Syljuåsen, 2012). Whereas firing of too few origins can cause under-replication and the 
loss of genetic material (Debatisse et al., 2012; Shima et al., 2007). Likewise, chromatin 
compaction may contribute to inhibition of replisome progression. In support of this,
increased replication-dependent DSBs have been observed in yeast heterochromatin 
regions and relaxation of chromatin at fragile sites reduces the occurrence of breakage
(Jiang et al., 2009; Lambert and Carr, 2013a). 
In summary, it is clear that almost all the elements required for efficient replisome 
progression, such as a pristine DNA template and sufficient dNTPs, can cause 
replication stress when impaired. Many of these impairments emerge from endogenous 
processes in the cell, such as transcription, or inherent elements of the genome, for 
example secondary-structure forming sequences. However, perhaps the most significant 
and well-characterised source of replication stress arises from DNA damage, which can 
be generated from both endogenous and exogenous sources.
1.4.2. DNA Damage
Surprisingly, given that its the carrier of genetic material, DNA is a rather unstable 
molecule which is liable to damage and decay (Lindahl, 1993). The scale of this problem 
for the preservation of genomic integrity, is highlighted by the estimation that there are 
up to 105 spontaneous DNA lesions generated per cell every day (Hoeijmakers, 2009). 
This DNA damage arises from three main sources, these are, spontaneous damage due 
28
to the inherent instability of the DNA molecule, by-products of normal endogenous 
cellular metabolism, and external physical and chemical mutagens. 
Spontaneous damage to DNA occurs in two main ways. The first of these is depurination 
which is estimated to occur around 9000 times per cell each day (Nakamura et al., 1998). 
This is caused by hydrolysis of the base-sugar bond, resulting in the loss of the base 
while the phosphodiester backbone remains intact. Consequently, an 
apurinic/apyrimidinic (Ap) site is generated which can stall replisome progression and 
lead to base substitution mutations following replication (Loeb and Preston, 1986). 
Secondly, spontaneous deamination can cause interconversion between bases, the 
most common example of this is deamination of cytosine to uracil which can lead to G®A 
transition mutations upon replication (Duncan and Miller, 1980).
Normal cellular metabolism contributes significantly to DNA damage through the 
generation of reactive oxygen species (ROS). These include hydrogen peroxide, 
superoxide anions, and hydroxyl radicals, which are primarily a product of oxidative 
phosphorylation (OXPHOS) in the mitochondria (Cadet et al., 2003). ROS attack the 
DNA, generating lesions, the most common of which are 8-oxo-2-deoxyguanosine (8-
oxo-dG) lesions, caused by the oxidation of guanine (Halliwell and Aruoma, 1991).
Although 8-oxo-dG lesions can be bypassed by the replisome, they direct 
misincorporation of adenine in the daughter strand, producing GC®TA transversion 
mutations. Meanwhile, oxidation of thymine moieties can produce thymine glycol (Tg)
lesions which act to stall the replisome (Ghosh et al., 2008). 
Lastly, there are numerous exogenous physical and chemical mutagens which damage 
DNA and threaten genomic integrity. Ionising radiation (IR) causes both direct damage 
to DNA through the creation of DNA strand breaks and also indirectly by generating ROS 
in the cell (vanAnkeren et al., 1988). Ultraviolet radiation, primarily from sunlight, causes 
covalent linkages to form between adjacent pyrimidines, forming bulky DNA lesions 
including cyclobutane pyrimdine dimers (CPDs) and pyrimidine (6-4) pyrimidone 
photoproducts (6-4PPs). Both of these lesions significantly distort the double helix and 
pose as potent obstacles to the replicative polymerases (Rastogi et al., 2010). Chemical 
agents, many of which are used in cancer chemotherapy, produce a variety of DNA 
lesions. These include alkylating agents, such as methyl methanesulfonate (MMS), 
which attach alkyl groups to bases, and crosslinking agents, including cisplatin, which 
can produce covalent linkages between bases in both the same strand (intrastrand 
crosslinks) and different strands (interstrand crosslinks) of DNA (Ciccia and Elledge, 
2010). Intercalating agents, such as the anthracycline class of chemotherapeutic drugs, 
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interfere with base stacking rather than causing covalent modifications, consequently
affecting replication and generating mutations (Minotti et al., 2004). 
1.4.3. An Overview of DNA Repair
Given the vulnerability of DNA to damage and decay, cells have evolved numerous DNA 
repair mechanisms to counteract this damage prior to replication, thereby reducing the 
chance of mutagenesis (summarised in Figure 1.8.). These mechanisms include, 
mismatch repair (MMR), base excision repair (BER), nucleotide excision repair (NER), 
single-strand break repair (SSBR), non-homologous end joining (NHEJ), and 
homologous recombination (HR) (Iyama and Wilson III, 2013).
MMR increases the fidelity of DNA replication 1000-fold by removing and correcting 
bases which have been misincorporated by the replicative polymerases (Hsieh and 
Yamane, 2008). Humans possess seven different MMR proteins; mutL homolog 1 
(MLH1), MLH3, mutS homolog 2 (MSH2), MSH3, MSH6, postmeiotic segregation 
increased 1 (PMS1), and PMS2 (Pal et al., 2008). Together these proteins are able to 
recognise misincorporated bases and form a complex to facilitate excision of the affected 
DNA before resynthesis by Pol  and subsequent ligation. 
BER works in a similar manner to MMR to repair base lesions, such as those caused by 
oxidative damage and spontaneous deamination (Almeida and Sobol, 2007; Hitomi et 
al., 2007). In this mechanism, DNA glycosylases hydrolyse the base-sugar bond before 
strand incision through apurinic/apyrimidinic lyase (AP lyase) endonuclease activity
(Hitomi et al., 2007). Pol  can subsequently insert a base into the gap left from incision
before DNA ligase III and X-ray repair cross complementing protein-1 (XRCC1) seals the 
DNA, this is termed short patch BER (Dianova et al., 2004). Alternatively, Pol , , or  
can work in conjunction with PCNA and poly(ADP-ribose) polymerase 1 (PARP) in long 
patch BER where 2 to 13 bases are displaced during gap-filling synthesis, producing a 
flap which is processed by FEN1 and DNA ligase I (Iyama and Wilson III, 2013). 
More bulky lesions, which distort the DNA backbone, are removed through NER (Iyama 
and Wilson III, 2013). Dysfunction in any of the main NER components causes 
Xeroderma pigmentosum (XP), an autosomal recessive disorder with eight different 
genetic complementation groups, representing the main NER proteins (XPA to XPG). 
Together these proteins, along with additional repair factors, bind to the distorted DNA, 
unwind the duplex, and remove a section of ssDNA 24-32 nucleotides in length
(Lehmann, 2011). The resulting ssDNA is then filled in by the replicative DNA 
polymerases and ligated. NER can also be coupled to transcription, here stalling of RNA 
polymerase (RNAP) triggers removal of the lesion and restart of transcription by the
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Figure 1.8. Summary of DNA damaging agents and repair mechanisms.
Numerous endogenous and exogenous agents contribute to DNA damage. This damage must be accurately repaired to prevent genome instability. Some of 
the agents contributing to DNA damage (blue), in addition to the types of damage produced (green) and the repair pathways employed to remove this damage 
(red) are displayed. DNA damage lesions which are unrepaired by BER or NER prior to replication can be bypassed by the replisome through DDT 
mechanisms (purple). 
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Cockayne syndrome (CS) proteins CSA and CSB, named after the autosomal recessive 
disease caused by their mutation (Iyama and Wilson III, 2013). 
Single-strand breaks occur at very high rates, estimated to be in the order of tens of 
thousands per cell per day (Lindahl, 1993). These breaks are formed by canonical DNA 
damage, in addition to enzymatic intermediates of repair pathways and catalytic 
intermediates of topoisomerases (Iyama and Wilson III, 2013). Due to the range of 
potential causes, single-strand breaks can generate a diverse range of damaged 3 and 
5 termini. Consequently, specialised enzymes including, DNA ligases, tyrosyl-DNA 
phosphodiesterase 1 (TDP1), aprataxin (APTX), polynucleotide kinase 3-phosphatase 
(PNKP), and AP endonuclease 1 (APE1), are employed to process and repair the DNA 
termini before sealing the break. Intriguingly, mutation of many of these factors, such as 
TDP1, APTX, and PNKP, are linked to neurological disorders, rather than cancer, 
suggesting that these mechanisms may be in non-dividing cells (Gueven et al., 2004; 
Shen et al., 2010; Takashima et al., 2002). 
Although occurring at a much lower rate, DSBs are extremely deleterious to the cell, with 
the potential to cause significant genome instability and ultimately cell death if left 
unrepaired (Bohgaki et al., 2010; Jackson and Bartek, 2009). Two major pathways are 
involved in the repair DSBs: HR and NHEJ. To operate HR requires a homologous sister 
chromatid and therefore is only active during the S and G2-phases of the cell cycle. Here, 
it primarily functions to repair DSBs caused by replication fork collapse as a result, for 
example, of polymerase stalling lesions (Iyama and Wilson III, 2013). The pathway 
involves the sensing of the DSB, 5-3 resection to generate 3 ssDNA overhangs, stand 
invasion of the intact homologous region of the sister chromatid, polymerase extension 
and D-loop formation, and finally Holliday junction formation and resolution or synthesis-
dependent strand annealing. In the absence of a sister chromatid NHEJ is used for DSB 
repair. The process involves three main steps which direct ligation of the two ends of the 
break, these include: the sensing and recognition of the break, processing of termini to 
remove damage and reveal microhomology, and joining and ligation of the two ends. 
Despite being the major DSB repair pathway in higher eukaryotes, NHEJ can often be 
error prone due to loss of genetic information at the break (Lieber, 2010). 
1.5. DNA damage tolerance
The structural features of the replicative DNA polymerases, which confer inherent high 
fidelity, also make the enzymes intolerant to distortions in the template DNA. 
Consequently, unrepaired DNA damage lesions and secondary structures, which persist 
into S-phase, block replication and cause fork stalling. The stalling of replicases at these 
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sites can elicit uncoupling of leading and lagging strand synthesis, due to the ability of 
the replicative helicase to bypass the lesion and facilitate continued unwinding of duplex
DNA (Lopes et al., 2006). The effect of this on the lagging strand is limited due the 
discontinuous nature of synthesis there. However, uncoupling of leading strand 
replication can generate stretches of RPA-bound ssDNA on one side of the fork, 
producing a substrate for ataxia-telangiectasia mutated- and Rad3-related (ATR) ATR-
interacting protein (ATRIP) binding and checkpoint kinase 1 (Chk1) activation (Zou and 
Elledge, 2003). This RPA-bound ssDNA also triggers DNA damage tolerance (DDT) 
mechanisms which allow replication to be completed in the presence of fork stalling 
lesions. Eukaryotes utilise two such mechanisms: recombination-dependent template 
switching (TS) which uses a homologous template, usually the sister chromatid, to 
bypass the lesion in a generally error-free manner, and translesion synthesis (TLS) 
where specialised DNA polymerases directly synthesise past the lesion in what is 
considered error-prone bypass. Additionally, the firing of dormant origins can help to 
ensure complete genome duplication in the presence of replication stress (summarised 
in Figure 1.9.). In this section, each of these mechanisms will be outlined and discussed
before focussing on their timing during replication and relationship with repriming.
1.5.1. Firing of Dormant Origins
During origin licensing in G1-phase a ~ 20-fold excess of MCM2-7 is loaded onto DNA 
over the level required for the number of origins used in normal DNA replication (Edwards 
et al., 2002). This excess MCM is not located at the same site as ORC and does not 
affect normal replication rates when depleted to a level of two per origin in Xenopus egg 
extract (Edwards et al., 2002; Mahbubani et al., 1997; Oehlmann et al., 2004; Ritzi et al., 
1998). Additionally, cells with a reduced amount of chromatin bound MCM display normal 
rates of S-phase progression (Tsao et al., 2004). However, loss of excess MCM 
sensitises DNA synthesis, cellular proliferation, and cell survival, to replication inhibitors, 
suggesting a role in the maintenance of DNA replication following perturbation (Ge et al., 
2007; Woodward et al., 2006). Indeed, studies of human U2OS cells identified that DNA 
replication inhibitors induced firing of dormant origins not used in normal DNA replication
(Ge et al., 2007). The firing of these origins was dependent on the excess chromatin 
bound MCM. Coupled with this, replication or checkpoint inhibition causes a decrease in 
replication origin spacing, demonstrating that additional origins are fired under these 
conditions (Gilbert, 2007; Maya-Mendoza et al., 2007; Woodward et al., 2006). 
It is thought the firing of dormant origins is regulated by a simple passive mechanism
(Ge et al., 2007). Following activation of an origin cluster, the dormant origins in that 
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Figure 1.9. DNA damage tolerance mechanisms. 
(A) DNA replication can proceed in presence of replisome-stalling obstacles though the 
activation of dormant origins of replication downstream of the damage. This allows 
unreplicated regions in between adjacent replisomes to be filled in. (B) DDT mechanisms at 
the replication fork. DNA damage lesions can be directly overcome by the action of TLS 
polymerases which are able to replicate over the lesion. Alternatively, fork regression can 
occur, generating a four way Holliday junction. Here, the nascent lagging strand can be 
utilised as a template for extension of the nascent leading strand, before reverse branch-
migration places the nascent leading strand in a position downstream of the lesion. Fork 
regression also places the stalling lesion in a dsDNA context which may permit repair and 
removal by NER to allow replisome progression. Finally, homologous recombination (HR) can 
be used, whereby the nascent leading strand is extruded and undergoes template exchange 
with homologous sequences which are used as a template for further extension. (C) Post-
replicative DDT mechanisms. Repriming of replication downstream of the lesion/obstacle 
leaves behind a ssDNA gap which can be subsequently filled in. This gap-filling may be 
performed by a TLS polymerase or through template switching where the sister chromatid is 
utilised as a template. 
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cluster have only a short time to fire before they are replicated by converging forks from 
neighbouring origins. Thus, if fork progression is slowed or stalled there is more time,
and therefore an increased probability, of the origin firing before it is replicated. In support 
of this, dormant origin firing is not dependent on checkpoint kinase activity (Ge et al., 
2007). However, it has also been speculated that phosphorylation of MCM by ATR may 
play a role in activating dormant origins during replication stress (Blow et al., 2011).
Regardless of the mechanism controlling MCM activation, by firing dormant origins
unreplicated DNA in between two stalled or slowed converging forks can be filled in, 
allowing bulk DNA synthesis to be completed (Figure 1.9.A.). The requirement of 
dormant origins in times of replication stress explains the excess MCM loaded onto DNA 
during origin licensing in G1-phase. Importantly, new origins cannot be licensed during 
S-phase, as this would occur on both replicated and unreplicated DNA, consequently 
leading to rereplication of nascent strands. 
1.5.2. Translesion Synthesis
Although the firing of dormant origins allows unreplicated DNA between stalled forks to 
be filled in, it does not permit synthesis opposite the stalling lesion and therefore cannot 
ensure complete genome duplication alone. In addition to ATRIP/ATR, the generation of 
RPA-bound ssDNA, following leading strand replication uncoupling, provides a substrate 
for binding of E3 ubiquitin ligase Rad18 and E2 ubiquitin-conjugating enzyme Rad6, 
which together mediate monoubiquitylation of PCNA (Davies et al., 2008; Hoege et al., 
2002). This enhances the affinity of TLS polymerases for PCNA through their ubiquitin-
binding zinc finger (UBZ) and ubiquitin-binding motif (UBM) domains (Bienko et al., 
2005). It is thought that this increased affinity for PCNA serves to recruit TLS 
polymerases to the damage site, here the polymerase can facilitate extension past the 
lesion, allowing replication to proceed and placing the damage in a dsDNA context to 
permit repair (Figure 1.9.B. and C.). Despite being firmly established in yeast, PCNA 
ubiquitylation as a mechanism of TLS polymerase recruitment in higher eukaryotes has 
not yet been confirmed and remains a subject of much debate (Despras et al., 2012; 
Durando et al., 2013; Göhler et al., 2011; Hedglin et al., 2016; Hendel et al., 2011; 
Sabbioneda et al., 2008, 2009; Zhao and Washington, 2017). One recent study identified 
that switching from human Pol  to TLS polymerases occurs independently of PCNA 
monoubiquitylation and is instead a passive process based on the intrinsic DNA binding 
properties of the different polymerases (Hedglin et al., 2016). This report also further 
suggests that PCNA monoubiquitylation may rather play a role in altering the local 
chromatin structure surrounding the lesion to facilitate access of TLS polymerases. 
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The best characterised human TLS polymerases include Pols , , , and Rev1 of the Y-
family, and Pol 	 of the B-family (Table 1.2.). Overall, these enzymes conform to the 
typical polymerase right-hand topology. However, they also possess a number of 
modified features which make them suitable for the bypass of DNA lesions. In 
comparison to the replicative DNA polymerases, TLS polymerases have much more 
spacious catalytic sites, stubbier finger and thumb subdomains, and lack exonuclease 
proofreading domains (Sale et al., 2012). Y-family TLS polymerases also possess an 
additional polymerase-associated domain (PAD) or little-finger, which is involved in 
binding the DNA template and is thought to confer lesion specificity to each polymerase
(Boudsocq et al., 2004). These features are exemplified by Pol  which can incorporate 
A-A opposite a T-T CPD with similar accuracy to unmodified T-T (Johnson et al., 1999). 
Importantly, Pol  can accommodate both of the thymine bases of the CPD in its 
particularly large active site, these bases are then further stabilised to allow accurate and 
efficient bypass (Biertümpfel et al., 2010; Silverstein et al., 2010). Following incorporation 
opposite the lesion, a specialised -strand in the enzymes little-finger subdomain 
provides a positively charged surface to counter the distortion created by the CPD
(Silverstein et al., 2010). This prevents frameshifts and slippage being caused by the 
distorted DNA duplex. Together, these specialised features allow the TLS polymerases 
to directly bypass bulky and distorting lesions, but also result in low fidelity and poor 
processivity on undamaged DNA. As a consequence, the contribution of these enzymes 
to DNA synthesis is kept to a minimum. Indeed, steric clashes cause Pol  to dissociate 
from the DNA template after only three post-lesion bases have been incorporated
(Silverstein et al., 2010). 
Interestingly, vertebrate Rev1 is able to interact with the other Y-family TLS polymerases 
and Pol 	 (Guo et al., 2003; Murakumo et al., 2001; Ohashi et al., 2004, 2009; Tissier et 
al., 2004). These interactions appear to play an important role in the recruitment of TLS 
polymerases to the replication fork during lesion bypass. Indeed, a number of studies 
have demonstrated that PCNA ubiquitylation is dispensable for lesion bypass at the 
replication fork, with polymerases potentially being recruited through their interaction with 
Rev1 instead (Bienko et al., 2005; Despras et al., 2012; Edmunds et al., 2008; Nelson et 
al., 2000). Here, it is likely that Rev1 simply serves as a scaffold to link TLS polymerases
to PCNA, due to its shared interaction with both (Sale et al., 2012). Additionally, it has 
been suggested that interactions between multiple TLS polymerases and PCNA can 
form higher order structures termed PCNA tool belts (Boehm et al., 2016). Intriguingly, 
these PCNA tool belts, and TLS polymerases linked to PCNA through Rev1, have been 
identified in single-molecule studies and appear to be able to interconvert without 
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Table 1.2. The canonical eukaryotic TLS polymerases. 
Displayed are the canonical and best characterised of the eukaryotic TLS polymerases, 
including the Y-family polymerases  (red),  (green),  (purple), and Rev1 (blue), in addition 
to Pol 	 of the B-family (orange). Adapted from Sale et al., 2012. 
Pol Family Features
Rev1 Y
 Incorporates dCMP opposite dG and Ap sites
 Acts as a scaffold by interacting with other Y-family
Pols and Pol 
 Generates mutations at G-C base pairs during
immunoglobulin gene somatic hypermutation
 Plays a role in G-quadruplex replication
Pol  Y
 Accurately bypasses CPDs
 Defects lead to XPV
 Generates mutations at A-T base pairs during
immunoglobulin gene somatic hypermutation
 Accumulates in replication foci
Pol  Y
 Has a unique replication fidelity  accurately replicates
dA, but is error-prone when replicating dT
 Accumulates in replication foci, but for a shorter time
than Pol 
 May play a role in BER
Pol  Y
 Prone to making -1 frameshift mutations, but accurately
bypasses a number of N2-dG lesions
 Has additional roles in the repair synthesis step of NER
 Most accurate of the Y-family Pols
 Efficient extender of mispaired termini
Pol  B
 Similar fidelity to Pol 
 Plays an extender role in TLS
 The gene is embryonic lethal in mice
 Required for post-replicative damage tolerance of
incorporated rNTPs
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dissociation (Boehm et al., 2016). Thus, this complex formation may permit rapid testing 
of multiple TLS polymerases to identify the most suitable one for bypassing a specific 
lesion in vivo. 
1.5.3. Template Switching and Recombination-Mediated Restart
Following fork stalling and Rad6/Rad18 binding, the additional recruitment of Rad5 and 
the heterodimeric Mms2-Ubc13 complex facilitates polyubiquitylation of PCNA (Hoege 
et al., 2002; Ulrich and Jentsch, 2000). This in turn inhibits TLS and promotes TS 
(Branzei et al., 2004; Haracska et al., 2004; Pfander et al., 2005; Zhang and Lawrence, 
2005). In addition to its E3-ubiquitin ligase activity, Rad5 also exhibits DNA-dependent 
ATPase activity which is linked to a DNA helicase function required for DDT. This 
helicase activity is able to promote replication fork regression in vitro and similar results 
have been observed with one of the human Rad5 homologues, helicase-like transcription 
factor (HLTF) (Achar et al., 2011; Blastyák et al., 2007). Fork regression or reversal can 
potentially promote restart in a number of ways (Figure 1.9.B.). Firstly, fork reversal 
causes rewinding of the nascent strands, which base-pair together, forming a four-way 
Holliday junction. This returns the stalling lesion to duplex DNA and may facilitate repair 
and removal, with nucleolytic degradation of the branched structure subsequently 
allowing replication restart (Courcelle et al., 2003). Alternatively, the displaced nascent 
leading strand can utilise the nascent lagging strand as a template through TS, before 
reverse branch migration places the 3 end of the lagging strand beyond the lesion to 
allow continued extension (Branzei and Szakal, 2016; Higgins et al., 1976). A third 
scenario is also possible whereby restart occurs through a HR-mediated mechanism
(Lambert et al., 2010). Here, the nascent leading strand is extruded and undergoes 
template exchange with homologous sequences, this leads to displacement loop (D-
loop) formation to allow continued elongation and produces Holliday junctions which
subsequently require resolution (Lambert et al., 2010; Minca and Kowalski, 2011). This 
mechanism can, however, lead to strand invasion events which use only limited 
homology, potentially causing genomic rearrangements (Branzei and Szakal, 2016; 
Lambert and Carr, 2013b). As such, this pathway appears to function as a last-resort or 
salvage pathway due its error-prone habit of using templates other than the sister 
chromatid (Branzei and Szakal, 2016). 
The identification of the fork remodelling activities of Rad5 and HLTF, in addition to DNA 
translocases with strand annealing capabilities, such as SWI/SNF-related matrix-
associated actin-dependent regulator of chromatin (SMARCAL1), legitimise the 
possibility that fork regression and TS function at the replication fork to mediate lesion 
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bypass (Bansbach et al., 2009). However, accumulating evidence suggests that TS 
occurs in a predominantly post-replicative fashion to fill in gaps left opposite lesions after
repriming events, here error-free DDT occurs through strand exchange with the 
homologous sister chromatid (Figure 1.9.C.) (Branzei and Szakal, 2016). 
1.5.4. Post-Replicative Repair and the Timing of DDT
In 1968, Rupp and Howard-Flanders observed that NER deficient E. coli could perform 
DNA replication in the presence of UV damage with only a slight delay (Rupp and 
Howard-Flanders, 1968). Moreover, they identified the presence of ssDNA gaps 
opposite UV lesions in the nascent daughter strands, which were subsequently filled and 
sealed in a process termed post-replicative repair (PRR). This seminal work, the first 
to describe DDT, also suggested that it functions behind the fork to fill in gaps left 
opposite lesions as a result of repriming. This is the obvious case for lagging strand 
synthesis where initiation of a new Okazaki fragment would easily allow resumption of 
replication after fork stalling. However, the long-standing view of leading strand synthesis 
as a continuous process, coupled with the discovery of TLS polymerases, led to the 
prevailing view for many years that DDT functions at the replication fork to promote 
continued progression. However, more recent studies are provoking a return to the 
original model for DDT, where both TS and TLS predominantly function as PRR 
mechanisms (Figure 1.9.C.). 
Importantly, for PRR to operate on the leading strand, reinitiation of replication by 
repriming downstream of the blockage is required. In E. coli, origin independent leading 
strand repriming by the replicative primase, DnaG, has been demonstrated and is now 
a well-established method of replication restart (Heller and Marians, 2006; Yeeles and 
Marians, 2011). Further studies have confirmed that this repriming mechanism operates 
without dissociation of the replication machinery, consequently instilling innate damage 
tolerance on the core replisome and allowing lesions to be skipped in an efficient manner
(Yeeles and Marians, 2013). Although leading strand repriming has not yet been 
demonstrated using a eukaryotic system in vitro, given recent advances in reconstituting 
eukaryotic replication, it seems likely the question of its existence will soon be addressed.
Indeed, accumulating in vivo evidence points to a leading strand repriming mechanism 
in eukaryotes. Notably, in both yeast and mammalian systems, ssDNA gaps in daughter 
strands have been observed following DNA replication in the presence of UV damage
(Lehmann, 1972; Lopes et al., 2006). Additionally, both TLS and TS mechanisms can be 
functionally separated from chromosomal replication without adverse effects (Daigaku et 
al., 2010; Karras and Jentsch, 2010). Post-replicative TLS in yeast is further supported 
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by the observation that Rev1 expression is cell-cycle regulated and peaks in G2-phase
(Waters and Walker, 2006). In human fibroblasts, high UV exposure during DNA 
replication was found to only produce a marginal reduction in fork speed which was 
independent of Pol  (Elvers et al., 2011). Here, discontinuous elongation of replication 
forks was also observed, leading to speculation that repriming downstream of UV lesions 
and not TLS at the fork, was maintaining replisome progression. Likewise, in Xenopus 
egg extracts, continued primer synthesis at replication forks stalled by aphidicolin has 
been demonstrated (Van et al., 2010). 
Recent studies provide further evidence for leading strand repriming in yeast and 
suggest that TS DDT mechanisms predominantly operate behind the fork in a gap-filling 
manner (Figure 1.9.C.). Firstly, impairment of repriming pathways and replicative 
helicase-primase coupling did not affect bulk DNA replication, but did cause a defect in 
error-free bypass by TS (Fumasoni et al., 2015). This decrease in TS was accompanied 
with increased mutagenic DDT, fork reversal, and genome rearrangements. Here, the 
authors suggest that in WT cells, repriming allows replication restart, leaving a ssDNA 
gap which is filled by TS. In the absence of repriming, leading/lagging replication 
uncoupling occurs, and forks are restarted by mutagenic reversal and HR mechanisms. 
Secondly, electron microscopy (EM) studies of TS switching intermediate structures
known as sister-chromatid junctions (SCJs), support the post-replicative gap-filling 
model (Giannattasio et al., 2014). Factors important for gap-processing during Okazaki 
fragment processing, including the 9-1-1 complex and exonuclease 1 (Exo1) also appear 
to play an important role in TS, lending further support to this model (Karras et al., 2013; 
Vanoli et al., 2010). 
Thus, the weight of evidence is clearly in support of post-replicative DDT as a conserved 
mechanism in eukaryotes as well as bacteria. Nevertheless, it remains likely that DDT at 
the fork also occurs in vivo. In particular, fork HR-mediated DDT is likely to be required 
to overcome obstacles which cannot be bypassed by the replicative helicase, and are 
therefore not amenable to repriming, such as interstrand crosslinks. At these regions fork 
stabilisation through reversal will also be required to prevent error-prone restart and 
genomic instability (Branzei and Szakal, 2016). Regardless of the contribution of both 
mechanisms, the requirement of leading strand repriming for PRR suggests that 
primases play an important role in maintaining fork progression during replication stress
and demonstrates that these enzymes are not only required for the initiation of replication 
at origins. Indeed, in recent years primases have emerged as a diverse class of enzymes
with a range of roles in DNA metabolism.
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1.6. Primase-Polymerases are a Functionally Diverse 
Superfamily of Replication and Repair Enzymes
Until relatively recently, DNA primases were viewed simply as a class of proteins that 
synthesise short RNA primers requisite for the initiation of DNA replication. However, 
recent studies have shown that this perception of the limited activities associated with 
these diverse enzymes can no longer be justified. Numerous examples can now be cited 
demonstrating how the term DNA primase only describes a very narrow subset of these 
nucleotidyltransferases, with the vast majority fulfilling multifunctional roles from DNA 
replication to damage tolerance and repair. This section of the introduction focuses on 
the archaeo-eukaryotic primase (AEP) superfamily, drawing on recently characterised 
examples from all domains of life to highlight the functionally diverse pathways in which 
these enzymes are employed. The broad origins, functionalities and enzymatic 
capabilities of AEPs emphasises their previous functional misannotation and supports 
the necessity for a reclassification of these enzymes under a category called Primase-
Polymerases within the broader functional grouping of polymerases. Importantly, the 
repositioning of AEPs in this way better recognises their broader roles in DNA 
metabolism and encourages the discovery of additional functions for these enzymes, 
aside from those highlighted here.
1.6.1. Two Distinct Primases: DnaG and AEP Primase Superfamilies
Early studies identified that the E. coli DnaG protein is responsible for the initiation of 
Okazaki fragment synthesis by the generation of short RNA primers (Bouché et al., 
1978). All bacteria possess DNA primases belonging to the DnaG superfamily, which 
fulfil the canonical primer synthesis role during DNA replication. Typically, these 
monomeric DnaG-like replicative primases are helicase-associated, permitting the 
synthesis of RNA primers of between 10 to 60 nucleotides in length on most ssDNAs 
(Frick and Richardson, 2001). These enzymes contain a characteristic catalytic domain 
of the topoisomerase-primase (TOPRIM fold, composed of an / core with four 
conserved strands and three helices, in addition to two conserved catalytic motifs (Keck 
et al., 2000). The first of these motifs, a conserved glutamate, is thought to act as a 
general base during nucleotide polymerisation. The second motif contains two 
conserved aspartates (DxD), which coordinate Mg2+ ions required for catalytic activity 
(Aravind et al., 1998a).  
Although functionally related, the AEP superfamily is evolutionarily and structurally 
distinct from the bacterial DnaG primases (Aravind et al., 1998a; Aravind and Koonin, 
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2001; Augustin et al., 2001; Frick and Richardson, 2001; Keck et al., 2000). In common 
with prokaryotic DnaG primases, AEPs are absolutely required for the initiation of DNA 
replication in archaea and eukaryotes (Frick and Richardson, 2001). Despite this, DnaG-
like primases have been identified in archaeal genomes and, similarly, AEPs are also 
found to be distributed across all domains of life. Replicative primases of the AEP 
superfamily typically form a heterodimeric complex containing both a small catalytic 
subunit (PriS/Prim1) and a large accessory subunit (PriL/Prim2). As previously 
mentioned, in eukaryotes this heterodimer forms a complex with the DNA Pol  subunits 
(PolA1 and PolA2) that together initiate DNA replication (Frick and Richardson, 2001). 
The AEP superfamily is distinguished by a characteristic catalytic core composed of two 
modules; an N-terminal ()2 unit that has no equivalent structural homology to other 
proteins in the structural database (PDB) and a C-terminal unit, which like the A-, B-, and 
Y-family DNA polymerases, is a highly derived RNA recognition motif (RRM) (Figure 
1.10.). This catalytic core harbours three conserved motifs (motifs I, II and III), an 
hhhDhD/E motif (where h is a hydrophobic residue), an sxH motif (where s is a small 
residue and x is any residue) and an hD/E motif (Iyer et al., 2005). The first and third of 
these motifs are involved in divalent metal ion coordination for catalysis, whilst the sxH 
motif is required for nucleotide binding (Augustin et al., 2001; S.-H. Lao-Sirieix et al., 
2005; Lipps et al., 2004). Multiple mutagenesis studies have shown these motifs to be 
essential for catalysis (Augustin et al., 2001; Bianchi et al., 2013; Copeland and Tan, 
1995; Della et al., 2004; Galal et al., 2012; Klinedinst and Challberg, 1994; Lao-Sirieix 
and Bell, 2004; Lipps et al., 2003; Mikhailov and Rohrmann, 2002). In addition to these 
motifs, some AEPs also possess additional associated domains including zinc-binding 
and helicase domains (Figure 1.11.).
Despite the apparent uniqueness of the AEP catalytic fold, the highly conserved catalytic 
aspartate residues of these enzymes are superposable with the catalytic core of the X-
family DNA polymerases, including Pol  (Augustin et al., 2001; Kirk and Kuchta, 1999a). 
However, this apparent similarity is thought to be a result of convergent evolution as the 
secondary structural contexts in which these aspartate residues are located differs (S. 
Lao-Sirieix et al., 2005; S.-H. Lao-Sirieix et al., 2005). Nevertheless, this similarity, 
coupled with the requirement of divalent metal ions for catalysis, allows inference of a 
two-metal ion mechanism of catalysis, similar to that employed by DNA polymerases 
(Kirk and Kuchta, 1999a; Steitz et al., 1994). This mechanism is now supported by the 
structure of a pre-ternary complex of a mycobacterial AEP bound to DNA (Brissett et al., 
2011). 
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Figure 1.10. Architecture of AEP catalytic subunits from the major domains of life.
Representative examples of the crystal structures of AEPs that have been elucidated. (A) Human primase subunit (Prim1) (PDBID: 4RR2), sky blue. (B) The 
primase small catalytic subunit (PriS/Prim1) from the archaeal species P. horikoshi (PDBID: 1V33), pale crimson. (C) The NHEJ repair polymerase 
(PolDom/LigD-Pol) from M. tuberculosis (PDBID: 2IRU), magenta. (D) The AEP domain of RepB encoded by the E.coli plasmid RSF1010 (PDBID: 3H20), 
gold. (E) The AEP domain of ORF904 encoded by the S. islandicus plasmid pRN1 (PDBID: 3M1M), sea green. The conserved catalytic core of these enzymes 
is shown in a lighter hue and catalytic triads are rendered as sticks with the acidic oxygens coloured red. Where present, the coordinated zinc atoms in the 
zinc finger domains are coloured tan.
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Figure 1.11. Domain organisation of members of the AEP superfamily.
The AEP superfamily is formed of a number of divergent enzymes with varying domain organisations. Some representative examples of members of the AEP 
superfamily are displayed here with the three signature catalytic motifs of the AEPs are depicted in red, in addition to any accessory domains associated with 
this domain. The blue, red, green and purple backgrounds correspond to the different domains of life in which these primase family members belong.
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1.6.2. Evolutionary History of AEPs
The lack of homology between the bacterial and archaeal/eukaryotic primase 
superfamilies also extends to other replicative proteins of these domains, including DNA 
polymerases and helicases. This clear distinction between the replicative machinery 
employed by bacteria and archaea/eukaryotes has generated debate as to how these 
two groups of replicative enzymes arose. Notably, in contrast to the differences in DNA 
replication machinery, the core components of transcription and translation are 
conserved across domains (Leipe et al., 1999; Sweetser et al., 1987). This observation 
led to a hypothesis that the two replicative systems evolved twice independently from a 
common ancestor which utilised reverse transcription to replicate an RNA/DNA genome 
(Leipe et al., 1999) (Figure 1.12.A.). The evolution of DNA replication-competent cells 
then subsequently led to the elimination of the reverse transcription pathway. In support 
of this model, a number of primases and polymerases possess, or can be engineered to 
exhibit, reverse transcriptase activity (Gill et al., 2014; Jozwiakowski et al., 2015; 
Jozwiakowski and Connolly, 2011; Myers and Gelfand, 1991; Ong et al., 2006). A second 
model proposes that the last universal common ancestor (LUCA) possessed both an 
AEP and TOPRIM primase (Hu et al., 2012) (Figure 1.12.B.). In bacteria, selective 
pressure resulted in the loss of AEPs as replicative primases and, similarly, in archaea 
TOPRIM primases lost their role in priming replication. Importantly, many bacteria and 
archaea still retained their respective AEP and TOPRIM primases, however the roles of 
these enzymes changed with the AEPs employed in DNA repair processes, e.g. non 
homologous end-joining (NHEJ) in bacteria (Della et al., 2004) and the TOPRIM 
primases potentially utilised for RNA degradation in archaea (Le Breton et al., 2007; 
Walter et al., 2006). This model also predicts that in eukarya the DnaG primase was lost 
and other proteins were acquired to replace its roles (Hu et al., 2012). An alternative 
scenario to these models is that LUCA possessed either a TOPRIM primase or an AEP 
and subsequent selective pressure led to the emergence of the second primase 
superfamily in either the bacterial or archaeal/eukaryotic lineages (Figure 1.12.C.). In this 
case, AEPs could have been acquired later by bacteria and viruses through horizontal 
gene transfer to fulfil alternative roles in DNA replication, repair and damage tolerance. 
Which of these models is likely to be correct remains to be established.
Despite the lack of homology between the primase superfamilies, the evolutionary history 
of the AEP superfamily displays an interesting parallel with that of the DnaG TOPRIM 
primases. Iyer et al. reported an extensive in silico analyses of the AEP superfamily and 
identified that the closest relatives of the AEP-fold, amongst the RRM-like proteins, are 
the rolling circle replication endonucleases (RCRE) and origin-binding domain proteins 
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Figure 1.12. Alternative hypotheses for the evolution of AEP and Toprim primases. 
(A) The first model of primase evolution suggests that primases evolved independently twice from a last universal common ancestor (LUCA). Bacterial 
ancestors evolved toprim primases and archaeal and eukaryotic ancestors evolved AEP primases. Subsequent horizontal gene transfer occurred between 
the two lineages to account for AEP primases role in NHEJ in bacteria and toprim-type primases role in archaeal RNA degradation. (B) The second model 
of primase evolution suggests that LUCA had a dual primase replication mechanism, consisting of both AEP and toprim primases. During the evolution of 
bacteria, they lost the replicative function of the AEP primases but retained them for the auxiliary function for NHEJ-mediated DNA repair. During the evolution 
of the archaeal/eukaryotic lineage, the replicative function of toprim primases was lost but their auxiliary role in archaeal RNA degradation was retained. (C) 
The third model of primase evolution suggests that LUCA had either an AEP or toprim-like primase. Significant, evolutionary pressures could then have driven 
the evolution or acquisition of a second class of primase. (D) 12 of the 13 major AEP families can be arranged into three higher order clades, the AEP Proper 
Clade, the NCLDV-Herpesvirus primase clade and the Prim-Pol clade. 
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(OBDs) of the papovaviruses. This close evolutionary relationship between the AEPs 
and RCRE echoes that of the DnaG TOPRIM primases with topoisomerases. 
Intriguingly, this reveals that both primase superfamilies share close evolutionary ties 
with nucleases, which offer an alternative solution to the DNA replication initiation 
problem (Iyer et al., 2005). Specifically, transfer of the 5 end of a nicked DNA strand to 
a tyrosine on the nuclease allows the elongation of the free 3 OH group by a DNA 
polymerase for synthesis of the new strand. In several families of DNA viruses and 
phage, this method of initiating rolling circle replication is employed. Iyer et al. suggest 
that RCRE and OBDs share a common ancestor with the AEPs that possessed 
polymerase activity. The RCRE subsequently evolved from this enzyme by acquiring 
nuclease and losing polymerase activities, meanwhile OBDs lost all catalytic activity. 
However, the authors also accept the possibility that the AEP-RCRE-OBD common 
ancestor was simply a nucleic acid binding protein, which utilised its divalent cation 
coordinating acidic residue to aid in DNA binding. This ancestral protein may then have 
acquired nuclease activity, whilst polymerase activity could have been independently 
acquired in numerous descendent lineages (Iyer et al., 2005). 
To date, the AEP superfamily can be classified into 13 major families, 12 of these can 
be further organised into three higher-order clades; the AEP proper clade, the NCLDV-
herpesvirus clade and the PrimPol clade (Figure 1.12.D.) (Iyer et al., 2005). Regardless 
of the somewhat murky evolutionary origins of the AEP superfamily, studies in recent 
years have illustrated that these enzymes have diversified to fulfil a range of specialist 
roles in DNA replication, repair and damage tolerance, as will be described in the 
following sections. 
1.6.3. Archaeal Primases can act as Replicative Polymerases 
As previously mentioned, in eukaryotes the replicative heterodimeric primase (Prim1/2) 
complexes with Pol  (PolA1/2) to form a tetrameric complex. The resolution of the 
crystal structure of the human heterodimeric primase identified that the small subunit 
(Prim1) utilises the same set of functional residues for primer initiation and elongation 
(Figure 1.10.), in addition, this study also identified the mode of association between the 
primase and Pol  (Kilkenny et al., 2013; Vaithiyalingam et al., 2014). This close 
partnership allows the polymerase subunit to easily access and extend the RNA primer 
synthesised by Prim1, before hand-off to the more processive replicases. However, this 
complexity does not exist in archaea, which lack Pol  subunits or any apparent 
interaction between the PriS/L complex and the archaeal B-family replicases (Le Breton 
et al., 2007; Liu et al., 2001). Remarkably, the replicative primase is able to synthesise 
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and elongate its own primers. Evidence for archaeal primases as DNA-dependent DNA 
polymerases was first noted in the archaeal Prim1 homologue, PriS, from the 
hyperthermophile Pyrococcus furiosus (Pfu) (Bocquier et al., 2001). In addition to 
displaying DNA polymerase activities (Figure 1.13.), Pfu PriS can also synthesise 
primers using dNTPs, as well as rNTPs. This contrasts with eukaryotic Prim1, which can 
only synthesise RNA primers (Liu et al., 2001). This ability to synthesise DNA primers 
and perform DNA-dependent DNA polymerase activity has also been observed in the 
PriS/L complexes from other archaea, including Pyrococcus horikoshii (Matsui et al., 
2003), Sulfolobus solfactaricus (Lao-Sirieix and Bell, 2004), Thermococcus 
kodakaraensis (Galal et al., 2012), and Archaeoglobus fulgidus (Jozwiakowski et al., 
2015). In fact, for each of these species, except Thermococcus kodakaraensis, the 
replicative primase actually shows a preference to prime using dNTPs over rNTPs. 
Strikingly, the primer elongation capacity of these enzymes ranges from less than 500 
bases in length to >7 kilobases (Bocquier et al., 2001; Galal et al., 2012; Lao-Sirieix and 
Bell, 2004; Le Breton et al., 2007; Liu et al., 2001). Together, these studies provided the 
first evidence that archaeal replicative primases can also be utilised in a role similar to 
that of Pol  in eukaryotes, thus establishing that these enzymes can act and be 
classified as primase-polymerases or Prim-Pols. 
1.6.4. Primases Acting as Extra-Chromosomal Plasmid Replicases
In addition to PriS, some archaea possess additional AEPs encoded by extra-
chromosomal plasmids, which are thought to partake in both the initiation and replication 
of these small molecules of DNA. The first of these to be identified was ORF904 encoded 
by the pRN1 plasmid (~5 kb) of Sulfolobus islandicus. ORF904 belongs to a novel family 
of primases present sporadically in crenarchaeal plasmids and Gram-positive bacterial 
plasmids, the Prim-Pol family (Iyer et al., 2005). The enzyme is composed of an N-
terminal AEP domain and a C-terminal helicase / translocase domain. This AEP domain
displays both DNA-dependent RNA/DNA primase and DNA polymerase activity (Figure 
1.13.), with the helicase domain exhibiting DNA-dependent ATPase activity (Lipps et al.,
2003). Notably, ORF904 shows a preference to generate DNA primers and, in the 
presence of dNTPs, it can extend these primers by several kilobases (Beck and Lipps, 
2007). The crystal structure of its AEP domain revealed that this enzyme shares strong 
structural similarities with the Pyrococcus archaeal primase (Lipps et al., 2003), 
particularly in the arrangement of the metal coordinating acidic residues, which display 
strict conservation within the -sheet region (Figure 1.10.) (S.-H. Lao-Sirieix et al., 2005). 
Interestingly, both enzymes possess zinc-binding motifs adjacent to the catalytic centre 
however, somewhat surprisingly, these motifs are located in unrelated positions in each 
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Figure 1.13. Nucleotidyltransferase activities associated with AEP members. 
AEP-type primase family members possess many more activities, in addition to catalysing primer synthesis DNA for replication. The reported additional 
nucleotidyltransferase activities for each of the different AEPs are depicted, including polymerase activity (either DNA-dependent DNA polymerase or DNA 
dependent RNA polymerase), lesion bypass, terminal transferase and strand-displacement. The observed ability of each enzyme to perform the indicated 
activity is noted by a tick. The blue, red, green and purple backgrounds correspond to the domain of life in which the primase family is found. References 
describing the associated activities described here: (Bartlett et al., 2013; Beck and Lipps, 2007; Bianchi et al., 2013; Brooks and Dumas, 1989; Conaway and 
Lehman, 1982; Copeland and Wang, 1993; Crute and Lehman, 1991; De Silva et al., 2009; Della et al., 2004; Desogus et al., 1999; Falco et al., 2004; García-
Gómez et al., 2013; Gill et al., 2014; Gong et al., 2005; Halgasova et al., 2012; Hines and Ray, 2011, 2010; Hu et al., 2012; Jozwiakowski et al., 2015; Keen 
et al., 2014; Klinedinst and Challberg, 1994; Le Breton et al., 2007; Lipps et al., 2004; Liu et al., 2001; Mikhailov and Rohrmann, 2002; Pitcher et al., 2007, 
2005; Prato et al., 2008; Samuels et al., 2009; Sanchez-Berrondo et al., 2012; Takechi et al., 1995; Takechi and Itoh, 1995).
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case. This observation has led to the suggestion that the common ancestor of both 
enzymes did not contain a zinc-binding domain and that two independent insertion 
events occurred to produce this domain in the evolution of each family (S.-H. Lao-Sirieix 
et al., 2005). In addition to ORF904, a highly related protein has been identified on the 
pIT3 plasmid of Sulfolobus solfataricus called Rep that also comprises an AEP domain 
fused to a putative helicase (Prato et al., 2008). The replicative N-terminal domain of this 
protein, termed Rep245, also possesses dNTP / rNTP-dependent primer synthesis and 
DNA polymerase activities (Figure 1.13.).
A recent report described the intriguing enzymatic activities of an AEP called PolpTN2 
encoded by the pTN2 plasmid of Thermococcus nautilus. PolpTN2 is uniquely a fusion 
of an N-terminal domain homologous to PriS and a C-terminal domain related to PriL 
(Figure 1.11.) (Gill et al., 2014). This domain conformation is at odds with other plasmid-
encoded primases, which are typically fused to helicases. Nevertheless, similar to other 
archaeal plasmid-encoded primases, PolpTN2 exhibits primase and DNA polymerase 
activities. The primase activity of PolpTN2 is exclusively limited to using dNTPs. In 
addition, the enzyme also has terminal transferase activity, which is greatly enhanced by 
the removal of the PriL-like region of the protein. This removal also confers reverse 
transcriptase activity to the primase (Gill et al., 2014). Interestingly, PolpTN2 and 
Rep(pIT3) lack a zinc-binding motif present in most other AEPs. The observation that 
the zinc-binding motifs of each AEP family may have arisen independently suggests that 
these plasmid-encoded AEPs may represent evolutionarily ancestral AEPs. 
Bacteria, like archaea, also harbour extra-chromosomal plasmid DNA. Two decades 
ago, a Rep protein from the colicin E2 (ColE2) plasmid was found to have DNA primase 
activity (Figure 1.13.) (Takechi et al., 1995; Takechi and Itoh, 1995). A decade later, it 
was shown that this primase was in fact a member of the AEP family, distantly related to 
the archaeal AEPs ORF904 (pRN1) and Rep (pIT3) (Iyer et al., 2005). However, it seems 
that, unlike the archaeal plasmid AEPs, Rep (ColE2) functions solely as an RNA primase, 
rather than as a DNA primase-polymerase. This enzyme, in addition to DNA polymerase 
I, is required for ColE2 DNA replication in vitro. Rep (ColE2) binds specifically to the 
plasmids origin of replication where it initiates synthesis through the generation of a short 
RNA primer, allowing DNA polymerase I to subsequently proceed with DNA replication 
(Beck and Lipps, 2007). Thus, it appears that Rep (ColE2) functions as a plasmid-
specific bacterial primase.
Another bacterial plasmid, RSF1010, found in a broad host range of over Gram-negative 
and some Gram-positive bacteria, encodes three Rep proteins; RepA, a helicase, RepB, 
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an AEP primase and RepC, a replication initiator protein (Scherzinger et al., 1984, 1991). 
RSF1010 contains two primase recognition sites ssiA and ssiB, each of which are 
recognised by RepB allowing the independent synthesis of two primers that can then be 
extended by the host DNA polymerase III. The crystal structure of RepB revealed the 
presence of two distinct domains; a large N-terminal domain containing two anti-parallel 
-sheets flanked by six -helices, and a smaller C-terminal region with a bundle of five 
-helices. Notably, the enzyme lacks a zinc-binding motif (Figure 1.10.) (Geibel et al., 
2009). This structure reveals a strong similarity between the N-terminal domain of RepB 
and the catalytic domain of P. furiosus PriS. However, these enzymes share limited 
sequence homology, in addition to differences in ssDNA template recognition and in their 
requirements for priming. The structure of the catalytic core of RepB bound to a ssiA 
recognition site has provided significant insights into DNA recognition by  these primases 
(Figure 1.14.C.) and suggested a mechanism for initiation of plasmid DNA replication 
(Hines and Ray, 2011). Interestingly, RepB displays a high degree of thermostability, 
presumably a result of its structural similarity to primases of the thermophilic archaea, 
raising interesting questions about the evolutionary origins of the RSF1010 plasmid 
(Geibel et al., 2009). 
The two bacterial plasmid AEPs discussed here, therefore, stand in contrast with those 
of archaea. The bacterial Rep (ColE2) and RepB enzymes represent prototypical AEPs, 
employed purely in initiating replication through synthesis of a short RNA primer. In 
contrast, the archaeal plasmid AEPs are proficient primase-polymerases, able to initiate 
and proceed with bulk replication of their host plasmid DNA. The conservative primase 
ability and lack of polymerase activity exhibited by these bacterial primases should not, 
however, be thought typical of all bacterial AEPs. The Bacillus cereus genome encodes 
BcMCM (mini-chromosome maintenance), an AEP/MCM primase/helicase from an 
integrated prophage. BcMCM was originally identified through BLAST analysis as an 
MCM homologue, with an N-terminal region of weak homology to AEPs (Figure 1.11.) 
(McGeoch and Bell, 2005). Initial biochemical studies identified 3-5 helicase and 
ssDNA-stimulated ATPase activity, but also noted the absence of any primase activity 
(Samuels et al., 2009). However, a more recent structure/function study was able to 
detect not only helicase activity, but also primase and DNA-dependent DNA polymerase 
activities (Figure 1.13.) (Sanchez-Berrondo et al., 2012). Interestingly, like many 
archaeal AEPs, BcMCM displays a strong preference for dNTPs during primer synthesis 
and extension. Together, these findings suggest that BcMCM may act as an important 
multi-functional enzyme, potentially being deployed in special circumstances during B. 
cereus DNA replication, such as the re-initiation of leading strand replication following 
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fork stalling. Importantly, BcMCM is not the only bacterial AEP with an unconventional 
cellular role, as discussed in section 1.6.6. multifunctional AEPs are also required for 
DNA DSB, and probably other, repair processes in most bacterial species (Della et al., 
2004). 
1.6.5. Viral AEPs Involved in DNA Replication 
Many of the AEPs distributed across the bacterial, archaeal, and eukaryotic genomes 
appear to have viral origins. Indeed, many viruses encode their own AEPs including, 
UL52-like primases from herpes simplex viruses, D5-like primases from NCLDVs and 
Lef-1 primases from phage and baculoviruses (Iyer et al., 2005). As is the case for 
cellular AEPs, viral AEPs also fulfil a number of key roles in DNA metabolism, particularly 
during replication. 
Perhaps the most well studied of the viral AEPs is the UL5-UL8-UL52 heterotrimeric 
primase-helicase complex found in the herpes simplex virus family (Crute et al., 1989). 
Originally identified in herpes simplex virus type 1 (HSV-1), a large double-stranded DNA 
virus, the UL5-UL8-UL52 complex is encoded by three of the seven genes essential for 
replication of the HSV-1 chromosome (Crute and Lehman, 1991). Of these three 
proteins, UL52 was identified as the AEP responsible for priming DNA replication (Crute 
and Lehman, 1991; Klinedinst and Challberg, 1994), UL5 has helicase activity
(Gorbalenya et al., 1989) and UL8 appears to be required for utilisation of primers by the 
UL30/UL42 polymerase. However, UL8 is dispensable for helicase and primase activity 
of UL5/UL52 (Marsden et al., 1997; Sherman et al., 1992). Where most primases have 
a zinc-binding motif in their catalytic domains (Augustin et al., 2001; S.-H. Lao-Sirieix et 
al., 2005; Lipps et al., 2004), UL52 has a strand-rich zinc finger domain that is located 
separately at its C-terminus (Figure 1.11.) and is absolutely required for primase activity 
in vitro (Biswas and Weller, 1999). The UL52 primase is capable of producing 
ribonucleotide primers of ~8-12 nucleotides in length, which are critical for initiating 
replication of the 153 kilobase viral genome (Crute and Lehman, 1991). 
Another group of large viruses encoding AEPs are the poxviruses, which includes 
smallpox, that undertake DNA replication in the cytoplasm of infected cells (Moss, 2007). 
Most studies of the poxviruses have focussed on vaccinia virus (VACV), which 
possesses D5, an AEP/helicase fusion protein (Figure 1.11.) (Silva et al., 2007). This 
enzyme has a C-terminal domain belonging to the helicase superfamily III and an N-
terminal region with sequence and structural features similar to AEPs (Silva et al., 2007).  
The N-terminal AEP domain of D5 is essential for viral replication in VACV-infected cells 
(Silva et al., 2007). In addition, this enzyme exhibits primase activity in vitro and stringent 
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template specificity, strongly suggesting a priming role for this enzyme in VACV DNA 
replication (Figure 1.13.) (De Silva et al., 2009; Silva et al., 2007). Based on extensive in 
silico analysis, Iyer et al. grouped the D5-like primases of poxviruses, irdoviruses, 
mimivirus, and African swine fever virus with the herpes simplex virus primases and their 
eukaryotic homologues, including eukaryotic PrimPol (Iyer et al., 2005). These enzymes, 
in addition to the A468R-like proteins of phycodnaviruses, make up the NCLDV-
herpesvirus clade of AEPs. However, it should be noted that not all viral AEPs belong to 
this primase clade.  
Unlike the UL52 herpesvirus and D5-like poxvirus AEPs, Lef-1-like primases of 
baculoviruses represent a family of AEPs that are more closely related to the replicative 
and NHEJ AEPs (see section 1.6.6.) that collectively form the AEP-proper clade (Iyer et 
al., 2005). Strikingly, the Lef-1-like primases of baculoviruses have the capacity to 
synthesise RNA primers that are extended by up to several kilobases in length (Mikhailov 
and Rohrmann, 2002) (Figure 1.13.). This ability is in line with the extension activities of 
the archaeal replicative primase PriS from Pyrococcus, supporting the fact that these 
enzymes belong to the same AEP clade. However, it has been suggested that the 
extension capabilities of Lef-1-like primases may be limited by other replication factors 
in vivo (Mikhailov and Rohrmann, 2002). Nevertheless, this ability raises the possibility 
that these enzymes may play additional roles in primer extension.
In contrast to the RNA primase activities of the viral AEPs discussed above, the gp43-
like proteins of corynephage BFK20, do not share this rNTP incorporation preference. 
Instead, the gp43-like proteins, part of the Prim-Pol clade of AEPs that includes ORF904 
and Rep(pIT3), can only incorporate dNTPs (Halgasova et al., 2012). In addition, the 
gp43-like proteins, similar to the archaeal AEPs, display both DNA primase and 
polymerase activities (Halgasova et al., 2012). Thus, showing that even within viruses, 
AEPs form a diverse group of enzymes with varying catalytic capabilities and potentially 
divergent roles. 
1.6.6. Primases Involved in DNA Double-Strand Break Repair
Around the time that archaeal primases were first reported to also be template-
dependent polymerases (Bocquier et al., 2001), AEP orthologues were unexpectedly 
identified in prokaryotic genomes (Aravind and Koonin, 2001; Koonin et al., 2000; Weller 
and Doherty, 2001). These AEP genes were frequently found to be co-operonic with Ku 
(Aravind and Koonin, 2001; Doherty et al., 2001; Weller and Doherty, 2001), a protein 
responsible for binding the ends of DNA DSBs during NHEJ in eukaryotes. These 
findings provided early clues that a conserved NHEJ pathway may exist in prokaryotes 
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and that AEPs may be intrinsically involved in this DSB repair process. Subsequent 
studies identified that a bona fide NHEJ DSB repair apparatus exists in bacteria (Della 
et al., 2004; Gong et al., 2005; Pitcher et al., 2007; Weller et al., 2002) and that these 
AEPs form part of a larger multi-protein repair complex known as ligase D (LigD). More 
recently, a closely related NHEJ apparatus has also been identified in some archaeal 
species (Bartlett et al., 2013). In mycobacteria, LigD is a fusion protein composed of 
AEP, nuclease and ligase domains (Della et al., 2004; Pitcher et al., 2005). However, in 
many species these domains exist as individual co-operonically expressed proteins 
that form a functional NHEJ complex (Bartlett et al., 2013). Prokaryotic NHEJ is therefore 
thought to be essentially facilitated by a Ku-LigD complex that possesses all of the 
activities required to bind to the break termini and catalyse re-joining of DSBs (Bartlett et 
al., 2013; Della et al., 2004; Gong et al., 2005; Pitcher et al., 2007). NHEJ AEPs are 
capable of performing an astonishing range of nucleotidyltransferase activities, 
presumably to accommodate the myriad of end configurations produced during formation 
of DSBs. Specifically, these enzymes can catalyse template-dependent DNA/RNA 
polymerase, terminal transferase, strand-displacement and gap-filling synthesis, with a 
notable preference to incorporate ribonucleotides (Bartlett et al., 2013; Della et al., 2004; 
Pitcher et al., 2007). In addition, these AEPs can readily extend mismatched primer-
template termini and perform TLS bypass of 8-oxo-dG lesions and Ap sites (Pitcher et 
al., 2007) (Figure 1.13.).  
Since the unexpected discovery that AEPs function as components of the DSB repair 
machinery in bacteria and archaea, there has been much conjecture about why members 
of the primase family evolved to become the primary NHEJ polymerases. It is likely that 
these bespoke repair enzymes, which belong to the AEP proper clade that also includes 
the replicative primases, evolved from a primordial AEP with an innate capacity to make 
short RNA primers into a novel class of adaptable end-joining polymerases capable of 
processing DNA ends during break repair. A comparison of the sequences and 
structures of the NHEJ AEPs with the replicative enzymes (PriS), reveals that whilst both 
share a common catalytic architecture (Figure 1.10.), there are several distinctive 
adaptations. NHEJ AEP polymerases possess a number of distinctive DNA binding 
modes that distinguishes them from related enzymes, enabling them to operate even at 
the extreme ends of DNA. These enzymes possess a positively charged surface pocket 
that enables them to bind specifically to a 5 phosphate, either close to or at the terminus 
of a DSB, thus stably tethering the enzyme to the break to permit end-processing (Figure 
1.14.A.). In addition, they have also evolved prominent surface loops (Loops 1 and 2) 
that facilitate a remarkable ability to promote break synapsis (Figure 1.14.B.), a process 
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Figure 1.14. Structures of AEPs bound to DNA substrates.
Structural examples of AEP members bound DNA intermediates. (A) Structure a pre-ternary catalytic conformation of a NHEJ repair polymerase (PolDom / 
LigD-Pol) from M. tuberculosis bound to a dsDNA break with a 3 overhanging terminus (PDBID: 4PKY, ice blue) and UTP and manganese cofactors, coloured 
cyan and pink, respectively. (B) Crystal structure of a micro-homology mediated end-joining (MMEJ) intermediate showing an NHEJ repair polymerase-
mediated synapsis of a DSB (PDBID: 4MKY, ice blue and lemon). (C) Structure of the AEP domain of RepB bound to a ssiA DNA replication initiation site 
(PDBID: 3H25, lawn green). The catalytic residues are rendered as sticks with the acidic oxygens coloured red. DNA strands are coloured red or green.
A CB
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that permits breaks to be annealed back together by a mechanism known as 
microhomology-mediated end joining (MMEJ). During this process, each side of the 
break is first bound by a polymerase, forming a pre-ternary complex in anticipation of 
receiving the other end of the break. Subsequently, the surface loops, conserved only in 
these AEPs, act in concert to present one end of the DSB to the other side in order to 
promote and accelerate break annealing. In the case of the 3 overhangs, this process 
configures the break to allow productive gap-filling synthesis to occur in trans (Brissett 
et al., 2007, 2011, 2013). This mechanism also provides a molecular basis for the 
template-dependent terminal transferase synthesis catalysed by these enzymes at the 
3 ends of DNA. Although these unprecedented MMEJ processes were initially 
considered by some to be specific to these polymerases, an analogous polymerase-
mediated MMEJ mechanism has since been reported for archaeal PriS, mammalian Pol 
q, and terminal transferase (TdT), suggesting that this is a functionally conserved 
mechanism (Gouge et al., 2015; Hu et al., 2012; Kent et al., 2015). 
Although the biological roles of the NHEJ and replicative AEPs are clearly distinct, these 
enzymes are closely related, belonging to the same clade, and therefore are likely to 
share common features despite their divergent evolution. The crystal structures of a 
number of catalytic intermediates of mycobacterial NHEJ AEPs bound to DNA have 
provided some important insights into the shared common catalytic mechanisms of AEPs 
and also explained why these enzymes may be suited to the task of break repair (Brissett 
et al., 2007, 2011, 2013). The structure of a preternary NHEJ AEP-DNA complex has 
revealed that these enzymes, in common with polymerases, employ a two metal 
mechanism of catalysis, with binding of the second metal dependent on engagement of 
the incoming nucleotide with both the active site and template strand (Figure 1.14.A.). 
As discussed, these AEPs have the ability to accept an incoming primer strand 
provided in trans by an adjacent AEP pre-ternary complex (Figure 1.14.B.). Significant 
in this regard, these enzymes can bind to and extend an incoming primer as short as a 
dinucleotide (Brissett et al., 2011). This mechanism is highly reminiscent of the initiation 
step performed by replicative primases. Here, a binary complex between the enzyme 
and ssDNA is formed first, followed by binding of the 3´nucleotide to form a pre-ternary 
complex. This is followed by recruitment of a 5´-nucleotide, which acts as the primer, 
to form a ternary complex. Notably, both NHEJ and replicative AEPs can catalyse an 
unconventional addition of a ribonucleotide in the 3´-5´ direction, followed by a more 
conventional 5´-3´elongation step. This innate ability of AEPs of this clade to accept short 
primers may explain why they were the most appropriate enzymes to evolve further, by 
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the acquisition of additional surface loops and phosphate binding residues, into highly 
effective NHEJ repair polymerases. 
1.6.7. Primases Involved in DNA Damage Tolerance 
In addition to the apparent absence of Pol  homologues, many archaeal species also 
lack canonical TLS polymerases, with only a subset of species possessing Y-family 
polymerases. Furthermore, many archaea do not encode NER or photolyase pathways 
to remove potential replication fork stalling UV-light induced DNA damage (Kelman and 
White, 2005). This raises the question as to how archaeal species lacking these 
pathways tolerate DNA damage, which is of paramount importance given the extreme 
environments in which many of these species reside. Recently, it was reported the 
replicative primase, PriS, from the Y-family deficient archaeal species (A. fulgidus and 
P. furiosus) is inherently damage tolerant (Figure 1.13.) (Jozwiakowski et al., 2015). 
Strikingly, it was identified that PriS from these organisms is capable of faithfully 
bypassing highly DNA-distorting CPDs, in addition to 8-oxo-dG. The extreme 
environments inhabited by thermophilic archaeal species generate significant amounts 
of cytosine deamination, generating uracil base adducts that induce profound fork stalling 
when encountered by the archaeal replicases (B- and D-family polymerases). Notably, 
PriS also replicates past templating uracil bases, even when stalled replicative 
polymerases are bound (Jozwiakowski et al., 2015), suggesting that PriS assists the 
replisome in maintaining active fork progression during genome duplication. These 
findings further corroborate that archaeal replicative primases, in addition to primer 
synthesis, play additional roles in replication. Likewise, PrimPol, the focus of this thesis, 
is also tolerant to duplex-distorting DNA lesions, as will be discussed later in this 
introduction (see section 1.7.).
1.6.8. Essential Roles for Multiple AEP Orthologues in Trypanosomes 
Kinetoplastids are a group of single-celled protozoa characterised by the presence of 
kinetoplasts, networks of circular DNA found inside a large single mitochondrion and 
composed of both maxi-circles (20-40 kb) and mini-circles (0.5-1 kb) (Shapiro and 
Englund, 1995). Within each organism, this network of kinetoplast DNA must be 
duplicated prior to division. One particularly well studied kinetoplastid protozoan is 
Trypanosoma brucei, the causative agent of human African trypanosomiasis (Brun et al., 
2010). Until recently, the kinetoplastid replication machinery of T. brucei could not be 
reconstituted as the primase involved in kinetoplast replication had not yet been 
identified. Two such primases have since been characterised, PRI1 and PRI2, 
responsible for maxi-circle and mini-circle replication initiation, respectively (Hines and 
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Ray, 2010, 2011). These primases belong to the NCLDV herpesvirus clade of AEPs, and 
each contains an RNA recognition motif and a PriCT-2 motif. In each case, RNAi 
depletion of these enzymes in T. brucei causes inhibition of cell growth and the depletion 
of kinetoplast DNA, clearly suggesting that these AEPs fulfil vital roles in priming 
kinetoplast DNA replication (Hines and Ray, 2010, 2011). 
Recently, two PrimPol-like orthologues (PPLs), referred to as PPL1 and PPL2, have 
been identified in T. brucei (Rudd et al., 2013). PPL1 is capable of synthesising RNA 
primers up to 50 nucleotides in length on poly(dT) templates. In contrast, PPL2 does not 
appear to exhibit any primase activity, representing another example where an AEP has 
ceased to function as a primase (Figure 1.13.). However, both PPL1 and PPL2 possess 
damage tolerance synthesis activities, specifically an ability to bypass 6-4PPs and 8-
oxo-dG lesions. Perhaps most surprising was the finding that PPL2 is essential for cell 
survival. Knockdown of PPL2 results in cell cycle arrest following bulk genome 
duplication. These cells accumulate a lot of DNA damage and die in a pre-mitotic phase. 
It has been proposed that PPL2 functions as a TLS polymerase that assists in restarting 
replication downstream of damage or DNA structures during the completion of genome 
duplication in G2 (Rudd et al., 2013). This inability to bypass damage likely leads to the 
generation of double-strand breaks observed when PPL2 is knocked down. The 
existence of PPL2 is probably a result of the duplication and subsequent diversification 
of PPL1 to remedy DNA replication issues specific to trypanosomes and other protists, 
such as the replication of repetitive sequence elements. These examples again 
demonstrate how AEPs have diversified to fill a range of roles in both nuclear and
mitochondrial DNA metabolism. 
1.6.9. Why do Primases Prefer to Incorporate RNA into DNA?
A common feature of many AEP enzymes, including replicative primases, is their marked 
preference to incorporate NTPs, rather than dNTPs, into the synthesised strand. A 
pertinent question here is why these specialized polymerases have maintained this 
preference to prime replication or repair damaged DNA by synthesising RNA, which is 
much less stable due to the presence of a 2 OH moiety that makes the sugar much more 
prone to hydrolysis. This is particularly surprising in the case of mammalian DNA 
replication, where the replicative primases incorporate lots of RNA into the newly 
synthesised DNA that must then be excised and replaced before genome duplication is 
completed. 
A shared structural feature of all AEP-related primases is their open and malleable active 
sites that, unlike canonical polymerases, enables them to accommodate a wide variety 
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of DNA configurations including: ss / ds DNA, mismatches, lesions and even termini of 
DSBs (Figure 1.10. and 1.14.). However, the price to be paid for this catalytic flexibility 
is low fidelity. To illustrate this point in more detail let us examine the NHEJ AEPs. These 
enzymes are highly adaptive polymerases that have effectively lost their primase activity 
and evolved to accommodate a wide range of DNA configurations in their active sites 
and perform a extensive variety of extension activities to ensure that DSB are repaired, 
irrespective of the nature of the break. However, they also preferentially incorporate 
NTPs to fill in any gaps with RNA, which are then preferentially ligated to seal the breaks 
(Bartlett et al., 2013). Why do these enzymes prefer to fill the gaps with DNA instead of 
RNA? The likely explanation for this preference is because of the very low fidelity 
exhibited by these polymerases. By incorporating RNA into the repaired breaks, the 
enzyme is flagging up the bases that it has incorporated. Once DSB repair has been 
completed by NHEJ, ribonucleases (e.g. RNase H2) can then excise the RNA, which 
can then be replaced with DNA by more accurate patch repair polymerases. In the case 
of DNA replication, primer synthesis is also a highly inaccurate process and given the 
large number of regions where RNA is incorporated into the genome, particularly on the 
lagging strand, this would result in the introduction of a very high mutagenic load during 
every round of replication. To prevent this from occurring in cells it is likely that, as during 
NHEJ, RNA is preferred for primer synthesis to demarcate regions of low fidelity 
synthesis that are subsequently excised and replaced with DNA in a more faithful 
synthesis process that occurs before the completion of genome synthesis.
1.6.10. Primase-Polymerases  Initiating Replication is Only the Beginning 
Since the first discovery of replicative DNA polymerases, well over half a century ago, it 
has been fully appreciated that there are also a more diverse range of families within this 
general classification, giving rise to many additional enzymes that have distinct roles in 
a wide variety of nucleic acid metabolism processes in cells, from replication to 
transcription. In contrast, the possibility that DNA primases may also have additional 
members and roles in cells has largely been overlooked until relatively recently. The 
reasons for this are partially down to their name, which categorically assigns a sole 
function to the bespoke nucleotidyltransferase activity associated with the first identified 
replicative primases, thus deterring significant further investigation of additional activities 
and functions associated with this grouping of enzymes. Whilst this primase label 
appropriately describes the de novo synthesis of RNA primers associated with toprim-
related DnaG primases and a small subset of the AEP-proper clade (Prim1), in most 
cases it is a misnomer that does not adequately describe the function of the vast majority 
of members that make up this superfamily (Figure 1.15.). AEP primases and canonical 
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Figure 1.15. Diversity of functional roles fulfilled by AEPs.
AEP superfamily members are employed in many different biological roles, in addition to replicative primases. These enzymes are also utilised as primer 
extenders, plasmid replicases, damage-tolerance re-priming enzymes, TLS polymerases, NHEJ DNA break repair and terminal transferase polymerases. 
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DNA polymerases most likely evolved from a common ancestral nucleic acid recognition 
domain (Iyer et al., 2005), the RRM, and share a number of common catalytic features, 
including divalent metal-dependent catalysed extension of nucleic acids in a 5-3 
direction. Therefore, it is more appropriate that all members of the AEP primase 
superfamily should be considered as belonging to the broad general grouping of 
enzymes called polymerases and, within this umbrella term, be further sub-classified as 
belonging to a sub-group of enzymes called Primase-Polymerases (Prim-Pols) to reflect 
their dual origins and, in most cases, their capacity to perform both synthesis functions 
(Figure 1.13.). This term has already gained acceptance to describe a number of different 
microbial and eukaryotic AEPs involved in a diverse range of functions, including plasmid 
replication, lesion bypass, and repriming. 
Although many additional roles have been identified for Prim-Pols in all domains of life
over the last decade or so (Figure 1.15.), much more remains to be discovered about 
the diverse functions and pathways in which these highly adaptable enzymes operate. 
For example, given that they can perform both priming and template-dependent 
synthesis events, it is likely that Prim-Pols undertake roles in other key cellular pathways, 
such as restart and bypass mechanisms associated with replication fork stalling at 
structural impediments. Given the propensity of many Prim-Pols to incorporate RNA 
during synthesis, it is also likely that they may also be involved in a range of 
transcriptional-related processes. AEP members are associated with some CRISPR 
operons suggesting potential roles in other processes, such as viral immunity in 
microbes. These are just some potential examples for novel AEP functions and many 
more await to be discovered. 
In addition to understanding the myriad of different functions associated with Prim-Pols, 
the identification of novel AEPs also provides an opportunity to explore potential 
associations between these enzymes and human disease. Critically, many Prim-Pols are 
also important for the life cycles of pathogenic bacteria, viruses and protozoa that infect 
mammals and therefore these enzymes are potentially attractive targets for the 
development of novel anti-microbial agents that specifically target essential DNA 
replication and repair pathways in these organisms.
1.7. PrimPol
Until recently, the only AEP member identified in higher eukaryotes was the Pol -
associated, PriS homologue, Prim1. However, a second eukaryotic AEP has now been 
described and characterised, this enzyme is named PrimPol (alternative names 
CCDC111, FLJ33167, EukPrim2 or hPrimPol1). PrimPol was originally identified as a 
61
novel uncharacterised member of the NCLDV-herpes virus clade of AEPs (Iyer et al., 
2005). PrimPol orthologues are present across a diverse range of unicellular and 
multicellular eukaryotes including species of animals, plants, and primitive early 
eukaryotes, such as fungi, protists, and algae. However, the enzyme is notably absent 
from a number of eukaryotes including Caenorhabditis elegans and Drosophila 
melanogaster. Importantly, this interrupted distribution suggests that PrimPol was 
acquired through horizontal gene transfer from a viral source and subsequently lost on 
a number of independent occasions (Iyer et al., 2005). PrimPol, similar to A. fulgidus and 
P. furiosus PriS, possesses both primase and DNA damage tolerance polymerase 
activities (Figure 1.13.) (Bianchi et al., 2013; García-Gómez et al., 2013; Keen et al., 
2014b; Mourón et al., 2013; Rudd et al., 2013; Wan et al., 2013). Specifically, PrimPol is 
capable of bypassing UV-induced 6-4PPs, in addition to 8-oxo-dG lesions (Bianchi et al., 
2013; García-Gómez et al., 2013). The enzyme is composed of two domains, an N-
terminal AEP domain, consisting of three canonical catalytic motifs, and a C-terminal 
UL52-like zinc finger, required for primase but not polymerase activity and conserved 
across the NCLDV-herpesvirus clade of AEPs (Figure 1.10.) (Iyer et al., 2005).
PrimPol is required for the maintenance of replication fork progression, with PrimPol 
knockout cells displaying decreased forks rates and increased sensitivity to DNA 
damaging agents (Bianchi et al., 2013). Furthermore, PrimPol has been implicated in the 
restart of stalled replication forks (Keen et al., 2014b; Mourón et al., 2013; Wan et al., 
2013), involving either TLS or repriming downstream of damage. As well as its 
involvement in nuclear DNA synthesis, a substantial proportion of PrimPol also localises 
to the mitochondria where it is thought to aid in the replication of the small circular 
mitochondrial genome, potentially by assisting 8-oxo-dG bypass or through repriming
(Bianchi, 2013; García-Gómez et al., 2013). In line with this, PrimPol-knockdown cells 
have been reported to exhibit mitochondrial DNA defects (Bianchi, 2013; García-Gómez 
et al., 2013). 
Coupled with the increasing evidence pointing towards a conserved repriming 
mechanism across all domains of life, there are some suggestions that PrimPol may fulfil 
this role in higher eukaryotes. Importantly, the dispensability of the zinc finger (ZnF)
domain of PrimPol for polymerase and TLS activities, coupled with its strict requirement 
for primase activity, has allowed separation of function studies to be performed in vivo
(Keen et al., 2014b; Mourón et al., 2013). These studies revealed that an intact ZnF 
domain is required for PrimPol to maintain normal replication fork rates following UV 
damage, suggesting that the primase activity of the enzyme is necessary for replication 
restart. Importantly, the potential involvement of PrimPol in repriming DNA replication 
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begs the question as to why the replicative primase Prim1 cannot also be employed in 
this role? It seems likely that, at least for lagging strand synthesis, this will be the case. 
Here, repriming would simply require the initiation of a new Okazaki fragment 
downstream of the lesion, facilitated by Prim1-dependent repriming. However, the 
requirement for PrimPol to reprime synthesis on the leading strand may be of more 
importance due to its preference to utilise dNTPs during primer synthesis, thus 
preventing incorporation of RNA. This offers a distinct advantage over Prim1 as it 
eliminates the possibility of RNA processing or hydroysis that would lead to formation of 
breaks on the leading strand that would eventually result in potentially lethal DSBs.
The overall aim of the articles presented in this thesis was to build upon the initial 
characterisation of PrimPol, with a specific focus on the mechanisms controlling 
recruitment and regulation. To this end, PrimPols interaction with recruitment and 
regulatory partners was investigated using both cellular and biochemical approaches.
The first of the articles focusses on the regulation of PrimPols enzymatic activities by
both RPA and mtSSB, in addition to the characterisation of the enzymes fidelity as a 
DNA polymerase (Chapter 2). The second article investigates the effect of a novel 
PrimPol interacting partner, Polymerase -interacting protein 2 (PolDIP2), on the 
enzymes primer extension activities using in vitro and in vivo approaches (Chapter 3). 
Chapter 4 describes the development of a fluorescent primase assay and demonstrates
how this technique was used to investigate PrimPols repriming activity in two further 
reports. The final results chapter provides an in depth characterisation of PrimPols 
interaction with RPA and proposes a mechanism for the recruitment and regulation of 
the enzyme at stalled replication forks (Chapter 5). These articles are presented 
chronologically and thus in the context of the wider PrimPol literature at the time they 
were published. In the final chapter, a review and discussion of the current PrimPol 
literature is provided, giving an overview and placing the work presented here in the 
wider context of this growing body of knowledge (Chapter 6). Together, the articles 
presented here build upon the initial characterisation of the enzyme and strongly support 
a role for PrimPol as the facilitator of leading strand repriming in higher eukaryotes,
following recruitment and regulation by both RPA and PolDIP2. 
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Chapter 2
Human PrimPol is a Highly Error-Prone 
Polymerase Regulated by Single-
Stranded DNA Binding Proteins
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2.1. Abstract
PrimPol is a recently identified polymerase involved in eukaryotic DNA damage
tolerance, employed in both repriming and TLS mechanisms to bypass nuclear and 
mitochondrial DNA lesions. In this report, we investigate how the enzymatic activities of 
human PrimPol are regulated. We show that, unlike other TLS polymerases, PrimPol is 
not stimulated by PCNA and does not interact with it in vivo. We identify that PrimPol 
interacts with both of the major single-strand binding proteins, RPA and mtSSB in vivo.
Using NMR spectroscopy, we characterize the domains responsible for the PrimPol-RPA 
interaction, revealing that PrimPol binds directly to the N-terminal domain of RPA70. In 
contrast to the established role of SSBs in stimulating replicative polymerases, we find 
that SSBs significantly limit the primase and polymerase activities of PrimPol. To identify 
the requirement for this regulation, we employed two forward mutation assays to 
characterise PrimPols replication fidelity. We find that PrimPol is a mutagenic 
polymerase, with a unique error specificity that is highly biased towards insertion-deletion 
errors. Given the error-prone disposition of PrimPol, we propose a mechanism whereby 
SSBs greatly restrict the contribution of this enzyme to DNA replication at stalled forks, 
thus reducing the mutagenic potential of PrimPol during genome replication. 
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2.2. Introduction 
Accurate and efficient DNA replication is essential for the maintenance of genomic 
integrity. The replication machinery is a highly specialised multi-protein complex 
employed for this purpose, with the replicative DNA polymerases, Pol , Pol , and Pol 
, tasked with the majority of bulk DNA synthesis in the eukaryotic nucleus. In 
mitochondria, this task is undertaken by Pol . These enzymes are superbly adapted to 
maximise faithful DNA synthesis, however this high degree of specialisation comes at a 
cost. Helix-distorting DNA lesions and structures, which persist into the S-phase of the 
cell cycle, present an obstacle to the replicative polymerases, causing stalling of the 
replication fork (Aguilera and Gómez-González, 2008). In response, cells employ a 
variety of DDT mechanisms to facilitate lesion/structure bypass and permit continued 
replication (Li and Heyer, 2008; Sale et al., 2012).
Mechanisms of replication restart include HR, in which an alternative sister template 
permits extension of the stalled primer terminus (Li and Heyer, 2008; Sale et al., 2012). 
Firing of dormant origins, discontinuous generation of Okazaki fragments on the lagging 
strand, or repriming of the replication fork downstream of the lesion on the leading strand, 
can also restart stalled forks (Heller and Marians, 2006). An alternative mechanism is 
TLS. Here, specialised DNA polymerases, predominantly of the Y-family, rescue stalled 
replication forks by directly synthesising across the damaged nucleotides. In contrast to 
replicative DNA polymerases, TLS polymerases display low fidelity during replication of 
undamaged DNA templates, thus requiring strict regulation (Sale et al., 2012). The 
primary level of regulation for TLS polymerases comes with their inherent distributive 
character. Additional regulation of access to the replisome is proposed to occur, in part, 
through post-translational modification of the PCNA (Friedberg et al., 2005). Collision of 
the replication fork with DNA lesions, and consequent stalling, stimulates mono-
ubiquitylation of PCNA, increasing its affinity for TLS polymerases, thus promoting 
recruitment of these enzymes to the fork. Following bypass of the lesion, the TLS 
polymerase dissociates and the high fidelity replicative polymerases proceed with DNA 
synthesis (Friedberg et al., 2005). The polymerase switch, therefore, acts to limit DNA 
replication by the low fidelity TLS polymerases, permitting access only when lesion 
bypass is required. Recently, a novel primase-polymerase called PrimPol has been 
reported to be involved in DDT and TLS during both nuclear and mitochondrial DNA 
replication (Rudd et al., 2014).
PrimPol is a eukaryotic DNA primase-polymerase, belonging to the AEP superfamily, 
that undertakes lesion bypass roles in both nuclear and mitochondrial DNA replication 
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(Bianchi et al., 2013; García-Gómez et al., 2013; Rudd et al., 2013, 2014; Wan et al., 
2013). This enzyme is capable of synthesising primers using either rNTPs or dNTPs, 
conferring the ability to reprime and restart replication downstream of DNA lesions. 
PrimPol also possesses robust template-dependent DNA polymerase activity, which it 
can utilise to bypass highly distorting 6-4 PPs and oxidative lesions, including the 
common 8-oxo-dG lesion, thus establishing PrimPol as a competent TLS polymerase 
(Bianchi et al., 2013; García-Gómez et al., 2013; Rudd et al., 2013; Wan et al., 2013). 
PrimPol possesses two distinct domains; an enzymatic AEP polymerase domain 
required for the catalytic activities of the enzyme and a UL52-like ZnF domain necessary 
for primase activity and modulating the processivity and fidelity of the enzyme (Keen et 
al., 2014b). PrimPol knockout (PrimPol-/-) cells display increased sensitivity to DNA 
damaging agents and decreased replication fork rates (Bianchi et al., 2013), in addition 
to defects in mtDNA replication (García-Gómez et al., 2013). Furthermore, PrimPol-/- 
mouse embryonic fibroblasts (MEFs) have increased metaphase aberrations and 
chromatid breaks, increasing substantially following low-dose aphidicolin treatment 
(Bianchi et al., 2013). In trypanosomes, deletion of a PrimPol orthologue leads to growth 
arrest in G2 followed by cell death (Rudd et al., 2013). Recent studies have established 
the involvement of PrimPol in DDT through at least two mechanisms, repriming and TLS. 
However, the regulation of PrimPols contribution to DNA replication has not previously 
been explored. 
In this report, we describe how the enzymatic activities of PrimPol are regulated. We 
observe that, in contrast to other TLS polymerases, PrimPol does not interact with PCNA 
and is not stimulated by its presence in vitro. Pull-down studies identify that human 
PrimPol interacts with RPA, the nuclear SSB, and its mitochondrial equivalent, mtSSB. 
We find that PrimPol interacts with the N-terminal domain of the RPA70 subunit 
(RPA70N), RPA has previously been shown to stimulate the activity of Pol  and Pol  
(Braun et al., 1997; Tsurimoto and Stillman, 1989), mtSSB also stimulates its respective 
polymerase partner, Pol  (Oliveira and Kaguni, 2010). However, in stark contrast we 
demonstrate that both of these proteins act to significantly limit both the primase and 
polymerase activities of PrimPol. We demonstrate that PrimPol is an error-prone DNA 
polymerase, with a strong preference to generate base insertions and deletions, thus 
necessitating strict regulation during its involvement in DNA synthesis. We propose that 
SSBs potentially act to limit the contribution of PrimPol to DNA replication in order to limit 
error-prone synthesis during the bypass of lesions and other genetic obstacles.
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2.3. Materials and Methods
2.3.1. Affinity Purification of PrimPol Complexes for Mass Spectrometry 
Analysis
For the large scale affinity purification of soluble human PrimPol for MS analysis, thirty 
175 cm2 flasks of confluent Flp-In T-REx-293 cells engineered for PrimPol expression 
were used, 1 day before harvesting, PrimPol expression was induced in 15 of these 
flasks by addition of 10 ng/ml doxycycline. Following harvesting and collection, cell 
pellets (~1 g each) were lysed in 15 ml lysis buffer (150mM NaCl, 30mM Tris pH 7.4, 
0.5% NP-40, with Roche protease inhibitor cocktail) and incubated at 4°C on a rocker for 
20 minutes. Input was retained (500 
l) and 1 ml of Strep-tactin resin (packed volume) 
added to the lysate and placed on a rocker for 2 hours at 4°C. Washes were also 
performed in batch mode (with lysis buffer containing 0.1% NP40) and then the Strep-
tactin resin was transferred to a gravity flow column and washed further. Five successive 
500 
l elutions with lysis buffer containing 2 mM desthiobiotin were performed, and each 
snap frozen with 10% glycerol. Following Western blot analysis to determine which 
affinity purifications were successful, the chosen elutions were concentrated using a 
VivaSpin 10,000 kDa molecular filter before resolving on a Bis-Tris 4-20% gel and 
colloidal Coomassie staining (Invitrogen). Whole lane gel extraction was performed with 
each lane being divided into 1-2 mm bands, which were placed in a 96-well plate before 
trypsin digestion and MS analysis.
2.3.2. Mass spectrometry
Polyacrylamide gel slices (1-2 mm) containing the purified proteins were prepared for 
MS analysis using the Janus liquid handling system (PerkinElmer, UK). Briefly, the 
excised protein gel pieces were placed in a well of a 96-well microtitre plate and 
destained with 50% v/v acetonitrile and 50 mM ammonium bicarbonate, reduced with 10 
mM DTT, and alkylated with 55 mM iodoacetamide. After alkylation, proteins were 
digested with 6 ng/µL Trypsin (Promega, UK) overnight at 37°C. The resulting peptides 
were extracted in 2% v/v formic acid, 2% v/v acetonitrile. The digest was analysed by 
nano-scale capillary LC-MS/MS using a Ultimate U3000 HPLC (ThermoScientific, San 
Jose, USA) to deliver a flow of approximately 300 nL/min.  A C18 Acclaim PepMap100 
5 µm, 100 µm x 20 mm nanoViper (Thermo Scientific, San Jose, USA), trapped the 
peptides prior to separation on a C18 Acclaim PepMap100 3 µm, 75 µm x 150 mm 
nanoViper (Thermo Scientific Dionex, San Jose, USA). Peptides were eluted with a 
gradient of acetonitrile. The analytical column outlet was directly interfaced via a modified 
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nano-flow electrospray ionisation source, with a hybrid linear quadrupolefourier 
transform mass spectrometer (LTQ Orbitrap XL/ETD, Thermo Scientific, San Jose, 
USA).  Data dependent analysis was carried out, using a resolution of 30,000 for the full 
MS spectrum, followed by eight MS/MS spectra in the linear ion trap.  MS spectra were 
collected with an automatic target gain control of 5x105 and a maximum injection fill time 
of 100 ms over a m/z range of 3002000.  MS/MS scans were collected using an 
automatic gain control value of 4x104 and a threshold energy of 35 m/z for collision 
induced dissociation.  LC-MS/MS data were then searched against a protein database 
(UniProt KB) using the Mascot search engine programme (Matrix Science, UK) (Perkins 
et al., 1999). Database search parameters were set with a precursor tolerance of 5 ppm 
and a fragment ion mass tolerance of 0.8 Da.  One missed enzyme cleavage was allowed 
and variable modifications for oxidized methionine, carbamidomethyl cysteine, 
pyroglutamic acid, phosphorylated serine, threonine and tyrosine were included.  MS/MS 
data were validated using the Scaffold programme (Proteome Software Inc., USA) 
(Keller et al., 2002).  All data were additionally interrogated manually. 
2.3.3. Construction of Human PrimPol Mutants 
Human PrimPol and PrimPol1-487 were cloned as previously described (Keen et al., 
2014b). PrimPol24-354 was constructed by PCR using the following forward and reverse 
primers; FWD: GTTTCTTCATATGCGGTTGTCCTCAGTGATAGACC, REV: 5-
GTTTCTTGCGGCCGCGATACTGTTAAAATATCCAACC-3.
2.3.4. Expression and Purification of Recombinant Proteins
Wild-type PrimPol and PrimPol24-354 were expressed in E. coli SHuffle Express cells 
overnight at 16°C, proteins were then purified as previously described (Keen et al., 
2014b). Human recombinant PCNA, Pol , RPA, and mtSSB proteins were expressed 
and purified as reported previously (Longley et al., 2009; Masuda et al., 2007). In 
addition, kTaq-Pol A and Tgo-Pol B (exo-) were purified as previously described 
(Engelke et al., 1990; Evans et al., 2000). Protein concentrations were determined based 
on absorbance at 280 nm corrected with the protein specific extinction coefficient. 
Extinction coefficient values for each of the recombinant proteins were calculated using
the ProtParam tool (ExPASy). Phage T4 SSB and T4 polymerase were purchased from 
New England Biolabs. Pol exo- was a kind gift from Dr Whitney Yin (University of Texas, 
USA). 
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2.3.5. Electrophoretic Mobility Shift Assays
Electrophoretic mobility shift assays (EMSAs) were performed for 60 min at room 
temperature in 20 
L volumes containing 50 mM Potassium acetate, 20 mM Tris-acetate 
pH 7.9, 10 mM Magnesium acetate, 1 mM DTT, 60 nM single stranded fluorescein 
labelled DNA (sequence 16, Table 2.1.), and varying concentrations of mtSSB or RPA 
(as indicated on Figure 2.1.). Reactions were supplemented with 2 
L 25% (w/v) Ficoll 
and resolved on a 5% (v/v) native polyacrylamide gel at 75 V for 60min in 0.5x TBE 
buffer. Gels were scanned using a FujiFilm FLA-5100 image reader.
2.3.6. NMR Methods
RPA70N and RPA32C were expressed and purified as described previously (Arunkumar 
et al., 2005; Frank et al., 2014). 15N-1H HSQC experiments were performed at 25°C on 
a Bruker Avance III 800 MHz NMR spectrometer with a cryogenically cooled probe. 
Spectra were acquired for samples of 15N-enriched RPA32C or RPA70N alone and in 
the presence of full-length PrimPol or PrimPol1-487. All samples were equilibrated in a 
buffer containing 20 mM HEPES, 80 mM NaCl, 2 mM DTT, and 5% deuterium oxide.
2.3.7. DNA Primase Assays
DNA primase assays were performed using the previously described protocol (Keen et 
al., 2014b), in buffer containing 50 mM Potassium acetate, 20 mM Tris-acetate pH 7.9, 
10 mM Magnesium acetate and 1 mM DTT. The templating oligonucleotide sequence 
can be found as sequence 10 in Table 2.1. In assays containing SSBs, reactions were 
supplemented with 4 
M mtSSB, 8 
M T4 SSB, or 8 
M RPA, before the addition of 
PrimPol. Note that twice as much RPA than mtSSB was used due to the increased level 
of RPA required to completely shift the DNA probe in EMSA reactions (Figure 2.1.). An 
excess of SSBs over ssDNA was used to ensure that the template was fully coated, 
taking into account the binding site size of the protein and the length of the ssDNA 
binding interface. Reaction products were resolved on a 15% (v/v) polyacrylamide gel 
containing 7M urea and 1x TBE buffer at 850 V for 2.5 hours in 1x TBE buffer. Gels were 
scanned with a FujiFilm FLA-5100 image reader. 
2.3.8. DNA Primer Extension Assays
Primer extension assays were performed using 5 Hexachlorofluorescein labelled DNA 
primers (ATDbio) (sequences 1-4 in Table 2.1.) annealed to complementary unlabelled 
DNA templates (sequences 5-15 in Table 2.1.). Extensions were carried out at 37°C in 
20 
L volumes containing; 100 nM of the assayed polymerase (or 3U/mL of T4 Pol), 20 
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Table 2.1. Primer/template sequences. 
Sequences of the DNA oligonucleotides used in primase and primer extension assays. Lesions within the sequences are denoted in red. 
# Oligonucleotide Modification Sequence (5-3)
1 HP-16 Primer 5-HEX CACTGACTGTATGATG
2 HP-20 Primer 5-HEX TGTCGTCTGTTCGGTCGTTC
3 HP-27 Primer 5-HEX TGTCGTCTGTTCGGTCGTTCGGTCTTC
4 HP-28 Primer 5-HEX TGTCGTCTGTTCGGTCGTTCGGTCTTCA
5 ND-50 TemplateTT N/A CGCGCAGGGCGCACAACAGCCTTGAAGACCGAACGACCGAACAGACGACA
6 ND-50 TemplateAA N/A CGCGCAGGGCGCACAACAGCCAAGAAGACCGAACGACCGAACAGACGACA
7 ND-50 TemplateCC N/A CGCGCAGGGCGCACAACAGAGCCGAAGACCGAACGACCGAACAGACGACA
8 ND-50 TemplateGG N/A CGCGCAGGGCGCACAACAGCCGGGAAGACCGAACGACCGAACAGACGACA
9 ND-97 Template 3-Biotin ACCGCGAACTTGAATTCTAGTTCAGTCTAAATGCTCTCAAGCACTGAGCAATTCACAACATATGGCTTTCGATTACCGAACGACCGAACAGACGACA
10 Poly(dT)-60 5-Biotin TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
11 6-4PP Template N/A CTCGTCAGCATCT^TCATCATACAGTCAGTG
12 CPD Template N/A CGCGCAGGGCGCACAACAGCCT=TGAAGACCGAACGACCGAACAGACGACA
13 8-oxo-dG Template N/A CGCGCAGGGCGCACAACAGCC8-oxo-dGTGAAGACCGAACGACCGAACAGACGACA
14 dU Template N/A CGCGCAGGGCGCACAACAGCCUTGAAGACCGAACGACCGAACAGACGACA
15 Ap Template N/A CGCGCAGGGCGCACAACAGCCApTGAAGACCGAACGACCGAACAGACGACA
16 ND-50 ssDNA Template 5-FAM CGCGCAGGGCGCACAACAGCCTTGAAGACCGAACGACCGAACAGACGACA
17 Primase Template 5-Biotin GTCTTCTATCTCGTCTATATTCTATTGTCTCTATGAATACCTTCATCAGTCTCACATAGATGCATC
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Figure 2.1. EMSA confirmation of RPA and mtSSB ssDNA binding. 
SSB/Oligo below each gel indicates the molar ratio of SSB to the ssDNA template. Note that more than twice as much RPA, compared to mtSSB, was 
required to fully shift the ssDNA template. Super-shifted bands indicate multiple SSBs bound to the ssDNA template, demonstrating that a large excess of 
protein over DNA is required to fully coat the template.
SSB/Oligo 0    0.25   0.5     1       2       4      8 16
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nM primer-template substrate, 100 
M dNTPs (NEB), 50 mM Potassium acetate, 20 mM 
Tris-acetate pH 7.9, 10 mM Magnesium acetate, 1 mM DTT, and 2 
g BSA (NEB). In the 
case of single nucleotide incorporation assays, 100 
M of the individual dNTP to be 
assayed was added in place of all dNTPs. For assays using SSBs, DNA templates were 
pre-incubated on ice with 200 nM mtSSB, 400 nM RPA, or 400 nM T4 SSB, before the 
addition of enzymes. Again, twice as much RPA than mtSSB was used due to the 
apparent lower affinity of RPA for DNA as perceived in EMSA experiments (Figure 2.1.). 
Extension reactions were monitored over varying time courses, typically 1min, 3min, 
5min, and 10min (except where indicated), and quenched with 20 
L stop buffer (95%
(v/v) formamide, 0.05% (v/v) bromophenol blue, 0.09% (v/v) xylene cyanol and 200 nM 
competitor oligonucleotide). Products were boiled at 95°C for 5min before resolution on 
a 15% (v/v) polyacrylamide/7 M urea gel. Gels were scanned using an FLA-5100 image 
reader (Fujifilm). Primer extension products were quantified using ImageQuant TL 
software (GE Life Sciences). 
2.3.9. The pSJ4 Plasmid-Based lacZ Fidelity Assay
The fidelity of human PrimPol was determined using the pSJ4 plasmid-based lacZa
reporter gene assay. The pSJ4 plasmid is a customised version of the previously 
described pSJ3 plasmid (Keith et al., 2013). The differentiating feature of the pSJ4 
plasmid is a short 64 nt long gap (versus the 163 nt long gap of pSJ3), which is more 
efficiently filled up by distributive DNA polymerases in vitro. This specific feature was 
necessary to implement in the pSJ4 plasmid to make it suitable for measurements of the 
fidelity of human PrimPol. Typical pSJ4 gap filling reactions were carried out in a total 
volume of 10 ml comprising: reaction buffer (50 mM Potassium acetate, 20 mM Tris-
acetate pH 7.9, 10 mM Magnesium acetate, 1 mM DTT, and 2 
g BSA), 20 fmol of 
gapped pSJ4 plasmid, 100 mM of each dNTP and 50 nM PrimPol. The gap filling reaction 
was carried out at 37°C for 30 minutes and completion was confirmed using an analytical 
digestion with EcoRI (Fermentas) restriction endonuclease followed by 1% agarose 
electrophoresis. As a control the pSJ4 lacZa reporter gene assay was used to measure 
the fidelity of two well characterised thermostable DNA polymerases, the Klenow 
fragment kTaq-Pol A and Tgo-Pol B (exo-). The fidelity of both of the thermostable 
polymerases was measured as described previously (Keith et al., 2013).
2.3.10. In vitro HSV-tk Mutagenesis Assay
Primed ssDNA and gapped-duplex substrates were prepared as previously described 
(Eckert et al., 2002; Hile and Eckert, 2008). Primer extension reactions were initiated 
with 1.6 
M PrimPol in buffer containing 10 mM Bis Tris Propane-HCl pH 7.0, 10 mM 
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MgCl2, 1 mM DTT, 500 
M dNTPs, and 200 nM primed ssDNA substrate in 50 
l total 
volume. Reactions were terminated after 15 minutes. The enzyme was used in excess 
conditions due to PrimPols distributive synthesis pattern and ssDNA binding capacity. 
The 81 nt HSV-tk target sequence was isolated by MluI and StuI digestion and hybridized 
to a gapped heteroduplex DNA molecule. After confirming hybridization by agarose gel 
electrophoresis, FT334 E. coli (upp, tdk) were transformed with hybridized DNA. 
Transformed bacteria were plated on VBA plates containing 50 µg/mL chloramphenicol 
(Cm) in the absence or presence of 40 
M 5-fluoro-2¢-deoxyuridine (FUdR) to determine 
HSV-tk mutation frequencies, as described (Eckert et al., 2002). The observed HSV-tk
frequency is calculated as the ratio of FUdRR/CmR to CmR colonies, and was determined 
for three independent reactions. DNA sequence analysis was conducted on independent 
mutants isolated from two independent PrimPol reactions per template. The polymerase 
error frequency (Pol EF) was calculated by subtracting the ssDNA background mutation 
frequency from the HSV-TK frequency. To correct the Pol EF for HSV-tk mutants with 
multiple polymerase errors, the Pol EFest was derived as described (Opresko et al., 
2000), using the following formula:
where n is the total number of detectable errors that were > 10 nucleotides apart within 
the same sequence. 
2.4. Results
2.4.1. PrimPol is not Stimulated by PCNA
Mono-ubiquitylation of PCNA in response to DNA damage increases its affinity for TLS 
polymerases such as Pol h, Pol k, Pol i, and Rev1, promoting their recruitment to the 
replication fork in order to facilitate lesion bypass (Lehmann et al., 2007). In vitro studies 
have shown that the ability of Pol h and Rev1 to bypass an abasic site is stimulated by 
the presence of mono-ubiquitylated PCNA over un-modified PCNA. However, on an 
undamaged template, PCNA stimulates the polymerase activities of these enzymes to a 
similar degree, regardless of its ubiquitylation status (Garg and Burgers, 2005a). In order 
to investigate whether PrimPol is stimulated by PCNA, we assessed the impact of both 
un-modified and mono-ubiquitylated PCNA on the polymerase activity of the enzyme in 
vitro. To do this, we employed primer extension assays on a 97-mer DNA template 
(sequence 9, Table 2.1.) annealed to a 20 nucleotide primer (sequence 2, Table 2.1.). 
Unlike the stimulating effect of PCNA on the polymerase activity of Pol h and Rev1, we 
  =  / 	 
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find that both un-modified and mono-ubiquitylated PCNA have no stimulatory effect on 
the polymerase activity of PrimPol (Figure 2.2.A.). In contrast, the presence of un-
modified PCNA increased the processivity of Pol  in the same conditions (Figure 2.2.A.). 
These results demonstrate that PrimPol, unlike other TLS polymerases, is not stimulated 
by either un-modified or mono-ubiquitylated PCNA, suggesting that the enzyme is 
regulated by another distinct mechanism. 
2.4.2. PrimPol Interacts with RPA and mtSSB in vivo
To identify cellular factors that associate with PrimPol, and thus may be involved in 
regulating this polymerase in vivo, we purified PrimPol from cultured human cells and 
identified co-purifying proteins using MS. To facilitate affinity purification of PrimPol, we 
fused it to a Strep-tag, which exploits the high affinity and specific binding between 
streptavidin and its natural ligand biotin (Schmidt et al., 1996). Specifically, the eight 
amino acid long Strep-Tag II (WSHPQFEK) was used, which allows affinity purification 
with the streptavidin derivative Strep-Tactin and specific elution with desthiobiotin
(Schmidt et al., 1996; Voss and Skerra, 1997). The Flp-In T-REx system was used to 
generate a stable cell line with doxycycline-inducible expression of Strep-tagged 
PrimPol. Affinity purified Strep-tagged PrimPol and co-purifying proteins were resolved 
by SDS-PAGE and excised gel bands analysed by MS.
Proteins identified in the MS analysis were ranked according to percentage of total 
spectra in the induced sample, and the fold enrichment calculated for each. A large set 
of proteins (1249) were identified, of these ~550 were present only in the induced sample 
and a further 65 showed a >3-fold enrichment, with PrimPol enriched 20-fold. Input of 
these proteins into the Database of Annotation, Visualisation, and Integrated Discovery 
(DAVID) clustered these proteins into a number of functionally related groups (Dennis et 
al., 2003; Huang et al., 2008). Consistent with the dual localisation of PrimPol, two of the 
predominant groups were nuclear and mitochondrial proteins. A large proportion of DNA 
and nucleotide binding proteins were also present, and more specifically proteins 
involved in DNA replication and repair, such as RPA (Figure 2.2.B.). In contrast, no 
mitochondrial replication enzymes were present, although mtSSB was enriched. 
To validate the potential PrimPol interacting proteins from the preliminary MS analysis, 
small-scale affinity purifications of Strep-tagged PrimPol from whole cell lysate were 
performed and analysed by Western blot. Following addition of doxycycline a 
predominant species of ~69 kDa was detected by Western blot analysis with an anti-
PrimPol antibody (Figure 2.2.C.), and furthermore, endogenous PrimPol was also 
detected, with little Strep-tagged PrimPol visible in the non-induced lysate (Figure 
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Figure 2.2. PrimPol is not regulated by PCNA but does interact with SSBs.
(A) PrimPol or Pol  (100 nM) were incubated with primer template substrates (20 nM) and dNTPs (100 µM) at 37ºC for increasing times (1, 3, 5, 10 mins) in 
the absence or presence of PCNA (200 nM). PrimPols primer extension activity was not stimulated in the presence of either un-modified or mono-ubiquitylated 
PCNA (Ubi-PCNA). In contrast, Pol  shows increased processivity when PCNA is present. C indicates the no enzyme control. (B) Identification of binding 
partners of PrimPol as analysed through mass spectrometry analysis, showing enrichment of RPA subunits 1 and 2, and mtSSB. The fold enrichment of each 
protein is indicated on the right of the table. (C) Western blot validation of PrimPol interacting proteins identified in the mass-spectrometry analysis. PrimPol 
co-purifies with both mtSSB and RPA, but not with PCNA. Flp-In T-Rex-293 cells engineered for inducible expression of PrimPolFlagStrep were grown in the 
presence or absence of doxycycline (10 ng/ml, 24 hours) and PrimPolFlagStrep was affinity purified from the soluble lysate using Strep-Tactin resin. Fractions 
from the affinity purification were analysed by Western blot with the indicated antibodies. Input + and - represent the clarified lysate of cells grown in the 
presence or absence of doxycycline, respectively.
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2.2.C.). Analysis of the affinity purification with RPA70 and RPA32 antibodies, and the 
mitochondrial equivalent, mtSSB, after stringent washing, all gave specific bands in the 
elutions (Figure 2.2.C), indicating that PrimPol associates with these proteins. The RPA 
findings agree with recent studies by Wan et al. (Wan et al., 2013), which reported that 
PrimPol interacts with RPA and that this interaction may be required for recruitment of 
PrimPol to stalled replication forks (Wan et al., 2013). ATAD3, a mitochondrial membrane 
associated ATPase and core nucleoid component, was also detected in the elutions, 
however ATAD3 did appear to bind to the Strep-tactin resin in the non-induced sample 
(data not shown). Notably, analysis of the affinity purification using an anti-PCNA 
antibody did not give detectable bands in the elutions (Figure 2.2.C.), suggesting that, 
unlike other TLS polymerases, PrimPol does not interact with PCNA. This result agrees 
with the inability of PCNA to stimulate PrimPol and further suggests that PrimPol is not 
regulated by PCNA in vivo. Although many potential interactions were identified by MS, 
we have validated that both major classes of cellular SSBs (RPA and mtSSB) co-purify 
with PrimPol, whilst PCNA does not. 
2.4.3. RPA70N Protein Recruitment Domain of RPA Mediates the Interaction 
with PrimPol 
In order to cross-validate the interaction between RPA and PrimPol, as well as 
characterise the domains responsible, we screened the two primary RPA protein 
recruitment domains DBD-N of RPA1 (RPA70N) and the winged-helix domain of RPA2 
(RPA32C) using NMR spectroscopy. To this end, 15N-1H Heteronuclear Single Quantum 
Coherence (HSQC) NMR spectra of 15N-enriched RPA70N1-120 and RPA32C172-270 were 
acquired in the absence and presence of two-fold molar excess of unlabelled PrimPol. 
These spectra monitor amide chemical shifts, which are sensitive to their local chemical 
environment. Thus, binding of a ligand is expected to perturb the location and/or intensity 
of the peaks from residues at the binding site. We note that additional chemical shift 
perturbations can occur within globular protein interaction domains as result of structural 
changes induced by ligand binding.
The NMR analysis of the interaction of RPA32C with PrimPol revealed no significant 
chemical shift perturbations (Figure 2.3.). In contrast, addition of PrimPol to RPA70N 
generated substantial perturbations (Figure 2.4.A). The primary effect observed is loss 
of signal intensity for the majority of peaks (Figure 2.4.A. red), which we attribute to the 
large increase in mass as the ~13 kDa protein tumbles much more slowly when part of 
the ~78 kDa complex. These observations indicate that RPA70N serves as the primary 
PrimPol interaction site on RPA.
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Figure 2.3. NMR titration of RPA32C with PrimPol. 
15N-1H HSQC overlay of 15N-enriched RPA32C alone (black) or in the presence of two-fold molar excess of PrimPol (red).
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Figure 2.4. Characterisation of the RPA-PrimPol domain interactions.
15N-1H HSQC overlays of 50 µM 15N-enriched RPA70N alone (A-B, black) and in the presence of 100 µM of PrimPol (A, red) or PrimPol1-487 (B, red). All 
spectra were obtained as 25 °C in a buffer containing, 20 mM HEPES, 80 mM NaCl, 2 mM DTT, and 5% deuterium oxide at pH 7.1. (C) Schematic showing 
the RPA binding domain (RBD) of PrimPol and the RPA70N domain of RPA where it binds. 
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Having mapped the primary interaction domain of RPA, we next used NMR to better 
define the interaction region of PrimPol. Previous immunoprecipitation data suggested 
that the C-terminal region of PrimPol is responsible for its interaction with RPA (Wan et 
al., 2013). We therefore examined the binding to RPA70N of a PrimPol deletion construct 
lacking the C-terminal 73 residues (PrimPol1-487). Figure 2.4.B. shows that the HSQC 
spectrum of RPA70N with PrimPol1-487 closely resembled that of the free protein. Thus, 
loss of the C-terminal region causes PrimPol to lose its ability to bind to RPA70N. 
Together, these results support a model in which the primary interaction between 
PrimPol and RPA is mediated by the RPA70N and PrimPol488-560 domains (Figure 2.2.C.). 
2.4.4. RPA and mtSSB Suppress de novo Primer Synthesis by PrimPol
Recent studies identifying that PrimPols C-terminal RPA-interacting domain is required 
for foci formation and appropriate functioning of the enzyme in vivo, suggest that RPA 
may act to recruit PrimPol to the replication fork (Wan et al., 2013). However, the effect 
of RPA on the enzymatic activities of PrimPol has not previously been studied. To 
determine the effect of both RPA and mtSSB on the primase activity of PrimPol, we 
analysed the enzymes ability to synthesise primers on a 60-mer poly-dT ssDNA 
template (sequence 10, Table 2.1.), coated with either RPA or mtSSB. T4 SSB coated 
ssDNA was also included as a non PrimPol-interacting control. As observed previously 
(Bianchi et al., 2013; Keen et al., 2014b), PrimPol facilitated primer synthesis on the 
ssDNA template in the absence of SSBs. However, RPA and mtSSB strongly inhibited 
the ability of PrimPol to synthesise primers, both with dNTPs and rNTPs (Figure 2.5.). 
PrimPol also failed to synthesise primers on ssDNA coated with T4 SSB. This suggests
that SSBs supress the primer synthesis ability of PrimPol by blocking potential DNA 
binding sites for the enzyme. These findings echo previous studies of the Pol  complex, 
which demonstrated that primer synthesis was suppressed on ssDNA templates coated 
with RPA (Collins and Kelly, 1991). 
2.4.5. RPA and mtSSB Impede Primer Extension by PrimPol
In contrast to the suppression RPA imposes on Pol  during primer synthesis, RPA 
stimulates the polymerase and processivity of the enzyme when elongating primers 
(Braun et al., 1997). This implies that RPA acts to prevent Pol  binding to ssDNA, hence 
negating primer synthesis but actively promotes primer extension. Furthermore, RPA 
and mtSSB have been shown to stimulate the polymerase activities of Pol  and Pol , 
respectively (Oliveira and Kaguni, 2010; Tsurimoto and Stillman, 1989). Therefore, we 
next investigated the effect of RPA and mtSSB on the polymerase extension activity of 
PrimPol. T4 SSB was again included as a non-interacting control. In order to investigate 
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Figure 2.5. The effect of SSBs on the primase activity of human PrimPol. 
Single-stranded poly-dT templates (500 nM) were incubated with dNTPs or rNTPs (500 µM) and human PrimPol (1 µM), either alone or in the presence of 
RPA (8 µM), mtSSB (4 µM), or T4 SSB (8 µM) for 1hr at 37ºC (see materials and methods for details). In the absence of SSBs PrimPol is capable of de 
novo primer synthesis using either dNTPs or rNTPs. However, when templates are coated with SSBs PrimPol is unable to synthesise primers. The schematic 
above represents how this inhibition is likely a result of RPA and mtSSB blocking PrimPol binding sites on the ssDNA template. 
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this, we employed a standard primer extension assay in the presence of RPA, mtSSB, 
or T4 SSB. This represents a physiologically relevant situation in which the replication 
fork has stalled at a site of DNA damage leading to uncoupling of the stalled replicative 
polymerase and the MCM helicase, resulting in the generation of long stretches of SSB-
bound ssDNA (Byun et al., 2005). In addition to full-length PrimPol, we also analysed a 
truncation of the enzyme (PrimPol24-354) that lacks both the ssDNA binding ZnF domain 
and the C-terminal region required for RPA interaction. This truncation allowed 
investigation into the effect of SSBs on the AEP domain of PrimPol alone, which has 
previously been shown to possess polymerase activity (Keen et al., 2014b).
In the absence of SSBs, the full length PrimPol and PrimPol24-354 fully extended the 
majority of primers by the final time point (Figure 2.6.A. and B.). However, the presence 
of RPA, mtSSB, or T4 SSB, dramatically impeded primer extension by both enzymes
(Figure 2.6.A. and B.). This inhibition caused both a reduction in the length of extended 
primers and an increase in the amount of unextended DNA substrate. The partial 
extension observed in the presence of SSBs suggests that PrimPol was unable to 
displace these proteins from the template DNA during primer extension. As a result of
the dynamic nature of SSBs binding to DNA, any ssDNA un-bound by SSBs that is close 
to the primer-template junction would be available for extension by PrimPol until the 
enzyme was restricted by SSBs bound downstream or dissociated and was unable to 
bind again due to exclusion by SSB. The varying levels of inhibition observed in the 
presence of different SSBs may therefore be a result of the different binding footprints 
and affinities of the SSBs used, in conjunction with the length of the template. The 
inhibition of PrimPol24-354, coupled with the inhibitory effect of T4 SSB on full-length 
PrimPol, indicates that this effect is not due to an interaction between PrimPol and the 
SSBs. Furthermore, inhibition of PrimPol24-354 suggests that the inhibitory effect of SSBs 
is not only due to competition with PrimPols ZnF domain for binding of ssDNA (Figure 
2.6.B.).
In order to ensure that the inhibitory effect of RPA and mtSSB on PrimPol primer-
extension is not simply a result of the amount of protein used, we repeated the assay in 
the presence of a large range of SSB concentrations. In each case, a similar level of 
inhibition was observed at protein concentrations sufficient to coat the single-stranded 
region of the DNA template (Figure 2.7. and 2.8.). A similar level of inhibition was also 
observed when PrimPol was pre-incubated with the template before adding dNTPs and 
SSBs (Figure 2.9.). In addition, Pol  with PCNA, Pol exo-, and T4 Pol were able to 
displace RPA, mtSSB, and T4 SSB respectively, and fully extend the primer in the same 
conditions in which PrimPol activity is limited (Figure 2.10.). This reveals a striking 
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Figure 2.6. The effect of SSBs on the primer extension activity of PrimPol. 
(A) Primer-template substrates (20 nM) and dNTPs (100 µM) were incubated with PrimPol (100 nM), either alone or with RPA (400 nM), mtSSB (200 nM) or 
T4 SSB (400 nM), for increasing times (1, 3, 5, 10 mins). In the presence of SSBs, full-length PrimPols primer extension activity is severely impeded. The 
primer runs at the position indicated N, with full extension denoted by N+77. C indicates the no enzyme control. For each gel, the 10 minute time-point 
was quantified to identify the percentage of primers extended more than 1, 5, 10, 15, 20, or 25 bases. This quantification is shown on the right of the gels. 
(B) The primer extension activity of PrimPol24-354 is also restricted in the presence of SSBs. Quantification of the 10 minute time-point for each gel is again 
shown to the right of the gels. (C) Schematic representation of the inhibitory effect of SSBs on the primer extension activity of PrimPol.
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Figure 2.7. mtSSB inhibits PrimPol over a large range of protein concentrations.
The concentration of mtSSB used in each assay is indicated above each gel. The time-points used are 1, 5, and 10 mins C indicates the no enzyme control. 
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Figure 2.8. RPA inhibits PrimPol over a large range of protein concentrations. 
The concentration of RPA used in each assay is indicated above each gel. C indicates the no enzyme control. 
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Figure 2.9. SSBs inhibit PrimPol when added second. 
Full-length and 24-354 PrimPol were pre-incubated with the DNA template to allow binding before the addition of dNTPs and either RPA or mtSSB. In each 
case, inhibition of primer extension was observed. C indicates the no enzyme control.
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Figure 2.10. Replicative polymerases displace SSBs. 
Pol  with PCNA, Polexo-, and T4 Pol, are able to displace RPA, mtSSB, and T4 SSB, from DNA, respectively. C indicates the no enzyme control.
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difference in the ability of PrimPol to displace SSBs in comparison to replicative 
polymerases. 
Stimulation of Pol  by mtSSB has previously been shown to be salt-dependent, 
maximally stimulated at 20 mM potassium chloride and inhibited at concentrations ~100 
mM (Oliveira and Kaguni, 2010). We tested whether the inhibition of PrimPol by RPA 
and mtSSB was also salt-dependent by repeating the primer extension assays in a range 
of salt concentrations. The restraining impact of RPA and mtSSB on the polymerase 
activity of PrimPol was consistent across the range of salt concentrations tested, 
between 0 and 60 mM KCl (Figure 2.11. and 2.12.), ruling out the possibility that this 
effect is salt-dependent. 
RPA has previously been implicated in modulating the fidelity of 8-oxo-dG bypass by Pol 
 and Pol , specifically acting to increase accurate dCTP incorporation opposite the 
lesion (Maga et al., 2007). We have recently reported that PrimPol is able to bypass 8-
oxo-dG lesions by incorporation of either dCTP or dATP. In addition, PrimPol incorrectly 
incorporates dTTP opposite the first T of a 6-4PP and incorporates dATP opposite 
deoxyuracil, whilst the full-length enzyme is unable to bypass CPDs or Ap sites in 
magnesium (Keen et al., 2014b). We examined whether RPA or mtSSB affected the 
ability, or fidelity, of lesion bypass across a range of different templating lesions 
(sequences 11-15, Table 2.1) using single incorporation primer extension assays with 
the lesion immediately downstream of the primer-template junction. RPA and mtSSB did 
not appear to alter either the ability to bypass lesions or the fidelity of this bypass, except 
in the case of the 6-4PP where bypass was inhibited in both cases (Figure 2.13.). This 
may be due to the shorter length of the 6-4PP template compared to the length of the 
other lesion-containing templates. Alternatively, the SSBs might prevent the looping out 
mechanism which has been proposed to be employed by PrimPol for bypass of 6-4PP
(Mourón et al., 2013).
These results demonstrate that PrimPols polymerase activity is severely limited in the 
presence of SSBs. PrimPol has been confirmed as a competent TLS polymerase with 
roles in DDT in vivo (Rudd et al., 2014). As such, PrimPol is likely to be recruited to 
stalled replication forks, possibly by RPA (Wan et al., 2013), where it will encounter long 
stretches of RPA/mtSSB-bound ssDNA, a result of uncoupling of the replicative 
polymerase and helicase. Therefore, the inability of PrimPol to displace SSBs during 
primer elongation likely acts as a mechanism to limit PrimPols contribution to DNA 
replication. In order to identify the necessity to restrict DNA synthesis by PrimPol during 
genome replication, we next investigated the fidelity and mutagenicity of this enzyme. 
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Figure 2.11. mtSSB inhibits PrimPol over a range of salt concentrations. 
The concentration of KCl in the buffer for each assay is indicated above each gel. The time-points used are 1, 5, and 10mins. C indicates the no enzyme 
control.
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Figure 2.12. RPA inhibits PrimPol over a range of salt concentrations. 
The concentration of KCl in the buffer for each assay is indicated above each gel. The time-points used are 1, 5, and 10 mins. C indicates the no enzyme 
control.
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Figure 2.13. RPA and mtSSB do not affect the lesion bypass fidelity of PrimPol.
The lesion present in each assay is indicated above the respective gel. Each individual reaction was carried out for a single 10 minutes time-point. Con 
indicates the no dTNP control.
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2.4.6. PrimPol Shows a Propensity for Misincorporation and Mispair 
Extension 
As an initial investigation into the base substitution fidelity of PrimPol, we used a primer 
extension assay based on single incorporation of either the correct or incorrect incoming 
base (Figure 2.14.). PrimPol was incubated with a short primer-template with either 
adenine (A), cytosine (C), guanine (G), or thymine (T), as the immediate templating base 
(N+1 position). This base was followed by two templating Cs (N+2 and N+3 positions), 
except where C was the base at N+1, in which case A and G were the upstream 
templating bases (N+2 and N+3 positions). For each primer-template substrate, the 
reaction was supplemented with only one of the four dNTPs (dATP, dCTP, dGTP, or 
dTTP). Quantification of these data and normalisation to correct incorporation suggest 
that PrimPol has a strong propensity to misincorporate dGTP, especially opposite a 
templating G (Figure 2.14.B.). However, when dGTP is the incoming base, significant 
product bands were visible at the N+2 and N+3 positions (Figure 2.14.A.). This increased 
N+2 and N+3 incorporation could result from PrimPol misaligning the N+1 templating 
base, rather than through misincorporation, which would in turn suggest a potential to 
generate base deletions. 
PrimPol also showed a preference to misincorporate dCTP and dATP opposite a 
templating C (Figure 2.14.A. and B.). Consistently, a significant N+2 product was visible 
on the G template when dCTP was the incoming base (Figure 2.14.A.). Again, this 
corresponds to misincorporation of dCTP opposite a templating C at the N+2 position. A 
similar result was observed on the T template with the correct incoming base (dATP), 
indicating misincorporation of dATP opposite a templating dC at the N+2 position (Figure 
2.14.A.). These results suggest that PrimPol has a propensity to misincorporate both 
dCTP and dATP opposite a templating C, which may be a potential error signature of 
PrimPol. 
We also analysed the ability of PrimPol to extend different terminal mismatched base 
pairs (Figure 2.14.C. and D.). PrimPol was particularly proficient at extending C-C 
mismatches, with ~12% of the primers being extended relative to extension of a correctly 
matched C-G primer-template junction. The enzyme also showed a capacity to extend 
A-A, C-T, G-G, and A-C/C-A mismatches, whilst showing a much lower ability to extend 
from T-T and G-A/A-G mismatches (Figure 2.14.C. and D.). Together, these data reveal 
that PrimPol is able to facilitate both misincorporation of bases and perform extension of 
these base mispairs. 
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Figure 2.14. PrimPol can misincorporate bases and extend from mismatched bases. 
(A) Analysis of misincorporation by PrimPol. PrimPol (100 nM) was incubated at 37ºC with primer-template substrates (20 nM) containing either A, C, G, or 
T, as the templating base immediately downstream of the primer for increasing times (1, 3, 5, 10 mins). Individual reactions contained either dATP, dCTP, 
dGTP, or dTTP (100 µM). The templating bases are indicated on the left, whilst the dNTP provided is shown above. Dotted lines separate reactions where 
the templating base is the same. N denotes the position at which the primer runs whilst N+1, N+2, and N+3 indicate incorporation of 1, 2, or 3, bases 
respectively. (B) Quantification of the misincorporation assays at each 10 minute time-point. Data were normalised against the correct incoming base. (C) 
Analysis of mismatch extension by PrimPol. PrimPol was incubated at 37ºC for increasing times (1, 3, 5, 10 mins) in the presence of all four dTNPs and 
primer-template substrates containing a mismatched base at the 3 end of the primer The templating base for each gel is indicated on the left, whilst the 
corresponding mismatched primer base is shown above. (D) Quantification of the mismatch extension assays at each 10 minute time-point. Data were 
normalised against extension from correctly matched bases.
dA dC
dG dA
dC
dT
dA
dG
dT
dC
dG
dT
0
2
4
6
8
10
12
14
16
18
20
E x
t e
n s
i o
n  
( %
)
Templating 
A
Templating 
C
Templating
G
Templating
T
A-A
A-C
A-G
C-A
C-C
C-T
G-A
G-G
G-T
T-C T-G
T-T
0
2
4
6
8
10
12
14
16
18
20
E x
t e
n s
i o
n  
( %
)
Templating 
A
Templating 
C
Templating
G
Templating
T
A
C
B
D
93
2.4.7. PrimPol is an Error-Prone Polymerase with a Preference to Generate 
Base Insertions and Deletions 
Unlike the major human replicative polymerases (Pol  and Pol ), PrimPol lacks a 3' to 
5' exonuclease proofreading domain and is therefore expected to be a potentially error-
prone DNA polymerase. To characterise PrimPols error frequency and spectrum, we 
employed a plasmid based lacZ reporter gap-filling assay (Keith et al., 2013). Due to 
the distributive nature of PrimPol we modified the recently developed pSJ3 plasmid to 
create a new plasmid (pSJ4) containing a shorter 64 nt long gapped region. Initially, the 
fidelity of two well characterised DNA polymerases (Klenow fragment of Taq-Pol A and 
exonuclease-deficient variant of Tgo-Pol Bexo-) was measured. From raw mutation 
frequencies an absolute error rate (number of mistakes made per base incorporated) 
was calculated as previously described (Keith et al., 2013). The Klenow fragment Taq-
Pol A and Tgo-Pol Bexo- presented error rates of 3.6 x 10-5 and 1.6 x 10-5, respectively 
(Table 2.2.; Figure 2.15.A.), agreeing with the previously reported fidelities of these 
enzymes (Jozwiakowski et al., 2014; Keith et al., 2013). Analysis of human PrimPol 
revealed an error-prone phenotype with a calculated error rate of 1 x 10-4, essentially an 
order of magnitude lower than the exonuclease-deficient variants of S. cerevesiae
replicative DNA polymerases ,  and the TLS specialised DNA polymerase 	 (Fortune 
et al., 2005; Shcherbakova et al., 2003; Zhong et al., 2006). 
The mutations generated by PrimPol whilst copying the 64 nt long fragment of the lacZ
reporter are visualised in Figure 2.2.C. PrimPol exhibited a tenfold preference for base 
substitution mutations when C or G were the templating bases, in comparison to errors 
introduced when copying A or T. Perhaps more intriguing however, was the finding that 
more than half of the mutations observed were base deletions/insertions, rather than the 
expected base substitutions (Figure 2.15.B.; Table 2.3). This apparent propensity of 
PrimPol to generate a very high proportion of insertion-deletion (indel) errors seems to 
support the previously proposed template scrunching mechanism, which PrimPol can 
employ to skip damaged nucleobases (Mourón et al., 2013). 
To investigate this phenomenon further and cross-validate the findings we also 
measured the fidelity of PrimPol using the HSV-tk forward mutation assay (Eckert et al., 
2002). We engineered the HSV-tk gene substrates to contain additional short tandem 
repeat (STR) sequences within the 5 region of the gene, in order to study polymerase
fidelity within repetitive sequences. Using [T]8 and [A]8 STR-containing substrates, the 
observed HSV-tk frequency resulting from PrimPol DNA synthesis is 1400 ± 360 x 10-4 
and 900 ± 210 x 10-4, respectively (Table 2.4.). In comparison to the replicative 
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Table 2.2. Mutation frequencies observed for the Klenow fragment Taq-Pol A, Tgo-Pol B (exo-) and human PrimPol enzymes. 
The fidelity measurements were determined using a plasmid-based gap filling assay (pSJ4-lacZa). The pSJ4 plasmid assay was developed to study the 
fidelity of TLS DNA polymerases and it is modified a version of the previously described pSJ3 plasmid (Keith et al., 2013).
Polymerase Total Number of Coloniesa
Number of White
(Mutant) Colonies
Corrected Mutation 
Frequencyb Error Rate
c
Klenow Taq-Pol A 58,555 96 1.6 x 10-3 3.6 x 10-5
Tgo-Pol B (exo-, 
D215A) 48,167 33 0.7 x 10
-3 1.6 x 10-5
PrimPol 54,667 264 4.6 x 10-3 1.0 x 10-4
aThe fidelity of each polymerase was determined in three separate experiments, each of which involved scoring E. coli colonies 
on 9 separate plates. The aggregated numbers are given.
bCorrected mutation frequency equals: ({number of white colonies/total number of colonies}  background mutation rate). A 
background mutation rate of 1.7 x 10-5 was used for gapped pSJ4.
cError rate is the number of mistakes made per base incorporated. The corrected mutation frequency was converted to error rate 
as previously described (Keith et al., 2013). An expression frequency (P) of 0.3 was used. Due to the limited amount of 
sequencing data an Ni/N value of 1 was used and the number of detectable sites (D) was the sum of the number of determined 
base substitutions plus insertion/deletions, that is, 147 for pSJ4. 
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Figure 2.15. Mutational signature of human PrimPol at the lacZ sequence.
(A) The average pSJ4-lacZ coding region error rate of PrimPol, relative to other polymerases. The fidelity of each polymerase was determined in three 
separate experiments, each of which involved scoring E. coli colonies on 9 separate plates. The aggregated numbers are given. (B) Proportions of base 
substitutions, insertions, and deletions generated in the pSJ4-lacZ coding region. Pie chart depicts percentages from 95 total mutational events observed.
(C) The diagram shows the 64 nucleotide long sequence of the lacZ reporter synthesised by human PrimPol in vitro in the pSJ4 gap-filling fidelity assay. A 
total of 95 white colonies were sequenced revealing a unique mutation signature of human PrimPol.
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Table 2.3. Mutations generated by PrimPol at the lacZ sequence.
Individual changes introduced into the lacZa indicator gene of pSJ4 by human PrimPol are shown. A total of 95 white colonies were sequenced in order to 
reveal the types and frequency of mutations.
Mutation Type Number Frequency (%)
A>T / T>A 1 1.05
A>C / T>G 2 2.1
A>G / T>C 0 0
G>A / C>T 24 25.3
G>C / C>G 4 4.2
G>T / C>A 2 2.1
Insertions 20 21.05
Deletions 42 44.2
Total 95 100
A>N / T>N 3 3.16
G>N / C>N 30 31.6
Transitions 24 25.3
Transversions 9 9.5
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Table 2.4. PrimPol error rates within STR and HSV-tk coding sequences.
Mutational Target
Frequency x 10-4
T8 A8
Observed HSV-tk Frequency ± SDa 1400 ± 360 900 ± 210
ssDNA Background 0.7 0.7
Pol EFestb 1300 (59)c 770 (40)
STR Region 470 (21) 210 (11)
HSV-tk Coding Region 860 (38) 560 (29)
Frameshifts 590 (26) 380 (20)
Large Deletions 110 (5) 100 (5)
Complex 160 (7) 80 (4)
Base Substitutions <23 (0) <19 (0)
aMutant frequencies are mean ± standard deviation of three independent 
reactions
bPol EFest is calculated as described in methods
cNumber of independent error from two reactions 
98
polymerases  and , PrimPol displays a 16 to 28-fold increase in HSV-tk frequency 
(Table 2.5.) (Ananda et al., 2014; Hile and Eckert, 2008). Furthermore, PrimPol displays 
an error frequency that is more than 2-fold higher than the repair and specialized Pols , 
, and . 
PrimPol creates errors within the artificial STR sequence at a rate comparable to Pols , 
, and  (Table 2.5.). Additionally, PrimPols error specificity within the STR region is in-
line with what we have previously observed for other polymerases at these repeats 
(Figure 2.16.), suggesting that STR errors are not what is driving PrimPols low fidelity. 
In contrast to the STR region, PrimPols error frequency within the coding-region of the 
HSV-tk gene is higher than any other polymerase analyzed to date (Figure 2.17.A.). In 
agreement with the lacZ gap-filling assay, PrimPols coding region error spectrum is 
almost entirely indel based, with a bias towards deletions (Figure 2.17.B.; Figure 2.18.).
The very high proportion of insertion errors (36%) is a phenotype never observed in this 
assay for other DNA polymerases, and is tremendously different from error-prone Pol  
which creates indel frameshift and base-substitution errors at similar rates (Ananda et 
al., 2014). Although we have observed Pol  insertion errors, the vast majority of Pol k
indels were deletions (Baptiste and Eckert, 2012), and all of the Pol  indel errors we 
have observed in the HSV-tk gene were deletion events  (Eckert et al., 2002). These 
findings show that PrimPol has an error specificity unique amongst DNA polymerases.
We observed a pronounced mutational hotspot that included both indels and complex 
errors within a sequence that can potentially from a hairpin structure (Figure 2.17.C.). 
Both the complex events and the insertion events result in changes to the template 
sequence that expand the [T]2 template sequence to a [T]3 or [T]4 sequence. Intriguingly, 
while such an observation would suggest PrimPol is prone to expand repeated 
sequences, only a single expansion event was observed at both the [T]8 and [A]8 STR 
sequences (Figure 2.16.).
2.5. Discussion 
PrimPol is a recently discovered primase-polymerase that is potentially important for TLS 
and repriming during DNA replication in eukaryotic cells. Unlike other TLS enzymes, 
PrimPol does not interact with, nor is it stimulated by, unmodified or mono-ubuitylated 
PCNA, indicating that other factors potentially regulate its activities in vivo. Nevertheless, 
our results do not rule out the possibility that PrimPol might interact with PCNA indirectly 
through an additional bridging partner. In this report we identify a potential regulatory 
mechanism employed to limit the contribution of PrimPol to DNA replication that is 
distinct from that used by other TLS polymerases. This mechanism involves SSBs that 
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Table 2.5. Comparison of PrimPol error rates within STR and HSV-tk coding sequences with TLS and replicative polymerases.
Polymerase
Pol EFest x 10-4
Overall HSV-tk Coding Region
STR 
Region
PrimPol
T8 Template 1300 (59)a 860 (38) 470 (21)
A8 Template 770 (40) 560 (29) 210 (11)
Pol b,c
T8 Template 440 (35) 210 (17) 230 (18)
A8 Template 270 (67) 87 (22) 180 (45)
Pol c
T8 Template 460 (49) 140 (15) 320 (34)
Pol b
T8 Template 47 (77) 1.8 (3) 45 (74)
A8 Template 55 (77) 4.3 (6) 51 (71)
Pol c
T8 Template 33 (32) 2.1 (2) 31 (30)
Pol 	b
T8 Template 380 (83) 32 (7) 350 (76)
A8 Template 400 (82) 15 (3) 390 (79)
aNumber of independent errors from two reactions
bPublished data from Ananda et al., 2014.
cPublished data from Hile et al., 2012
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Figure 2.16. PrimPol HSV-tk coding region error spectrum. 
Base substitutions are shown above the template sequence, highlighted green for detectable events or yellow for non-detectable. Single deletion and insertion 
events are shown below the template with open and closed triangles respectively, while diamonds indicate a tandem deletion. Superscripts mark the errors 
found within an individual complex event. Long lines under the template sequence note >2nt deletion events.
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Figure 2.17. PrimPols replication of the HSV-tk coding region is error-prone and unique. 
(A) The average HSV-tk coding region error frequency of PrimPol, relative to other human polymerases. Data generated from Table 2.5. (B) Types of errors 
created by PrimPol in the HSV-tk coding region. Pie chart depicts percentages from 67 total mutational events observed. (C) A mutation hot-spot in the coding 
region is shown to highlight PrimPols unique error specificity. Base substitutions are shown above the template sequence, and are highlighted green for 
phenotypically detectable events or yellow for non-detectable events. Single deletion and insertion events are shown below the template with open and 
closed triangles respectively, while diamonds indicate a tandem deletion. Superscripts mark the errors found within an individual complex event. The 
underlined bases within the template denote the sequence with hairpin-forming potential.
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Figure 2.18. The STR is not driving PrimPols elevated mutation frequency.
Error specificity at the STR is shown for PrimPol in comparison to the other polymerases examined on both templates.
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directly restrict DNA synthesis by PrimPol by limiting the availability of ssDNA template, 
downstream of the stalled replisome, thus preventing re-binding of PrimPol. 
It was recently reported that PrimPol interacts with RPA1 and that this interaction is 
required for foci formation in vivo (Wan et al., 2013). These initial studies suggested that 
RPA may be involved in the recruitment/regulation of PrimPol at sites of DNA damage. 
Here, the RPA binding domain of PrimPol, in conjunction with the ssDNA binding ZnF 
domain, may act as a docking mechanism for recruitment of the enzyme. This would 
allow tethering of PrimPol to stretches of ssDNA partially coated with RPA, following 
stalling of the replication fork. In this report, we further explored the interaction between 
PrimPol and SSBs, in addition to the impact that these proteins have on the activity of 
PrimPol in vitro. We identified that PrimPol interacts with mtSSB, as well as RPA (Figure 
2.2.C), pertaining to the role of the enzyme in mitochondrial, as well as nuclear, DNA 
replication (Bianchi et al., 2013; García-Gómez et al., 2013). Furthermore, we establish 
that PrimPol interacts with the RPA70N protein recruitment domain (Figure 2.4.). This is 
in contrast to previous reports suggesting that PrimPol interacts with RPA70C (Wan et 
al., 2013). This revision is consistent with the absence of any other published data 
suggesting RPA70C is involved in interactions with other proteins. However, it remains 
possible that PrimPol may have two different sites of interaction on the RPA70 subunit. 
It is surprising that both RPA and mtSSB, in addition to the non-interacting T4 SSB, act 
to significantly impede the primase and polymerase activities of PrimPol, (Figure 2.5. 
and 2.6.). Previously, RPA has been shown to suppress the ability of the Pol  complex 
to synthesise primers, identifying a role for RPA in preventing non-specific priming events 
(Collins and Kelly, 1991). Our results establish that this role also extends to regulating 
priming by PrimPol, with mtSSB fulfilling an analogous role in mitochondria. Interestingly, 
this suggests that PrimPol is only able to synthesise primers at regions of the genome 
not occupied by SSBs, either where SSBs have been displaced by other replication 
factors, or where the topology of the DNA template prevents SSB binding, for example 
where DNA secondary structures occur.
Previous studies have shown that RPA can stimulate the polymerase activity of Pol  
and Pol  (Kenny et al., 1989; Tsurimoto and Stillman, 1989), with mtSSB acting to 
stimulate Pol  (Oliveira and Kaguni, 2010). In stark contrast, our results show that both 
RPA and mtSSB severely restrict the polymerase activity of PrimPol (Figure 2.6.).
Interestingly, in E. coli, SSB inhibits the progression of the TLS polymerase, Pol II (Indiani 
et al., 2013), and additionally, Pol IV when the interaction between the two proteins is 
disrupted (Furukohri et al., 2012). We have previously shown that PrimPol displays very 
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low processivity as a polymerase, incorporating only ~4 bases per binding event, 
suggesting that the enzyme is only required for very short stretches of DNA synthesis 
(Keen et al., 2014b). Notably, the ZnF domain of PrimPol, which only binds ssDNA, is 
involved in modulation of the enzymes processivity (Keen et al., 2014b). This domain is 
believed to be spatially separated from the polymerase domain, fulfilling a role in 
regulating both the primase and polymerase activities of PrimPol.  This distributive nature 
of PrimPol likely acts as the primary level of regulation to limit the involvement of PrimPol 
in DNA synthesis. Indeed, the limiting effect of SSBs on PrimPols polymerase activity 
may be in part due to the prevention of rebinding of the enzyme to ssDNA, following its 
dissociation as a result of its low processivity. However, interestingly, we also find that 
the 24-354 truncation of PrimPol, lacking the ssDNA binding ZnF domain, is also 
inhibited by SSBs. These results suggest that, in addition to the low processivity of 
PrimPol, RPA and mtSSB contribute to restraining the enzyme to limit its potentially 
mutagenic DNA synthesis during replication restart. However, it is possible that in vivo
additional remodeling factors may permit synthesis by PrimPol on SSB-coated DNA. The 
contrasting effects of SSBs on replicative polymerases and PrimPol do, however, 
suggest a potential mechanism of regulation represented by a model summarised in 
Figure 2.19.
The stimulatory effect of SSBs on the progression of replicative polymerases permits 
DNA synthesis on SSB-coated DNA until a lesion is encountered on the template strand 
(Figure 2.19.A.). The intolerant replicative polymerase stalls at the lesion and idles 
upstream, as a result of its 3-5 exonuclease activity (Garg et al., 2004), consequently 
displacing any surrounding SSBs and generating a ssDNA interface for access of 
PrimPol (Figure 2.19.B.). PrimPol is then recruited to the SSB bound immediately 
downstream of the lesion via its RBD, additionally binding the exposed ssDNA interface 
through its ZnF domain. Subsequently, PrimPol utilises its AEP domain to perform a TLS 
reaction, extending the primer terminus over the DNA lesion, before further extension is 
prevented by the downstream SSB (Figure 2.19.C.). Bypass of the lesion allows 
replication to proceed, with the previously stalled replicative polymerase continuing 
extension (Figure 2.19.D.). 
Importantly, DNA synthesis by PrimPol is limited by SSBs which likely act to ensure that 
the enzyme only participates in the synthesis of short stretches of DNA. This level of 
regulation may be necessary due to the mutagenic potential of PrimPol. We provide 
experimental evidence that PrimPol is a highly error-prone DNA polymerase. Strikingly, 
in two forward mutation assays, PrimPol shows a strong propensity to indel errors. Within 
the HSV-tk sequence, PrimPol created indel errors almost exclusively, with base 
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Figure 2.19. Model for regulation of PrimPol synthesis by SSBs during DNA replication. 
(A) Unperturbed replication proceeds up to the lesion on the SSB-bound ssDNA template, with the replicative DNA polymerase displacing the bound SSB as 
it synthesises the daughter DNA strand. (B) Replication continues until a lesion is encountered, here the intolerant replicative polymerase stalls at the lesion 
and idles upstream, displacing any surrounding SSBs and generating a ssDNA interface. This allows recruitment of PrimPol to the downstream SSB, with 
additional binding to the exposed ssDNA interface through the ZnF domain. (C) PrimPol utilises its AEP domain to catalyse a TLS reaction, here the primer 
terminus is extended over the lesion before further synthesis is prevented by the downstream SSB. (D) Following bypass of the lesion, the replicative 
polymerase again proceeds with replication. 
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insertions accounting for more than one-third of PrimPols error spectrum (Figure 
2.17.B.). We observed a unique mutational hot-spot for PrimPol (Figure 2.17.C.). This 
region is rich with [CG] repeats, and contains several sequences with the potential to 
form hairpin structures. The single base insertion events can be explained by classic 
primer strand misalignment, while the complex events are more difficult to dissect. 
However, the common result of both insertion and complex errors within this hotspot is 
the expansion [T]2 to [T]3, suggesting that the PrimPol complex errors are generated 
primarily within the loop of the hairpin. PrimPol can displace the template strand when 
copying sequences with microhomology (Mourón et al., 2013). Possibly, at the HSV-tk 
hotspot sequence, PrimPol is forced to slip both the primer and template strand to get 
through the hairpin. While this mechanism is speculative, the data we present do confirm 
that PrimPols error specificity is unique from other human polymerases. Together, our 
observations support the template scrunching mechanism, which PrimPol can employ to 
skip damaged nucleobases (Mourón et al., 2013). Initially, the scrunching mechanism 
was observed in the presence of manganese ions during translesion bypass of Ap sites 
and UV damage lesions (Mourón et al., 2013). Our data suggest that the same 
scrunching mechanism is utilised by this enzyme when copying non-damaged DNA, in 
the presence of magnesium ions. 
Therefore, PrimPols modus operandi during synthesis appears to be a double-edged 
sword, facilitating replication restart at bulky lesions (e.g. 6-4PPs) but potentially 
introducing base insertions and deletions into undamaged templates. This threat to 
genomic integrity requires tight regulation of the activity of PrimPol during DNA 
replication and we propose that PrimPols inability to displace SSBs at the replication 
fork ensures that the mutagenic potential of this enzyme is greatly limited. In addition, 
nuclear PrimPol is active primarily in S-phase (Mourón et al., 2013). Intermolecular 
proofreading of PrimPol synthesis products by either Pols  or  could limit mutagenesis. 
Similarly, in mitochondria, pol , which has a very active exonuclease domain, could 
correct PrimPols errors. Finally, the error-prone bypass of lesions by PrimPol produces 
a structure that is readily detected by the post-replicative MMR machinery. Clearly, 
PrimPols important role in replication and the prevention of chromosomal instability must 
be balanced with its potential mutagenic activity.
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Chapter 3
PolDIP2 Interacts with Human PrimPol 
and Enhances its DNA Polymerase 
Activities
108
3.1. Abstract 
TLS employs specialised DNA polymerases to bypass replication fork stalling lesions. 
PrimPol was recently identified as a primase and TLS polymerase involved in DDT. Here, 
we identify a novel PrimPol binding partner, PolDIP2, and describe how it regulates 
PrimPols enzymatic activities. PolDIP2 stimulates the polymerase activity of PrimPol, 
enhancing both its capacity to bind DNA and the processivity of the catalytic domain. In 
addition, PolDIP2 stimulates both the efficiency and error-free bypass of 8-oxo-dG 
lesions by PrimPol. We show that PolDIP2 binds to PrimPols catalytic domain and 
identify potential binding sites. Finally, we demonstrate that depletion of PolDIP2 in 
human cells causes a decrease in replication fork rates, similar to that observed in 
PrimPol-/- cells. However, depletion of PolDIP2 in PrimPol-/- cells does not produce a 
further decrease in replication fork rates. Together, these findings establish that PolDIP2 
can regulate the TLS polymerase and primer extension activities of PrimPol, further 
enhancing our understanding of the roles of PolDIP2 and PrimPol in eukaryotic DDT. 
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3.2. Introduction 
In eukaryotes, the replicative polymerases , , and  are primarily responsible for bulk 
DNA replication. These enzymes, which duplicate DNA with extremely high efficiency 
and accuracy, are prone to stalling upon encountering helix-distorting DNA lesions 
generated by DNA damage (Aguilera and Gómez-González, 2008). The inability of the 
replicative polymerases to synthesise across damaged nucleobases in turn causes 
replication fork stalling and requires DDT mechanisms in order to proceed with 
replication and prevent fork collapse (Li and Heyer, 2008; Sale et al., 2012). 
A number of distinct replication restart mechanisms exist in order to permit continued 
replication in the presence of damage. These include the firing of dormant origins 
downstream of the damage, the generation of new Okazaki fragments on the lagging 
strand or repriming on the leading strand, the use of an alternative sister template to 
bypass the damage via HR, and direct synthesis past the damage through TLS (Heller 
and Marians, 2006; Li and Heyer, 2008; Sale et al., 2012). Whilst it has long been 
appreciated that specialised DNA polymerases, particularly those of the Y-family, play a 
key role in eukaryotic DDT by TLS, the role of DNA primases in this process has until 
recently been mostly overlooked. However, novel roles for primases in DNA repair and 
damage tolerance are emerging from both archaea and eukarya (Guilliam et al., 2015b). 
Notably, archaeal replicative primases are now known to display TLS activity 
(Jozwiakowski et al., 2015), whilst most eukaryotes possess a specialised primase-
polymerase (PrimPol) that appears to play roles in TLS and repriming (Rudd et al., 2014).
PrimPol is a member of the AEP superfamily (Guilliam et al., 2015b) and demonstrates 
primer synthesis capabilities with both rNTPs and dNTPs (Bianchi et al., 2013; García-
Gómez et al., 2013; Rudd et al., 2013). In addition, the enzyme displays robust template-
dependent TLS polymerase activity, which it utilises to bypass 6-4PPs and 8-oxo-dG
lesions (Bianchi et al., 2013; García-Gómez et al., 2013). These activities have been 
shown to be relevant in vivo as cells lacking PrimPol show increased sensitivity to DNA 
damaging agents and decreased replication fork speeds (Bianchi et al., 2013; Keen et 
al., 2014b). In vivo PrimPol localises to both the nucleus and mitochondria, indeed 
PrimPol-/- cells also present mtDNA replication defects (Bianchi, 2013; García-Gómez et 
al., 2013). Unlike canonical Y-family polymerases, PrimPol does not seem to be 
regulated through interactions with PCNA (Guilliam et al., 2015a). Despite this, PrimPol 
is a low fidelity polymerase and alternative mechanisms must exist to regulate its activity 
in vivo (Guilliam et al., 2015a). One such regulator is the inherent distributive nature of 
the enzyme, which limits incorporation to ~4 nucleotides per binding event (Keen et al., 
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2014b). In addition, PrimPols activities are also regulated by its association with SSBs
(Guilliam et al., 2015a). Interactions with these proteins may also be involved in the 
recruitment of PrimPol to the replisome (Wan et al., 2013). Nevertheless, it is likely that 
additional replication factors also regulate the activity of PrimPol during replication. 
In addition to SSBs, PolDIP2 (also known as PDIP38) was also identified in a pull-down 
screen as a possible cellular binding partner of PrimPol (Guilliam et al., 2015a). Recently, 
it was reported that PolDIP2 may play a role in DDT, specifically through the regulation 
of TLS (Maga et al., 2013; Tissier et al., 2010). However, PolDIP2 is a relatively 
understudied protein, which has been ascribed multiple roles in vivo and its function in 
DNA replication is still unclear. This protein was first identified through yeast two-hybrid 
screening as a binding partner of the p50 subunit of Pol , as well as PCNA (Liu et al., 
2003). Further characterisation suggested that PolDIP2 is a mitochondrial protein 
(Cheng et al., 2005), which inhibits Pol  and might be involved in Pol -mediated viral 
DNA replication (Xie et al., 2005). However, in contrast to this initial characterisation, 
more recent studies have identified that PolDIP2 also localises to the nucleus (Wong et 
al., 2013) and actually stimulates the activity of Pol  in vitro (Maga et al., 2013). 
Additionally, PolDIP2 has been shown to increase the processivity and fidelity of lesion 
bypass by Pols  and  (Maga et al., 2013). The protein was previously found to interact 
with Pols , 	, and Rev1, with depletion causing persistent Pol  nuclear foci and 
decreased cell survival following UV (Tissier et al., 2010). 
Aside from a potential role in DNA replication, PolDIP2 has also been reported to have 
roles in regulating the nuclear redox environment (Lyle et al., 2009), mitotic spindle 
formation (Klaile et al., 2008), and in pre-mRNA processing in the spliceosome (Wong 
et al., 2013). The multitude of roles assigned to PolDIP2 highlights the multi-functional 
nature of the protein but also obscures the interpretation of many results. This has 
brought into question the role of PolDIP2 in TLS and DNA replication (Wong et al., 2013),
thus necessitating further study to properly characterise its function in these areas. 
In this report, we aimed to further explore the regulation of PrimPol, and the role of 
PolDIP2 in TLS, by investigating the relationship between these two proteins. We 
observed that PolDIP2 stimulates the polymerase activity of PrimPol. This stimulation 
appears to be the result of an increase in DNA binding by PrimPol in the presence of 
PolDIP2, consequently producing an increase in the processivity of the enzyme to levels 
not previously observed. Furthermore, we found that PolDIP2 alone is sufficient to 
stimulate the efficiency and fidelity of 8-oxo-dG bypass by PrimPol, an effect similar to 
that seen with Pols  and  in the presence of PCNA, RPA and PolDIP2 (Maga et al., 
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2013). We used cross-linking and MS analysis to investigate the interaction between 
PrimPol and PolDIP2. We found that PolDIP2 binds to the catalytic domain of PrimPol 
and identify potential binding sites, including a region displaying homology to the 
previously identified PolDIP2-interacting region of Pol  (Tissier et al., 2010). Finally, we 
explored the role of PolDIP2 in replication in vivo. We observed that depletion of PolDIP2 
decreased replication fork rates in human cells following UV irradiation. The level of 
decrease in replication fork rates was similar to that observed in the absence of PrimPol 
and, additionally, no further decrease in fork speeds was evident when PolDIP2 was 
depleted in PrimPol-/- cells. Together, these findings support a role for PolDIP2 in 
regulating TLS and enhancing the primer extension activities of PrimPol during DNA 
replication. We propose that PolDIP2 acts specifically to enhance PrimPols primer 
extension and TLS activities, whilst having minimal effect on its primase activity. Overall, 
this study provides further evidence for the involvement of both PrimPol and PolDIP2 in 
DDT during replication in higher eukaryotes.  
3.3. Materials and Methods
3.3.1. Expression and Purification of Recombinant Proteins 
Full-length Human PrimPol and PrimPol24-354 were cloned and purified as described 
previously (Guilliam et al., 2015a; Keen et al., 2014b). Recombinant GST-PolDIP2, Pol 
, PCNA, RPA, and mtSSB, were expressed and purified as previously reported 
(Biertümpfel et al., 2011; Longley et al., 2009; Maga et al., 2013; Masuda et al., 2007). 
Untagged PolDIP2 was purified from GST-PolDIP2 through cleavage of the GST tag 
using PreScission protease before further purification using a GSTrap column and ion 
exchange chromatography to remove the cleaved GST tag and protease. 
PolDIP251-368 was constructed by PCR using the following forward and reverse primers; 
FWD: 5-GTTTCTTCATATGCTCTCGTCCCGAAACCGACCAGAGGGCAAA-3, REV: 
5-CAAAGAAGCGGCCGCCTACCAGTGAAGGCCTGAGGG-3, followed by cloning 
into pET28a via the introduced NdeI and NotI restriction sites. The resulting construct 
was expressed in E. coli at 20°C overnight. Cells were then pelleted before resuspension 
in buffer A (50 mM TrisHCl (pH 7.5), 200 mM NaCl, 30 mM imidazole, 10% (v/v) 
glycerol, 17 
g/ml PMSF, 34 
g/ml benzamidine) supplemented with IGEPAL to a final 
concentration of 0.5%. Cells were lysed by sonication and the lysate clarified by 
centrifugation. The clarified lysate was applied to a Ni2+-NTA agarose chromatography 
column (Qiagen) pre-equilibrated with buffer A. The protein was eluted with buffer A 
supplemented with 300 mM imidazole following sufficient washing. The resulting eluate 
was diluted into buffer B (50 mM TrisHCl (pH 8.5), 50 mM NaCl, and 10% (v/v) glycerol) 
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and subject to ion exchange chromatography using a 5 ml MonoS column (GE 
Healthcare) prior to a gradient elution with buffer B containing 1 M NaCl. Fractions 
containing PolDIP251-368 were further purified by size exclusion chromatography on a 
Superdex S-75 analytical gel-filtration column (GE Healthcare) equilibrated with buffer C 
(50 mM TrisHCl (pH 7.5), 300 mM NaCl, 10% (v/v) glycerol). 
Following purification, all proteins were snap frozen in liquid nitrogen and stored at -80°C. 
Protein concentrations were calculated based on sample absorbance at 280nm and 
corrected to the protein specific extinction coefficient as determined using the ProtParam 
tool (ExPASy). 
3.3.2. Electrophoretic Mobility Shift Assays
Assays were performed as previously described (Guilliam et al., 2015a) in 20 
l reactions 
containing 10 mM Bis-Tris-Propane-HCl (pH 7.0), 10 mM MgCl2, 100 
M DTT, 20 nM 
primer/template substrate (sequences 2 and 9, Table 2.1.), and varying concentrations 
of PrimPol and PolDIP2 (as indicated on individual figures). Reactions were resolved on 
5% (v/v) native polyacrylamide gels at 75 V for 60min in 0.5x TBE buffer. Fluorescently 
labelled DNA was detected using a FujiFilm FLA-5100 image reader.
3.3.3. DNA Primase Assays
Reactions were assembled in buffer containing 10 mM Bis-Tris-Propane-HCl (pH 7.0), 
10 mM MgCl2, and 100 
M DTT, supplemented with 2 
M PrimPol, 250 
M dNTPs, 2.5 

M FAM dNTPs (dATP, dCTP, dUTP) (Jena-Biosciences), 1 
M single-stranded 
template (sequence 17, Table 2.1), and varying concentrations of PolDIP2 or GST (as 
indicated on individual figures). Reactions were incubated at 37°C for 15 mins before 
quenching in binding-washing (B-W) buffer (10 mM Tris-HCl pH 7.5, 500 mM NaCl, 10 
mM EDTA). Quenched reactions were incubated with ~20 
l streptavidin coated beads 
for 1 hour at 4°C to allow capture of the DNA templates and primase reaction products. 
Following capture, beads were washed 3 times with 1 mL volumes of B-W buffer before 
final suspension in 20 
L stop buffer (95% formamide solution with 0.25% bromophenol 
blue and xylene cyanol dyes). Samples were then boiled for 5 mins and products 
detected by resolution on a 15% (v/v) polyacrylamide gel containing 7 M urea and 1x 
TBE buffer run at 850 V for 2.5 hours in 1x TBE. Reaction products were visualised using 
a FujiFilm FLA-5100 image reader.
3.3.4. DNA Primer Extension Assays
Reactions (20 µl) were assembled containing; 20 nM 5 Hexa-chlorofluorescein (HEX)-
labelled DNA primers annealed to the appropriate DNA templates (Sequences 1-5, 7, 9, 
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11-15, and 17, Table 2.2.), 10 mM Bis-Tris-Propane-HCl (pH 7.0), 10 mM MgCl2, 100 

M DTT, and 100 µM dNTPs. Reactions were supplemented with varying amounts of 
PrimPol or Pol  (as indicated in figure legends), and incubated at 37ºC (time points are 
shown in figure legends). Where present, accessory proteins were added prior to the 
addition of the enzyme at the concentrations indicated on figures. In the case of single 
nucleotide incorporation analysis, dNTPs were substituted for 100 µM of the single dNTP 
being analysed (dATP, dCTP, dGTP, or dCTP). Reactions were quenched with buffer 
containing 95% formamide, 0.05% bromophenol blue, 0.09% xylene cyanol, and 200 nM 
competitor oligonucleotide. Quenched reactions were heated to 95ºC for 5 mins before 
electrophoresis on a 15% (v/v) polyacrylamide/7 M urea gel. Extended fluorescent 
primers were imaged using a FujiFilm FLA-5100 image reader. All quantification was 
performed using ImageQuant TL software (GE Life Sciences). Data were plotted and 
analysed using GraphPad Prism 6.
3.3.5. Polymerase Processivity Assays
PrimPols processivity in the presence of varying amounts of PolDIP2 was analysed 
using the method previously described (Keen et al., 2014b). Extension reactions were 
assembled containing 100 nM PrimPol, varying concentrations of PolDIP2, 40 nM 
primer/template substrate (sequences 2 and 9, Table 2.2.), 10 mM Bis-Tris-Propane-HCl 
(pH 7.0), 10 mM MgCl2, and 100 
M DTT, and incubated at 37ºC. Reactions were 
initiated by supplementation with 100 µM dNTPs and 1 mg/ml sonicated herring sperm 
trap DNA. Reaction products were monitored over a time course and quenched at 
various time points (as indicated in figure legends) using buffer containing 95% 
formamide, 0.05% bromophenol blue, 0.09% xylene cyanol, and 200 nM competitor 
oligonucleotide. The efficiency of the trap DNA was analysed using control reactions 
containing the trap DNA in the initial reaction assembly to ensure no extension was 
observed. Extension products were resolved and imaged as described in DNA primer 
extension assays. Reaction products were quantified using ImageQuant TL software 
(GE Life Sciences) and the previously described method (Keen et al., 2014b).
3.3.6. Crosslinking and Mass Spectrometry Analysis 
Purified untagged-PolDIP2 and PrimPol24-354 were mixed at equimolar concentrations in 
buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, and 10% (v/v) glycerol, for 30 
mins on ice to allow binding. Following this, protein samples were supplemented with 
bis(sulfosuccinimidyl)suberate (BS3) crosslinker at increasing concentrations (from 1:1 
to 20:1 crosslinker:protein molar ratios). Samples were incubated on ice for 45 mins to 1 
h to allow crosslinking reactions to proceed, before quenching with 50 mM Tris and 
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further incubation for 15 mins. Crosslinked samples were supplemented with Laemmli 
buffer and resolved by electrophoresis on a polyacrylamide gel. Bands corresponding to 
a 1:1 PrimPol:PolDIP2 complex molecular weight were excised and processed for MS
as described (Shevchenko et al., 2007). 
MS samples were analysed using a nano-LC-MS (ThermoFisher U3000 nanoLC and 
Orbitrap XL mass spectrometer) as previously described (Hatimy et al., 2015). Raw MS 
and MS/MS spectra were converted to the .mgf format using Compass (Wenger et al., 
2011) and searched against the SwissProt database with Mascot (Matrix Science). 
Search parameters employed a precursor tolerance of 5 ppm and a fragment ion 
tolerance of 0.6 Da. Crosslinked peptides were identified by analysing .mgf files using 
StavroX crosslinking analysis software as described previously (Götze et al., 2012). 
3.3.7. Cell Culture and DNA Fibre Analysis 
MRC5 cells were cultured in MEM supplemented with 15% FCS, 1% L-glutamine and 
1% PenStrep (v/v), at 37°C in CO2 controlled incubators. Cells were transfected with 
PolDIP2 siRNA (SMARTpool ON-TARGET plus siRNA Thermo Fisher Scientific), or 
mock siRNA treated, using Lipofectamine RNAiMAX (Invitrogen) according to the 
manufacturers instructions. 72 h following siRNA transfection cells were subject to DNA 
fibre analysis as described previously (Bianchi et al., 2013). All DNA fibre analysis was 
performed in triplicate. MRC5 PrimPol-/- cells were generated using the zinc finger 
nuclease knockout method according to the manufacturers recommendations (Sigma-
Aldrich).
3.4. Results
3.4.1. PolDIP2 Stimulates the Polymerase Activity of PrimPol 
PolDIP2 was originally identified in a large-scale pull-down/MS screen previously 
performed to identify cellular binding partners of PrimPol (Guilliam et al., 2015a; Rudd, 
2013). This screen also identified the SSBs, RPA and mtSSB, as interacting partners of 
PrimPol, whilst an interaction with PCNA was not established. Further studies suggested 
that RPA and mtSSB regulate PrimPols enzymatic activities and revealed that, unlike 
canonical TLS polymerases, PrimPol is not stimulated by the presence of PCNA in vitro 
(Guilliam et al., 2015a). In light of reports implicating PolDIP2 in the regulation of TLS 
(Maga et al., 2013; Tissier et al., 2010), we aimed to analyse whether PolDIP2 might 
also act as a PrimPol regulator. To do this, we employed primer extension assays on a 
20/50-mer DNA primer/template substrate (sequences 2 and 5, Table 2.2.), in the 
presence of increasing concentrations of GST-PolDIP2. When titrated into primer 
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extension reactions containing PrimPol, we observed that PolDIP2 stimulated the activity 
of the enzyme, producing an increase in the amount of extended primers in a dose-
dependent manner (Figure 3.1.A.). Notably, PolDIP2 generated a similar effect when 
titrated into reactions containing PrimPol1-354, a truncation of the enzyme comprising the 
catalytic AEP domain only. Intriguingly, when plotted, these data produced a sigmoidal 
kinetic profile, suggesting that PrimPol may bind multiple PolDIP2 molecules (Figure
3.1.B.). Indeed, assays using both full-length PrimPol and PrimPol1-354, generated Hill 
coefficients of 5.176 ± 1.481 and 5.258 ± 1.466 respectively, revealing positive 
cooperativity in PolDIP2 binding. The Khalf values for both PrimPol and PrimPol1-354 were 
41 ± 1.817 nM and 33.93 ± 2.112 nM, respectively, with stimulation slightly more 
pronounced for the truncated enzyme. 
Furthermore, at higher PrimPol and PolDIP2 concentrations an increase in the length of 
extended primers, with a significant increase in the amount of fully extended primers, 
was observed (Figure 3.1.C. and D. and Figure 3.2.). Notably, the GST-tag was not 
responsible for this stimulation as GST alone did not affect the polymerase activity of 
PrimPol (Figure 3.2.). In line with previous reports (Maga et al., 2013), GST-PolDIP2 was 
used for these assays due to the ease of purification and increased solubility over the 
untagged protein. These results establish that PolDIP2 is able to stimulate the 
polymerase activity of PrimPol, increasing both the amount and length of extended 
primers. 
Given the stimulatory effects of PolDIP2 on the polymerase activity of PrimPol, we next 
sought to assess if it also modulated PrimPols primase activity. To determine this, we 
analysed the primase activity of the enzyme on a 66-mer mixed sequence ssDNA 
template (sequence 17, Table 2.1.) in the presence of increasing concentrations of GST-
PolDIP2 or GST alone. As observed previously (Schiavone et al., 2016), PrimPol was 
able to synthesise primers on this ssDNA template in the absence of PolDIP2 or GST. 
When present, PolDIP2 did not significantly increase the amount of primers synthesised 
(Figure 3.3.). However, in the presence of PolDIP2, PrimPol did appear to extend 
generated primers further. This supports a scenario where PolDIP2 is unable to increase 
the rate at which primers are synthesised but is able to increase the rate and length to 
which these primers are extended. 
3.4.2. PolDIP2 Enhances PrimPols DNA Binding 
PrimPol has previously been shown to bind relatively poorly to DNA (Keen et al., 2014b), 
thus it seems likely that additional factors assist it in the coordination of DNA in vivo.
Previously, it was reported that PolDIP2 increases the DNA binding affinity of Pol , whilst 
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Figure 3.1. PolDIP2 stimulates the polymerase activity of PrimPol.
(A) PrimPol or PrimPol1-354 (20 nM) were incubated with 5 labelled primer/template DNA 
substrates (20/50-mer; 20 nM) and dNTPs (100 µM) in the presence of increasing 
concentrations of GST-PolDIP2 (0, 10, 20, 40, 60, 80, 100, and 120 nM) for a single 5 minute 
timepoint. C indicates the no enzyme control reaction. (B) Relative increase in the rate of 
primer extension by PrimPol and PrimPol1-354 in the presence of increasing GST-PolDIP2 
concentrations (0, 10, 20, 40, 60, 80, 100, and 120 nM). Data were fitted using GraphPad Prism 
6 software. Values are the means of four independent experiments. Error bars are ± SD. (C)
PrimPol generates a greater proportion of fully extended primers in the presence of PolDIP2. 
PrimPol (100 nM) was incubated with 5 labelled primer/template DNA substrates (20/50-mer; 
20 nM) and dNTPs (100 µM) in the presence of increasing GST-PolDIP2 concentrations (0, 
0.1, 0.2, 0.4, and 0.8 µM) for increasing timepoints (0, 1, 3, 5, 10, and 20 mins) Fully extended 
primers (as indicated on Figure 3.2.) were quantified for each timepoint as a percentage with 
respect to the total primers present. Data were fitted using GraphPad Prism 6 software. Values 
are the means of three independent experiments. Error bars are ± SD. Representative gels 
used for quantification are shown in Figure 3.2. (D) Fold increase in fully extended primers by 
PrimPol in the presence of increasing PolDIP2/PrimPol molar ratios at a single 3 min timepoint. 
Data were fitted using GraphPad Prism 6 software. Values are the means of three independent 
experiments. Error bars are ± SD. Representative gels used for quantification are shown in 
Figure 3.2.
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Figure 3.2. PolDIP2 stimulates full-length primer extension by PrimPol.
PrimPol (100 nM) was incubated with 5 labelled 20/50-mer primer/template substrates (20 nM) and dNTPs (100 µM) in the absence or presence of increasing 
concentrations of GST-PolDIP2 over a time course (1, 3, 5, 10, 20 mins). C indicates the no enzyme control. Quantification of the data is shown in Figure 
3.2.C. and D.  
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Figure 3.3. PolDIP2 does not increase primer synthesis by PrimPol.
(A) The primase activity of PrimPol was analysed in the absence and presence of GST-PolDIP2 or GST only over a range of concentrations (as indicated).
(B) Quantification of the data shown in A, showing the percentage of primer synthesis reaction products generated in the presence of varying concentrations 
of GST-PolDIP2 or GST only. Nucleotide (Nt) size markers are shown on the left of the figure.
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lacking the capacity to bind DNA itself (Maga et al., 2013). Consequently, the effect of 
PolDIP2 on the DNA binding of PrimPol was analysed. To this end, EMSAs were 
performed using a 20/97-mer DNA primer/template substrate (sequences 2 and 9, Table 
2.1.) in the presence of varying amounts of untagged-PolDIP2 and PrimPol. In order to 
analyse the effect of PolDIP2 on the DNA binding affinity of the catalytic domain of 
PrimPol only, a truncation of the enzyme (PrimPol24-354) was used that contained only the 
AEP domain. Importantly, this eliminates possible binding artefacts being introduced by 
the presence of  the ssDNA-binding ZnF domain (Keen et al., 2014b). 
When titrated into EMSAs supplemented with a fixed concentration of PolDIP2, PrimPol 
bound to a significantly increased amount of DNA compared to EMSAs with PrimPol 
alone (Figure 3.4.A. and B.). Consistent with previous reports, PolDIP2 alone showed no 
ability to bind the DNA substrate (Maga et al., 2013), suggesting that this increase in 
binding was due to PolDIP2s effect on PrimPol. A smaller increase in binding was also 
observed when PolDIP2 was titrated into EMSAs with a fixed concentration of PrimPol 
(Figure 3.4.C and D.). Together, these data show that PolDIP2 exerts a similar influence 
on the DNA binding avidity of PrimPol, as previously reported for Pol  (Maga et al., 
2013). Furthermore, this confirms that PrimPol forms a complex with PolDIP2 on the 
DNA. As these assays were conducted with the AEP domain alone, it suggests that 
PolDIP2 binds PrimPol via the catalytic domain. This is in agreement with the stimulation 
observed in primer extension assays, as is also the case with Pol  (Maga et al., 2013).
3.4.3. PolDIP2 Increases the Processivity of PrimPol 
PrimPol is a poorly processive polymerase, incorporating only ~4 nt per binding event 
(Keen et al., 2014b). Interestingly, it has previously been shown that this low processivity 
is partially due to the restraining effect of the ZnF domain, in combination with the 
enzymes weak affinity for DNA binding (Keen et al., 2014b). The ssDNA binding activity 
of the ZnF domain is thought to produce inter-domain collisions with the catalytic AEP 
domain following synthesis of ~4 nt, thus limiting PrimPols contribution to DNA synthesis 
to very short stretches. However, in light of the fact that PolDIP2 can increase PrimPols 
DNA binding ability, we hypothesised that the protein may also increase PrimPols 
processivity. To investigate this, we employed a standard primer extension assay on 
DNA primer/template substrates (20/97-mer) in the presence of excess unlabelled trap 
DNA. Pre-incubation of PrimPol and the DNA template before initiation with dNTPs and 
a DNA trap allowed incorporation during a single association/dissociation event to be 
analysed and thus enabled us to determine the processivity of the enzyme. 
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Figure 3.4. PolDIP2 enhances the DNA binding of the AEP domain of PrimPol. 
(A) Increasing concentrations of PrimPol24-354 (0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.75, 1 µM) were incubated in EMSA reactions containing 5-labelled 20/97-mer 
primer/template substrates in the absence or presence of untagged-PolDIP2 (100 nM). The PolDIP2 lane indicates the no PrimPol control, showing that 
PolDIP2 (100 nM) alone does not bind to the primer-template substrate. (B) Quantification of the data presented in A. For each PrimPol concentration the 
percentage of DNA bound (in relation to the total DNA) was calculated and compared for EMSAs containing PrimPol only, or PrimPol and PolDIP2. (C)
PrimPol24-354 alone (0, 0.2, 0.5 and 1 µM) and with increasing concentrations of PolDIP2 (200 nM PrimPol; 0, 50, 100 and 250 nM PolDIP2) was incubated in 
EMSA reactions containing 5-labelled 20/97-mer primer-template substrates. (D) Quantification of the data shown in C. For each PolDIP2 concentration the 
percentage of DNA bound (in relation to the total DNA) was calculated. Reactions containing PolDIP2 only again confirm that PolDIP2 alone does not bind 
to the primer-template substrate.
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In the absence of PolDIP2, PrimPols processivity was in line with the previously 
determined levels, confirming the efficiency of the DNA trap (Keen et al., 2014b). 
However, when titrated in identical reaction conditions, PolDIP2 produced a significant 
dosage-dependent increase in the processivity of PrimPol (Figure 3.5.A., B., and C.). At 
the highest concentration of PolDIP2 (1.6 
M) and longest time point (2 mins), products 
of more than 16 nt in length were visible, representing a > 4-fold increase in PrimPols 
processivity. In addition to the increased length of the synthesised products, PrimPol 
also produced longer products more rapidly in the presence of PolDIP2. This is 
evidenced by analysing reaction products from the shortest time point where, in the 
absence of PolDIP2, PrimPol had still not synthesised products of 4 nt in length. In 
contrast, in the presence of PolDIP2 products > 8 nt in length were apparent. Again, no 
stimulation of processivity was observed in the presence of GST alone, confirming that 
the GST tag is not causing this effect. Furthermore, untagged PolDIP2 was able to 
produce similar increases in processivity when used at higher concentrations (Figure 
3.6.). Higher concentrations were probably required due to the decreased solubility of 
the protein in the absence of the GST tag. Together, these data reveal that in the 
presence of PolDIP2, PrimPol produces longer products more efficiently in a single 
binding event compared to PrimPol alone. Importantly, these results suggest that 
PrimPol is potentially involved in synthesis of longer stretches of DNA than previously 
thought. 
3.4.4. PolDIP2 Does Not Allow PrimPol to Displace SSBs
We previously observed that, unlike many replicative polymerases, PrimPol was unable 
to displace both RPA and mtSSB from DNA during synthesis and we proposed a model 
whereby these SSBs regulate PrimPols activity to restrict the enzymes potentially 
mutagenic contribution to DNA replication (Guilliam et al., 2015a). However, in light of 
the increased processivity and DNA binding potential of PrimPol when in complex with 
PolDIP2, we postulated that this complex might be able to overcome negative regulation 
by SSBs. To test this hypothesis, we employed standard primer extension assays with 
PrimPol in the presence of PolDIP2 and RPA or mtSSB. Here, PolDIP2 was unable to 
relieve the inhibitory effects of RPA and mtSSB on the primer extension activity of 
PrimPol (Figure 3.7.). In each case, primer extension was significantly inhibited when 
compared to reactions in the absence of accessory proteins. These results show that 
even in the presence of PolDIP2, PrimPol is unable to displace SSBs from DNA and is 
therefore unable to overcome their negative regulatory effects. 
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Figure 3.5. PolDIP2 enhances the processivity of PrimPol.
(A) PolDIP2 was titrated into reactions containing PrimPol (100 nM) and 5 labelled 20/97-mer primer/template substrates (20 nM). Reactions were initiated 
with dNTPs (100 µM) and excess trap DNA and quenched at 0.5, 1, and 2 min time-points. Reactions containing GST only show no increase in PrimPols 
processivity. C indicates the control reaction with trap DNA added before the enzyme. (B) Quantification of processivity reactions containing either PrimPol 
alone, or PrimPol and PolDIP2 (1.6 µM). Reaction products were quantified as a function of their size in relation to the total primers present for each time-
point. Data represent the means of three independent experiments. Error bars are ± SD. (C) Quantification of PrimPol processivity in the presence of 
increasing GST-PolDIP2 concentrations (as shown) at the 2 min timepoint. Reaction products were quantified as a function of their size in relation to the total 
primers present for each time-point. Data represent the means of three independent experiments. Error bars are ± SD.
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Figure 3.6. Untagged PolDIP2 increases PrimPols processivity at higher concentrations. 
Untagged-PolDIP2 was titrated into reactions containing PrimPol (100 nM) and 5 labelled 20/97-mer primer/template substrates (20 nM). Reactions were 
initiated with dNTPs (100 µM) and excess trap DNA and quenched at 0.5, 1, and 2 min time-points.
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Figure 3.7. PolDIP2 does not allow PrimPol to displace mtSSB or RPA. 
The primer extension activity of PrimPol was analysed in the absence and presence of PolDIP2 and mtSSB or RPA using a 5 labelled 20/97-mer 
primer/template substrate. C indicates the no enzyme control.
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3.4.5. PrimPol is Inhibited in the Presence of Both PolDIP2 and PCNA
PolDIP2 has previously been found to interact with PCNA (Liu et al., 2003). Coupled with 
this, it has been shown that the protein can increase the affinity of Pol  for PCNA, 
resulting in increased stimulation of the enzymes polymerase activity in presence of 
PolDIP2 and PCNA over either factor alone (Maga et al., 2013). These studies suggest 
that PolDIP2 is able to act as a bridging factor to help tether polymerases to PCNA, 
leading to further stimulation of their activity. It was previously found that PrimPol does 
not interact with, and is not stimulated in the presence of, PCNA (Guilliam et al., 2015a). 
This apparent lack of interaction and stimulation by PCNA is in contrast with canonical 
TLS polymerases, leading to speculation that PrimPol is not regulated by the PCNA-
mediated polymerase switch mechanism, which regulates the activity of the Y-family TLS 
polymerases. However, given that PolDIP2 can interact with PCNA, it is possible that the 
protein might act as a bridging partner between PrimPol and PCNA, thus allowing 
PrimPol to be regulated by the classical PCNA-mediated polymerase switch model. To 
test this, we again used standard primer extension assays with PrimPol in the presence 
of PCNA alone or PCNA and PolDIP2. As shown previously, in the presence of PCNA 
PrimPols activity is not affected, with no stimulation or inhibition observed compared to 
PrimPol alone (Figure 3.8.). However, somewhat unexpectedly, in the presence of both 
PCNA and PolDIP2, PrimPols polymerase activity was actually inhibited when 
compared to reactions with the enzyme alone, or with PCNA only. This inhibitory effect 
may be due to PolDIP2 associating with, and stabilising, PCNA on the primer/template 
substrate and in turn blocking access by PrimPol. Nevertheless, this suggests that 
PolDIP2 does not act to tether PrimPol to PCNA, and in opposition to what has previously 
been reported with Pol , PCNA prevents stimulation of PrimPol by PolDIP2. These 
results further support the proposal that PrimPol is regulated by a mechanism distinct 
from that employed by canonical Y-family TLS polymerases. 
3.4.6. PolDIP2 Increases the Efficiency and Fidelity of 8-oxo-dG Bypass by 
PrimPol 
PrimPol has previously been shown to possess TLS polymerase activity, displaying an 
ability to tolerate templating 8-oxo-dG lesions and 6-4PPs (Bianchi et al., 2013; García-
Gómez et al., 2013; Keen et al., 2014b). It has been postulated that the ability of PrimPol 
to bypass 8-oxo-dG lesions may be of particular importance in the mitochondria given 
the localisation of PrimPol there and the fact that Pol  deals poorly with these lesions 
(Bianchi, 2013; García-Gómez et al., 2013). Intriguingly, PolDIP2 has also been shown 
to localise to the mitochondria (Cheng et al., 2005; Xie et al., 2005), in addition to 
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Figure 3.8. PrimPol is inhibited in the presence of PolDIP2 and PCNA in combination.
PrimPols (100 nM) polymerase activity was examined using a 5 labelled 20/97-mer primer/template substrate in the presence of PCNA alone, or a 
combination of PCNA and PolDIP2 over a time course (1, 3, 5, 10, 20 mins). C indicates the no enzyme control.
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stimulating 8-oxo-dG bypass by Pols  and  (Maga et al., 2013). Therefore, we set out 
to analyse the influence of PolDIP2 on the activity of PrimPol during 8-oxo-dG bypass.
PrimPols 8-oxo-dG bypass efficiency, in the absence and presence of PolDIP2, was 
initially investigated using a primer/template (20/50-mer) containing a single 8-oxo-dG 
lesion located 8 nucleotides downstream from the primer/template junction (sequences 
2 and 13, Table 2.2.). We observed that in the presence of increasing PolDIP2 
concentrations, PrimPol and PrimPol1-354 synthesised a greater number of post-8-oxo-
dG extension products in a dose-dependent manner, compared to reactions containing 
PrimPol only (Figure 3.9.A., B., and C.). However, it is important to note that, unlike Pol 
 (Maga et al., 2013), this stimulation was not significantly greater than that observed on 
non-damaged DNA templates (Figure 3.9.B., and C.). Nevertheless, the enhancement 
of PrimPols polymerase activity by PolDIP2 does increase the efficiency of 8-oxo-dG 
bypass compared to the enzyme alone. Together, these results suggest that PolDIP2 
stimulates PrimPol-mediated 8-oxo-dG bypass by enhancing the polymerase activity of 
the enzyme rather than the ability of PrimPol to traverse the lesion. 
Despite possessing the ability to bypass 8-oxo-dG lesions, PrimPols inherent bypass 
fidelity is relatively poor, displaying around 1:1 error-prone (dATP) to error-free (dCTP) 
incorporations opposite the 8-oxo-dG lesion (Keen et al., 2014b). In addition to 
stimulating 8-oxo-dG bypass, PolDIP2 has also been shown to increase bypass fidelity 
by Pols  and , but only in the added presence of PCNA and RPA, with the protein alone 
not affecting lesion bypass fidelity (Maga et al., 2013). Therefore, we next analysed the 
effect of PCNA, RPA, and PolDIP2 on PrimPols fidelity when bypassing 8-oxo-dG 
lesions. To examine this, we employed primer extension assays with a primer/template 
(28/50-mer), where the immediate templating base was an 8-oxo-dG lesion (position 29
on the template) (sequences 4 and 13, Table 2.1.). Reactions were supplemented with 
either dATP or dCTP to allow analysis and quantification of error-prone and error-free 
bypass. As demonstrated previously (Keen et al., 2014b), in the absence of auxiliary 
proteins PrimPol incorporates both dATP and dCTP opposite the 8-oxoG lesion at ~ 1:1 
ratio (Figure 3.9.D.). This ratio was largely unchanged in the presence of RPA, which 
has previously been shown to increase the fidelity of 8-oxo-dG bypass by Pol  and Pol 
 (Maga et al., 2007). It should be noted that RPA was used at low concentrations to 
prevent inhibition of PrimPol (Guilliam et al., 2015a). PCNA also did not significantly 
affect the fidelity of lesion bypass by PrimPol. However, in the presence of PolDIP2 
alone, PrimPols fidelity opposite 8-oxo-dG was significantly improved, with the enzyme 
demonstrating an almost 2-fold increase in dCTP incorporation, whilst dATP 
incorporation remained largely the same. However, in the presence of both PolDIP2 and
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Figure 3.9. PolDIP2 enhance the efficiency and fidelity of 8-oxo-dG bypass by PrimPol. 
(A) PrimPol or PrimPol1-354 (40 nM) were incubated with dNTPs (100 µM) and 5-labelled 
20/50-mer primer/template substrates containing a single 8-oxoG lesion 8 nt downstream of 
the primer-template junction in the presence of increasing GST-PolDIP2 concentrations (0, 
20, 40, 80, 120, 160, 200, 240 nM) for a single 10 min timepoint. C indicates the no enzyme 
control reaction. (B) Relative increase in the rate of TLS product synthesis (as indicated on 
figure) by PrimPol on non-damaged (ND) and 8-oxo-dG containing templates in the presence 
of increasing GST-PolDIP2 concentrations (0, 20, 40, 80, 120, 160, 200, 240 nM). Data were 
fitted using GraphPad Prism 6 software. Values are the means of four independent 
experiments. Error bars are ± SD. (C) Relative increase in the rate of TLS product synthesis 
(as indicated on figure) by PrimPol1-354 on non-damaged (ND) and 8-oxo-dG containing 
templates in the presence of increasing GST-PolDIP2 concentrations (0, 20, 40, 80, 120, 160, 
200, 240 nM). Data were fitted using GraphPad Prism 6 software. Values are the means of 
four independent experiments. Error bars are ± SD. (D) PrimPol (100 nM) was incubated with 
either dATP or dCTP (100 µM) and 5labelled 28/50-mer primer/template substrates with a 
single 8-oxoG lesion as the immediate templating base (position 29 on the template) in the 
absence and presence of GST-PolDIP2 (300 nM), PCNA (100 nM), and RPA (25 nM), or a 
combination of each. Reaction products were quantified to give the relative amounts of correct 
(dCTP, red) and incorrect (dATP, blue) incorporation. Data represent the mean of 3 
independent experiments. Error bars are ± SD. Data were subject to an unpaired t-test, 
PolDIP2 alone data p<0.05.
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PCNA, or PolDIP2, PCNA, and RPA, in combination, this increase in fidelity was 
reduced and the overall amount of incorporation (both dATP and dCTP) decreased. 
These data therefore demonstrate that, unlike Pols  and  (Maga et al., 2013), PrimPols 
fidelity opposite 8-oxo-dG is increased in the presence of PolDIP2 alone. Furthermore, 
addition of RPA and PCNA actually act to lessen the effect of PolDIP2 on PrimPols 
lesion bypass fidelity. 
The catalytic domain of PrimPol alone has the ability to bypass CPDs, however the full-
length enzyme is stalled by these lesions. In the presence of magnesium, PrimPol is also 
stalled by Ap sites (Bianchi et al., 2013; Keen et al., 2014b). We also tested whether 
PolDIP2 permits bypass of these lesions by PrimPol. In each case, the presence of 
PolDIP2 did not allow PrimPol to synthesise across the damaged nucleotide (Figure 
3.10.). In addition, we analysed the lesion bypass fidelity of PrimPol in the presence of 
PolDIP2 when traversing a uracil and 6-4PP lesion. Again, PrimPols fidelity was in line 
with the previously published results, incorporating dATP opposite uracil, and dTTP 
opposite the 6-4PP (Keen et al., 2014b). 
PrimPol is an error-prone polymerase, which has previously been shown to 
misincorporate bases and extend base mismatches (Guilliam et al., 2015a). In particular, 
the enzyme shows a propensity to misincorporate and extend mismatched bases 
opposite a templating dC (Guilliam et al., 2015a). Since PolDIP2 increases PrimPols 
fidelity when synthesising past an 8-oxo-dG lesion, we also tested whether the protein 
affects PrimPols fidelity on non-damaged DNA. To measure this, we analysed PrimPols 
level of misincorporation opposite a templating dC in the absence and presence of 
PolDIP2 (Figure 3.11.). However, we observed that PolDIP2 does not reduce PrimPols 
level of misincorporation, suggesting that the protein does not improve the enzymes
fidelity on non-damaged DNA. Together, these results suggest that PolDIP2 acts to 
increase PrimPols efficiency and fidelity when specifically bypassing an 8-oxo-dG 
lesion, rather than improving the enzymes overall fidelity rates. 
3.4.7. Analysis of the Interaction of PolDIP2 with PrimPol 
PolDIP2 was originally identified as a potential PrimPol interacting protein in a large-
scale pull-down screen performed previously (Rudd, 2013). In order to analyse this 
interaction in more detail, we employed BS3 cross-linking and MS analysis. This type of 
analysis allows non-covalent interactions between proteins to be converted into covalent 
bonds, specifically BS3 is able to cross-link primary amines on the side chains of lysine 
residues, in addition to the N-terminus of proteins. Further protease digestion and MS 
analysis of cross-linked protein complexes allows the covalently attached regions of each 
130
Figure 3.10. PolDIP2 does not enable PrimPol to bypass CPDs or Ap sites, or alter the fidelity of dU or 6-4PP bypass. 
(A) PrimPol was incubated with dNTPs (100 µM) and 5-labelled 20/50-mer primer/template substrates containing a single CPD or Ap site 8 nt downstream 
of the primer-template junction in the absence or presence of PolDIP2 (800 nM). Reactions were monitored over a time-course of 1, 3, 5, 10, and 20 mins. 
C indicates the no enzyme control reaction. (B) PrimPol was incubated with single dNTPs (dATP, dCTP, dGTP, or dTTP) (100 µM) and 5-labelled 
primer/template substrates with a single dU or 6-4PP as the immediate templating base in the presence of GST-PolDIP2. C indicates the no dNTP control.
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Figure 3.11. PolDIP2 does not affect PrimPols fidelity on non-damaged DNA.
(A) PrimPol was incubated with single dNTPs (dATP, dCTP, dGTP, or dTTP) (100 µM) and 5-labelled 27/50-mer primer/template substrates containing dC 
as the immediate templating base. Reactions were monitored over a time-course of 1, 3, 5, 10, and 20 mins. C indicates the no dNTP control reaction. (B)
The data shown in A were normalised against the correct incoming base (dGTP) and quantified to give the relative misincorporation of each base opposite 
the templating dC. 
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protein to be recognised and thereby interacting regions to be identified (Rappsilber, 
2011). StavroX cross-linking analysis software was used to identify and score cross-
linked peptides, as detailed previously (Götze et al., 2012). Since EMSA data suggested 
an interaction between PolDIP2 and the catalytic domain of PrimPol (Figure 3.4.), 
untagged PolDIP2 and PrimPol24-354 were used for this analysis. 
Intriguingly, the vast majority of PrimPol-PolDIP2 cross-links identified were mediated by 
the N-terminus of PolDIP2 (residues 1-8), with additional secondary crosslinks also 
identified (Table 3.1., Figure 3.12.A. and B.). The most abundant and highest scoring 
cross-linked peptide identified on PrimPol, which cross-linked to the N-terminus of 
PolDIP2, was located between amino acid positions 60 and 70 on the full-length protein 
(EDVHVFALECK), with the cross-linked residue identified as lysine 70 (Table 3.1). 
Notably, this peptide displays strong homology to a region of Pol  previously found to 
mediate the enzymes interaction with PolDIP2 (Figure 3.12.C.) (Tissier et al., 2010), 
potentially suggesting that PrimPol and Pol  share a similar mode of binding to PolDIP2. 
A number of other cross-linked peptides were also identified on PrimPol. The majority of 
these were located towards the C-terminus of the truncated protein. However, analysis 
of intra-PrimPol cross-links, suggests that these regions are in close proximity to the 
EDVHVFALECK peptide in the folded protein (Table 3.2., Figure 3.12.A. and B.).
Given that the N-terminal 50 amino acids of PolDIP2 comprise a mitochondrial targeting 
sequence (MTS), which is likely cleaved off upon entry to the mitochondria (Xie et al., 
2005), it was somewhat surprising to identify this region as the mediator of the PrimPol 
interaction. In order to validate the findings of the crosslinking and MS analysis, we 
generated a truncated form of PolDIP2 lacking the first 50 amino acids (PolDIP251-368) 
and assayed its ability to stimulate PrimPols processivity in comparison to the full-length 
protein. In addition, we also analysed the effect of PolDIP251-368 on the processivity of Pol 
. In line with previous results, we find that full-length PolDIP2 is able to stimulate the 
processivity of both PrimPol and Pol  (Figure 3.12.D.) (Maga et al., 2013). However, in 
contrast, PolDIP251-368 failed to stimulate the processivity of either enzyme. This assay 
was repeated across a range of PolDIP251-368 concentrations with no increase in 
PrimPols processivity identified (Figure 3.13.). Furthermore, PolDIP251-368 failed to 
produce an increase in the DNA binding of PrimPol, which was previously observed with 
the full-length protein (Figure 3.13.). These results further support the findings of the MS 
analysis, suggesting that the interaction between PolDIP2 and PrimPol is mediated by 
the N-terminus of PolDIP2. Furthermore, these findings suggest that Pol  may also 
interact with the N-terminus of PolDIP2. 
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Table 3.1. MS analysis of PolDIP2-PrimPol cross-linked peptides. 
The amino acid sequence of cross-linked PolDIP2 (blue) and PrimPol (green) peptides identified in the MS analysis are shown. Crosslinked residues in each 
case are shown in bold. Peptide location indicates the location of peptide in the specific constructs used for the analysis, not the wild-type protein. Scores 
are based on the probability of the occurrence of an ion in addition to the intensity of the signal in the fragment spectrum, as given by the StavroX analysis 
software (Götze et al., 2012). m/z indicates the mass to charge ratio, z shows the charge of the precursor.
Score m/z z Measured Mass
Calculated 
Mass
PolDIP2 
Peptide
Peptide 
Location
PrimPol
Peptide
Peptide
Location
131 807 3 2420 2420 MAABTARR 0-8 EDVHVFALEBK 58-68
105 411 4 1643 1643 MAABTAR 0-7 LYKSSK 290-295
101 755 3 2263 2263 MAABTARR 0-8 ILTBEPSQNK 341-350
90 567 4 2263 2263 MAABTARR 0-8 ILTBEPSQNK 341-350
87 768 3 2301 2301 AENPAGHGSKEVKGK 115-129 MFTEK 231-235
86 411 4 1643 1643 MAABTAR 0-7 LYKSSK 290-295
84 532 4 2125 2125 ETLRAWQEK 215-223 QGFSFNK 224-230
81 709 3 2125 2125 ETLRAWQEK 215-223 QGFSFNK 223-230
63 1132 2 2263 2263 MAABTARR 0-8 ILTBEPSQNK 341-350
43 548 3 1643 1643 MAABTAR 0-7 LYKSSK 290-295
40 554 3 1659 1659 MAABTAR 0-7 LYKSSK 290-295
32 567 4 2263 2263 MAABTARR 0-8 ILTBEPSQNK 341-350
29 411 4 1643 1643 MAABTAR 0-7 LYKSSK 290-295
24 617 5 3083 3083 MAABTAR 0-7 FSDTLRILTBEPSQNKQK 335-353
23 771 4 3083 3083 MAABTAR 0-7 FSDTLRILTBEPSQNKQK 335-353
22 411 4 1643 1643 MAABTAR 0-7 LYKSSK 290-295
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Figure 3.12. Analysis of the PrimPol-PolDIP2 interaction. 
(A) PrimPol24-354 (green) and untagged-PolDIP2 (blue) cross-links were analysed by digest and MS revealing potential interacting regions on each protein 
(Table 3.1.). The locations of intra-PrimPol and inter-PrimPol/PolDIP2 cross-links are indicated by dotted lines. The relative amino acid positions are shown 
below. (B) The amino acid sequences of PrimPol-PolDIP2 cross-linked peptides. Dotted lines between peptides indicate the specific residues cross-linked in 
each case. Cross-linked PrimPol peptides are shown in green and PolDIP2 peptides in blue. (C) Alignment of the PolDIP2-interacting regions of PrimPol and 
Pol  showing the high degree of homology between the two peptides. (D) PrimPol (100 nM) and Pol  were incubated with 5-labelled 20/97-mer 
primer/template substrates and dNTPs (100 µM) in the absence and presence of GST-PolDIP2 or PolDIP251-368. GST-PolDIP2 stimulated the processivity of 
both PrimPol and Pol , however PolDIP251-368 failed to stimulate the processivity of either enzyme.
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Table 3.2. MS analysis of intra-PrimPol cross-links. 
The amino acid sequence of cross-linked PrimPol (green) peptides identified in the MS analysis are shown. Cross-linked residues in each case are shown in 
bold. Peptide location indicates the location of peptide in the specific constructs used for the analysis, not the wild-type protein. Scores are based on the 
probability of the occurrence of an ion in addition to the intensity of the signal in the fragment spectrum, as given by the StavroX analysis software (Götze et 
al., 2012). m/z indicates the mass to charge ratio, z shows the charge of the precursor.
Score m/z z Measured Mass
Calculated 
Mass Peptide 1
Peptide 
location Peptide 2
Peptide 
location
172 665 3 1993 1993 FSDTLR 335-340 VALEVTEDNK 300-309
137 712 3 2134 2134 QK 351-353 SBKEDVHVFALEBK 55-68
30 496 5 2478 2478 SSK 293-295 MFTEKATEESWTSNSKK 231-247
27 542 6 3245 3245 NFRLYKSSK 287-295 VALEVTEDNKFFPIQSK 300-316
25 1311 3 3932 3932 PANPGADGKK 118-127
DVSDEYQYFLS
SLVSNVRFSDT
LR
317-340
20 579 5 2890 2890 IGKR 296-299 NNMGEKHLFVDLGVYTRNR 268-286
15 1475 3 4423 4423 IYLVTTYAEFWFYYK 75-89
NNMGEKHLFVD
LGVYTRNR 268-286
11 712 3 2134 2134 QK 351-353 SBKEDVHVFALEBK 55-68
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Figure 3.13. PolDIP251-368 does not stimulate PrimPols processivity or DNA binding.
(A) PolDIP251-368 was titrated into reactions containing PrimPol (100 nM) and 5 labelled 20/97-mer primer/template substrates (20 nM). Reactions were 
initiated with dNTPs (100 µM) and excess trap DNA and quenched at 0.5, 1, 2, 5, and 10 min time-points. (B) PrimPol24-354 was incubated with increasing 
concentrations of PolDIP251-368 (0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.75, 1 µM) in EMSA reactions containing 5-labelled 20/97-mer primer-template substrates. 
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3.4.8. Depletion of PolDIP2 Causes Slowed Replication Fork Rates after UV 
Damage 
Despite the inability of PolDIP251-368 to stimulate the processivity of Pol , existing data 
suggests that these proteins do share a functional interaction in vivo. Specifically, it has 
been shown that depletion of PolDIP2 causes persistent Pol  foci in the absence of 
damage. Furthermore, PolDIP2 depleted cells showed increased UV sensitivity to a 
similar level as cells lacking Pol  (XPV cells) however, no further increase in sensitivity 
was observed when PolDIP2 was depleted in XPV cells (Tissier et al., 2010). 
Additionally, cells depleted of PolDIP2 showed an increased sensitivity to oxidative 
damage (Maga et al., 2013). These studies implicate PolDIP2 in the regulation of TLS in 
vivo, although the direct impact of depletion of PolDIP2 on DNA replication has not 
previously been examined. 
To analyse the impact of depletion of PolDIP2 on replication fork rates following DNA 
damage, both wild-type and PrimPol-/- MRC5 cells were either PolDIP2 siRNA or mock 
treated before DNA fibre analysis was conducted (Figure 3.14.A.). Cells were pulse 
labelled with chlorodeoxyuridine (CldU) for 20 mins before UV irradiation (20 J/m2), 
following this, cells were pulse labelled again with iododeoxyuridine (IdU) for an 
additional 20 mins and the ratios of the two labels determined. Significantly, depletion of 
PolDIP2 in wild-type MRC5 cells causes a significant decrease in replication fork rates 
following UV-C irradiation (Figure 3.14.B., C., and D.). This suggests that PolDIP2 is 
involved in DNA replication and, more specifically, in DDT, supporting published studies 
implicating it in TLS processes. Although to a lesser extent than observed in the 
previously studied PrimPol-/- DT40 cells (Bianchi et al., 2013), MRC5 cells lacking 
PrimPol also display a decrease in replication fork rates following UV-C irradiation. 
However, intriguingly, depletion of PolDIP2 in PrimPol-/- cells did not produce a further 
decrease in replication fork rates, suggesting that PrimPol and PolDIP2 work epistatically 
in the same pathway to promote continued DNA replication in the presence of UV 
damage (Figure 3.14.B., C., and D.). This also suggests that PolDIP2 may also operate 
in a post-replicative manner during gap-filling by other TLS polymerases, potentially 
explaining why a further decrease in replication fork rates was not observed, despite 
PolDIP2 likely partnering other TLS enzymes.
3.5. Discussion 
Previous studies have implicated PolDIP2 in TLS damage tolerance processes through 
the regulation of Pols  and  (Maga et al., 2013; Tissier et al., 2010). In addition, this 
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Figure 3.14. Depletion of PolDIP2 causes decreased replication fork speeds following UV damage. 
(A) Western blot analysis of PolDIP2 silencing by siRNA in wild-type (WT) and PrimPol-/- MRC5 cells, compared to mock depleted cells. (B) DNA replication 
fork rates in PolDIP2 siRNA or mock treated wild-type and PrimPol-/- MRC5 cells were analysed by DNA fibre analysis. Cells were pulsed with CldU for 20 
mins followed by UV irradiation (20 J/m2) and pulse labelled again with IdU for a further 20 mins. The mean CldU/IdU ratio of wild-type and PrimPol-/- MRC5 
cells either mock or PolDIP2 siRNA treated is shown. Error bars indicate ± SE (n = 3). (C) DNA replication fork rate data for wild-type MRC5 cells shown as 
the ratio of CldU to IdU (n = 3). Green lines indicate analysis of mock treated cells, whilst red lines indicated analysis of PolDIP2 siRNA treated cells. (D) 
DNA replication fork rate data for PrimPol-/- MRC5 cells shown as the ratio of CldU to IdU (n = 3). Green lines indicate analysis of mock treated cells, whilst 
red lines indicated analysis of PolDIP2 siRNA treated cells.
A
C
B
0
5
10
15
20
0
0 .
5 1
1 .
5 2
2 .
5 3
3 .
5 4
4 .
5 5
5 .
5 6
6 .
5 7
7 .
5 8
8 .
5 9
9 .
5
%
 F
o r
k s
CldU/IdU ratio
PrimPol-/- PolDIP2 RNAi
PrimPol-/- Mock
0
0.5
1
1.5
2
2.5
WT Mock
RNAi
WT
PolDIP2
RNAi
PrimPol-/-
Mock
RNAi
PrimPol-/-
PolDIP2
RNAi
M
e a
n  
C
l d
U
/ I d
U
r a
t i o
0
5
10
15
20
0
0 .
5 1
1 .
5 2
2 .
5 3
3 .
5 4
4 .
5 5
5 .
5 6
6 .
5 7
7 .
5 8
8 .
5 9
9 .
5
%
 F
o r
k s
CldU/IdU ratio
WT PolDIP2 RNAi
WT Mock RNAi
D
PolDIP2
 - actin
WT PrimPol-/-
PolDIP2 RNAi - +         - +
**
139
protein has also been shown to interact with PCNA, Pol , Pol 	, and Rev1 (Tissier et al., 
2010). In this current study, we show that PolDIP2 is also involved in the regulation of 
PrimPols polymerase activity. Specifically, PolDIP2 is able to increase the polymerase 
activity of PrimPol by increasing the enzymes DNA binding capacity and processivity. In 
addition, PolDIP2 also acts as a fidelity factor for PrimPol during the bypass of 8-oxo-
dG, enhancing dCTP incorporation opposite this oxidative lesion. In contrast, PolDIP2 
has a minimal effect on PrimPols primase activity. This suggests that the protein acts 
specifically to promote PrimPols polymerase activity. Previously, it has been shown that 
PrimPols ZnF domain is required for the primase activity of the enzyme, and additionally, 
is involved in negatively regulating its processivity (Keen et al., 2014b). This raises the 
possibility that binding of PolDIP2 may alleviate this negative regulation by the ZnF 
domain, in turn promoting increased processivity of the enzyme. Together, the in vitro 
data presented here suggests that PolDIP2 increases the processivity and 
polymerisation rates of PrimPol by stabilising the enzyme on DNA and improving 
PrimPols inherently poor DNA binding capacity (Keen et al., 2014b). 
Previously published results, and data presented here, suggest that PrimPol is not 
regulated through a canonical PCNA-mediated polymerase switch mechanism (Guilliam 
et al., 2015a). Furthermore, the presence of PCNA inhibited the positive impact of 
PolDIP2 on PrimPols primer extension activity. It has previously been suggested that 
PolDIP2 might act as a bridging factor to enhance polymerase-PCNA interactions and 
thereby further stimulate polymerase activity (Maga et al., 2013). However, our data 
imply that PolDIP2 acts alone, in the absence of PCNA, to enhance PrimPols activity. In 
further support of this, it was previously found that PolDIP2 only enhances Pol  and  
bypass fidelity opposite 8-oxo-dG in the presence of RPA and PCNA (Maga et al., 2013). 
However, in the case of PrimPol, we observed that PolDIP2 alone is sufficient to increase 
its 8-oxo-dG bypass fidelity and the further presence of RPA and PCNA actually reduces 
this effect. 
Additionally, we found that PrimPol possesses a potential PolDIP2 binding motif with 
homology to that of Pol  (Tissier et al., 2010). Interestingly, we identified that this motif 
appears to bind to the very N-terminus of PolDIP2. However, the first ~50 amino acids 
of PolDIP2 are thought to comprise a MTS and are likely cleaved off upon entry to the 
mitochondria (Xie et al., 2005). PolDIP2 lacking this MTS was not able to stimulate the 
processivity of either PrimPol or Pol . Importantly, previous studies reporting stimulation 
of Pols , , and  by PolDIP2 only employed full-length PolDIP2 with the N-terminal 50 
amino acids intact (Maga et al., 2013). Additionally, it was originally reported that 
PolDIP2 inhibits Pol  activity at higher concentrations, however this study was 
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performed using truncated PolDIP2 without the MTS (Xie et al., 2005). Therefore, it 
seems that these contradictory reports can be explained by the different PolDIP2 
constructs used in each case. Furthermore, these reports support data presented here 
that the first 50 amino acids of PolDIP2 are required for stimulation of, and likely the 
interaction with, polymerases including not only PrimPol but also Pol  and Pol . 
Despite this, in vivo data does support a role for PolDIP2 in DNA replication, and more 
specifically DDT. Here we have shown that depletion of PolDIP2 from cells causes a 
decrease in replication fork rates following UV irradiation to a similar level as that seen 
with PrimPol-/- cells. Furthermore, depletion of PolDIP2 in PrimPol-/- cells does not 
produce a further decrease in fork speed. Therefore, it appears that PolDIP2 and PrimPol 
cooperate to promote continued replication in the presence of DNA damage. Importantly, 
this does not rule out the possibility that PolDIP2 also assists other TLS polymerases in 
a post-replicative gap filling manner. Indeed, this is supported by previous studies 
suggesting that PolDIP2 acts to promote interactions between canonical TLS 
polymerases and PCNA. In support of this, previous reports suggest that PCNA 
ubiquitylation is not required to maintain normal fork progression on damaged DNA but 
is instead essential for filling-in post-replicative gaps (Edmunds et al., 2008). 
Importantly, the initial characterisation of PolDIP2 suggested that the protein was 
primarily mitochondrial (Xie et al., 2005). However, it was also acknowledged that 
PolDIP2 may also be present in the nucleus in small amounts and that interactions 
between PolDIP2 and Pol  may only occur during specific cellular events, such as 
following DNA damage. This study also suggested that additional isoforms of PolDIP2 
may exist, which localise to the nucleus and possibly serve different functions to those 
in the mitochondria (Xie et al., 2005). Since this initial characterisation, additional reports 
indicate that PolDIP2 does indeed localise to the nucleus, with an increase following UV 
damage (Wong et al., 2013). Therefore, it is possible that nuclear and mitochondrial 
PolDIP2 fulfil different functions in vivo. Whilst PolDIP2 localised to the mitochondria will 
likely have its MTS removed, it is possible that a small amount of PolDIP2, which 
localises to the nucleus does not. This suggests that the stimulatory effects of PolDIP2 
on PrimPol may be primarily nuclear and in response to DNA damage, rather than 
mitochondrial. PrimPol is a highly error-prone enzyme and must be strictly regulated to 
restrict its contribution to DNA synthesis (Guilliam et al., 2015a). Thus, it seems likely 
that the PrimPol-PolDIP2 interaction may also be mediated by post-translational 
modifications in response to DNA damage, this would prevent PrimPols DNA binding 
and processivity from being constantly enhanced and therefore limit its involvement in 
DNA synthesis. However, further studies are required to assess potential PrimPol and 
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PolDIP2 post-translational modifications and their influence on the interactions between 
these proteins. 
Overall, the findings presented here establish that PolDIP2 is able to enhance the 
polymerase activities of PrimPol in vitro. In support of these findings, we also 
demonstrate that cells depleted of PolDIP2 show replication defects similar to PrimPol-/- 
cells after UV irradiation. These effects are not further increased when PolDIP2 is 
depleted in PrimPol-/- cells, clearly suggesting that PolDIP2 is a binding partner of 
PrimPol in vivo and likely mediates its primer extension activities in response to DNA 
damage. These findings further support the accumulating published evidence implicating 
PolDIP2 as a general DDT factor involved in promoting TLS by a number of different 
polymerases. Together, our work describes a new regulatory partner of PrimPol and 
enhances our understanding of the emerging role of PolDIP2 in DDT. 
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Chapter 4
The Development of a Fluorescent Gel-
Based Primase Assay to Analyse 
PrimPols Repriming Activity
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4.1. Overview
Both Chapter 2 and Chapter 3 focussed on the characterisation of PrimPols functional 
interaction with its binding partners, RPA, mtSSB, and PolDIP2. The articles presented 
in these chapters identified that PrimPols activities are restricted by SSBs, potentially to 
reduce its contribution to DNA synthesis and thus the chance for mutagenesis, whilst 
PolDIP2 promotes PrimPols primer extension capabilities, stabilising it on the DNA 
template and increasing its processivity. Chapter 4 switches focus to the primase activity 
of PrimPol. This chapter is a combination of work from three published articles. The first 
half of the chapter (section 4.2) describes the development of a fluorescence-based 
primase assay, following a detailed discussion of previous methods for characterising 
primases, covering their advantages and limitations. This part of the chapter is accepted 
for publication in Methods in Enzymology. The primary motivation for developing this 
assay was to allow a more accurate characterisation of PrimPols repriming activities, 
without the use of radioactivity. Notably, the previous method used in the Doherty 
laboratory was time-consuming and relied on indirect observation of primase reaction 
products by labelling and extension using Klenow-Taq polymerase (Bianchi et al., 2013; 
Keen et al., 2014b). During the development of this assay it was observed that PrimPol 
can extend the 3 end of ssDNA templates. An investigation of the mechanism 
responsible for this extension is therefore included after the Methods in Enzymology
article. Note that this data and discussion were not published in the article itself (section 
4.3). The second half of the chapter (section 4.4) describes the use of this assay in 
analysing PrimPols involvement in the bypass non-canonical replication impediments, 
including G4-quadruplexes and chain-terminating nucleotide analogues (CTNAs). The 
data produced from these studies are published in Molecular Cell (Schiavone et al., 
2016) and Cell Cycle (Kobayashi et al., 2016), respectively.
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4.2. Current and Emerging Assays for Studying the 
Primer Synthesis Activities of DNA Primases 
4.2.1. Abstract 
Primases play a crucial role in the initiation of DNA synthesis during replication by de 
novo synthesis of short RNA or DNA primers. In recent years, evidence has 
accumulated which expands the essential roles of primases to include, not only the 
initiation of replication, but also other critical roles in DNA metabolism, including damage 
tolerance and repair. Despite the broadening roles for these enzymes, the methods used 
to identify and characterise primase activities are limited. Historically, biochemical 
analysis of primases has been based on the synthesis of radioactively-labelled primers 
and their detection on denaturing polyacrylamide gels. In the last two decades, a number 
of alternative primase assays have been developed in an effort to supersede radioactive 
methods. However, the radioactive gel-based assay, which has not significantly changed 
since its conception in the late 1970s, remains the most widely used and favoured 
method. In this chapter, we discuss the background to, and the advantages and 
disadvantages of, the current techniques used to characterise primase activity in vitro. 
Finally, we describe an alternative, gel-based, fluorescent primase assay, which we have 
successfully used in the characterisation of a recently identified primase-polymerase, 
PrimPol.  
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4.2.2. Introduction 
Primases, unlike DNA polymerases, possess the unique ability to utilise ssDNA 
templates for the initiation of RNA or DNA synthesis de novo. The short RNA or DNA 
chains produced from this synthesis are termed primers and provide the 3 hydroxyl 
required for further extension by DNA polymerases during the initiation of DNA 
replication. Due to the semi-discontinuous nature of DNA replication, primase activity is 
essential not only during initiation, but also throughout replication to prime Okazaki 
fragment synthesis on the lagging strand. All domains of life employ primases in this 
crucial role, however two distinct primase superfamilies, DnaG primases and AEPs, 
facilitate bacterial and archaeal/eukaryotic DNA replication, respectively. Recently, 
evidence has accumulated suggesting that primase-polymerases of the AEP superfamily 
also play key roles in DNA damage tolerance and repair, here their primase activity is 
essential for replication restart mechanisms including repriming of replication 
downstream of lesions and secondary structures (Guilliam et al., 2015b; Guilliam and 
Doherty, 2017). 
Historically, DNA polymerases were studied in vitro using radioactive primer extension 
assays. Here, a 5' radiolabelled primer annealed to a DNA template is extended by the 
DNA polymerase of interest. Subsequently, resolution of the reaction products on a 
denaturing polyacrylamide gel, followed by autoradiography or phosphorimaging allows 
visualisation and analysis of primer extension products and thus polymerase activity. 
These assays have been reliably used for many years to study DNA polymerase kinetics, 
fidelity, processivity, repair, and translesion synthesis. However, over recent years, 
fluorescent tags have begun to replace radioactive labels offering clear advantages in 
safety and speed, whilst maintaining sensitivity. 
Despite the use of fluorescence in primer extension assays, gel-based primase assays 
still routinely make use of radiolabelled nucleotides. In these assays, primase activity is 
determined by the quantification of radiolabelled nucleotide containing primers, 
visualised on denaturing polyacrylamide gels. In this chapter, we discuss the advantages 
and limitations of existing methods used to study primases in vitro, including both 
traditional radioactive gel-based assays and more recently developed non-radioactive 
high-throughput screening (HTS) approaches. Finally, we describe a gel-based primase 
assay of particular use in the analysis of primase-polymerases. This assay, which utilises 
fluorescently labelled nucleotides, removes the need for potentially hazardous 
radioactivity, allowing the assay to be performed in any laboratory without requiring 
training in the handling of radioactivity. Furthermore, this assay can be used in the same 
146
way as traditional radioactive primase assays to study inherent primase activity, as well 
as to determine the effect of binding partners and reaction conditions, in addition to 
sequence preference and the location of priming, on the assayed primase. To 
demonstrate the effectiveness of this assay, we make use of purified human PrimPol, a 
recently characterised primase-polymerase involved in DNA damage tolerance in higher 
eukaryotes. 
4.2.3. Radioactive-Based Primase Assays 
4.2.3.1. Traditional Radioactive Primase Assays 
In the early 1970s, in vivo studies of T7 DNA replication implicated the phage gene 4 
protein in priming DNA synthesis (Strätling and Knippers, 1973; Wolfson and Dressler, 
1972). Subsequent in vitro studies developed a DNA primase complementation assay to 
analyse the T7 gene 4 product, this assay helped to confirm that the protein acts to 
synthesise primers required for the initiation of DNA synthesis by T7 DNA polymerase 
(Hinkle and Richardson, 1975; Romano and Richardson, 1979; Scherzinger et al., 1977; 
Scherzinger and Litfin, 1974). Consequently, the T7 gene 4 product became the first 
designated DNA primase (Scherzinger et al., 1977). 
The assay used in these early studies measured the ability of purified T7 primase to 
stimulate DNA synthesis in extracts prepared from Escherichia coli infected with T7 
lacking the gene 4 protein (Hinkle and Richardson, 1975). Here, reactions were 
assembled containing rNTPs and dNTPs, one of which was 3H or 32P labelled, extracts 
from T7 infected E. coli, purified T7 primase and T7 linear duplex DNA. Following 
incubation, the reaction products were precipitated and washed on filter paper and 
radioactivity was measured by a liquid scintillation counter (Hinkle and Richardson, 
1975). Thus, the ability of T7 primase to stimulate DNA synthesis in the extracts could 
be determined by the increase in acid insoluble radioactivity produced following 
incubation. In addition to analysing the effect of T7 primase on DNA synthesis in extracts, 
these reports also examined the effect of the enzyme on T7 polymerase activity using a 
similar approach. In these experiments, reactions were assembled in the same manner, 
however extract was omitted and replaced with purified T7 DNA polymerase. Again, it 
was identified that T7 primase markedly stimulated DNA synthesis by the polymerase on 
duplex T7 DNA (Hinkle and Richardson, 1975). 
Despite indicating that the stimulation observed in these early studies was due to de 
novo primer synthesis by T7 primase, interpretation of results was somewhat limited due 
to the duplex linear DNA template used. In order to gain further clarity, pycnographic 
analysis of reaction products was required. In this case, template T7 DNA was 3H, 13C, 
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and 15N labelled and -32P dATP was provided for primer synthesis. Subsequent CsCl 
density gradient centrifugation confirmed that the 32P labelled reaction products 
separated from the heavy template DNA, thereby indicating that the reaction products 
and template DNA were not covalently linked and allowing inference that de novo
initiation of DNA synthesis had occurred (Hinkle and Richardson, 1975). Follow-up 
studies of T7 primase were able to avoid this issue by using circular ss phage 174 
DNA as a template, thereby removing the possibility of synthesis being initiated by a loop 
mechanism (Scherzinger et al., 1977). Interestingly, it was later found that the T7 gene 
4 protein is also a DNA helicase, thus explaining the initial observation of stimulation of 
DNA synthesis on duplex linear DNA (Bernstein and Richardson, 1988). 
A similar complementation based primase assay was used in the initial characterisation 
of the E. coli replicative primase DnaG (Bouché et al., 1975; Rowen and Kornberg, 
1978). Here, it was determined that DnaG is required for stimulation of DNA synthesis in 
extract prepared from E. coli expressing a temperature-sensitive DnaG mutant (Rowen 
and Kornberg, 1978). Furthermore, in the absence of extract, DnaG was able to initiate 
DNA synthesis on phage G4 DNA in the presence of E. coli SSB and DNA polymerase 
III holoenzyme (Rowen and Kornberg, 1978). Additionally, priming by DnaG was also 
observed on G4 and M13 DNA, as well as poly(dT) templates, in the presence of the 
DnaB helicase but in the absence of SSB or DNA polymerase III (Arai and Kornberg, 
1979). 
Similar assays have also been used in the basic characterisation of other prokaryotic 
and phage primases (Krevolin and Calendar, 1985; Lanka et al., 1979; Morris et al., 
1975). These assays were highly useful in the early analysis and identification of 
primases. Importantly, they allowed potential primases, initially identified through in vivo
studies, to be confirmed, in addition to permitting investigation into the requirements of 
either rNTPs or dNTPs for synthesis, the importance of other replication machinery 
components on priming and the requirement of different DNA templates and initiation 
sites. 
Nevertheless, the information gleaned from these assays was limited. Notably, primer 
synthesis could often only be detected in the presence of additional replisome 
components and results could be obscured by the DNA template used. Furthermore, 
analysis of reaction products by liquid scintillation counting was not able to provide 
qualitative information about the length and sequence of the synthesised primers. 
Consequently, follow-up studies of phage and prokaryotic primases, as well as early 
analyses of the replicative eukaryotic primase Prim1/2 from yeast and Drosophila, further 
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resolved primase reaction products by polyacrylamide gel electrophoresis (PAGE) 
(Biswas et al., 1987; Bouché et al., 1978; Conaway and Lehman, 1982a, 1982b; Romano 
and Richardson, 1979; Scherzinger et al., 1977; Wu et al., 1992). Here, reactions were 
assembled in essentially the same manner as described previously using ss phage or 
poly(dT) DNA templates, however other replisome components such as DNA 
polymerases and helicases were omitted, allowing direct synthesis by the primase to be 
examined (Biswas et al., 1987). Following incubation, reactions were typically stopped 
by supplementation with EDTA and ionic surfactants such as SDS or sarkosyl. 
Additionally, reactions were often incubated with proteinase K for 1-2 hrs before phenol 
chloroform extraction or ethanol precipitation. Subsequently, pellets were resuspended 
in buffer containing formamide, in addition to the dyes bromophenol blue and xylene 
cyanol, and denatured by heating before loading onto the gel. Electrophoresis was 
performed on urea-polyacrylamide gels which were autoradiographed using x-ray film 
(Biswas et al., 1987; Conaway and Lehman, 1982a). 
By resolving reaction products on polyacrylamide gels, the synthesised primers could be 
analysed to single nucleotide resolution, thus providing more direct information about 
primase activity than liquid scintillation counting alone. Many studies have utilised this 
approach in the basic characterisation of viral, prokaryotic, and eukaryotic primases in 
order to determine the length of synthesised primers (Frick and Richardson, 2001). 
Further processing of RNA primase reaction products by limited alkali or ribonuclease 
digestion, prior to resolution on urea-polyacrylamide gels, has also been used to 
determine the sequence of these primers (Romano and Richardson, 1979). 
Since the development of gel-based radioactive primase assays in the late 1970s and 
early 1980s, the basic outline of this technique has largely remained unchanged. 
However, clean-up steps including proteinase K digestion and phenol chloroform 
extraction are now generally omitted. This greatly increases the speed and ease of the 
technique without significantly affecting the quality of results. In addition, advances in 
oligonucleotide synthesis technology have allowed specific DNA templates of known 
sequence to be generated and analysed in the assay, thus increasing the applicability of 
the technique. One example of this is in the analysis of T7 primase recognition sites. In 
this report, numerous oligonucleotides containing different modified primase recognition 
sites were synthesised and tested for their ability to act as primer synthesis templates 
(Frick and Richardson, 1999). This allowed the authors to identify the requirements for 
sequence-specific DNA binding and primer synthesis by T7 primase. Synthetic 
oligonucleotides were also used in the early characterisation of human Prim1/2 (Kirk and 
Kuchta, 1999b). Here, oligonucleotides containing increasing amounts of deoxycytidine 
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were used to analyse the effect of manganese (Mn2+) ions on primase activity. It was 
found that the level of stimulation of processivity by Mn2+ decreased on templates 
containing higher amounts of deoxycytidine. The authors suggested that this was due to 
the inherently higher processivity of Prim1/2 on deoxycytidine-rich templates (Kirk and 
Kuchta, 1999b). Thus, the use of synthetic oligonucleotides in primase assays has a 
number of advantages over traditional phage DNA templates. These include the ability 
to use shorter oligonucleotides of known sequence, allowing primase initiation sites and 
product sequences to be much more easily determined. Furthermore, synthetic 
templates can be easily modified in order to examine the effect of different sequences 
and DNA secondary structures on primase activity. Nevertheless, phage DNA, in 
particular ss M13, is often still used as a general template to identify primase activity, 
due to its affordability and circular nature, which prevents snap-back and extension of 
the 3 end of the template. 
In addition to advances in oligonucleotide synthesis, developments in other accessory 
components of the radioactive primase assay have increased the speed and ease with 
which it can be performed. One particular advancement is in the methods used to detect 
radiolabelled primase products. Traditionally, autoradiography was used to detect 
radioactivity by exposing X-ray films to polyacrylamide gels following resolution. The 
resulting images could then be quantified by densiometry, permitting kinetic analysis of 
the reaction products. However, these techniques can be time-consuming and require 
long exposure times for high sensitivity to be achieved. In addition, X-ray film is easily 
over exposed, resulting in signal lying outside the linear dynamic range and thus 
preventing accurate quantification. Generally, radioactive gels are now analysed by 
phosporimaging. Here, storage-phosphor screens replace X-ray films, subsequent 
scanning of these with a helium-neon laser causes emission of luminescence 
proportional to the level of radiation which is quantified using a photomultiplier, 
consequently producing a digital image. The resulting image and reaction products can 
then be quantified using image analysis software. In comparison to X-ray film detection, 
phosphorimaging has greatly increased, sensitivity, linear dynamic range, and speed of 
image development, despite increased expense and lower resolution (Van Kirk et al., 
2010). 
In summary, the radioactive gel-based primase assay has remained largely unchanged 
since its initial development in the late 1970s, however refinements of the technique and 
advances in accessary components have greatly increased the speed and ease with 
which it can be performed. Typically reactions are now assembled in optimum buffer 
conditions containing, the primase of interest, activating metal ion cofactors, a synthetic 
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or phage ssDNA template of known length and sequence, unmodified dNTPs or rNTPs, 
and radiolabelled dNTPs or rNTPs. Following incubation, reactions are stopped by 
addition of formamide and EDTA, before heat denaturation and loading onto a urea-
polyacylamide gel. After resolution, the gel is visualised by phosphorimaging, the 
resulting digital image can then be analysed and quantified using image analysis 
software (outlined in Figure 4.1.). 
Despite relatively few changes to the original gel-based primase assay, the technique is 
still the go-to option when analysing primase activity due to its excellent sensitivity and 
ability to provide information on the size and yield of reaction products. This is highlighted 
by the use of the assay in the characterisation of recently discovered archaeal and viral 
primases (De Silva et al., 2009; Galal et al., 2012; Lipps et al., 2004; Silva et al., 2007; 
Zuo et al., 2010). However, the assay also has a number of limitations and 
disadvantages. Perhaps the most significant of these is the reliance on potentially 
hazardous radioactivity. This requires training in the handling and disposure of 
radioactivity, in addition to the implementation of rigorous safety measures, before the 
assay can be performed. Coupled with this, radiolabelled dNTPs have a short half-life, 
limiting the amount of time that they can be stored and increasing the cost of the assay 
if used over a long period of time. Radioactivity imaging methods can also suffer from 
poor linear dynamic range, indeed over exposure can result in a signal outside of the 
linear range, therefore preventing accurate quantification. Additionally, in spite of 
refinements of the original assay, the technique is still relatively time consuming thus 
making it unsuitable for certain applications, such as HTS of primase inhibitors. 
4.2.3.2. A High-Throughput Radioactive-Based Primase Assay
Due to the limited applicability of the traditional gel-based radioactive primase assay in 
HTS approaches, a modified 96-well plate scintillation proximity assay (SPA) was 
developed to screen E. coli DnaG inhibitors (summarised in Figure 4.2.) (Zhang et al., 
2002). In this assay, reactions are assembled in a 96-well plate in the typical manner, 
containing an appropriate buffer, metal ion cofactors, unlabelled dNTPs, [3H]CTP, a 
ssDNA template, DnaG, DnaB, and the test compound or DMSO. Following incubation, 
a suspension of polyvinyl toluene-polyethyl-eneimine (PVT-PEI) coated SPA beads are 
added and after 1 hour the plates are read on a Topcount instrument (Packard) (Zhang 
et al., 2002). The assay is based upon the capture of primase reaction products on the 
PVT-PEI SPA beads. This capture brings the 3H-labelled reaction products in close 
proximity to the SPA beads. Consequently, decay of the 3H releases -particles, which 
stimulate the scintillant in the beads to emit photons. The emitted photons can then be 
151
Figure 4.1. Outline of the radioactive gel-based primase assay.
1. Primase reactions are assembled containing the primase of interest (shown in green), a ssDNA template, native rNTPs or dNTPs, and radiolabelled rNTPs 
or dNTPs (indicated by red star) in an appropriate buffer. Incorporation of radiolabelled nucleotides during synthesis and extension generates radiolabelled 
primers. 2. Following primer synthesis, reactions are quenched through addition of EDTA and primer-template duplexes are denatured by heating in buffer 
containing formamide. 3. Reaction products are loaded onto a denaturing urea-polyacrylamide gel and electrophoresis is performed to resolve the 
radiolabelled primers. 4. Synthesised primers are visualised by autoradiography using X-ray film, or phosphorimaging.
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Figure 4.2. Overview of the high throughput radioactive-based primase assay.
1. Primer synthesis reactions are assembled in 96-well plates containing E. coli DnaG primase (shown in green), DnaB helicase (shown in purple), native 
rNTPs, 3H-CTP (indicated by red star), ssM13 template DNA, and the test compound (shown as red triangle) or DMSO, in an appropriate buffer. Incubation 
of reactions permits synthesis of 3H-CTP-labelled primers on the M13 template. 2. Polyvinyl toluene-polyethyl-eneimine (PVT-PEI) scintillation proximity 
assay (SPA) beads are added to the reaction. Capture of the radiolabelled primers on the PVT-PEI SPA beads stimulates photon emission from the scintillant 
in the beads. Free 3H-CTP does not bind the beads, and therefore does not stimulate photon emission. 3. Photon emission is detected and quantified using 
a photomultiplier tube based scintillation counter.
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detected and quantified using a photomultiplier tube based scintillation counter. Free 
3H[CTP], not bound to the SPA beads, does not stimulate photon emission due to the 
insufficient energy of the -particles to reach the beads. Thus, SPA has the advantage 
that no separation or washing step is required to remove the free 3H[CTP]. 
This assay overcomes the time-consuming nature of the traditional gel-based primase 
assay and extends the application of the technique to HTS. The assay provides a 
sensitive and efficient method to quantify primase activity and screen DnaG inhibitors 
that, when coupled with a DnaB helicase assay, can provide insights into the mechanism 
of action of those compounds (Zhang et al., 2002). However, the technique is still reliant 
on the use of radioactivity and, due the HTS approach, is costly and may generate large 
amounts of liquid waste, potentially making it unsuitable in an academic setting. 
Additionally, unlike gel-based approaches, the assay does not provide qualitative 
information about the size or sequence of the synthesised primers, which may have 
important implications for the interpretation of the mechanism of action of inhibitors being 
screened.
4.2.4. Non-Radioactive Primase Assays 
Given the drawbacks of radioactive-based primase assays, a number of alternative non-
radioactive assays have been developed, some of which are applicable to HTS. In this 
section, the background to these methods and their advantages and disadvantages will 
be discussed. 
4.2.4.1. Thermally Denaturing High-Performance Liquid Chromatography Primase 
Assay
In order to avoid the cost and safety issues associated with radioactive based assays, 
an alternative primase assay was developed, based upon high-performance liquid 
chromatography (HPLC) analysis of reaction products (outlined in Figure 4.3.) (Koepsell 
et al., 2004). To develop the assay, the authors made use of E. coli DnaG and enzymatic 
reactions were assembled in appropriate buffer conditions containing the primase, 
ssDNA template (< 30 nt in length) blocked at the 3 end, and native rNTPs. Importantly, 
by blocking the 3 end of the template, the user can directly examine de novo synthesis 
by the primase, rather than elongation from a 3-end hairpin on the synthetic ssDNA 
template, which can be produced by template snap-back. Notably, other assays, 
including the radioactive HTS method, did not control for this phenomenon, potentially 
generating misleading data and interpretation of results. Indeed, Koepsell et al. found 
that when the 3 end of the template was not blocked, 10-fold more primase was required 
for de novo primer synthesis and the rate constant of primer synthesis was three times 
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Figure 4.3. Summary of the thermally denaturing HPLC primase assay.
1. Primase reactions are assembled containing the primase of interest (shown in green), native dNTPs or rNTPs, and a ssDNA template blocked at the 3 
end by a C3 linker, in an appropriate buffer. Assembled reactions are incubated allowing synthesis of unlabelled primers. 2. Reactions are stopped by heating, 
before being desalted, dried, and resuspended in water. 3. Samples are then loaded onto an alkylated non-porous polystyrene-divinylbenzene copolymer 
microsphere bead column and analysed by HPLC under thermally denaturing conditions (80 °C). 4. Primase reaction products and template DNA are detected 
upon elution by monitoring UV absorbance at 260 nm. The resulting chromatogram can be used for quantification of primer synthesis by comparison to a 
standard curve, taking into account the extinction coefficient of the oligonucleotide.
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greater than that reported when using the radioactive HTS method (Koepsell et al., 2004; 
Zhang et al., 2002). Following incubation, reactions were stopped by heat denaturation, 
and desalted and dried, before resuspension in 1/10th the reaction volume of water. 
Subsequently, reaction products were analysed by HPLC on an alkylated non-porous 
polystyrene-divinylbenzene co-polymer microsphere bead column under thermally 
denaturing conditions. UV detection of the eluted oligonucleotides at 260 nm produced 
chromatograms with peaks corresponding to the template and various smaller products 
(Koepsell et al., 2004). Reaction products could then be quantified by analysing the area 
under each peak, taking into account variations in extinction coefficients between 
oligonucleotides, and compared to a standard curve. Importantly, analysis by denaturing 
HPLC allows reaction products to be separated by both size and hydrophobicity, thus 
producing qualitative, as well as quantitative, information about the synthesised primers. 
The assay was used to determine the kinetics of de novo primer synthesis by DnaG, as 
well as to identify the IC50 for dNTP inhibition of primase activity (Koepsell et al., 2004). 
The denaturing HPLC primase assay has a number of advantages over traditional gel-
based radioactive assays. Perhaps the greatest of these is that the assay is performed 
with native rNTPs/dNTPs, removing all hazards associated with radioactivity. 
Additionally, the removal of radioactivity also decreases the cost of the assay, 
discounting initial costs for equipment. Like the traditional gel-based assays, this method 
is able to provide sensitive qualitative and quantitative information about primer 
synthesis. Furthermore, the HPLC analysis is automated and scalable to a degree, with 
each run taking ~ 20 mins (Koepsell et al., 2004). This makes the assay much quicker 
for individual experiments requiring only a short number of runs, when compared to gel 
based assays. However, with larger experiments requiring multiple runs, the analysis 
time can be much greater and it is here that gel based assays have the advantage of 
resolving multiple samples at the same. Likewise, this method lacks sufficient throughput 
for HTS approaches, making it unsuitable for screening large chemical libraries to identify 
inhibitors. Quantification of reaction products using chromatogram peaks can also be 
more difficult than analysing gels, notably variations in extinction coefficients between 
products requires knowledge of the nucleotide content of the peak, in addition to the 
generation of a standard curve. Coupled with this, HPLC analysis requires optimisation 
to each specific ssDNA template being used, prior to performing experiments. 
4.2.4.2. A Fluorometric High-Throughput Primase Assay 
Given the limitations of the HPLC primase assay in HTS, Koepsell et al. then developed 
a high throughput microplate-based fluorescent primase assay, adaptable to robotic 
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screening methods (summarised in Figure 4.4.) (Koepsell et al., 2005). This assay is 
based on PicoGreen nucleic acid dye, a fluorochrome that binds specifically to dsDNA. 
When bound, PicoGreen fluoresces at an excitation maximum of 480 nm, with an 
emission peak at 520 nm. The dye was previously found to offer an effective and 
sensitive way to quantify dsDNA due to its high level of fluorescence enhancement upon 
DNA binding, thus making it suitable for the detection of primer-template duplexes (Ahn 
et al., 1996). In this high throughput fluorescent primase assay, reactions are assembled 
in a 96-well microplate and incubated for the desired time to allow primer synthesis. 
Following incubation, PicoGreen dye is added, which binds to the RNA-DNA duplexes 
generated from primer synthesis and fluoresces upon excitation, allowing detection and 
quantification of primase reaction products using a spectrofluorometer. Additionally, 
PicoGreen dye quenches the primase reaction, removing the need for quenching with 
EDTA (Koepsell et al., 2005). 
This high-throughput fluorometric primase assay, therefore, offers a non-radioactive 
alternative for HTS studies of potential primase inhibitors. The assay is able to provide 
quantitative information on primer synthesis but, like the radioactive HTS method, does 
not generate qualitative information, such as primer length or sequence. Although the 
microplate format, fast analysis time, and ability to function in the presence of DMSO, 
makes the method an attractive option for HTS, there are a number of potential 
drawbacks to the technique. Firstly, the assay is effective in detecting primers longer 
than ~ 6 nt due to their stable association with the template DNA. However, shorter 
primers may not provide the stable duplex required for PicoGreen binding and 
fluorescence enhancement. Secondly, a potential issue in using fluorometric assays for 
HTS is the interaction of non-polar and aromatic compounds with the fluorescent label, 
which may interfere with the signal and obscure results (Biswas et al., 2012). 
4.2.4.3. A High-Throughput Primase-Pyrophosphatase Activity Assay 
A more recently developed alternative to the fluorometric primase assay, with similar 
HTS applications, is the primase-pyrophosphatase assay (outlined in Figure 4.5.) 
(Biswas et al., 2012). In this assay, primase activity is coupled to inorganic 
pyrophosphatase (PPase), which cleaves the pyrophosphate (PPi) released during the 
priming reaction into phosphate (Pi). The Pi concentration can then be measured using 
malachite green reagent (MGR), which displays increasing absorbance at 620 nm as the 
concentration of Pi increases, producing a colour change from yellow to green that is 
quantifiable using a plate reader. Importantly, PPase does not exhibit any cleavage 
activity on NTPs, consequently making the enzymes activity dependent upon PPi 
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Figure 4.4. Overview of the fluorometric high-throughput primase assay.
1. Reactions are assembled in a 96-well plate containing the primase of interest (shown in green), a ssDNA template with a blocked 3 end, unlabelled dNTPs, 
and the chemical compound to be screened (indicated by red triangle) or DMSO, in a suitable buffer. Incubation of reactions facilitates primer synthesis and 
extension, generating primer-template duplexes. 2. PicoGreen dye (shown as a green circle) is added to the reaction which binds to the primer-template 
duplexes, producing fluorescence enhancement. Addition of PicoGreen dye also quenches the reaction, removing the need to add EDTA. 3. The 96-well 
plate is scanned using a spectrofluorometer with an excitation at 485 nm and an emission at 538 nm. Thus, the level of fluorescence is determined by the 
amount of PicoGreen dye bound to dsDNA, which is dependent upon the amount of primer synthesis. 
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Figure 4.5. Outline of the high-throughput primase-pyrophosphatase activity assay.
1. For HTS, primase reactions are assembled in 384-well plates containing Mtb DnaG (shown in green), Mtb pyrophosphatase (PPase) (shown in orange), 
unlabelled rNTPs, a ssDNA template, and the inhibitors to be tested (shown as a red triangle) or DMSO, in a suitable buffer. Incubation of the reactions 
permits primer synthesis and extension. 2. Incorporation of nucleotides by the primase during synthesis releases pyrophosphate (PPi). The released 
pyrophosphate is then cleaved by PPase into phosphate (Pi). 3. Malachite green reagent (MGR) (indicated by purple circle) and sodium citrate are added to 
the reaction. MGR forms a complex with the phosphate which produces a colour change from yellow to green. Thus, the colour change is dependent on the 
level of free Pi, which is consequently dependent upon PPi release, and ultimately the level of primase activity. 4. The colour change is detected and quantified 
by measuring absorbance at 620 nm in a plate reader.
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released during primer synthesis (Biswas et al., 2012). Additionally, ssDNA templates 
lacking thymidine nucleotides in their 5 half are used, allowing ATP to be omitted and 
thus preventing any background signal from being generated by ATPase activity present 
in the protein preparations. 
Biswas et al. were able to successfully use this assay to screen 2560 small molecules 
for Mycobacterium tuberculosis DnaG (Mtb DnaG) inhibition (Biswas et al., 2012). For 
HTS, reactions were assembled in 384-well plates containing the inhibitors, rNTPs, 
ssDNA template, Mtb DnaG, and Mtb PPase, in the appropriate buffer. After incubation, 
MGR and sodium citrate were added and absorbance at 620 nm was measured in a 
plate reader (Biswas et al., 2012). Thus, PPi release can be used to provide a 
quantitative measure of primer synthesis, permitting kinetic analyses of Mtb DnaG. Using 
this method for HTS, the authors identified a number of hits for DnaG inhibitors, including 
suramin and doxorubicin. Further kinetic analysis of primase activity, in the presence of 
these inhibitors, measured the release of PPi as a function of inhibitor concentration 
under various DNA and NTP concentrations. This analysis provided insights into the 
mode of inhibition, which suggested that the inhibitors may act by blocking the binding 
of DnaG to DNA (Biswas et al., 2012). 
The primase-pyrophosphate assay is thus a proven method for HTS of primase 
inhibitors. Like the previously discussed assays, the method benefits from being non-
radioactive, significantly reducing potential hazards and making it more suitable for HTS 
in an academic setting. Additionally, the assay is quick to perform and directly measures 
NTP incorporation, allowing any primase activity to be detected regardless of primer 
length. Importantly, however, the use of PPase in the method requires further analysis 
to confirm that the screened inhibitors are acting upon the primase itself and not PPase. 
Indeed, the authors used the traditional gel-based radioactive primase assay to confirm 
that DnaG was inhibited by the identified compounds (Biswas et al., 2012). 
4.2.5. A Fluorescent Gel-Based Primase Assay
Given the disadvantages of radioactive assays, and the limited ability of non-radioactive 
HTS methods to generate qualitative information (e.g. primer length or sequence), we 
aimed to develop a gel-based non-radioactive primase assay with the same benefits and 
basic set-up as the classic radioactive assay but without the hazards and time-
consuming nature of radioactive work. To this end, we have developed a fluorescent gel-
based primase assay, which utilises 6-carboxyfluoroscein (6-FAM) labelled nucleotides
in place of radioactivity. In this section, the background and outline of the method will be 
described, before moving onto provide a detailed method for the assay using PrimPol as 
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an example primase and, finally, a discussion of the advantages and disadvantages of 
the technique. 
4.2.5.1. Theory and Overview of the Fluorescence-Based Primase Assay
The fluorescence-based primase assay described here has the same basic layout as the 
traditional radioactive-based primase assay (Figure 4.6.). Reactions are assembled in 
appropriate buffer conditions containing the purified primase to be studied, a ssDNA 
template, native dNTPs or rNTPs, 6-FAM dNTPs or rNTPs (~ 100 fold lower 
concentration than unmodified nucleotides), and the required activating divalent metal 
ions. Incubation of the assembled reactions permits primer synthesis and extension on 
the ssDNA template. The majority of synthesis occurs using unlabelled nucleotides, 
however incorporation of 6-FAM dNTPs or rNTPs during extension of the primers allows 
the reaction products to be visualised. Following quenching of the reactions, background 
given by the fluorescent nucleotides can be reduced using a number of optional DNA 
precipitation and clean-up approaches. The resulting reaction products are subsequently 
resolved on a denaturing urea-polyacrylamide gel and visualised on a fluorescence 
image reader. 
4.2.5.2. Preparation of Primase Assay Reagents 
Prior to performing the assay, the primase of interest must be expressed and isolated to 
a high level of purity. Importantly, the purified primase must be free from contaminating 
primases, polymerases, and nucleases, which can interfere with the interpretation of 
results. In addition to preparing the primase of interest, a suitable purified ssDNA 
template must be obtained. Both synthetic linear and circular phage templates are 
suitable for this assay, although reaction products smaller than ~10 nucleotides can be 
difficult to distinguish from background without further extension, therefore templates >10 
nt are recommended. 
4.2.5.3. Primer Synthesis Reaction 
4.2.5.3.1. Buffers and Reagents 
· 10 x TBE: 1 M Tris (pH 7.6), 1 M boric acid, 20 mM EDTA
· 7 M urea 15 % polyacrylamide gel mix 60 ml: 28.8 g urea, 22.5 ml acrylamide : 
bisacrylamide (19:1), 199.2 µl APS, 24 µl TEMED, 6 ml 10 x TBE (add APS and 
TEMED immediately before pouring gel) (see tip 1 and 2)
· 10 x reaction buffer: 100 mM Bis-Tris-Propane-HCl (pH 7.0), 100 mM MgCl2, 10
mM DTT (buffer available from NEB as NEBuffer 1)
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Figure 4.6. Summary of the fluorescence gel-based primase assay.
1. Primase reactions are assembled containing the primase of interest (shown in green), a ssDNA template blocked at the 3 end with a dideoxynucleotide, 
unlabelled dNTPs or rNTPs, and 6-FAM labelled dNTPs or rNTPs (indicated by green star), in an appropriate buffer. Incubation of the reaction facilitates 
primer synthesis and extension with incorporation of 6-FAM dNTPs/rNTPs during synthesis by the primase generating fluorescently labelled primers. 2. 
Reactions are quenched in buffer containing EDTA and formamide, and primer-template duplexes are denatured by heating. 3. Reaction products are 
resolved on a denaturing urea-polyacrylamide gel. 4. Following electrophoresis, gels are scanned with a fluorescent image reader. An example gel image is 
shown. Here, the fluorescence gel-based primase assay was performed as described in experimental procedure using increasing concentrations of PrimPol 
(0.25, 0.5, 1, 2, and 4 µM) (indicated by black triangle) on a 66 nt template (sequence shown in buffers and reagents), blocked at the 3 end with a 
dideoxynucleotide. Reactions were incubated for a single 15 min time point. C indicates the no enzyme control. Nucleotide size markers of 50 and 29 nt are 
shown to the left of the image.
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· 10 µM ssDNA template (5-Biot-GTCTTCTATCTCGTCTATATTCTATTGTCTCT
ATGAATACCTTCATCAGTCTCACATAGATGCAT-dideoxyC-3 or another 
suitable ssDNA template)
· 2.5 mM dNTP stock solution: 2.5 mM of each dNTP (NEB), diluted in ddH2O 
(dNTPs can be replaced with rNTPs if required)
· 25 µM FAM dNTP stock solution: 25 µM N6-(6-amino)hexyl-dATP-6-FAM, 25 µM 
5-Propargylamino-dCTP-6-FAM, 25 µM Aminoallyl-dUTP-6-FAM 
(JenaBioscience), diluted in ddH2O (can also be replaced with 6-FAM rNTPs)
· Purified Primase: PrimPol (or another primase of interest) 
· 2 x stop buffer: 95 % formamide, 20 mM EDTA, 0.25 % bromophenol blue and 
xylene cyanol (see tip 3)
· FAM-labelled oligonucleotide size marker 
4.2.5.3.2. Equipment 
· Vertical nucleic acid PAGE set up (adjustable gel slab system, 165 mm x 280 
mm glass plates, 0.75 mm spacers, 20 well combs) (C.B.S.Scientific) or suitable 
equivalent (see tip 4)
· Incubator, water bath or dry heating block 
· Standard microcentrifuge
· FLA-5100 fluorescent image analyser (Fujifilm) 
· ImageQuant TL for image analysis 
4.2.5.3.3. Experimental Procedure 
1. Before assembling the primase assay reactions, urea-polyacrylamide gels should 
be prepared and poured according to the manufacturers instructions. This will 
allow sufficient time for setting. Note that the gel should be pre-run in 1 x TBE for 
0.5 - 1 hr before loading (see tip 5).
2. On ice, assemble 10 µl reactions for each variable in the following order:  5 µl 
ddH2O, 1 µl 10 x reaction buffer (1 x final), 1 µl ssDNA template (1 µM final), 1 µl 
dNTP stock solution (250 µM final), and 1 µl FAM dNTP stock solution (2.5 µM 
final) (see tip 6). If taking multiple time points, make one stock reaction with 10 µl 
per time point and an additional 10 µl to account for pipetting errors, e.g. if taking 
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5 time points make a 60 µl reaction. A no enzyme control should also be 
prepared. Exposure of the FAM dNTP stock, and reactions containing FAM 
dNTPs, to light should be kept to a bare minimum. 
3. On ice, make a 10 x stock of PrimPol using 1 x reaction buffer for dilution. For 
each primase, the concentration required to give the desired level of activity 
should be determined by testing a range of concentrations. In this case, the 
amount of ddH2O added to the reaction can be adjusted to account for the 
changing volume.
4. Pre-incubate the assembled reactions at 37 °C for 5 mins (see tip 7).
5. Initiate the reaction by adding 1 µl of 10 x PrimPol stock and mix by pipetting. 
6. Incubate the reactions for the desired time point or time course at 37 °C (see tip 
7).
7. Stop the reaction by adding 10 µl 2 x stop buffer. If using a stock reaction and 
taking multiple time points, 10 µl of the reaction should be removed and added to 
10 µl of 2 x stop buffer.
8. Incubate the quenched reactions at 90 °C for 3 mins and spin briefly in a 
microcentrifuge. 
9. Load each 20 µl sample onto the pre-run urea-polyacrylamide gel and resolve 
according to the manufacturers recommendations (see tip 5 and 8). Observe the 
migration of the bromophenol blue and xylene cyanol dyes to monitor progression 
of the samples. 
10. A FAM-labelled oligonucleotide size marker should be run alongside the samples 
to allow determination of product sizes.
11. Before imaging, the gel system should be disassembled and the plates 
thoroughly cleaned with dH2O and ethanol. Failure to do this will affect the image 
quality. Note that it is not necessary to remove the gel from the glass plates before 
scanning. 
12. Visualise the gel using an FLA-5100 image reader, or an equivalent imager. 
13. The resulting digital image can be analysed using image analysis software, such 
as ImageQuant TL, if quantification of primase reaction products is desired. 
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4.2.5.3.4. Tips
1. For optimal resolution the concentration of acrylamide should be adjusted 
according to the expected product size. A higher polyacrylamide concentration 
will resolve smaller oligonucleotide products.
2. Following the addition of APS and again after the addition of TEMED, the gel mix 
should be mixed gently by inverting to avoid aeration and the generation of
bubbles.
3. The inclusion of these dyes in the stop buffer can interfere with the fluorescent 
signal if migrating at the same size as the reaction product. In this case, the dyes 
can be omitted from the stop buffer and run in an empty well to still allow 
monitoring of sample progression. 
4. Using a large sequencing PAGE set up allows much great resolution of reaction 
products compared to smaller gels. Addition of a metal heat dispersion plate in 
the set-up can help prevent smiling of the samples.
5. Prior to pre-running the gel and again before loading samples, the wells should 
be washed 2 x using a 1 x TBE filled syringe and needle to remove any gel pieces 
and urea. 
6. If assembling a large number of reactions, it is beneficial to make a single reaction 
stock and aliquot this for each sample, taking into account the different amount 
of ddH2O which might be required for each reaction depending on the variable 
being analysed. This also minimises variation between reactions caused by 
pipetting error.
7. Although a bench top dry heating block is sufficient for short time-courses, an 
incubator should be used for long time points to prevent evaporation and 
condensation on the inside of the Eppendorf tube lid.
8. If all of the wells of the gel are not being used, loading of blank samples, 
containing 1 x TBE and 1 x stop buffer, into the empty wells can help prevent gel 
smiling.
4.2.5.3.5. Methods to Reduce Background 
Although the primase assay can be used reliably without any clean-up steps to remove 
unincorporated 6-FAM dNTPs, background signal from the dNTPs is visible lower down 
the gel. To remove this background and improve the quality of results, a number of DNA 
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precipitation techniques can be implemented. These clean-up steps should be 
performed following incubation of the reactions, but before the addition of stop buffer 
(between Steps 6 and 7). 
We have reliably precipitated primer-template duplexes and removed free 6-FAM dNTPs 
using magnetic streptavidin beads (Roche) (note that the ssDNA template must be biotin 
labelled to use this method), Oligo Clean & Concentrator columns (Zymo Research), and 
ethanol precipitation (Figure 4.7.). Of these techniques, ethanol precipitation, following a 
standard protocol (note that incubation on ice for 10-15 mins is sufficient for 
precipitation), is the most cost-effective and efficient method. If using this method, note 
that the pellet will likely not be visible. Use of the Oligo Clean & Concentrator columns 
(Zymo Research) or equivalent, following the manufacturers protocol, may be desirable 
in the interest of time when analysing a large number of samples. Following precipitation, 
the DNA should be suspended in 1 x stop buffer and the protocol continued as described 
above. 
4.2.5.4. Considerations when Performing the Fluorescence-Based Primase Assay
The fluorescent gel-based primase assay described above has been successfully used 
in both published and unpublished primase studies from our group (Kobayashi et al., 
2016; Schiavone et al., 2016). However, there are a number of points which must be 
considered before performing the assay. Firstly, we have used this assay to study both 
human PrimPol and archaeal replicative primases with success. These primases are 
able to incorporate the 6-FAM labelled dNTPs during primer synthesis and extension 
(Figure 4.8.). However, it must be noted that 6-FAM labelled dNTPs are significantly 
modified in comparison to native or radiolabelled dNTPs and thus care must be taken to 
ensure that the primase of interest is able to efficiently incorporate these modified 
nucleotides. Note that PrimPol and replicative archaeal primases preferentially 
synthesise primers using dNTPs over rNTPs, hence the use of 6-FAM dNTPs here. In 
the case that the primase of interest synthesises RNA primers, 6-FAM dNTPs can be 
substituted for 6-FAM rNTPs, which are also commercially available. 
Secondly, when using a linear ssDNA template with a free 3 end, products larger than 
the template may be observed (Figure 4.9.). We have determined that this is likely due 
to formation of a hairpin at the 3 end of the template, produced by snap-back (see 
section 4.3.). Extension of this 3 end hairpin by the primase consequently produces 
reaction products much larger than expected and may additionally sequester the enzyme 
away from performing de novo primer synthesis. This can be avoided by blocking the 3 
end of the template with a 3 C3 spacer, dideoxynucleotide, or other suitable modification. 
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Figure 4.7. DNA precipitation methods used to reduce FAM dNTP background.
The assay was performed as described in experimental procedure using 250 nM PrimPol. 
The black triangle indicates increasing time points of 1, 5, and 10 mins. Following incubation, 
reactions were either immediately quenched with stop buffer (as indicated in buffers and 
reagents) (shown on the left as no clean-up) or were subject to DNA precipitation clean-up 
techniques. Pull down reaction samples were quenched with binding-washing buffer (10 mM 
Tris-HCl pH 7.5, 500 mM NaCl, 10mM EDTA) and supplemented with 20 µl streptavidin 
coated beads (Roche). Binding was performed for 1 hr at 4 °C and samples were 
subsequently washed 3 x 1 ml with binding-washing buffer, before resuspension in 1 x stop 
buffer. Clean-up column reaction samples were bound, washed, and eluted from Oligo Clean 
& Concentrator columns (Zymo Research) according to the manufacturers instructions, 
before resuspension in 1 x stop buffer. EtOH precipitation samples were supplemented with 
1/10 volume 3M NaOAc and 3 volumes of 100% EtOH, before incubation for 15 mins on ice. 
Following incubation, samples were spun in a microcentrifuge at top speed for 30 mins at 4 
°C, washed with 70 % EtOH, centrifuged again for 15 mins, dried, and resuspended in 1 x 
stop buffer. FAM-dNTP background can be seen at bottom of the gel for the no clean-up 
samples, but not in any of the DNA precipitation sample lanes. C indicates the no enzyme 
control. Nucleotide (nt) size markers of 50 and 29 nt are shown on either side of the image.
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Figure 4.8. PrimPol can incorporate 6-FAM dATP, dCTP, and dUTP.
Reactions were assembled containing 250 nM PrimPol and either 6-FAM dATP, dCTP, dUTP, 
or all three, at increasing concentrations (0.5, 1, and 2 µM), and performed as outlined in 
experimental procedure for a single 10 min time point. C indicates the no enzyme control. 
Nucleotide (nt) size markers of 50 and 29 nt are shown on either side of the image.
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Figure 4.9. Comparison of the fluorescence gel-based primase assay on a linear ssDNA 
template with either a free 3 end, or a 3 end blocked with a dideoxynucleotide.
Assays were performed as detailed in experimental procedure containing 250 nM PrimPol, 
and a 66 nt template with a free 3 end or containing a dideoxynucleotide at the 3 end 
(sequence in buffers and reagents). When the 3 end is free, reaction products larger than 
the template are observed (3-free sample lanes), however, addition of a 3 
dideoxynucleotide removes these products (3-ddNTP sample lanes), suggesting they are 
produced by extension of the 3 end of the template due to template snap-back. The black 
triangle indicates increasing time points of 5, 10, and 15 mins. C indicates the no enzyme 
control. Nucleotide (nt) size markers of 50 and 29 nt are shown on the left side of the image.
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Alternatively, a circular ssDNA template may be used. Although often overlooked, 3 end 
snap-back is a general problem when analysing primase activity using linear ssDNA 
templates and was briefly discussed by Koepsell et al. in their denaturing HPLC primase 
assay method (Koepsell et al., 2004). 
Lastly, this assay is most applicable for the analysis of primase-polymerases, such as 
PrimPol, which are able to synthesise and extend their own primers. When using linear 
ssDNA templates < 100 nt, these enzymes can perform extension up to the end of the 
template. By analysing these reaction products, taking into account the length of the 
oligonucleotide product and template, the primase initiation site can be determined. This 
is particularly useful when assessing activities such as repriming (Kobayashi et al., 2016; 
Schiavone et al., 2016). Very short primase reaction products, which arent extended 
after the initial synthesis, may be difficult to distinguish from the background given by 6-
FAM dNTPs without any additional clean-up steps. However, the short nature of these 
primers may make them more liable to being washed away during clean-up due to their 
less stable duplex formation with the template DNA. Coupled with this, a higher 
concentration of 6-FAM dNTPs may need to be used in assays where the product size 
is very small, in order to increase the probability of the primase incorporating the 6-FAM 
dNTP into, and therefore labelling, its primer. Alternatively, a single native dNTP may be 
omitted and replaced with the equivalent 6-FAM dNTP. This problem can also be 
overcome by coupling the primase with a processive polymerase, as has been described 
previously in both fluorescent and radioactive assays (Bianchi et al., 2013; Galal et al., 
2012; Keen et al., 2014a, 2014b). Here, primers synthesised by the primase of interest 
are extended by the polymerase, producing larger and more easily distinguishable 
reaction products. 
4.2.5.5. Advantages and Limitations 
This assay is intended to be used in place of the classic radioactive gel-based primase 
assay, which is still widely used in the identification and characterisation of primases. By 
utilising fluorescence, rather than radioactivity, the assay has a number of major 
advantages. Firstly, the potential hazards, rigorous safety measures, training, and cost 
of waste disposal, associated with handling radioactivity are avoided. Secondly, 
substitution of radioactivity with fluorescence permits more accurate quantification of 
reaction products due to the improved linear dynamic range. Radioactive dNTPs also 
have a short half-life, for example in the case of [-32P]dATP and [-32P]dCTP this is only 
14 days. In contrast, 6-FAM dNTPs can be stored at -20 °C for up to 1 year before 
performance decreases. Consequently, despite their initial cost, fluorescent dNTPs can
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be a more affordable option if assays are to be performed over a long period of time. 
Additionally, fluorescent gels can be immediately and rapidly scanned (~10 mins 
scanning time) following electrophoresis. This avoids the lengthy phosphor screen 
exposure times required for radioactivity detection, which can often take up to 12 hrs. 
Coupled with this, the gel-based nature of the assay allows a large number of samples 
(up to 20 per gel) to be resolved and imaged at the same time, taking in total 2-3 hrs. 
This potentially makes the technique faster than alternatives, such as the denaturing 
HPLC primase assay (20 min run time per sample), if a large number of samples are to 
be analysed. 
Another major advantage of the assay is its similar set-up and readout to the traditional 
radioactive method. This allows the technique to be easily adopted by laboratories used 
to performing gel-based radioactive primase assays without extensive alterations to the 
method and equipment, or additional training. Indeed, despite alternatives, such as 
denaturing HPLC, gel-based primase assays are still most commonly used due to the 
ease of interpretation and lack of requirement for extensive optimisation when changing 
templates and enzymes. 
Although possessing a number of advantages over similar qualitative primase assays, 
the fluorescence-based primase assay also shares some drawbacks with these 
techniques. Most notably, similar to the gel-based radioactive and HPLC primase 
assays, the fluorescence primase assay is not yet amenable to HTS. However, gel-
based radioactive assays have previously been used to confirm inhibitors identified from 
large HTS methods, such as the primase-pyrophosphatase activity assay (Biswas et al., 
2012). In these instances, fluorescence could be used to replace radioactivity, in order 
to confirm hits from HTS, and thus make the approach completely non-radioactive. 
Neverthless, it must be noted that the fluorescence does not provide the same level of 
sensitivity as radioactivity, requiring micromolar, in comparison to nanomolar, 
concentrations of labelled dTNPs. Lastly, it is possible that some primases may not 
tolerate the FAM-labelled nucleotides and we have yet to test the assay with FAM-rNTPs.
4.2.6. Summary and Conclusion 
Since the identification of the first primases in the 1970s, characterisation of these 
enzymes has largely relied upon radioactive gel-based methods. Despite possessing 
excellent sensitivity and generating valuable qualitative primer synthesis information,
these assays have major disadvantages, primarily due to their use of radioactivity. 
Consequently, in the last two decades a number of alternative non-radioactive primase 
assays have been developed. In most cases, these techniques have focused on enabling 
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HTS of potential primase inhibitor compounds. Although these assays suit this purpose 
well, they generally lack the capability to provide qualitative information about reaction 
products and often require large-scale optimisation prior to being performed. As a 
consequence, in spite of its time-consuming and hazardous nature, the gel-based 
radioactive primase assay remains the go-to option in the identification and basic 
characterisation of primases. 
In this chapter, we have described how fluorescence provides a reliable alternative to 
radioactivity in the traditional gel-based primase assay, without requiring significant 
changes to the procedure or set-up. By replacing radioactive dNTPs with 6-FAM labelled 
dNTPs, all the disadvantages associated with radioactive work are eliminated. 
Furthermore, this substitution also offers clear advantages in speed over the traditional 
technique. We have used this fluorescent primase assay in published studies of the 
recently discovered eukaryotic primase-polymerase, PrimPol, thereby highlighting the 
general applicability of this technique in primase characterisation. This assay can be 
used in place of radioactive techniques to characterise basic primase activity, identify 
initiation sites, assess the impact of binding partners and accessory proteins, determine 
the effect of different reaction conditions, and to confirm primase inhibitor compounds 
identified through HTS. In summary, the fluorescent gel-based primase assay described 
here offers a safer and faster alternative to the classic, but still widely used, radioactive 
assay.   
4.3. A Brief Investigation into the Mechanism Permitting 
Extension of Free 3 Template Termini by PrimPol
4.3.1. Introduction 
During the development of the fluorescent primase assay, it was observed that PrimPol 
produced reaction products longer than the ssDNA template (Figure 4.9.). These 
products could be eliminated by blocking the 3 end of the template with a 
dideoxynucleotide. Thus, it was clear that these larger products were being generated
by elongation of the template rather than through de novo primer synthesis. However, 
there exist a number of possible mechanisms by which PrimPol could facilitate this 
extension. Firstly, PrimPol could extend the 3 termini in a template independent fashion. 
Secondly, PrimPol could promote synapsis and extension of the template by annealing 
it to another template molecule, which may be suggestive of an end-joining-like role. 
Lastly, the 3 termini of the template may snap-back and anneal with itself, potentially 
mediated by PrimPol, consequently producing a pseudo primer-template for extension 
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by the enzyme. Intriguingly, it has previously been reported that PrimPol has a capacity 
to promote template synapsis and template-independent extension (Keen et al., 2014b; 
Martínez-Jiménez et al., 2015). However, these activities were only observed in the 
presence of manganese (Mn2+) as a cofactor and the possibility that they were produced 
by template snap-back was not considered. Nevertheless, a number of reports have 
shown that bypass of some lesions, including 6-4PPs and Ap sites, by PrimPol, is 
achieved through a pseudo-TLS mechanism, although again these experiment were 
performed in the presence of Mn2+. In this mechanism, PrimPol realigns the primer 
downstream of the lesion, mediated by microhomologies in the template strand. This 
effectively loops out the lesion to permit further extension (García-Gómez et al., 2013; 
Mourón et al., 2013). These observations are consistent with the preference of the 
enzyme to generate deletion mutations (Guilliam et al., 2015a). Therefore, it is not 
inconceivable that this ability to promote primer realignment might also allow PrimPol to 
perform template synapsis and extension. In this section, the mechanism by which 
PrimPol extends template 3-ends is investigated and discussed. 
4.3.2. Materials and Methods
4.3.2.1. Terminal Transferase Assay
PrimPol and Pol  were expressed and purified as previously described (Biertümpfel et 
al., 2011; Keen et al., 2014b). The terminal transferase assay was performed in the same 
manner as a standard primer extension assay, however a 5-FAM labelled ssDNA 
template (sequence 1, Table 4.1.) or dsDNA template (sequences 1 and 2, Table 4.1.) 
was provided for extension. Reactions were assembled containing 100 nM PrimPol or 
Pol , 20 nM template DNA, 100 µM dNTPs (Roche), 10 mM MgCl2, 10 mM Bis-Tris-
Propane-HCl (pH 7.0), and 1 mM DTT. Assembled reactions were incubated at 37ºC for 
a time course of 1, 3, 5, 10, and 20 minutes before quenching with 2x stop buffer (95% 
formamide, 20 mM EDTA, 200 nM competitor oligonucleotide) and heated to 95 ºC 
before resolution on a 15% (v/v) polyacrylamide gel containing 7 M urea in 1x TBE buffer. 
Reaction products were visualised using a Fujifilm FLA-5100 image reader. 
4.3.2.2. MMEJ Assays
MMEJ assays were performed as described previously (Kent et al., 2015). Reactions 
were assembled containing 100 nM of 5-FAM labelled ssDNA or partially ssDNA 
(pssDNA) templates with varying degrees of 3 homology (sequences 3-7, Table 4.1.), 
100 nM polymerase, and 500 µM dNTPs, in primase assay buffer (10 mM Bis-Tris-
Propane-HCl (pH 7.0), 10 mM MgCl2, 1 mM DTT, with or without 1 mM MnCl2) or the 
buffer used by Kent et al. (25 mM Tris-HCl pH 8.8, 10% glycerol, 1 mM DTT, 0.01% NP-
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Table 4.1. Terminal transferase and MMEJ oligonucleotides. 
Sequences of oligonucleotides used for terminal transferase and micohomology-mediated end-joining assays. Underlined sequences indicate regions of 3 
microhomology. 
# Oligonucleotide Modification Sequence (5-3)
1 Terminal Transferase 1 5-FAM CATATCCGTGTCGCCCCTTATTCCGATAGTGACTACA
2 Terminal Transferase 2 N/A GTATAGGCACAGCGGGGAATAAGGCTATCACTGATGT
3 MMEJ DNA-6 5-FAM CACTGTGAGCTTAGGGTTAGCCCGGG
4 MMEJ DNA-4 5-FAM CACTGTGAGCTTAGGGTTAGCCGG
5 MMEJ DNA-2 5-FAM CACTGTGAGCTTAGGGTTAGCG
6 MMEJ DNA-0 5-FAM CACTGTGAGCTTAGGGTTAGATAC
7 MMEJ Comp 14 mer 5-Phosphate CTAAGCTCACAGTG
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40, 10 mM MgCl2, and 0.1 mg/ml BSA). Experiments were performed and samples 
processed as described by Kent et al. (Kent et al., 2015), before resolution on a 15% 
nondenaturing or denaturing (urea) polymacrylamide gel. Reaction products were 
visualised using a Fujifilm FLA-5100 image reader. 
4.3.3. PrimPol can Extend Single-Stranded but not Double-Stranded DNA 
Templates
AEPs involved in NHEJ possess a limited ability to perform template-independent 
extension of both ssDNA and blunt dsDNA ends (Della et al., 2004; Pitcher et al., 2005). 
Previously, in the presence of high concentrations of Mn2+, PrimPol was demonstrated 
to be capable of template-independent extension of ssDNA but not dsDNA ends (Keen 
et al., 2014b). As an initial investigation in to the mechanism of 3-end template extension 
by PrimPol, this ability was analysed in the same buffer as that used in the fluorescent 
primase assay. To this end, a standard primer extension assay was performed using a 
5-FAM labelled 37-mer template, either with (dsDNA) or without (ssDNA) an unlabelled 
complementary 37-mer strand (sequences 1 and 2, table 4.1.). Pol , which is not 
capable of template-independent extension and was previously reported to be unable to 
perform template synapsis, was also analysed for comparison (Kent et al., 2015). 
Both PrimPol and Pol  were unable to extend the blunt dsDNA template, confirming the 
absence of any terminal transferase-like activity in these conditions (Figure 4.10.).
However, both enzymes showed some capacity to extend the ssDNA template, with 
notable differences in the reaction products produced. In the case of Pol , a single 
predominant product of ~8 nt in length was observed. However, with PrimPol, both an 8 
nt product and a ~29 nt product were generated (Figure 4.10.). Analysis of the DNA 
template sequence reveals that the 8 nt product could be produced by snap-back of the 
dA and dC nucleotides, present at positions 37 and 36, to the dT and dG nucleotides at 
positions 9 and 10 on the ssDNA template strand, respectively. Thus, extension of this 
snap-backed 3 end would produce an 8 nt product. Given the distance between the 3 
end of the template and the two complementary nucleotides at positions 9 and 10, it is 
unlikely that this product would be produced by polymerase-mediated end synapsis of 
two template strands. The ~29 nt product, however, could be produced by either snap-
back or synapsis and extension. Here, the dA and dC at the very 3 end of the template 
could base-pair with the dT and dG nucleotides at positions 30 and 31 on the template 
strand, respectively (Figure 4.10.). Given the short distance between these sets of 
nucleotides, it is not inconceivable that this base-pairing was mediated in an end-
synapsis fashion. Thus, the appearance of the additional 29 nt product in the PrimPol 
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Figure 4.10. PrimPol extends ssDNA but not dsDNA templates. 
PrimPol and Pol  were incubated in standard primer extension assay conditions containing 
either ssDNA templates or blunt-ended dsDNA templates for increasing time-points. Both 
PrimPol and Pol  were unable to extend blunt dsDNA templates. However, each enzyme 
generated reaction products by extending ssDNA templates. PrimPol and Pol  produced a 
predominant product of 8 nt, with PrimPol generating a second 29 nt product. The potential 
template configurations permitting generation of these products are shown in the schematic 
below. Here, the 8 nt product is likely generated by snap-back and extension of the 3-end of 
the ssDNA template. The 29 nt product could be produced by either snap-back or MMEJ. 
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but not Pol  reactions, could be due to PrimPol-mediated synapsis of two ssDNA 
template molecules, followed by extension. 
4.3.4. Can PrimPol Perform Microhomology-Mediated End-Joining?
The results obtained from the initial experiments described above were potentially 
consistent with PrimPol harbouring an ability to promote end-synapsis and extension of 
ssDNA templates based on microhomologies within the template sequence. Over a 
decade since the discovery of the NHEJ repair polymerase PolDom in prokaryotes (Della 
et al., 2004; Weller et al., 2002), evidence has emerged which is suggestive of a role for 
Pol  in an analogous microhomology-mediated end joining (MMEJ) pathway in 
eukaryotes (Chan et al., 2010; Koole et al., 2014; Roerink et al., 2014; Yousefzadeh et 
al., 2014). MMEJ is an alternative pathway for the repair of DSBs, here limited resection 
of DNA ends generates a 3 ssDNA overhang and exposes microhomologies on each 
side of the break. PolDom or Pol  dimers are then able to facilitate DNA synapse 
formation by promoting the annealing of these microhomologies, before extension and 
strand displacement (Della et al., 2004; Kent et al., 2015; Weller et al., 2002). The ability 
of Pol  to perform this activity was recently characterised in vitro by analysing its 
capacity to promote MMEJ of DNA templates with either 6 (DNA-6), 4 (DNA-4), 2 (DNA-
2), or 0 (DNA-0), base-pairs of microhomology at their 3 end (Kent et al., 2015). 
Experiments were performed using these templates alone (ssDNA) or with a 14 nt 
complementary strand, with a 5-terminal phosphate, annealed to 3 end of the template, 
thus leaving a 3 ssDNA overhang (pssDNA). Analysis of reaction products on non-
denaturing polyacrylamide gels revealed that Pol  was able to efficiently promote 
synapsis of the pssDNA templates containing 6, 4, and 2, but not 0, base-pairs of 
microhomology. Synapsis of ssDNA templates without the 14 nt complementary strand 
was inefficient, with the major product being snap-back extension. 
In order to examine the ability of PrimPol to perform MMEJ, we performed the same 
assay used in the studies of Pol , on identical DNA templates (sequences 3-7, Table
4.1.). Reactions were performed in both the buffer used for the fluorescent-primase 
assay (Figure 4.11.A.), and the buffer used in the Pol  report (Figure 4.11.B.). The assay 
was also performed in reactions containing a mix of Mg2+ and Mn2+ (Figure 4.11.C.). Pol 
 was used for comparison (Figure 4.12.), in the same conditions as those in the Pol  
report, where it was unable to promote synapsis of templates containing 4 base-pairs of 
microhomology (Kent et al., 2015). 
In each case, PrimPol displayed a limited ability to perform MMEJ of templates 
containing either 6 or 4 nt of homology at their 3 end (Figure 4.11.). A slight increase in 
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Figure 4.11. Analysis of PrimPols ability to perform MMEJ. 
Non denaturing gels analysing PrimPols ability to promote MMEJ of templates with varying 
lengths of 3 microhomology either single-stranded (ssDNA) or annealed to a 14 nt 
complementary strand (pssDNA), as shown above. (A) PrimPol MMEJ assays performed in 
primase assay buffer (10 mM Bis-Tris-Propane-HCl (pH 7.0), 10 mM MgCl2, and 1 mM DTT). 
(B) PrimPol MMEJ assays performed in the buffer used by Kent et al. (2015) (25 mM Tris-
HCl pH 8.8, 10% glycerol, 1 mM DTT, 0.01% NP-40, 10 mM MgCl2, and 0.1 mg/ml BSA). (C)
PrimPol MMEJ assays performed in primase assay buffer containing 1 mM MnCl2. 50bp 
indicates the migration position of a ds50-mer. PrimPol displayed a limited ability to promote 
MMEJ of templates containing 6 and 4 nt of 3 microhomology. 
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Figure 4.12. Analysis of Pol s ability to perform MMEJ. 
Non denaturing gels analysing Pol s ability to promote MMEJ of templates with varying 
lengths of 3 microhomology either single-stranded (ssDNA) or annealed to a 14 nt 
complementary strand (pssDNA), as shown above. Reactions were performed in primase 
assay buffer (10 mM Bis-Tris-Propane-HCl (pH 7.0), 10 mM MgCl2, and 1 mM DTT). Pol  
showed an ability to promote MMEJ of of templates containing 6 and 4 nt of 3 microhomology.
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this activity was apparent on pssDNA templates. No significant difference was observed 
when using primase assay buffer (Figure 4.11.A.) in comparison to the buffer used by 
Kent et al. (Figure 4.11.B.), additionally, no increase in MMEJ products was seen when 
using buffer containing Mn2+ (Figure 4.11.C.). Despite this limited MMEJ activity, Pol  
produced near identical results to PrimPol, with reaction products generated when using 
templates with 6 or 4 nt of homology (Figure 4.12.). Therefore, PrimPol does not appear 
to be proficient at MMEJ at a level above that observed with other lesion bypass 
polymerases. Moreover, a significant amount of snap-back products were observed in 
these reactions, indicated by a slight shift in the template band but much less than that 
observed for MMEJ products, as was previously determined (Kent et al., 2015).
4.3.5. PrimPol is Proficient at Snap-Back Synthesis
To better analyse the overall activity of PrimPol in the reactions described above, 
products were resolved on denaturing urea-polyacrylamide gels. Here, PrimPol 
displayed a significant level of activity on all templates except pssDNA-2 (Figure 4.13.). 
The lack of activity on this particular template is likely a result of the complementary 
strand blocking snap-back of the 3 end. Notably, in the absence of the complementary 
strand, significant activity was observed (template ssDNA-2). Furthermore, a significant 
level of extension was apparent on templates ssDNA-0 and pssDNA-0, which display no
microhomology and which didnt produce any MMEJ products, therefore confirming that 
this activity is a result of snap-back extension (Figure 4.13.). The predominant sizes of 
the reaction products in each case are also consistent with potential snap-back locations 
on each template. Interestingly, the size of the products produced on pssDNA templates
is not significantly limited by the complementary strand, suggesting that PrimPol may 
possess some strand-displacement activity. 
In summary, it is likely that the template extension products observed in the primase 
assay are a result of 3 end snap-back and extension by PrimPol. Although the enzyme 
appears to display some MMEJ activity, the level of this activity is not significantly higher 
than that observed with Pol . Furthermore, there is currently a lack of in vivo evidence 
supporting a role for PrimPol in MMEJ or DSB repair. Wan et al., observed the formation 
of PrimPol foci in response to ionising radiation (IR), however another report failed to 
observe the same effect (Bianchi et al., 2013; Wan et al., 2013). Nevertheless, both 
reports agree that PrimPol-/- cells are not sensitive to IR (Bianchi et al., 2013; Wan et al., 
2013). The experiments presented here do, however, reveal that PrimPol is proficient at 
snap-back extension and exhibits some strand-displacement activity. It is currently 
unclear what the in vivo relevance of these activities are and it remains possible that they 
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Figure 4.13. Denaturing gel analysis of PrimPol MMEJ reaction products. 
Denaturing gel analysis of PrimPol MMEJ reaction products shown in Figure 4.11.A. Reaction products generated on templates lacking 3 micohomology 
(pssDNA-0 and ssDNA-0) due to template 3-end snap-back are indicated. The intra-template homology permitting the synthesis of these products is displayed 
in the schematic to the right of the gels. The results reveal that PrimPol is proficient at template snap-back extension. 
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are simply the by-product of the accommodating catalytic requirements of priming. 
However, Pol  has also been shown to efficiently perform snap-back synthesis, termed 
templated-extension in cis by the relevant reports, which was suggested to support a 
role in end-joining, although the usefulness of this activity in vivo is not immediately 
obvious (Black et al., 2016; Kent et al., 2016). At the least, PrimPols propensity to 
perform snap-back synthesis and to some degree strand-displacement and MMEJ,
highlights the versatility of the enzyme and opens up the possibility of additional, as yet 
unknown, roles. 
4.4. PrimPol Bypasses Non-Canonical Replication 
Impediments by Repriming Downstream 
4.4.1. Introduction
The identification of a role for PrimPol in the tolerance of DNA damage lesions generated 
interest in the potential of the enzyme to bypass other non-canonical replication 
impediments. In collaboration with the Sale and Hirota laboratories, the role of PrimPol 
in bypassing G-quadruplex structures and CTNAs, respectively, was investigated. The 
remainder of Chapter 4 outlines the in vivo findings of our collaborators and describe the 
complementary in vitro investigations performed. These in vitro studies, permitted by the 
development of the fluorescent primase assay, support the in vivo results suggesting 
that PrimPol reprimes, and consequently, restarts replication downstream of G-
quadruplexes and CTNAs, in addition to more canonical DNA damage lesions. 
4.4.2. PrimPol is Required for Replicative Tolerance of G-Quadruplexes in 
Vertebrate Cells
G-quadruplex structures, formed by the stacking of quartets of Hoogsteen-bonded 
sequences of guanines, present a potent obstacle to replisome progression. Indeed, in 
vitro replicative polymerases are stalled by these structures (Woodford et al., 1994). A 
number of specialised helicases including, Fanconi Anemia Group J Protein (FANCJ), 
ATP-dependent DNA helicase PIF1, Bloom syndrome helicase (BLM), and Werner 
syndrome helicase (WRN), in addition to Pol , Pol , and Rev1, have been implicated 
in enabling G-quadruplex replication (León-Ortiz et al., 2014; Wickramasinghe et al., 
2015). The Sale laboratory previously developed an assay to monitor G-quadruplex 
replication in chicken DT40 cells (Sarkies et al., 2011; Schiavone et al., 2014). This assay 
measures the expression of the Bu-1a cell surface glycoprotein, the locus of which 
contains a G-quadruplex structure downstream of the transcription start site. When cells 
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lack replication machinery components required for G-quadruplex replication, the 
replisome stalls at the site of the structure, consequently leading to stochastic loss of Bu-
1a expression following cell division. This loss of expression arises due to the uncoupling 
of DNA synthesis and histone recycling which causes a loss of parental histone 
modifications. Thus, loss of Bu-1a expression is as a result of epigenetic, rather than 
genetic, instability. 
Using this assay, the Sale laboratory observed that PrimPol-/- DT40 cells exhibited three 
levels of Bu-1a expression, termed Bu-1ahigh, Bu-1amedium, and Bu-1alow (Schiavone et al., 
2016). In comparion, wild-type DT40 cells uniformally expressed Bu-1a at a high level. It 
was determined that the Bu-1amedium and Bu-1alow populations of PrimPol-/- cells arose 
stochastically from the Bu-1ahigh population. The decrease in Bu-1a expression in the 
absence of PrimPol was found to be due to epigenetic instability at the BU-1A locus, 
importantly deletion of the G-quadruplex forming sequence stabilised Bu-1a expression
and reintroduction caused instability again. Additionally, when reintroduced in a manner 
which would cause lagging-strand stalling, no instability was observed. These 
observations were consistent with a role for PrimPol in facilitating replisome bypass of 
the G-quadruplex structure on the leading strand. In light of these results, the potential 
mechanism employed by PrimPol to bypass G-quadruplexes was investigated 
biochemically. 
4.4.2.3. Materials and Methods
4.4.2.3.1. Primer Extension Assays
PrimPol, Pol , and A. fulgidus Pol B were purified as previously described (Biertümpfel 
et al., 2011; Jozwiakowski et al., 2014; Keen et al., 2014b). Primer extension assays 
were performed using 5 Hexachlorofluorescein labelled DNA primers annealed to their 
complementary DNA templates (sequences 1-13, Table 4.2.). Extensions were carried 
out at 37°C in 20 
L volumes, typically containing 10 mM Bis-Tris-Propane-HCl pH 7.0, 
50 mM KCl (except where otherwise stated), 10 mM MgCl2, 1 mM DTT, 20 nM primer-
template substrate, 100 
M dNTPs (NEB), 100 
g/mL BSA (NEB), and 100 nM of the 
assayed polymerase. Extension reactions were monitored over a time course and 
quenched with 20
L stop buffer (200 nM competitor oligonucleotide in a 95% formamide 
solution with 0.25% bromophenol blue and xylene cyanol). Products were boiled at 95°C 
for 5 min before resolution on a 15% (v/v) polyacrylamide/7M urea gel. Gels were 
scanned using an FLA-5100 image reader (Fujifilm). 
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Table 4.2. G-quadruplex primer-template oligonucleotides. 
Sequences of the primers and G-quadruplex containing templates used in primer-extension assays. Sequences predicted to form G-quadruplexes and DNA 
secondary structures are shown in red. 
# Oligonucleotide Modification Sequence (5-3)
1 HP-20 Primer 5-HEX TGTCGTCTGTTCGGTCGTTC
2 HIV Integrase Template 3-Biotin ACCGCGAACTTGAATTCTATGGGTGGGTGGGTGGGTCAATGCACAACATATGGCTTTCGAAGACCGAACGACCGAACAGACGACA 
3 G4#1 Template 3-Biotin ACCGCGAACTTGAATTCTATTGGTTTTGGTTTTGGTTTTGGTCAATGCACAACATATGGCTTTCGAAGACCGAACGACCGAACAGACGACA
4 G4#2 Template 3-Biotin ACCGCGAACTTGAATTCTATGGGTTTGGGTTTGGGTTTGGGTCAATGCACAACATATGGCTTTCGAAGACCGAACGACCGAACAGACGACA
5 G4#3 Template 3-Biotin ACCGCGAACTTGAATTCTATGGGGTTGGGGTTGGGGTTGGGGCAATGCACAACATATGGCTTTCGAAGACCGAACGACCGAACAGACGACA
6 G4#4 Template 3-Biotin ACCGCGAACTTGAATTCTATTTTGGGTGGGTGGGTGGGTTTTCAATGCACAACATATGGCTTTCGAAGACCGAACGACCGAACAGACGACA
7 ND-97 Template 3-Biotin ACCGCGAACTTGAATTCTAGTTCAGTCTAAATGCTCTCAAGCACTGAGCAATTCACAACATATGGCTTTCGATTACCGAACGACCGAACAGACGACA
8 
-Globin Template 3-Biotin ACCGCGAACTTGAATTCTAGGGGAGTAAAAGGGAGCGGGGTGCTGGGGCAATGCACAACATATGGCTTTCGAAGACCGAACGACCGAACAGACGACA 
9 Bu-1a Template 3-Biotin ACCGCGAACTTGAATTCTAGGGCTGGGTGGGTGCTGTCAAGGGCTGGGCAATGCACAACATATGGCTTTCGAAGACCGAACGACCGAACAGACGACA 
10 Mt-G4 Template 3-Biotin ACCGCGAACTTGAATTCTAGGGTGGGATGGGCGGGGGCAATGCACAACATATGGCTTTCGAAGACCGAACGACCGAACAGACGACA
11 T4 Telomeric G4 Template 3-Biotin ACCGCGAACTTGAATTCTATTAGGGTTAGGGTTAGGGTTAGGGCAATGCACAACATATGGCTTTCGAAGACCGAACGACCGAACAGACGACA 
12 MtOL Template 3-Biotin ACCGCGAACTTGAATTCTGCCGGGGCTTCTCCCGCCTTTTTTCCCGGCGGCGGGAGAAGTAGATTAACATATGGCTGAACGACCGAACAGACGACA
13 T.Bu Sb. Tel. Template 3-Biotin ACCGCGAACTTGAATTCAGCTTTCGGGTTAGGGTGTTTCGGGTTAGCGGGCAAACAACATATGGCTTTCGAAGACCGAACGACCGAACAGACGACA 
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4.4.2.3.2. Primase Assay
For G-quadruplex repriming assays, 5 biotin-labelled DNA templates (sequences 1-4, 
Table 4.3.) was incubated at 95ºC in annealing buffer with 50 mM KCl and cooled to 
allow G4 structure formation and primer annealing. PrimPol (2 µM) was incubated with 
templates (1 µM) for 30 min at 37ºC in primase assay buffer (10 mM Bis-Tris-Propane-
HCl [pH 7.0], 10 mM MgCl2, 1 mM DTT, 250 µM dNTPs or rNTPs, and 2.5 µM FAM 
dNTPs). Reactions were quenched with Bindng-Washing (B-W) buffer (10 mM Tris-HCl 
[pH 7.5], 500 mM NaCl, 10 mM EDTA) and incubated with streptavidin beads (Roche) 
for 1 hr at 4ºC. Beads were washed with B-W buffer and suspended in stop buffer. 
Samples were heated to 95ºC and resolved on a 15% polyacrylamide / 7 M urea gel for 
90 min. Products were visualized on an FLA-5100 imager. Lesion and CTNA repriming 
assays were performed in a similar manner using 1 µM PrimPol and a 15 min incubation 
time (sequences 4-9, Table 4.3.). Oligonuclotides containing Carbovir or Acyclovir were 
chemically synthesised as previously described (sequences 7 and 8, Table 4.3.)
(Yamamoto et al., 2011).
4.4.2.3.3. Circular Dichroism Analysis of G-Quadruplexes 
Circular dichroism (CD) spectra were measured using a Jasco spectropolarimeter. The 
HIV integrase quadruplex containing template (sequence 2 without biotin tag, Table 4.2.)
was diluted to a final concentration of 1 
M in buffer containing 10mM Bis-Tris-Propane-
HCl pH 7.0, 10 mM MgCl2, and varying levels of KCl. CD spectra of oligomers were 
recorded in a 0.5 cm quartz cuvette from wavelengths of 320 nm to 220 nm with a 0.2
nm data pitch, a speed of 50 nm min-1, and a band width of 1 nm. The average of 4 
accumulations for each condition was recorded and the CD spectrum of the buffer alone 
was subtracted from samples containing DNA templates. In melting experiments the 
temperature was increased incrementally from 25°C to 90°C, the cuvette was incubated 
at each temperature for 10 mins before spectra were recorded. 
4.4.2.4. Structure Stability and Loop Length Influence Polymerase Bypass of G-
Quadruplexes
Given that PrimPol has both primase and TLS polymerase activities, it could potentially 
facilitate G-quadruplex bypass in two different ways, either directly through a TLS-like 
mechanism, or indirectly by repriming and restarting replication downstream of the 
structure. Initial investigations focussed on analysing PrimPols ability to directly read 
through a G-quadruplex in a TLS-like manner. 
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Table 4.3. Template and primer sequences used for repriming assays. 
Sequences of primers and templates used in G-quadruplex, CTNA, and lesion repriming assays. Modified nucleotides, lesions, and G-
quadruplex forming sequences are shown in red. 
# Oligonucleotide Modification Sequence (5-3)
1 G4 Repriming Primer 3-ddG GATGCATCTATGTddG
2 G4 Repriming Template 1 5-Biotin GTCTTCTATCTCGTCTATATTCTATTGTCTCTATGGGTGGGTGGGTGGGTCTCACATAGATGCATC
3 G4 Repriming Template 2 5-Biotin GTCTTCTATCTCGTCTATATTCTATTGTCTCTATGGGTGGGTGGGTGGGTCTCA
4 Repriming Control Template 5-Biotin GTCTTCTATCTCGTCTATATTCTATTGTCTCTATGAATACCTTCATCAGTCTCACATAGATGCATC
5 Ap Repriming Template 5-Biotin GTCTTCTATCTCGTCTATATTCTATTGTCTCTATGAATACCTTCATCAApTCTCACATAGATGCATC
6 Tg Repriming Template 5-Biotin GTCTTCTATCTCGTCTATATTCTATTGTCTCTATGAATACCTTCATCATgTCTCACATAGATGCATC
7 ACV primer 3-ACV TCCGTTGAAGCCTGCTTTACV
8 CBV primer 3-CBV TCCGTTGAAGCCTGCTTTCBV
9 ACV/CBV ReprimingTemplate 5-Biotin
GTCTTCTATCTCGTCTATATTCTATTGTCTCTATGAATACCTTCATCCAAAGCA
GGCTTCAACGGA
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Prior to analysing the ability of PrimPol to replicate through different G-quadruplex 
structures in vitro, it was first necessary to ensure the correct folding of these structures 
under the experimental conditions to be used. The HIV-integrase aptamer was chosen 
as a model for this purpose. This template has an ideal quadruplex forming sequence 
of d(GGGT)4 which previous studies have shown folds into a parallel quadruplex 
structure with a high level of stability (Kelley et al., 2011). To investigate the stability of 
this structure in different KCl concentrations and temperatures CD was employed. This 
analysis confirmed that the HIV-integrase template correctly folds into a parallel G-
quadruplex structure in vitro. This is revealed by a maximum at ~260 nm and a minimum 
at ~240 nm, with the structure becoming less stable as the temperature is increased 
(Figure 4.14.A. and B.). In addition, the stability of the structure was dependent on the 
concentration of KCl present, with 50 mM KCl promoting a more stable structure than 
5mM KCl (Figure 4.14.A. and B.). These results therefore confirmed that the G-
quadruplex sequence correctly folds in to the expected structure in the context of the 
synthetic substrate and conditions used. This permitted further analysis of polymerase 
bypass of the structure.
PrimPol and Pol h were subject to primer extension assays using the HIV integrase 
template in the presence of a range of monovalent cations (50 mM K+, Na+, Li+, or no 
salt). It has previously been reported that different monovalent cations affect quadruplex 
structure stability with K+ being the most stabilising, whilst Li+ has a destabilising effect
(Hardin et al., 1992; Prakash et al., 2011). The ability of both PrimPol and Pol  to
replicate through the HIV-integrase quadruplex was dependent upon on the monovalent 
cation present (Figure 4.14.C. and D.). In the presence of NaCl, LiCl, and when no salt 
was present, both Pol  and PrimPol were able to fully extend the primer with only slight 
pausing being observed at the G-quadruplex forming region. However, in the presence 
of KCl, full primer extension by both Pol  and PrimPol was inhibited, supporting previous 
reports of the ability of K+ to stabilise the DNA secondary structure. 
To further establish the ability of PrimPol to read through these structures, templates 
containing G-quadruplex-forming sequences with different loop lengths (Figure 4.15.A.)
were used in primer extension assays. In addition to PrimPol (Figure 4.15.B.) and Pol 
(Figure 4.15.C.), A. fulgidus Pol B (A.fu Pol B) (Figure 4.15.D.) was analysed for 
comparison of the ability of replicative polymerases to bypass these structures. The 
results of the assays revealed that all three polymerases exhibit a similar inability to read 
through the structures, indicating that PrimPol does not possess an increased ability to 
synthesise through these G-quadruplexes (Figure 4.15.). Here, loop length was 
correlated with bypass, with structures which possess longer loops being more easily 
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Figure 4.14. G-quadruplex structure stability governs DNA polymerase bypass ability. 
(A/B) CD spectra of the HIV integrase G-quadruplex containing template in the presence of 5 mM (A) or 50 mM (B) KCl at increasing temperatures (25, 35, 
55, 75, and 90°C). (C/D) Primer extension reactions performed using PrimPol (C) or Pol  (D) on the HIV-integrase G-quadruplex containing template in the 
presence of 50 mM KCl, NaCl, LiCl, or in the absence of salt. The sequence of the HIV integrase G-quadruplex containing template is shown above with the 
primer location and positions of stalling at the structure (30) and full-length extension (65) indicated. 
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Figure 4.15. G-quadruplex loop length affects polymerase bypass ability. 
(A) Sequences of the G-quadruplexes used in primer extension assays, showing the melting temperature (Tm), topology, and loop length. (B/C/D) Primer 
extension reactions with PrimPol (B), Pol  (C), and A. fulgidus Pol B (D) on templates containing G-quadruplexes with different non-G loop lengths. All 
polymerases show increased levels of inhibition on templates containing G-quadruplexes with shorter loop lengths and a higher Tm. 
G-Quadruplex
Sequence (5-3) Tm (°C) Topology
Non-G 
Loop
G1 TTGGTTTTGGTTTTGGTTTTGGT 27.6 Antiparallel 4
G2 TGGGTTTGGGTTTGGGTTTGGGT 60.8 Hybrid 3
G3 TGGGGTTGGGGTTGGGGTTGGGG 86.2 Hybrid 2
G4 TTTTGGGTGGGTGGGTGGGTTTT >95 Parallel 1
A B
C D
C C C C
G1 G2 G3 G4
PrimPol
C C C C
G1 G2 G3 G4
Pol 
C C C C
G1 G2 G3 G4
A. fu Pol B
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replicated. Loop length also negatively correlates with melting temperature (Tm) (i.e. 
those structures with longer loops display a lower in vitro Tm), suggesting that structures 
with shorter loop lengths are more stable. Interestingly, the Sale group previously found 
that in Rev1-deficient cells, Bu-1a instability correlated with G-quadruplex loop length but 
not in vitro Tm (Schiavone et al., 2014). However, when analysing PrimPol-deficient cells 
the opposite effect was observed, with the greatest instability being observed with G-
quadruplexes possessing short loops and a high in vitro Tm (Schiavone et al., 2016). The 
inability of PrimPol to directly read through structures with these characteristics in vitro
would suggest that it does not employ a TLS-like bypass mechanism in vivo. This 
observation may be indicative of two different G-quadruplex bypass mechanisms. Less 
stable structures with longer loop lengths are bypassed in a Rev1 dependent TLS-like 
mechanism, whereas more stable structures with shorter loop lengths potentially require 
PrimPol-mediated repriming. 
4.4.2.5. PrimPol does not Bypass G-Quadruplexes Through a TLS-like Mechanism
The results presented above suggested that PrimPol does not possess an increased 
ability to perform TLS bypass of G-quadruplexes in comparison to Pol  or A.fu Pol B. 
However, the possibility remained that this was due to the limited range of G-quadruplex 
structures tested. To rule out this possibility, bypass by PrimPol, Pol  and A.fu Pol B 
was compared on templates containing various G-quadruplex motifs using primer 
extension assays (sequences 1-2 and 7-13, Table 4.2.). Again, PrimPol did not exhibit 
an increased ability to bypass any of the structures tested in comparison to Pol  and 
A.fu Pol B (Figure 4.16). Together, these results strongly suggest that PrimPol does not 
perform TLS bypass of G-quadruplex structures in vivo. Note that these experiments 
were repeated and followed-up by Dr Stanislaw Jozwiakowski using a range of primer 
lengths, templates, and accessory factors. The same results were observed and can be 
found in the final published manuscript (Schiavone et al., 2016). Additionally, these 
follow-up experiments identified that PrimPol shows a preference for binding to G-
quadruplex structures and homopolymeric dG sequences in EMSAs. 
4.4.2.6. PrimPol can Catalyse Close-Coupled Repriming Downstream of a G-
Quadruplex Structure
Given the inability of PrimPol to extend through G-quadruplex structures in vitro, its 
capacity to reprime on the distal side of these structural barriers was next examined
using the fluorescent primase assay. G4#4, which forms a highly stable G-quadruplex 
(Schiavone et al., 2014) and potent block to PrimPol (Figure 4.15.B.), was incorporated 
into a mixed sequence template strand. In order to analyse repriming downstream of the 
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Figure 4.16. Comparison of bypass of various DNA secondary structures by PrimPol, 
Pol , and A. fulgidus Pol B.  
(A/B/C) Primer extension assays using PrimPol (A), Pol  (B), and A. fulgidus Pol B (C) on 
templates containing various G-quadruplexes and DNA secondary structures. The no 
structure template was included for comparison of polymerase activity in the absence of DNA 
secondary structures.  
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G-quadruplex, and better represent a situation where replication has stalled at the 
structure, a primer containing a 3-dideoxynucleotide (3-dd) (sequence 1, Table 4.3.)
was annealed upstream of the G-quadruplex motif (sequence 2, Table 4.3) (Figure 4.17). 
Additionally, templates containing only a short sequence (5 bases) upstream of the G-
quadruplex, and no 3-dd primer, were used to eliminate any artifactual results caused 
by the primer (sequence 3, Table 4.3.). Although PrimPol was unable to synthesise 
through this G-quadruplex, it did catalyse de novo synthesis of primer strands on the G-
quadrupelx templates (Figure 4.17). The size of the extended products, both on 
templates with and without a 3-dd primer, were consistent with repriming ~6 nucleotides
downstream of the G-quadruplex structure. When tested on the equivalent templates
containing no G-quadruplex structure (sequence 4, Table 4.3.), PrimPol synthesised 
longer and more variable products, suggesting priming in multiple locations further 
upstream. Based on template configurations and the lengths of fully extended primers, it 
is apparent that repriming on the G-quadruplex templates is occurring almost 
immediately after the structure, leaving only a minimal sized gap before the restart of
replication is resumed. Although PrimPol has a preference for primer synthesis on 
pyrimidine tracts (Bianchi et al., 2013), repriming is initiated on these mixed sequence 
templates. This mechanism is consistent with a role in reinitiating DNA synthesis 
immediately after G-quadruplexes during replication.
As previously mentioned, PrimPols primase, but not polymerase, activity is dependent 
upon an intact ZnF domain (Keen et al., 2014b). In order to further investigate the 
repriming mechism indicated by in vitro experiments, the Sale laboratory analysed the 
ability of a ZnF-knockout (ZfKO) mutant of PrimPol to permit G-quadruplex replication in 
vivo. Here, complementation of PrimPol-/- DT40 cells with the ZfKO PrimPol mutant, in 
contrast to the wild-type protein, was not able to restore Bu-1a expression (Schiavone et 
al., 2016). These findings, therefore, support the in vitro results and together strongly 
suggest that PrimPol reprimes downstream of G-quadruplex structures following stalling 
of the replisome on the leading strand. 
4.4.3. Repriming by PrimPol is Critical for DNA Replication Restart 
Downstream of Lesions and Chain-Terminating Nucleosides
The identification of the importance of PrimPol in tolerating UV-induced lesions 
generated interest into what other types of damage the enzyme may be required for the 
tolerance of (Bianchi et al., 2013). In collaboration with the Hirota group, it was revealed 
that PrimPol-/- DT40 cells are sensitive to methymethane sulfonate (MMS), cisplatin, and 
hydroxyurea (HU), which cause Ap sites, crosslinks, and reduction of the dNTP pool, 
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Figure 4.17. PrimPol can catalyse close-coupled repriming downstream of a G-
quadruplex.
PrimPol (2 µM) was incubated for 30 min at 37°C with dNTPs or rNTPs (250 µM), FAM-dNTPs 
(dATP, dCTP, dUTP) (2.5 µM), and mixed sequence G-quadruplex-containing or control 
templates (1 µM) (as shown in the schematic). Identical reactions were also performed with 
rNTPs (250 µM) instead of dNTPs on the G4 containing templates only (middle lanes). 
Templates were either annealed to primers containing a 3 dideoxynucleotide (shown in red) 
upstream of the G-quadruplex structure or contained only a short sequence (5 nt) before the 
structure. Priming and extension are represented as green and blue, respectively. The length 
of products extended to the end of the template by PrimPol allows analysis of the priming 
location; identically sized extension products on both G-quadruplex-containing templates 
reveals close-coupled repriming downstream of the structure in each case. Nucleotide (Nt) 
length markers are shown in the left panel. 
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respectively. However, loss of PrimPol did not sensitise cells to camtothecin, ICRF193, 
or  rays, all agents which cause strand breaks (Kobayashi et al., 2016). These results 
therefore support a role for PrimPol in DDT, but not repair. Moreover, as had previously 
been observed with UV sensitivity (Bianchi et al., 2013), further loss of Pol  and Pol 	
increased the sensitivity of PrimPol-/- cells to replisome stalling DNA damage, indicating 
that PrimPol is employed in a distinct pathway to these TLS polymerases. 
In addition to the canonical DNA damaging agents examined above, the sensitivity of 
PrimPol-/- cells to CTNAs was also explored. CTNAs prevent extension of DNA polymers 
following incorporation into the 3-termini, often because they lack a 3 hydroxyl group, 
consequently causing replicases to stall. Importantly, these obstacles cannot be 
overcome by conventional TLS or TS as they prevent polymerase-mediated elongation 
of the daughter strand. Intriguingly, PrimPol-/- cells displayed sensitivity to a number of 
CTNAs, including Abacavir, Zidovudine, and acyclovir, suggesting a role in restarting 
replication downstream by repriming (Kobayashi et al., 2016). 
4.4.3.1. PrimPol Reprimes Replication Downstream of CTNA Incorporated Sites 
and DNA Damage Lesions In vitro
Given the critical role of PrimPol in cellular tolerance to CTNAs and the presumed
requirement of the enzymes primase activity for this tolerance, its capacity to reprime 
downstream of the 3 side of an incorporated CTNA was investigated. Since Abacavir is 
phosphorylated in a unique stepwise anabolism and converted to the triphosphated 
guanine analog, carbovir, in cells, repriming downstream of carbovir, in addition to 
acyclovir, was tested in vitro (Faletto et al., 1997). In order to analyse repriming
downstream of a CTNA incorporation site, a primer containing a CTNA (carbovir or 
acyclovir) at its terminal 3 end was annealed to a biotinylated DNA template (sequences
7-9, Table 4.3.). In addition, we analysed the ability of PrimPol to reprime downstream 
of an Ap site and Tg lesion located in the template strand (sequences 5 and 6, Table
4.3.), both of which PrimPol is unable to bypass through TLS in the presence of 
magnesium (Keen et al., 2014b). In this case, a 3 dideoxynucleotide primer was 
annealed upstream of the templating lesion to represent a situation where replication has 
stalled at the damage site (sequence 1, Table 4.3.). The 3 dideoxy moiety also prevents 
template-independent primer extension that interferes with the evaluation of PrimPols 
repriming activity. Although PrimPol was unable to synthesise through the lesions or 
extend from 3 terminal CTNAs, the enzyme displayed a capacity to perform close-
coupled de novo synthesis of primer strands downstream in each case (Figure 4.18.).
The size of the extended products, both with 3 carbovir and 3 acyclovir primers, in 
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Figure 4.18. PrimPol catalyses repriming downstream of 3 incorporated CTNAs and templating abasic sites or thymine glycol lesions. 
PrimPol (1 µM) was incubated for 15 min at 37°C with dNTPs (250 µM), FAM-dNTPs (dATP, dCTP, dUTP) (2.5 µM), and mixed sequence primer-templates 
(1 µM) (as shown in the schematic). Primers containing a 3 dideoxynucleotide were annealed upstream of the lesion on templates containing a single Ap 
site (Ap) or thymine glycol lesion (Tg) to allow analysis of repriming, rather than TLS, activity. In the case of CTNAs, a single CTNA (acyclovir (ACV) or 
carbovir (CBV)) was located at the 3 end of the primer in place of the dideoxnucleotide. The length of primase reaction products extended to the end of the 
template allows analysis of the priming location by PrimPol; the near identical extension products produced in each case show close-coupled repriming by 
PrimPol downstream of the lesion or CTNA. Nucleotide (Nt) length markers are shown on the left. Priming and extension are represented in the schematic 
as green and blue, respectively. C indicates the no enzyme control. ND indicates the non-damaged template without an annealed primer.
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addition to the templating Ap site and Tg lesion, were consistent with repriming ~14 nt 
downstream of the CTNAs or lesion site. Importantly, in the absence of the CTNA primer 
or lesion, PrimPol generated longer and more variable synthesis products, indicating that 
the enzyme is capable of performing close-coupled repriming downstream of a stalled 
replication fork. 
These in vitro observations of repriming were supported by further in vivo work. PrimPol-
/- cells were complemented with wild-type PrimPol, the ZfKO mutant, or PrimPolY89D and 
damage sensitivity was analysed. Previously, it was shown that mutation of tyrosine 89 
to aspartic acid (PrimPolY89D) causes significantly reduced polymerase activity, but 
primase activity is retained (Keen et al., 2014a). As previously mentioned, mutation of 
the ZnF abolishes primase activity. It was found that wild-type PrimPol and PrimPolY89D,
but not the ZfKO mutant, were able to suppress hypersensitivity to MMS, UV, cisplatin, 
and CTNAs (Kobayashi et al., 2016). This confirms that PrimPols primase activity is 
critical for the tolerance of these DNA damaging agents in vivo, thus supporting the in 
vitro results.  
4.5. Discussion
Taken together, the results generated in this chapter, enabled by the development of the 
fluorescence-based primase assay, support a model whereby PrimPols primary role is 
to reprime leading strand replication downstream of a range of replisome-stalling 
obstacles. Coupled with the in vivo results of the Sale and Hirota groups, it is clear that 
PrimPols primase activity is sufficient and critical for the tolerance of non-canonical 
replication impediments, including G-quadruplexes and CTNAs. Moreover, the enzymes 
primase activity is required for bypass of canonical DNA damage, such as Ap sites and 
Tg lesions, which it cannot bypass by TLS. In this regard, the range of fork stalling 
damage types which PrimPol participates in the tolerance of, is at odds with a specialised 
role in TLS bypass of specific lesions. Indeed, the enzyme appears to be more important 
for overcoming obstacles which it cannot directly read through, including DNA secondary 
structures, lesions, and CTNAs. This is strongly indicative that PrimPol is employed as 
a general DDT enzyme, required to reprime downstream of a range of replisome 
impediments, rather than as a TLS polymerase. Importantly, to be able to reprime 
downstream of a stalled replicase, the mechanism controlling PrimPols recruitment must 
be distinct from that of TLS and replicative polymerases. Here, PrimPol would need to 
contact ssDNA downstream of the impediment and not the primer template junction, 
potentially explaining the lack of an interaction with PCNA reported in Chapter 2. In 
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Chapter 5 the molecular basis and potential mechanism responsible for recuiting PrimPol 
to reprime replication is investigated. 
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Chapter 5
Molecular Basis for PrimPol 
Recruitment to Replication Forks by 
RPA
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5.1. Abstract
DNA damage and secondary structures can act as potent obstacles to the replication 
machinery. Persistent stalling events lead to genomic instability and therefore numerous 
cellular tolerance mechanisms exist to complete genome duplication in the presence of 
such impediments. In addition to TLS polymerases, eukaryotic cells contain a multi-
functional replicative enzyme called PrimPol that is capable of directly bypassing DNA 
damage by TLS, as well as repriming replication downstream of lesions and secondary 
structures. Here, we report that PrimPol is recruited to reprime replication through its 
interaction with RPA. Using crystallographic and biophysical approaches, we identify that 
PrimPol possesses two RPA-interacting motifs and identify the key residues required for 
these interactions. We demonstrate that one of these motifs is critical for PrimPols 
recruitment to stalled replication forks in vivo thus facilitating its role in repriming DNA 
synthesis. In addition, biochemical analysis reveals that RPA serves to stimulate the 
primase activity of PrimPol. Together, these findings provide unprecedented molecular 
insights into PrimPols mode of recruitment to stalled forks that enables it to efficiently 
reprime and restart DNA replication. 
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5.2. Introduction
An intricate complex of molecular machines, known collectively as the replisome, 
duplicate the genome during DNA replication. At the heart of the replisome are the 
replicative polymerases, which synthesise DNA with a high degree of accuracy and 
efficiency during this process. Nevertheless, these enzymes are vulnerable to 
aberrations in the DNA template, including DNA damage lesions and secondary 
structures, which lead to the stalling of replication at these sites. A number of 
mechanisms exist to permit the resumption of replication during these events (Blow et 
al., 2011; Li and Heyer, 2008; Sale et al., 2012). One such mechanism is the generation 
of a nascent primer downstream of the obstacle, termed repriming (Yeeles et al., 2013). 
This allows the replisome to effectively skip over the impediment and restart replication. 
Until recently, Pol -primase was thought to be the only eukaryotic primase, we now 
know eukaryotes possess a second primase, known as PrimPol, which has been 
discovered and characterised by a number of groups (Bianchi et al., 2013; García-
Gómez et al., 2013; Wan et al., 2013). PrimPol is a member of the archaeo-eukaryotic 
primase (AEP) superfamily, whose members fulfil a range of roles in DNA replication, 
repair and damage tolerance (Guilliam et al., 2015b). In line with this, PrimPol displays 
both primase and TLS polymerase activity (Bianchi et al., 2013; García-Gómez et al., 
2013). Evidence is accumulating that suggests the primary role of PrimPol in vivo is to 
reprime DNA replication downstream of DNA damage lesions and secondary structures 
(Keen et al., 2014b; Kobayashi et al., 2016; Mourón et al., 2013; Schiavone et al., 2016). 
Despite assisting the replisome through this role, PrimPol could be potentially deleterious 
to genomic integrity due to its low fidelity and penchant for generating frame-shift 
mutations (Guilliam et al., 2015a). As a result, the enzyme must be tightly regulated and 
only allowed to contribute to DNA synthesis when absolutely required.
We previously identified the nuclear and mitochondrial single-stranded DNA binding 
proteins, RPA and mtSSB, as PrimPol interacting partners in vivo. Using biochemical 
approaches, we demonstrated that both of these binding-partners could serve to restrict
the contribution of PrimPol to DNA synthesis during replication and therefore limit the 
opportunity for mutagenesis (Guilliam et al., 2015a). PrimPol was also identified as an 
RPA-binding partner by another group (Wan et al., 2013). In this study, it was suggested 
that RPA may act to recruit PrimPol to stalled replication forks in vivo, although 
interpretation of these results is limited as large deletion-mutants (~80 amino acids 
removed) were used for analysis. 
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In this study, we present an in-depth interrogation of the interaction between PrimPol 
and RPA, identifying that PrimPol possesses two RPA-binding motifs (RBMs) in its C-
terminal domain (RBM-A and RBM-B). Both of these are able to bind directly to RPA70N, 
a primary recruitment domain of RPA that mediates interactions with a number of DNA 
damage response proteins, including p53, ATRIP, RAD9 and MRE11 (Xu et al., 2008). 
Using crystallographic and biophysical approaches, we elucidated the molecular basis 
of each of the PrimPol RBM-RPA interactions and identified the critical residues involved 
in each case. We generated PrimPol RBM mutants in vivo and analysed the importance 
of each of these sites for PrimPols role in DNA damage tolerance. We identify that RBM-
A is the primary mediator of PrimPols interaction with RPA in vivo, with RBM-B 
potentially playing a more secondary role. The interaction between RBM-A and RPA70N 
is critical for the recruitment of PrimPol to chromatin and for stimulating the enzymes 
role in repriming DNA replication. Notably, mutations in both RBMs affecting key residues 
involved in binding (e.g. F522V and I554T) have been identified in cancer patient cell 
lines and these mutations are sufficient to abrogate binding of RPA70N to the affected 
RBM. Collectively, these results describe the molecular and cellular basis for PrimPols 
recruitment by RPA to stalled replication forks and demonstrate the importance of these 
interactions for maintaining PrimPols function in replication fork progression in vivo.
5.3. Materials and Methods
5.3.1. Construction and Expression of Human PrimPol and RPA Truncation 
Variants 
Full-length PrimPol was expressed and purified as previously described (Bianchi et al., 
2013). PrimPol amino acids 480-560 (PrimPol480-560) was cloned into pET28a by 
polymerase chain reaction using wild-type PrimPol as a template via standard methods
(primers 1 and 2, Table 5.1.). PrimPol480-560 was expressed in BL21(pLysS) cells 
overnight at 25 °C and purified using Ni Sepharose (Qiagen), followed by Q Sepharose 
(GE Healthcare) and gel filtration using a Superdex 75 10/300 GL column (GE 
Healthcare) according to the manufacturers instructions. PrimPol residues 480-546 
(PrimPol480-546), PrimPol D514R, D518R, D519R (PrimPolRBM-A-KO), PrimPol D514R, 
D518R, D519R, D551R, I554A, I555A (PrimPolRBM-A-KO/RBM-B-KO), PrimPol F522V on an 
RBM-B-KO background, and PrimPol I554T on an RBM-A-KO background were cloned 
by site-directed mutagenesis (primers 3-12, Table 5.1.). PrimPol 480-546 with the 
D514R, D518R, D519R mutations (PrimPol480-546/RBM-A-KO) was also cloned, using the 
480-546 construct DNA as a template. All these proteins were expressed and purified as 
described for PrimPol480-560. 
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Table 5.1. PCR primers used to construct PrimPol RBM mutants.
Sequences of the primers used in PCR for site-directed mutagenesis and cloning of various PrimPol constructs. 
# PCR Primer Sequence (5-3)
1 480 FWD GTTTCTTCATATGACAACAGATGAAGCAGATGAAAC
2 560 REV CAAAGAAGCGGCCGCTTACTCTTGTAATACTTCTATAATTAGTTC
3 1-546 FWD GTGAAGTGTAGTAAATTCCTGATGAACTAATTATAG
4 1-546 REV CAGGAATTTACTACACTTCACTGTTATAACTGAG
5 D514R/D518R/D519R FWD GGATCCGCCGCGCTTATTTTTTAGAAGCTACTGAAGATGCTGAATTAG
6 D514R/D518R/D519R REV AAGCGCGGCGGATCCCATTTCTCCAGACAGCATCAGCAGATG
7 D551R/I554A/I555A FWD TCTCAGTTATAACAGTGAAGTGGATGAAATTCCTCGCGAACTAGCGGCGGAAGTACTGCAGGAG
8 D551R/I554A/I555A REV GGTGGTGGTGCTCGAGTGCGGCCGCTTACTCCTGCAGTACTTCCGCCGCTAGTTCGCGAGGAATTTC
9 F522V FWD GATGATGCTTATGTTTTAGAAGCTACTGAAGATGCTGAATTAGCTGAAGC
10 F522V REV CTTCTAAAACATAAGCATCATCAATGCCATTATCCCAGACAGCATC
11 I554T FWD CTGATGAACTAACTATAGAAGTATTACAAGAGTAAGATCCGAATTCGAGCTC
12 I554T REV ATACTTCTATAGTTAGTTCATCAGGAATTTCATCCACTTCACTGTTATAACTGAGAAG
13 N-FLAG 1 FWD
GTTTCTTGGATCCATGGATTACAAGGATGACGACGATAAGGGAAGCCATGGAAGCCATATGAATAGAAAATGGGAA
GCAAAACTG
14 N-FLAG 480 FWD
GTTTCTTGGATCCATGGATTACAAGGATGACGACGATAAGGGAAGCCATGGAAGCCATATGACAGATGAAGCAGAT
GAAAC
15 D519R/F522A FWD GGCATTGATCGTGCTTATGCTTTAGAAGCTACTGAAGATGC
16 D519R/F522A REV GCTTCTAAAGCATAAGCACGATCAATGCCATTATCCCAGAC
17 D551R/I554A FWD GAAATTCCTCGTGAACTAGCTATAGAAGTATTACAAGAG
18 D551R/I554A REV CTTCTATAGCTAGTTCACGAGGAATTTCATCCACTTCAC
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The full RPA timer was expressed and purified as previously described (Masuda et al., 
2007). RPA70N (RPA701-120) was cloned as described previously (Souza-Fagundes et 
al., 2012; Xu et al., 2008). The RPA70NE7R variant that readily forms crystals with basic-
site ligands was utilised in the experiments shown here (Feldkamp et al., 2013); the 
properties of this protein variant are not affected in any way apart from in its crystal lattice 
contacts. Protein concentrations were determined based on absorbance at 280 nm 
corrected with the protein-specific extinction coefficient. Extinction coefficient values for 
each of the recombinant proteins were calculated using ProtParam tool (ExPASy).
RBM-A (510-528) and RBM-B (546-560) peptides for NMR were synthesised 
(GenScript), purified with a Waters Delta 600 HPLC using a Proto 300 C4 column 
(Higgins Analytical, Inc.), and confirmed using mass spectrometry. The PrimPol514-528 
peptide used for co-crystallisation experiments was synthesised (Genscript) and used as 
supplied
5.3.2. Nuclear Magnetic Resonance Methods 
15N-1H HSQC experiments were performed at 25 °C on a Bruker Avance III 800 or 900 
MHz NMR spectrometer with a cryogenically cooled probe. Spectra were acquired for 
100 
M samples of 15N-enriched RPA70N or 15N-enriched PrimPol480-560 alone and in the 
presence of 200 
M unlabeled binding partner. All samples were equilibrated in a buffer 
containing 20 mM HEPES (pH 7.5), 80 mM NaCl, 2 mM DTT and 5% deuterium oxide. 
5.3.3. Analytical Size-Exclusion Chromatography and SEC-MALS
Protein interactions were analysed by size-exclusion chromatography (SEC) on a 
Superdex S75 10/300 GL gel filtration column (GE Healthcare). The column was 
calibrated using albumin (67,000 Da), ovalbumin (43,000 Da), chymotrypsinogen A 
(25,000 Da), ribonuclease A (13,700 Da), and aprotinin (6,512 Da). The protein was 
loaded at 0.5 mL min-1. Retention volume of the proteins were plotted against the 
molecular weight of each protein to reliably predict protein molecular weights. The 
column was pre-equilibrated in a buffer containing 50 mM Tris-HCl (pH 7.5), 100 mM 
NaCl and 2 mM TCEP that had been sterile-filtered using a 0.2 
m pore size vacuum 
filtration system (Nalgene). 0.5 mL of protein was loaded at a concentration of 35 
M. 
Protein interactions were determined by a shift in the chromatograph peaks relative to 
individual protein peaks. 
SEC multi angle light scattering (MALS) was performed on an AKTA Purifier FPLC 
system (GE) connected to an Agilent Technologies 1200 Series Refractive Index (RI) 
Detector and a Wyatt Technologies Dawn Helios 8+ MALS unit. A Superdex 75 increase 
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10/300 GL (24 mL) column was equilibrated in running buffer consisting of 20 mM 
HEPES (pH 7.1), 80 mM NaCl, 0.5 mM TCEP. The flow was maintained at a consistent 
0.5 mLmin-1 and sample injections of 100 µL from a static loop were initiated at the 0 mL 
point of each run. UV, RI, Quasi-Elastic LS, and LS values were recorded using ASTRA 
6.1 (Wyatt) software. Data were collected using samples of RBD at 185 µM with RPA70N 
E7R added at 0, 1, 2 and 4x molar ratios. Estimated molecular weights for RBD and its 
saturated complexes were calculated using the Zimm algorithm surrounding the peak 
maximum.
5.3.4. Crystallisation and X-ray Structure Solution 
Crystals of the RPA70N-PrimPol complex were grown at 293 K by vapour diffusion as 
sitting drops. The protein complex was screened at a 2.5:1 ratio of 1.75 mM PrimPol514-
528 peptide: 0.70 mM of RPA70NE7R in drops containing 0.5 
L of protein complex mixed 
with 0.5 
L of crystallization buffer (0.2 M Ammonium acetate 0.1 M Sodium acetate 4.5 
20 % w/v PEG 3350). Prior to data collection, crystals were cryoprotected by soaking in 
mother liquor containing 20% ethylene glycol. 1.542 Å X-ray diffraction data was 
collected in-house at 100 K using a Rigaku MicroMax 007-HF. The diffraction data were 
processed with SCALA (Evans, 2006) with additional processing by programs from the 
CCP4 suite (Collaborative Computational Project, Number 4, 1994). 
Crystals of the RPA70N-PrimPol complex were grown at 293 K by vapour diffusion as 
sitting drops. The protein complex was screened at a 1:1 ratio with 700 
M of each of 
RPA70NE7R and PrimPol480-560; 0.5 
L of protein complex was mixed with 0.5 
L of 
crystallisation buffer (0.2 M imidazole malate (pH 6.0), 30% (w/v) PEG 4000). Prior to 
data collection, crystals were soaked in mother liquor containing 20% ethylene glycol. 
0.914 Å X-ray diffraction data was collected at 100 K using a synchrotron source at
station I03 Diamond Light Source, Didcot, UK. The diffraction data were processed with 
xia2 (Winter et al., 2013) with additional processing by programs from the CCP4 suite 
(Collaborative Computational Project, Number 4, 1994). The statistics for data 
processing are summarized in Table 1. For both models, initial phases were obtained by 
molecular replacement with PHASER (McCoy et al., 2007) (using RPA70NE7R (4IPC) 
(Feldkamp et al., 2013) as a search model). Iterative cycles of model building and 
refinement were performed using Coot (Emsley et al., 2010) and Phenix (Adams et al., 
2010). A final refined model at 2.0 Å resolution, with an Rfactor of 18.73% and Rfree of
22.86% was obtained for the RPA70N-PrimPol514-528 peptide complex. The 
Ramachandran statistics for this complex place 97.9% of residues in the favoured region 
and 2.1% in the allowed region. For the RPA70N-PrimPol complex a refined model at 
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1.28 Å resolution, with an Rfactor of 15.37% and Rfree of 17.85 % was obtained with
Ramachandran statistics of 98.6% of residues in the favoured region and 1.4% in the 
allowed region. Structural images were prepared with CCP4mg (McNicholas et al., 
2011). Stereo images for portions of the electron density of RPA70N-PrimPol514-528 and 
RPA70N-PrimPol480-560 are shown in Figure 5.1. The structures of the RPA70N-
PrimPol514-528 peptide complex and the RPA70N-PrimPol480-560 complex are deposited in 
the Protein Data Bank under accession codes 5N85 and 5N8A, respectively.
5.3.5. Circular Dichroism 
PrimPol RBD samples for CD were equilibrated in 20 mM HEPES (pH 7.5), 80 mM NaCl, 
and 2 mM DTT, and then diluted 1:10 with ultrapure water to a final concentration of 20 

M. A JASCO J-810 spectrophotometer equilibrated at 25 °C was used to collect 5 scans 
over the spectral width 190-250 nm. Molar ellipticity was calculated based on the final 
protein concentration of 20 
M.
5.3.6. Dynamic Light Scattering 
Light scattering experiments were performed using a Wyatt Technology DynaPro 
NanoStar instrument.  PrimPol RBD was equilibrated in 20 mM HEPES (pH 7.5), 80 mM 
NaCl, and 2 mM DTT at a concentration of 200 
M. A 5 
L sample was then equilibrated 
in a COC cuvette at 25 °C for 5 minutes prior to acquisition. Ten data points were 
acquired and fitted using the coils protein shape model using Wyatt Dynamics software. 
The resulting regularization graph was plotted as a function of %Mass and Mw-R 
calculated based on observed sample radius.
5.3.7. Isothermal Titration Calorimetry 
Isothermograms were recorded using a MicroCal VP-ITC instrument. 10 
L injections of 
400 
M PrimPol RBD (either WT or variants) were added to a 1.4 mL cell with RPA70N 
at 20 
M. The system was equilibrated for 5 minutes between injections. Both proteins 
were dialysed in the same pool of 20 mM HEPES (pH 7.5), 80 mM NaCl, and 3 mM -
mercaptoethanol buffer. Dissociation constants were calculated with MicroCal Origin 
software using a single site binding model.
5.3.8. Fluorescent M13 Primase Assay 
Full-length PrimPol (400 nM) was incubated in 20 
L reactions containing 10 mM Bis-
Tris-Propane-HCl (pH 7.0), 10 mM MgCl2, 1mM DTT, 250 
M dNTPs, 2.5 
M FAM 
dTNPs (dATP, dCTP, dUTP), and 20 ng/
L single-stranded M13 template, at 37 °C for 
15 mins. Individual reactions were supplemented with increasing concentrations of RPA 
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Figure 5.1. Stereo views of electron density for RBM-A and RBM-B. 
(A) A stick representation of the residues I517-A520 of RBM-A (light green). Residues R43 
and R31 from RPA70N that form the ionic interactions with RBM-A are also depicted 
(magenta). Density from a weighted 2Fo-Fc map scaled at 0.6 is depicted in blue. (B)
Residues I549-I554 of RBM-B are depicted (dark green). Residues R91, S54, R43, R31 and 
T34 from RPA70N involved in ionic interactions with RBM-B are also shown (purple). Density 
from a weighted 2Fo-Fc map scaled at 0.8 is also depicted in blue.
A
B
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(0, 0.0625, 0.125, 0.25, 0.5, 1, 2, 4, and 8 
M) prior to the addition of PrimPol. Following 
primer synthesis, remaining free FAM dNTPs were removed using an Oligo Clean and 
Concentrator kit (Zymo Research) according to the manufacturers instructions. Eluted 
primers were supplemented with loading buffer (95% formamide with 0.25% 
bromophenol blue and xylene cyanol dyes) (total volume 20 
L). Samples were boiled 
and resolved on a 15% polyacrylamide/7M urea gel for 90 mins. Products were 
visualised on an FLA-5100 imager. 
5.3.9. Maintenance and Generation of Stable HEK293 Flp-In T-Rex Cells 
HEK293 Flp-In T-REx (Invitrogen) cells were cultured in DMEM containing 10% foetal 
calf serum (FCS), 1% L-glutamine, and 1% PenStrep. For the generation of stable 
inducible N-terminal FLAG-tagged PrimPol HEK293 Flp-In T-REx, cells were grown in 
medium containing 15 
g/mL Blasticidin (Invitrogen) and 100 
g/mL Zeocin prior to 
transfection. Cells were transfected with pOG44 plasmid and pcDNA5/FRT/TO plasmid 
(1:9 ratio) encoding FLAG-PrimPol (WT, D519R/F522A, D551R/I554A, 
D519R/F522A/D551R/I554A, and PrimPol480-560) using Lipofectamine 2000 following the 
manufacturers instructions. pcDNA5/FRT/TO constructs encoding N-terminal FLAG-
PrimPol and FLAG-PrimPol480-560 were generated by standard PCR and cloning 
procedures (primers 13, 14 and 2, Table 5.1.). RBM mutant N-FLAG PrimPol constructs 
were produced by site-directed mutagenesis (primers 15-18, Table 5.1.). 48 hours after 
transfection selective medium containing 15 
g/mL Blasticidin and 100 
g/mL 
Hygromycin (Invitrogen) was added. Selective medium was replaced every 2-3 days, 
until resistant clones appeared. Clones were then pooled, expanded, and stocks made.  
5.3.10. Co-Immunoprecipitation in HEK-293 Cells Expressing FLAG-
PrimPol
HEK293 Flp-In T-REx cells engineered for inducible expression of FLAG-PrimPol (WT, 
D519R/F522A, D551R/I554A, D519R/F522A/D551R/I554A, and PrimPol480-560) were 
grown in the presence or absence of doxycycline (10 ng/mL) 24 hours before harvesting. 
Cell pellets were re-suspended in 1 mL lysis buffer (150 mM NaCl, 30 mM Tris-HCl (pH 
7.5), 0.5% NP40, 2.5 mM MgCl2, 100 
g/mL DNase I) and incubated at 4 °C for 30 mins. 
The resulting lysate was clarified by centrifugation at 10,000xg for 10 mins at 4 °C. The 
supernatant was retained (sample taken as input), added to 100 
L pre-washed anti-
FLAG magnetic beads (Sigma) and incubated at 4 °C overnight. Unbound material was 
removed and the beads were washed 3x5 mins with 1 mL wash buffer (Lysis buffer 
without DNase I and with 0.1% NP40). Three successive 5 min elutions were performed 
using 200 
L elution buffer (25 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM PMSF, and 
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200 
g/mL 3xFLAG peptide (Sigma)). Eluted samples were boiled in Laemmli buffer and 
analysed by western blot using the following antibodies; Anti-FLAG (Sigma F3165; 
1:1000 dilution), Anti-RPA2 (Calbiochem NA18; 1:500 dilution), HRP (horseradish 
peroxidase) conjugated Anti-mouse IgG (Abcam ab6728; 1:5000 dilution).
5.3.11. Triton X-100 Fractionation of HEK-293 Cells 
HEK-293 cellular fractionation was performed as previously described (Bianchi et al., 
2013). Briefly, protein expression was induced (10 ng/mL doxycycline, 24 hours) in 
HEK293 Flp-In T-REx cells stably transfected with various FLAG-PrimPol constructs 
(WT, D519R/F522A, D551R/I554A, and D519R/F522A/D551R/I554A). The following day 
cells were either mock or UV-C (30 J/m2) irradiated and allowed to recover for 3 hours. 
Cells were  harvested and pellets resuspended in cytoskeletal buffer (100 mM NaCl, 300 
mM sucrose, 3 mM MgCl2, 10 mM PIPES (pH 6.8), 1 mM EGTA, 0.2% Triton X-100, and 
protease and phosphatase inhibitors (Roche)), followed by incubation on ice for 5 mins. 
Samples were then centrifuged at 13,000 rpm for 10 mins. Supernatant was retained as 
the soluble fraction. The insoluble pellet was washed three times in PBS and boiled in 
Laemmli buffer. Whole cell extract, soluble, and insoluble, samples were analysed by 
western blot using Anti-FLAG, Anti-RPA2, and Anti-mouse IgG antibodies sourced and 
used as described above, in addition to Anti-Histone H3 (Abcam ab1791; 1:5000 dilution) 
and HRP conjugated Anti-Rabbit IgG (Abcam ab6721; 1:3000 dilution).
5.3.12. Chromatin Isolation from Xenopus egg Extract 
Demembranated sperm nuclei were prepared by lysolecithin treatment as previously 
described (Murray, 1991). Preparation of Xenopus egg extracts and the isolation of 
chromatin from egg extract were carried out as previously described (Taylor et al., 2013).
Western blot analysis was performed using the following antibodies; Anti-GST (Abcam 
ab92; 1:2000 dilution), Anti-Orc2 (gift from Julia Blow; 1:2000 dilution), HRP conjugated 
Anti-mouse IgG (DAKO P0260; 1:5000 dilution), and HRP conjugated Anti-rabbit IgG 
(DAKO P0448; 1:5000 dilution).
5.3.13. Complementation and DNA Fibre Assays in PrimPol-/- DT40 Cells
DT40 cells were cultured in RPMI 1640 medium containing 10% FCS, 1% chicken 
serum, 10 
M -mercaptoethanol, 1% L-glutamine, and 1% PenStrep. Mutant DT40 cell 
lines were derived from DT40 Clone 653 from Prof. S. Takeda's group (Kyoto University). 
PrimPol-/- DT40 cells (previously generated (Bianchi et al., 2013)) were stably 
complemented with pCI-neo plasmid encoding WT PrimPol, PrimPolD519R/F522A, and 
PrimPolD551R/I554A by electroporation as previously detailed (Bianchi et al., 2013). pCI-neo 
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contructs encoding RBM-mutant PrimPol were generated by site-directed mutagenesis 
(primers 15-18, Table 5.1.). Positive clones were selected using medium containing 2 
mg/mL G418 (Sigma) and expression was confirmed by western blot using Anti-PrimPol 
(raised against recombinant purified PrimPol, 1:1000), Anti--Tubulin (Sigma T5168, 
1:3000 dilution), and HRP conjugated Anti-Rabbit IgG and Anti-Mouse IgG (sourced and 
used as described above). All DNA fibre analysis was performed as described previously 
in triplicate (Bianchi et al., 2013). 
5.3.14. Yeast Two-Hybrid Assay
Full-length PrimPol and its C-terminal RBM domain (PP-RBM  a.a. 480-560) were 
cloned into the NdeI site of the pGADT7 vector using polymerase chain reaction with 
wild-type PrimPol as a template, and T4 polymerase to process the DNA ends. PrimPol 
mutants were prepared by site-directed mutagenesis. RPA70N (a.a 1-120) was cloned 
into NdeI site of the pGBKT7 vector. Plasmids containing the GAL4 activation domain 
(pGADT7) fused to the PrimPol variants or the empty vector were transformed into the 
S. cerevisiae strain PJ69-4a. Plasmids containing the GAL4 DNA binding domain 
(pGBKT7) fused to RPA70N or the empty vector were transformed into PJ69-4 strain. 
The haploid strains were mated on a YPD plate and replica plated on selective medium 
lacking leucine and tryptophan. The resulting diploid strains were grown to A600 ~ 1 and 
spotted as 10-fold serial dilutions on media lacking leucine, tryptophan, histidine, or 
adenine. 1 mM 3-Amino-1,2,4-triazole (3AT) was added to decrease the background 
HIS3 expression. Plates were scanned after 3 days of incubation at 30 °C
5.4. Results
5.4.1. PrimPols CTD Interacts with RPA70N
Previously, we identified that full-length PrimPol interacts directly with RPA70N (Guilliam 
et al., 2015a). In contrast, deletion of the C-terminal RPA binding domain (RBD) ablated 
this interaction. In order to determine if PrimPols RBD (480-560) is sufficient to mediate 
binding, we performed analytical gel filtration chromatography (GFC) on PrimPolRBD
titrated with RPA70N (Figure 5.2.A.). With one equivalent of RPA70N added, a bimodal 
peak appears with broadened densities between a position near free PrimPolRBD and a 
peak presumably of the complex (blue dot trace). With two equivalents of RPA70N 
added, the peak at the PrimPolRBD position is much weaker, while the complex elutes 
slightly earlier and increases in intensity (blue dash trace). With four equivalents of 
RPA70N added, the complex peak increases in intensity, the free PrimPolRBD peak 
disappears, and a peak at the free RPA70N position becomes visible (blue solid trace). 
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Figure 5.2. PrimPols RBD interacts with RPA70N. 
(A) Chromatograph showing the retention volumes of the PrimPol RBD (residues 480-560) 
(Red), RPA70N (Green) and RBD titrated with varying molar ratios of RPA70N (Blue). (B)
MALS analysis of the major peak eluted from the saturated RBD-RPA70N E7R sample at a 
1:4 molar ratio.  The observed Refractive Index (blue), UV (green), and Light Scattering (red) 
readings were used to calculate the molecular weight of the complex over the course of elution 
(black). (C) Circular dichroism spectrum of 20 
M PrimPolRBD collected between 190-250 nm 
showing a spectral shape characteristic of an unstructured protein lacking any significant -
helical or -strand propensity. (D) Regularisation graph of 10 accumulations of dynamic light 
scattering data collected on PrimPolRBD samples at 200 
M. A single peak was observed with 
a radius of 1.25 nm that corresponds to a predicted molecular weight of ~6 kDa when 
modelled with random coil protein shape algorithms. This is close to the expected 8.8 kDa of 
the monomeric protein. (E) 15N-1H HSQC spectra of 15N-enriched PrimPol RBD in the absence 
(black) and presence (red) of unlabelled RPA70N (70N) titrated at a 2:1 ratio. (F) 15N-1H 
HSQC spectra of 15N-enriched RPA70N in the absence (black) or presence (red) of 2-fold 
molar excess of unlabelled PrimPol RBD.
0
100
200
300
400
500
9 11 13
m
AU
Volume (ml)
A B
C
E F
PrimPol480-560
RPA70N
RPA70N:PrimPol480-560 1:1
RPA70N:PrimPol480-560 2:1
RPA70N:PrimPol480-560 4:1
D
210
This data indicates a heterogeneous interaction, most likely from two binding sites of 
similar affininty (Figure 5.2.A.). The stoichiometry of the binding is most likely 2:1 
RPA70N:PrimPolRBD due to the complete disappearance of the individual RPA70N peak 
at this ratio (Figure 5.2.A.). This stoichiometry was further confirmed by multiangle light 
scattering (MALS) analysis of the eluted peak fractions, identifying a heterogenous mix 
of both 1:1 and 2:1 RPA70N:PrimPolRBD complexes (Figure 5.2.B.). PrimPolRBD had a 
much lower retention volume (10.39 mL) than expected for an 8.8 kDa protein, 
corresponding to a predicted molecular weight of ~42 kDa if the protein was globular. 
Nevertheless, circular dichroism (CD) and Dynamic Light Scattering (DLS) revealed that 
PrimPolRBD is monomeric in solution with a largely non-globular structure (Figure 5.2.C. 
and D.). 
NMR spectroscopy was next utilised to cross-validate this interaction. To this end, 15N-
enriched PrimPolRBD was produced and analysed by two-dimensional (2D) 15N-1H 
heteronuclear single quantum coherence (HSQC) NMR (Figure 5.2.E.). The low 
dispersion observed in the 1H dimension of the spectrum is characteristic of a protein 
with non-globular structure. Upon addition of unlabelled RPA70N to a two-fold molar 
excess, there was a significant effect on the spectrum, with peaks attenuating, 
broadening or shifting. These observations confirm that there is an interaction between 
the two proteins. We also observed significant peak shifting and disappearance in the 
corresponding spectrum of 15N-enriched RPA70N in the presence of a 2-fold excess of 
unlabeled PrimPolRBD (Figure 5.2.F.). The large number of peaks affected and the variety 
of effects on the signals suggest the interaction is not mediated by a single high-affinity 
site, but rather some form of heterogeneous binding. 
5.4.2. PrimPols RBD Contains a Conserved RPA Binding Motif
RPA70N contains a prominent surface cleft that binds many interacting partners, 
including RAD9, MRE11, ATRIP and p53 (Xu et al., 2008). These partners utilize a 
similar highly negatively charged motif, which interacts with the exposed basic residues 
in the RPA70N cleft (Xu et al., 2008). Examination of the sequence of human PrimPol 
revealed a divergent acidic motif within its RBD (residues 513-527; Figure 5.3.A.), we
termed this motif RPA binding motif A (RBM-A).
To investigate the potential interaction between PrimPols RBM-A and RPA70N, we 
employed NMR spectroscopy using an RBM-A peptide (RBM-A510-528). An overlay of 2D 
15N-1H HSQC spectra of 15N-enriched RPA70N acquired in the absence (black) and 
presence (red) of a 2-fold excess of RBM-A510-528 revealed significant chemical shift 
perturbations (CSPs) induced by binding of the peptide (Figure 5.3.B.). The CSPs above 
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Figure 5.3. PrimPol possesses a conserved RPA binding motif that binds to the basic 
cleft of RPA70N. 
(A) Schematic showing the sequence of PrimPols RBM-A (residues 510-528), located in the 
C-terminal RBD (residues 480-560). (B) 15N-1H HSQC spectra showing RPA70N in the 
absence (black) or presence (red) of 2-fold molar excess of unlabelled RBM-A peptide. (C)
Electrostatic surface model of RPA70N with RBM-A (green) bound in the basic cleft. Basic 
and acidic surfaces are coloured blue and red, respectively. (D) Key stabilising interactions 
of RBM-A (green) in the RPA70N basic cleft (purple). RBM-A binds between  sheets in the 
 barrel of RPA70N. Of particular importance for binding are the electrostatic interactions of 
D519 with the side chains of two arginines (R31 and R43) in the RPA70N basic cleft.
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a defined threshold ( > 0.1) were mapped onto the RPA70N structure and compared 
with the corresponding CSPs caused by the binding of other RPA-interacting proteins; 
ATRIP, Rad9 and MRE11 (Figure 5.4.A. and B.) (Xu et al., 2008). Similar to these binding 
partners, RBM-A bound within the basic cleft of RPA70N. Together, these studies 
establish that RBM-A interacts with RPA via the basic cleft of RPA70N. 
5.4.3. Molecular Basis for RBM-A / RPA70N Interaction
To determine the molecular basis for RPA70N binding to the RBM-A site of PrimPol, 
RPA70NE7R (an RPA70N mutant optimized for crystallization of complexes (Feldkamp et 
al., 2013) and the RBM-A peptide residues (PrimPol514-528) were co-crystallised. Co-
crystals contained a 1:1 molar ratio in a P212121 crystal lattice (Figure 5.3.C. and D.). 
The statistics for data processing are summarised in Table 5.2. Continuous electron 
density covers the entirety of RPA70NE7R and 12 residues (514-525) of the 15-mer 
PrimPol514-528 peptide are visible in the electron density maps. Within this short peptide, 
residues aspartate 519 to leucine 523 are -helical in content. Given that no -helices 
were identified from CD of the free RBD, it is likely that the -helical peptide identified 
here is induced upon binding. A striking feature of this -helix is that the primary 
interactions with the basic cleft of RPA70NE7R are via salt bridges between aspartate 519 
of PrimPol and RPA70NE7R arginines R31 and R43. Hydrogen bonds are also found 
between isoleucine 517 of PrimPol and RPA70NE7R arginine 43. In addition to the ionic 
interactions, PrimPol phenyalalnine 522 sits in a hydrophobic pocket made up of 
RPA70NE7R serine 55, methionine 57 and valine 93. Isoleucine 517 of PrimPol also has 
an aliphatic interaction with the side chain of RPA70NE7R arginine 91 (Figure 5.3.C. and 
D.). The combination of these electrostatic and hydrophobic interactions drives the 
stabilisation of this complex.
5.4.4. PrimPols RBD Contains a Second RPA Binding Motif 
To determine the molecular basis for binding of PrimPol RBM-A to RPA70N, in the wider 
context of the whole RBD, we co-crystallised a complex of PrimPol480-560 bound to 
RPA70NE7R. Again, co-crystals contained a 1:1 molar ratio in an orthorhombic P212121
crystal lattice (Figure 5.5.B., C. and E.). The statistics for data processing are 
summarised in Table 5.2. Similar to the RBM-A peptide, continuous electron density 
covers the entirety of RPA70NE7R and nine amino acids of an -helical peptide from 
PrimPol480-560 are visible in the electron density maps. Surprisingly, model building and 
density refinement revealed that RPA70N bound to PrimPol residues 546-560 (Figure 
5.5.A. and B.) rather than RMB-A. An excellent fit to the high-resolution (1.28 Å) electron 
density is evident for amino acids 548-556, despite residues 480-547 not being visible in 
213
Figure 5.4. PrimPol interacts with RPA70N in the same region as other RPA70N binding 
partners. 
(A) Chemical shift perturbations (CSPs) observed in the 15N-1H HSQC NMR spectra following 
titration of PrimPol RBM-A peptide quantified and plotted versus RPA70N residue number. 
(B) Structure of RPA70N mapped with CSPs above a  threshold of 0.1 ppm shown in red. 
The interacting region of PrimPol is similar to that of other binding partners such as ATRIP, 
RAD9, and MRE11, which bind mostly on one side of the -barrel. 
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Table 5.2. Data collection and refinement statistics (molecular replacement).
Data Collection RPA70NE7R/A-pep RPA70NE7R/RBD
Spac roup P212121 P212121
Cll msos
a, b, c (Å) 37.86, 53.09, 54.63 38.05, 53.49, 53.9
a, b, g (°) 90.00, 90.00, 90.00 90.00, 90.00, 90.00
Rsoluto (Å) 31.12 (2.00) * 16.25 (1.28)*
Rsym or Rmr 0.217 (0.751) 0.044 (0.655)
I / sI 10.9 (3.0) 26.9 (2.7)
Compltss (%) 99.6 (98.1) 99.8 (98.2)
Ruacy 12.8 (10.4) 12.1 (7.4)
Rfmt
Rsoluto (Å) 31.12 (2.00) 16.25 (1.28)
No. rflctos 7825 28966
Rwor / Rfr 0.1873/0.2286 0.1537/0.1785
No. atoms 1148 1210
Prot 1074 1070
La/o
Watr 74 140
B-factors
Prot 25.25 19.73
La/o
Watr 31.23 32.95
R.m.s. vatos
Bo lt
s (Å) 0.004 0.007
Bo als (°) 0.785 0.912
*Data from one crystal for each structure. *Values in parentheses are for highest-resolution shell.
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Figure 5.5. PrimPol possesses a second RPA binding motif that also binds to the basic 
cleft of RPA70N. 
(A) The sequence of PrimPols RBM-B (residues 542-560), located in the C-terminal RBD 
(residues 480-560). (B) The continuous electron density of RBM-B residues 548-556 in the 
complex with RPA70N. (C) Electrostatic surface model of RPA70N with RBM-B (green) bound 
in the basic cleft. Basic and acidic surfaces are coloured blue and red, respectively. (D) 15N-
1H HSQC spectra showing RPA70N in the absence (black) or presence (red) of a 2-fold molar 
excess of unlabelled RBM-B peptide. (E) Key stabilising interactions of RBM-B (green) in the 
RPA70N basic cleft (purple). RBM-B binds between  sheets in the  barrel of RPA70N. D551 
is of particular importance as it forms a number of electrostatic interactions with both the side 
chains and a backbone amide NH of the RPA70N peptide.
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the area of contiguous electron density (Figure 5.5.B.). As PrimPols RBD lacks 
significant secondary structure or globular fold, and residues 480-547 are not tethered 
to RPA in the lattice, we expect that these residues remain flexible in the crystal and this 
disorder inhibits their resolution.
The crystal structure revealed that the second RBM, termed RBM-B, also binds to the 
basic cleft of RPA70N (Figure 5.5.C.). Like RBM-A, RBM-B has a low pI (pI=3.25) but 
this motif contains two adjacent Asp-Glu motifs instead of the typical di-Asp motif (Figure 
5.5.A.), not previously identified in the RPA70N binding motifs of other RPA partner 
proteins. To confirm that the interaction observed in the crystal is a bona fide RPA70N 
binding motif, we examined the binding to RPA70N of a PrimPol542-560 peptide using 15N-
1H HSQC NMR. The spectrum of 15N-enriched RPA70N in the absence and presence of 
a 2-fold molar excess of the RBM-B peptide reveals significant CSPs induced by the 
binding of PrimPol RBM-B (Figure 5.5.D.). As observed for the RBM-A titration, the RBM-
B peptide causes chemical shift perturbations of residues in RPA70Ns basic cleft, 
including characteristic residues S55 and R31 (Figure 5.5.D.). Together, these data 
demonstrate that PrimPols RBD contains a second independent RPA70N binding motif.
5.4.5. Molecular Basis for RBM-B / RPA70N Interaction 
Notably, the RBM-A sequence and the structure of its complex with RPA70N is at odds 
with the well-defined canonical RBMs (e.g. p53, ATRIP) and likewise, the structure of 
RBM-B bound to RPA70N in the crystal of PrimPol RBD confirms these distinct features
(Figure 5.3.D., 5.5.E. and Figure 5.6.A.). Notably, these differences arose despite the 
absence of any significant effects on the structure of RPA70N. The orientation of the 
RBM-B helix is stabilised by a number of electrostatic interactions (Figure 5.5.E.). The 
aspartate at position 551 of PrimPol is perhaps the most important point of contact as it 
interacts with the two arginines of RPA70N (R31 and R43) and a threonine (T34) side 
chain, as well as the backbone amide N-H of T34. The carbonyl group of PrimPols 
isoleucine at position 549 likely acts as a hydrogen bond acceptor for the RPAs R43. 
The glutamate at position 548 forms an electrostatic interaction with an arginine (R91) 
on the other side of RPA70Ns -barrel, acting to secure the helix of PrimPol in this 
orientation. These electrostatic interactions are of paramount importance in the binding 
of PrimPols RBM-B to RPA70N in vitro (Figure 5.5.B. and E.).
Comparison of the RBM-A and RBM-B structures reveals that the peptides adopt almost 
identical helical conformations that occupy the basic cleft in a similar fashion (Figure 
5.6.A., B. and C.). Intruigingly, the interactions between PrimPols RBM-A / B and 
RPA70N are significantly different from the interactions reported for either a modified 
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Figure 5.6. RBMs bind with a reverse polarity to the basic cleft of RPA70N.
Ribbon representations of RPA70NE7R from the current PrimPol514-528 peptide complex 
superposed with helical elements from previously established RPA70N protein complexes. 
The RBM helices are seen to bind in reverse polarity to these established complexes. The 
RPA70N is coloured magenta. (A) All the helices from the different RPA70N complexes 
superposed: PrimPol514-528 peptide complex coloured light green, PrimPol480-560 coloured dark 
green, peptide from Dna2 (PDBID: 5EAY) coloured cyan, p53N (fragment 33-60) (PDBID: 
2B3G) coloured sky blue, 3,4 dichlorophenyalanine ATRIP derived peptide (PDBID: 4NB3) 
coloured turquoise. (B-F) Combined ribbon and main chain representations of: (B) The 
current PrimPol514-528 peptide complex. (C) The PrimPol480-560 complex. (D) RPA70N binding 
a peptide from Dna2 (PDBID: 5EAY). (E) RPA70N binding p53N (fragment 33-60) (PDBID: 
2B3G). (F) RPA70N binding 3,4 dichlorophenyalanine ATRIP derived peptide (PDBID: 4NB3).
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ATRIP stapled peptide or a p53 peptide bound to RPA70N (Bochkareva et al., 2005; 
Frank et al., 2014). A superposition of the modified ATRIP peptide with RBMs shows that 
the two helices bind in a similar region to RPA70N however, they are in opposite 
orientations (Figure 5.6.). In addition, the main interaction of the modified ATRIP peptide 
is of its modified 3,4-dichlorophenyl amino acid into a hydrophobic pocket on RPA70N, 
and in p53 there is a phenylalanine residue that extends into this pocket. This pocket is 
also the region where a RPA70N binding inhibitor (VUO79104) bound to a co-crystal 
structure (Feldkamp et al., 2013). PrimPols RBM-A and RBM-B have hydrophobic 
residues phenylalanine (F522) and isoleucine (I554) that occupy the hydrophobic pocket 
on RPA70N (Figure 5.3.D. and 5.5.E.). F522 forms hydrophobic non-bonding contacts 
with a serine (S55) methionine (M57) and a valine (V93) of RPA70N in this pocket. 
Whereas, I554 forms hydrophobic non-bonding contacts with the methionine and valine 
only. We propose that the RPA70N binding modes observed for PrimPol may be more 
physiological as the bound motifs are not modified in any way, unlike p53 and ATRIP 
where co-crystals could only be obtained by altering the peptides (Frank et al., 2014).
5.4.6. Exchangeable Binding of PrimPol RBMs to RPA70N
As both RBM-A and RBM-B interact in the basic cleft, we next analysed whether these 
sites bind co-ordinately or competitively. To this end, we constructed RBM-A 
(D514R/D518R/D519R) and B (480-546 truncation) knock-out (K.O.) mutants in the 
PrimPolRBD construct. Both NMR and GFC were used to analyse the binding of these 
mutants to RPA70N. Similar to results observed with PrimPolRBD, PrimPolA-K.O. and 
RPA70N eluted together as a well-defined multimeric complex from GFC (Figure 5.7.A.). 
Additionally, HSQC titrations of 2-fold molar addition of PrimPolA-K.O. into 15N-enriched 
RPA70N produced clear evidence of binding (Figure 5.7.B.). Likewise, PrimPolB-K.O. was 
found to bind RPA70N in both GFC and NMR analyses (Figure 5.7.C. and D.). Notably, 
in each GFC analysis a small fraction of unbound RPA70N was observed, unlike GFC 
using the wild-type RBD. Similarly, NMR analysis produced results mimicking those of 
the isolated motifs, suggesting that both mutants retain binding activity characteristic of 
the unaltered RBM-A and B. By overlaying the HSQC spectra of RPA70N in the presence 
of WT, or mutant RBM-A/B, RBD, we identified that, whilst most of the signals from the 
complex with mutant RBM-A/B RBD are identical to the complex with WT RBD, (Figure 
5.8.A.), some peaks from the RBM-A/B-bound spectra do not overlap. These signals
correspond to residues that attenuate or disappear in the complex with WT RBD. 
Analysis of this phenomenon suggests that RPA70N binds to both sites in solution and 
this process is exchangeable. This is consistent with ITC data showing that PrimPolA-K.O
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Figure 5.7. RPA70N dynamically interacts with both RBM-A and RBM-B. 
(A) Mutation of RBM-A does not abolish binding of PrimPols RBD to RPA70N. 
Chromatographs showing the retention volumes of RBDA-K.O. (purple), RPA70N (black), and 
RBDA-K.O. with RPA70N in a 1:1 ratio (green). (B) 15N-1H HSQC spectra showing RPA70N 
alone (black), in the presence of 2-fold molar excess of either RBDA-K.O. (green) or RBM-B 
peptide (residues 542-560) (red). The perturbations observed for RBDA-K.O. are similar to those 
induced by the RBM-B peptide. (C) Truncation of RBM-B does not prevent binding of 
PrimPols RBD to RPA70N. Chromatographs showing the retention volumes of RBDB-K.O. 
(purple), RPA70N (black), and RBDB-K.O. with RPA70N in a 1:1 ratio (blue). (D) 15N-1H HSQC 
spectra showing RPA70N alone (black) or in the presence of 2-fold molar excess of RBDB-K.O. 
(blue) or RBM-A peptide (residues 510-528) (red). The perturbations observed for RBDB-K.O. 
are similar to those induced by the RBM-A peptide. (E) Mutation of both RBM-A and RBM-B 
abolishes the binding of PrimPols RBD to RPA70N. Chromatographs showing the retention 
volumes of RBDA/B-K.O. (purple), RPA70N (black), and RBDA/B-K.O. with RPA70N in a 1:1 ratio 
(red). (F) 15N-1H HSQC spectra showing RPA70N alone (black) or in the presence of 2-fold 
molar excess of RBDA/B-K.O. (red). The near identity of the two spectra indicates there is no 
interaction.
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Figure 5.8. RPA70N dynamically interacts with both RBM-A and RBM-B. 
(A) 15N-1H HSQC overlay comparing RPA70N bound to wild type RBD or constructs mutated 
to inhibit binding to RBM-A or B. The RPA70N spectrum (black) shows distinct chemical shift 
perturbations (CSPs) when titrated with 2-fold molar excess of RBD constructs that select for 
binding to only RBM-A (blue) or RBM-B (green). These are different from the combination of 
signal shifting and broadening induced by the wild type RBD (red), which is indicative of 
dynamic exchange between RBMs. (B-D) Isothermal titration calorimetry data showing the 
heat of binding evolved upon titrating a cell containing 1.4 mL of 20 
M RPA70N with iterative 
10 
L injections of 400 
M PrimPolRBD mutants (B) PrimPol480-546 (B-K.O.), (C) RBM-A-K.O. 
and (D) RBM-A/B-K.O. Dissociation constants were calculated with a single site binding 
model to give statistically equivalent values of 7.8 ± 0.6 µM and 6.7 ± 1.5 µM for the A-K.O. 
and B-K.O. mutant domains, respectively.  The double knockout RBM-A/B-K.O. showed no 
significant heat evolved upon titration, indicating that no interaction was observed.
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and PrimPolB-K.O bind to RPA70N with statistically identical affinities of 7.8 ± 0.6 µM and 
6.7 ± 1.5 µM, respectively (Figure 5.8.A. and B.). 
In contrast, there was no observed binding in the GFC or NMR when the double mutant 
(PrimPolA/B-K.O) was incubated with RPA70N (Figure 5.7.E. and F.). Additionally, no heat 
of binding was observed by ITC (Figure 5.8.C.). Therefore, whilst retaining either one of 
these domains is sufficient to maintain RPA70N binding in vitro, knocking out both RBM-
A and RBM-B completely abrogates binding. This indicates that there are no additional 
RPA70N binding sites beyond RBM-A and RBM-B.
To obtain less perturbing mutants for experiments in vivo, we analysed finer point 
mutants of both RBM-A and B, based on the crystallographic data. We found that the 
PrimPolA-RA (D519R/F522A) and PrimPolB-RA (D551R/I554A) mutants retained the ability 
to bind RPA70N in GFC. However, binding was lost when all four residues were mutated 
(Figure 5.9.A.). We additionally analysed these mutations in the context of the full-length 
protein and RBD (480-560) using the yeast two-hybrid assay. Here, PrimPolA-RA and 
PrimPolB-RA exhibited decreased binding to RPA70N, with an additional decrease when
both sites were mutated. Near identical results were observed when analysing both the 
full-length enzyme and RBD, confirming that both RBM-A and RBM-B are able to bind 
RPA70N when outside their innate vertebrate cell environment (Figure 5.9.B.). These 
results, therefore, confirmed that each RBM is accessible for RPA70N binding in the 
context of the full-length protein. Furthermore, they provided minimally perturbing 
PrimPol variants to probe the functional significance of the RPA interaction, and the 
contributions of the two RPA-binding motifs, in vivo.  
5.4.7. RBM-A Mediates the PrimPol-RPA interaction in vivo
To ascertain the importance of each RBM in mediating PrimPols interaction with RPA in 
vivo, we introduced doxycycline-inducible N-terminal FLAG-tagged PrimPol variants 
lacking either RBM, or both, into HEK-293 derivative cells (Flp-In T-Rex-293) (Figure 
5.10.A. and B.) and performed co-immunoprecipitation experiments. We find that RPA 
co-precipitates with FLAG-PrimPol in vivo when both RBMs are unmodified (Figure 
5.10.C.), confirming that FLAG-PrimPol interacts with RPA in a damage-independent 
manner, as observed previously (Guilliam et al., 2015a; Wan et al., 2013). Additionally, 
FLAG-PrimPolRBD (the CTD only) also co-precipitates with RPA, supporting our in vitro 
data and previous reports that PrimPol interacts with RPA via its CTD (Figure 5.9.C.) 
(Guilliam et al., 2015a; Wan et al., 2013). Interestingly, we find that mutation of RBM-A 
(D519R/F522A) alone abolishes this interaction, despite the protein possessing an intact 
RBM-B (Figure 5.10.D.). Furthermore, when RBM-B is mutated (D551R/I554A), but 
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Figure 5.9. PrimPols RBD interacts with RPA in vivo.
(A) Validation of RBMA/B-RA mutants used for in vivo analysis. Chromatographs showing the 
retention volumes of PrimPol480-560 RBMA/B-RA mutants (D519R/F522A and D551R/I554A) 
in the presence (red) and absence (purple) of RPA70N (black) in a 1:1 ratio. (B) PrimPol 
interacts with RPA70N in the yeast two-hybrid assay. To study the interaction with RPA70N, 
either full-length PrimPol (upper panels) or its RBD (PP-RBD  a.a. 480-560; lower panels) 
were used. The following amino acids of PrimPol were mutated - D519R and F522A in A-
K.O.; D551R and I554A in B-K.O.; D519R, F522A, D551R, I554A in A+B-K.O. Diploid strains 
containing plasmids with the indicated genes fused to the GAL4 activation domain (AD) and 
GAL4 DNA binding domain (BD), were spotted as 10-fold serial dilutions on media lacking 
leucine, tryptophan, histidine, or adenine. 1mM 3-Amino-1,2,4-triazole (3AT) was added to 
decrease the background HIS3 expression (panels in 3rd. row). (C) RPA co-precipitates with 
PrimPols RBD. Flp-In T-Rex-293 cells transfected with FLAG-tagged PrimPol480-560 were 
grown in the presence or absence of doxycycline (10 ng/mL, 24 hrs), FLAG-PrimPol480-560
was immunoprecipitated from the soluble cell lysate using anti-FLAG antibody and western 
blotted for PrimPol (anti-FLAG) and RPA (anti-RPA2). The presence and absence of 
doxycycline is indicated by +/- Dox, In indicates the input, E1, E2, and E3, indicate 
elutions 1, 2, and 3, respectively. 
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Figure 5.10. PrimPols RBM-A is critical for RPA binding in vivo. 
(A) Schematic detailing the domain architecture of N-terminal FLAG-tagged PrimPol 
transfected into HEK-293 derivative cells (Flp-In T-Rex-293). The RBD (480-560) containing 
the RBM-A and B sites is shown below with the mutations forming the A-K.O. (D519R and 
F522A) and B-K.O. (D551R and I554A) highlighted. (B) Flp-In T-Rex-293 cells were 
transfected with wild-type and RBM-A and B mutated PrimPol. Expression was confirmed by 
addition of 10 ngmL-1 doxycycline (indicated by Dox +/- on figure) for 24 hrs and subsequent 
western blotting. (C) Flp-In T-Rex-293 cells transfected with FLAG-tagged wild-type (WT) 
PrimPol were grown in the presence or absence of doxycycline (10 ngmL-1, 24 hrs), FLAG-
PrimPol was immunoprecipitated from the soluble cell lysate using anti-FLAG antibody and 
western blotted for PrimPol (anti-FLAG) and RPA (anti-RPA2). The presence and absence of 
doxycycline is indicated by +/- Dox, In indicates the input, E1, E2, and E3, indicate 
elutions 1, 2, and 3, respectively. (D) Immunoprecipitation of FLAG-PrimPolA-K.O.
(D519R/F522A) from Flp-In T-Rex-293 cells grown in the presence and absence of 
doxycycline. (E) Immunoprecipitation of FLAG-PrimPolB-K.O. (D551R/I554A) from Flp-In T-
Rex-293 cells grown in the presence and absence of doxycycline. (F) Immunoprecipitation of 
FLAG-PrimPolA+B-K.O. (D519R/F522A and D551R/I554A) from Flp-In T-Rex-293 cells grown in 
the presence and absence of doxycycline. 
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RBM-A is intact, a reduced, but significant, amount of RPA still co-precipitates with 
FLAG-PrimPol (Figure 5.10.E.). Unsurprisingly, when both RBMs are mutated, the 
interaction with RPA is again lost (Figure 5.10.F.). Together, these findings identify that 
RBM-A is the primary mediator of PrimPols interaction with RPA in vivo and residues 
D519 and F522 as essential for forming the complex. In contrast, RBM-B appears to play 
a more secondary role in RPA binding in vivo.  
5.4.8. PrimPols Interaction with RPA is Required for its Role in Replication 
Restart
PrimPol has previously been shown to promote DNA replication fork restart following UV 
damage by repriming (Bianchi et al., 2013; Keen et al., 2014b; Mourón et al., 2013). To 
define the importance of each RBM on PrimPols role during this process, we 
complemented PrimPol-/- DT40 cells with RBM-A (D519R/F522A) and RBM-B 
(D551R/I554A) mutants (Figure 5.11.A.) and performed DNA fibre analysis on these cells 
in the presence of UV damage. We labelled replicating cells with the nucleotide analogue 
chlorodeoxyuridine (CldU) for 20 minutes, cells were then UV-C irradiated (20 J/m2) and 
labelled with a second nucleotide analogue, iododeoxyuridine (IdU), for an additional 20 
minutes (Figure 5.11.B.). Following detection by immunofluorescence, the degree of fork 
stalling after UV damage in the PrimPol RBM-mutant cells was determined by analysing 
the CldU:IdU tract length ratios. An increase in this ratio indicates a shorter IdU tract and 
therefore an increase in the amount of fork stalling or slowing following UV-C irradiation.  
Cells expressing RBM-A-mutant PrimPol presented a significant increase in the mean 
CldU:IdU tract length ratio when compared to cells complemented with wild-type PrimPol 
(Figure 5.11.C. and D.). Additionally, these cells displayed more variation in CldU:IdU 
ratios with an increase in the percentage of forks with higher ratios (Figure 5.11.C. and 
D.). This indicates that there was an increase in fork stalling events, or a decreased 
ability to restart stalled forks, in these cells.  The observed effect was not as severe as 
that seen in PrimPol-/- cells, however given that RBM-A-mutant PrimPol is catalytically 
identical to wild-type PrimPol, and over-expressed in these cells, this was not surprising. 
This result suggests that mutation of RBM-A affects PrimPols recruitment to stalled 
replication forks, and therefore causes an impairment in the ability to restart these forks. 
Given the level of over-expression of RBM-A-mutant PrimPol in these cells, we expect 
some PrimPol would still localise to where it is required, resulting in a delay rather than 
total block to fork restart. 
In contrast, RBM-B mutant complemented PrimPol-/- cells did not display a significant 
increase in the mean CldU:IdU ratio when compared to cells expressing wild-type 
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Figure 5.11. RBM-A is required for PrimPol function in DNA replication restart.
(A) PrimPol-/- DT40 cells were complemented with un-tagged human PrimPol constructs; wild-
type hPrimPol (+ WT), hPrimPolD519R/F522A (+ A-K.O.), and hPrimPolD551R/I554A (+ B-K.O.). WT 
indicates lysate from wild-type DT40 cells, -/- indicates lysate from PrimPol-/- DT40 cells. (B)
DNA fibre analysis was performed on DT40 cells expressing each PrimPol construct. Cells 
were UV-C irradiated (20 Jm-2) between the CldU and IdU labelling periods (each 20 mins). 
Representative DNA fibres showing 1:1, 2:1, and 3:1 CldU:IdU ratios are presented; >100 
individual DNA fibres were scored for each experiment. (C) Mutation of RBM-A causes 
increased fork stalling following UV-C irradiation. Data are representative of the means of 
three individual experiments and were subject to an unpaired t-test showing a significant 
difference between the mean CldU/IdU ratio for the + WT hPrimPol and + A-K.O. hPrimPol 
data sets (P < 0.05). (D) DNA fibre analysis from the + A-K.O. hPrimPol DT40 cells presented 
as a cumulative percentage of forks at each ratio. (E) Mutation of RBM-B does not significantly 
alter the level of fork stalling following UV-C irradiation. DNA fibre analysis of the + B-K.O. 
hPrimPol DT40 cells, showing the percentage of forks at each CldU:IdU ratio.  Data are 
representative of the means of three individual experiments. (F) DNA fibre analysis from the 
+ B-K.O. hPrimPol DT40 cells presented as a cumulative percentage of forks at each ratio.
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PrimPol (Figure 5.11.E. and F.). There was a slight increase in the variation of CldU:IdU 
ratios, however the majority of forks conformed to wild-type ratios (Figure 5.11.E.). Again, 
given that PrimPol is over-expressed in these cells, a more significant effect may be 
observed upon mutation of the endogenous protein, with over-expression potentially 
masking subtle impacts on PrimPol recruitment. Nevertheless, this suggests that RBM-
B is not essential for PrimPols role in replication restart in vivo. Together, these results 
show that PrimPols interaction with RPA, primarily mediated by RBM-A, is important for 
the enzymes role in repriming and restarting stalled replication forks following DNA 
damage.
5.4.9. RBM-A is Essential for Recruitment of PrimPol to Chromatin 
We previously reported that PrimPol is recruited to chromatin in response to UV damage 
(Bianchi et al., 2013). Given the effect of mutating PrimPols RBM-A on the enzymes 
role in replication restart, we aimed to confirm if this was due to a defect in recruitment. 
To this end, we prepared detergent-insoluble chromatin-rich fractions from HEK-293 
cells, expressing RBM-mutant PrimPol constructs, 3 hours following mock or UV-C 
irradiation (30 J/m2). As previously observed, wild-type PrimPol partitioned to the 
detergent-insoluble chromatin-enriched fraction following UV irradiation (Figure 5.12.A 
and 5.13.A. and B.). A similar increase in the level of RPA enrichment was observed in 
the insoluble fraction, confirming that replication forks were stalled by the damage and 
an increase in RPA binding had occurred (Figure 5.12.A.). In contrast, we find that 
mutation of RBM-A, either alone or in combination with RBM-B, abolishes the localisation 
of PrimPol to chromatin, both in the absence or presence of UV damage. Mutation of 
RBM-B, however, did not affect the level of enrichment of PrimPol following UV 
irradiation (Figure 5.12.A.). This suggests that PrimPols recruitment to chromatin is 
dependent upon its RBM-A, which is the primary mediator of the interaction of the 
enzyme with RPA in vivo.
To confirm these findings and examine the role played by the RBD of PrimPol in the 
recruitment of the protein to replicating chromatin, we employed a Xenopus synchronous 
cell-free extract system. We previously showed that recombinant hPrimPol accumulates 
on chromatin when the elongation phase of DNA replication is inhibited with aphidicolin 
(Bianchi et al., 2013). Similarly the presence of PrimPols RBD (480-560) is sufficient to 
allow recruitment of a GST fusion protein to chromatin in aphidicolin-treated extracts 
(Figure 5.12.B.). RBD recruitment is severely reduced by mutation of the D519 and F522 
residues within RBM-A. Mutation of the corresponding residues in RBM-B (D551, I554) 
also results in a modest reduction in the level of protein recruited to the chromatin, 
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Figure 5.12. RPA recruits PrimPol to stalled replication forks in vivo.
(A) PrimPols RBM-A, but not RBM-B, is critical for recruitment to chromatin. Flp-In T-Rex-293 
cells transfected with WT and RBM-A and B mutant PrimPol constructs were either mock (-) 
or UV-C (30 Jm-2) (+) irradiated before separation into Triton X-100 (0.5%) soluble and 
insoluble fractions. Samples were analysed by western blot alongside whole-cell extracts 
(WCE). Only insoluble samples are presented here, WCE and soluble blots can be found in 
Figure 5.13. (B) PrimPols RBD is recruited to Xenopus egg extract chromatin in response to 
aphidicolin treatment, RBM-A is critical for this recruitment. Recombinant hPrimPol-GST 
constructs (4 ng
l-1) were added to Xenopus egg extract supplemented with sperm nuclei (3 
x 103
l-1). Extract was treated with aphidicolin 100 
gml-1 and incubated at 21 °C for 80 
minutes. Chromatin was isolated and associated proteins analysed by SDS-PAGE and 
western blotting using the antibodies indicated. (C) Low concentrations of RPA stimulate 
PrimPols primase activity, high concentrations inhibit. Primer synthesis by WT hPrimPol (400 
nM) on M13 ssDNA templates (20 ng
L-1) in the presence of increasing concentrations of 
RPA. C indicates the no enzyme control, oligonucleotide (Nt) length markers are shown on 
the left of the gel. (D) Quantification of data shown in c. For each RPA concentration the fold 
increase in primer synthesis relative to reactions containing no RPA was calculated. Data are 
representative of three repeat experiments. (E) Schematic showing the effect of increasing 
RPA concentrations on PrimPols primase activity. When no RPA is present a proportion of 
PrimPol binds to the M13 template and facilitates primer synthesis (left). When low/moderate 
concentrations of RPA are present PrimPol is recruited to the RPA/ssDNA interface causing 
an increase in primer synthesis activity (middle). At high RPA concentrations the M13 DNA 
template is fully saturated, blocking access of PrimPol to the DNA and inhibiting primer 
synthesis (right).
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Figure 5.13. Whole-cell extracts and soluble samples from PrimPol chromatin recruitment experiments.
(A) Whole cell extract samples corresponding to the chromatin extraction experiment presented in Figure 5.12.A. (B) Soluble samples from the chromatin 
extraction experiment presented in Figure 5.12.A. (C) Analysis of the effect of PrimPol RBM mutations F522V and I554T, identified in cancer patient cell 
lines, on the RPA70N interaction. Chromatographs showing the retention volumes of unmodified PrimPol480-560, PrimPol480-560 F522V (on a B-K.O. construct), 
and PrimPol480-560 I554T (on an A-K.O. construct), in the presence (red) and absence (purple) of RPA70N (black) in a 1:1 ratio. Unmodified PrimPol480-560 is 
able to bind RPA70N (top panel). However, introduction of the mutations F522V (middle panel) or I554T (bottom) panel, in the absence of a second functional 
RBM, significantly abrogates binding to RPA70N.
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although this reduction is much less severe than that observed with the RBM-A 
mutations. Consistent with these observations, a construct carrying mutations in both 
RBM-A and RBM-B is not detectable on the chromatin. These results demonstrate that 
RBM-A plays the major role in recruiting PrimPol to chromatin, with a relatively minor 
contribution from RBM-B. 
Intriguingly, some of the key residues involved in binding of both RBM-A and RBM-B to 
RPA70N have been found to be mutated (F522V and I554T) in cancer patient cell lines 
(see COSMIC, CBioportal, CIGC repositories). We therefore generated these cancer-
related PrimPol RBD mutants (F522V and I554T) in RBM-B K.O. and RBM-A K.O. 
backgrounds, respectively, and analysed their binding to RPA70N using GFC (Figure 
5.13.C.). In each case, we identify that these mutations significantly abrogate binding of 
the affected RBM to RPA70N, potentially suggesting that both sites play an important 
role in appropriate PrimPol function in vivo. 
5.4.10. RPA Stimulates the Primase Activity of PrimPol 
In light of the role for RPA in recruiting PrimPol to stalled replication forks in vivo, we next 
assessed the impact of RPA on the primase activity of the enzyme in vitro. Using an 
indirect fluorescent primase assay, we previously identified that saturating 
concentrations of RPA are able to block primer synthesis by PrimPol on 60-mer poly-dT 
linear templates (Guilliam et al., 2015a). To better determine the effect of RPA on 
PrimPols primase activity, we performed direct fluorescent primase assays using single-
stranded M13 templates in the presence of increasing concentrations of RPA. Here, we 
observe that sub-saturating concentrations of RPA act to significantly increase the 
amount of primer-synthesis by PrimPol, when compared to reactions containing the 
enzyme only (Figure 5.12.C. and D.). Above concentrations calculated to fully coat the 
M13 template (~1.6 µM), the level of stimulation by RPA decreases and at higher 
concentrations severely inhibits primer synthesis (Figure 5.12.C. and D.). This 
demonstrates that lower concentrations of RPA significantly stimulate the primase 
activity of PrimPol, presumably by recruiting the enzyme and mediating binding to the 
DNA template. In contrast, high concentrations of RPA saturate the DNA template and 
block access of PrimPol, thus inhibiting primase activity (Figure 5.12.E.). These results 
suggest that PrimPol requires a ssDNA interface adjacent to the bound RPA in order to 
be recruited and facilitate primer synthesis. 
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5.5. Discussion 
Despite possessing the ability to perform TLS, recent studies suggest that PrimPols 
primary role in replication restart is to reprime downstream of DNA damage lesions and 
secondary structures (Keen et al., 2014b; Kobayashi et al., 2016; Mourón et al., 2013; 
Schiavone et al., 2016). The data presented here support a model whereby PrimPol is 
recruited to fulfil this repriming role through its interaction with RPA (Figure 5.14.). This 
interaction is primarily mediated by residues D519 and F522 of PrimPols RBM-A, which 
bind to the basic cleft of RPA70N, with RBM-B potentially playing a secondary role in 
RPA binding in vivo. In this regard, an intriguing possibility, consistent with our findings, 
is that RBM-B binds a second RPA molecule following initial recruitment through RBM-
A in vivo, potentially contributing to the stabilisation of PrimPol on the template DNA to 
further promote repriming. In addition to ATRIP, Mre11 and p53, we identified divergent 
RBM-like acidic motifs in a wide range of other DNA repair, replication and checkpoint 
proteins, many of which are known to interact with RPA e.g. Werner helicase (Figure 
5.15.) (Oakley and Patrick, 2010).
Notably, it has been shown through crystallographic and biochemical analyses that RPA 
binds to ssDNA with a defined polarity (Fan and Pavletich, 2012; Iftode and Borowiec, 
2000; Kolpashchikov et al., 2001; Laat et al., 1998). Initial binding is mediated by the 
tandem DNA-binding domain A (DBD-A) and DBD-B OB folds of RPA70, forming an 8-
nt binding complex. A 20-30-nt binding mode is subsequently generated by the binding 
of RPAs DBD-C and DBD-D (Brosey et al., 2013). This occurs in a strict 5-3 direction 
on the template strand, which likely positions the PrimPol-recruiting RPA70N domain 5 
relative to the other OB-folds (Figure 5.14.A.). This polarity suggests that PrimPol may 
bind downstream of RPA following recruitment through RPA70N on the leading strand.  
In a previous scenario (Guilliam et al., 2015a), we speculated that PrimPol may bind 
upstream of RPA during TLS, due to the requirement of the ssDNA-binding ZnF domain 
to contact the template downstream. However, during primer-synthesis the ZnF domain 
can access ssDNA both upstream and downstream of the AEP domain. Recent studies 
highlighting the importance of PrimPols primase activity in vivo (Keen et al., 2014b; 
Kobayashi et al., 2016; Mourón et al., 2013; Schiavone et al., 2016), coupled with the 
recruitment of the enzyme via RPA70N shown here, argue that PrimPol more likely binds 
downstream of RPA, with the ZnF bound to ssDNA upstream of the AEP domain, during 
primer synthesis (Figure 5.14.B.). 
PrimPol displays low processivity, only extending primers 1-5 nt in a single binding event 
(Keen et al., 2014b). This processivity is in part regulated by the ZnF domain, which 
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Figure 5.14. Model for PrimPol recruitment to stalled replication forks by RPA.
(A) Unrepaired DNA damage lesions, or DNA secondary structures, in the leading strand 
template lead to stalling of polymerase . This causes uncoupling of replication, generating 
ssDNA downstream of the DNA damage lesion/structure and facilitating binding of RPA. Note 
that for simplicity other replisome components and lagging strand synthesis machinery are not 
shown. (B) PrimPol is recruited to the ssDNA interface uncovered by the replicative helicase 
through the interaction of its RBM-A with RPA70N. This interaction is stabilised by the binding 
of the ZnF and AEP domains to ssDNA. (C) PrimPol catalyses the synthesis of a new DNA 
primer, before further extension is prevented by the restraining effect of the RPA-interaction 
and ZnF domain, coupled with the enzymes low processivity. (D) Unable to continue with 
primer extension, PrimPol dissociates from the template strand. Re-binding upstream is 
prevented by RPA. (E) The nascent primer is utilised by the replicative polymerase for 
continued DNA replication. This leaves behind a short RPA-coated ssDNA region opposite 
the lesion to be filled in by template switching or TLS.
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Figure 5.15. RBM-A and RBM-B represent common protein interaction motifs. 
(A) The domain architecture of PrimPol showing the positions of RBM-A and RBM-B relative 
to the functional domains of the protein. RBM-A and RBM-B motifs are conserved across 
chordate species. (B) Sequences similar to that of RBM-A are identified in Topoisomerase I 
and the Werner helicase. RBM-A of PrimPol aligns to a short acidic sequence in the N-
terminus catalytic subunit of Pol  of Pseudozyma antarctica. A comparable sequence is found 
in the human homologue suggesting that this may be an RPA-interacting region of Pol  (Pol 
1). (C) PrimPol RBM-B resembles the Ctf4(AND1)-binding motif. The Ctf4-binding motif that 
has previously been identified in the catalytic polymerase subunit of Pol  and Sld5 of GINS 
is present in PrimPol at the C-terminus in RBM-B. This region of PrimPol interacts with 
RPA70N and represents a potential multiple protein binding motif. A PSI-BLAST of this motif 
from human PrimPol and Pol  identifies a number of other proteins involved in the metabolism 
of DNA.
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serves as a counting mechanism to limit primer extension by the AEP domain (Keen et 
al., 2014b), as has been observed with other primases (Kuchta and Stengel, 2010a). The 
ZnF and AEP domains therefore likely form a hinge-like structure with the ZnF domain 
limiting extension by PrimPol following initial primer synthesis (Keen et al., 2014b; Kuchta 
and Stengel, 2010a). Given that PrimPol is recruited by RPA in vivo, it is likely that the 
enzyme initially binds the ssDNA downstream of RPA in a closed hinge mode (Figure 
5.14.B.). Primer synthesis and polymerisation then proceed until PrimPol reaches its 
maximum open conformation, dictated by the ZnF domain and interaction with RPA, 
which thereby prohibit further extension (Figure 5.14.C. and D.). The newly synthesised 
primer can then be utilised by the replicative polymerase for continued extension (Figure 
5.14.E.). 
We previously reported that, in contrast to the effect on replicative polymerases, RPA 
acts to inhibit the polymerase activity of PrimPol (Guilliam et al., 2015a). This 
phenomenon may be explained by the polarity of RPA when bound to ssDNA, in addition 
to the proteins interaction with PrimPol. It has been suggested that replicative 
polymerases are able to readily displace RPA from DNA because they encounter the 
protein from the 3 side (Iftode et al., 1999). As the replicative polymerase synthesises 
DNA, moving 3-5 on the template strand, it would first encounter the relatively weakly 
bound RPA32 DBD-D and RPA70 DBD-C, before RPA70 DBD-B and A. By approaching 
RPA in this orientation and making specific protein-protein interactions, the replicative 
polymerase may shift the equilibrium from the stronger 20-30-nt RPA binding mode to 
the weaker 8-nt mode (Brosey et al., 2013), and in turn, the more weakly bound RPA 
can be displaced by further DNA synthesis. In contrast, recruitment of PrimPol to the 5 
side of RPA would result in the enzyme moving away from the protein, making it unable 
to displace RPA in the same manner as canonical polymerases. 
In addition, we show that RPA stimulates the primase activity of PrimPol at sub-
saturating concentrations. However, when the template is fully coated with RPA the 
primase activity of PrimPol is inhibited. This suggests that PrimPol requires a ssDNA 
interface adjacent to RPA to be efficiently recruited for priming. Given that PrimPol likely 
binds downstream of RPA on the leading strand during replication, this ssDNA interface 
could be formed following uncoupling of leading and lagging strand replication upon 
stalling at a DNA lesion or secondary structure (Lopes et al., 2006). Continued unwinding 
of duplex DNA by MCM may generate the leading strand ssDNA interface necessary for 
PrimPol to reprime, following recruitment by RPA. It was recently reported that the 
mitochondrial replicative helicase Twinkle is able to stimulate DNA synthesis by PrimPol 
(Stojkovi et al., 2016), potentially suggesting that replicative helicases can facilitate 
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synthesis by the enzyme in vivo. However, the exact interplay between RPA, PrimPol, 
and other PrimPol-interacting partners, such as PolDIP2 requires further examination 
(Guilliam et al., 2016). The necessity of a ssDNA interface for PrimPol activity, in 
conjunction with the enzymes inability to displace RPA, may act as an important 
regulatory mechanism to prevent un-scheduled primer synthesis during replication. 
Intriguingly, it has been hypothesised that recruitment of DNA damage response proteins 
to RPA70N may be regulated by phosphorylation of RPA32C (Oakley and Patrick, 2010). 
In support of this, it has been shown that binding of Mre11 and Rad9 to RPA is increased 
upon RPA32C phosphorylation (Robison et al., 2004; Wu et al., 2005), it remains to be 
determined if this is the case for PrimPol. 
Together, the findings presented here describe the molecular basis of PrimPols 
interaction with RPA and provide insights into its biological roles. We found that the 
PrimPol-RPA interaction, mediated primarily by RBM-A, is essential for PrimPol 
recruitment and its function as a repriming enzyme during DNA replication. Notably, 
mutations of critical residues in both RBMs have been identified in the genomes of some 
cancer patient cell lines and we have shown that these mutations are sufficient to 
abrogate the functionality of their respective RBMs. Further studies are underway to 
more precisely define how PrimPol is recruited to stalled replication forks and regulated 
by interactions with other replisome components to better understand the critical roles of 
PrimPol in the restart of stalled replication forks. 
5.6. Further Work 
5.6.1. Initial Investigations into the Polarity of RPA-Mediated PrimPol 
Recruitment and Repriming
An important question to arise from the work described in the above article is, which side 
of RPA does PrimPol get recruited to and reprime on? This question has important 
mechanistic implications for repriming. If PrimPol is recruited to the 3 side of the bound 
RPA molecule on the ssDNA template, repriming would likely occur close to the 
replication impediment and stalled replicase. Whereas, repriming on the 5 side of RPA 
would permit replication restart close to the replicative helicase, preventing a situation 
where the replicase has to catch-up with the CMG complex following leading/lagging 
strand replication uncoupling and repriming. Moreover, each scenario has implications 
for the domain organisation of PrimPol during repriming, due to the requirement of the
ZnF to contact the ssDNA template (Keen et al., 2014b). Recruitment to the 3 side of 
RPA would require the ZnF to bind downstream of the AEP domain, with initial binding 
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of PrimPol in an open conformation. In comparison, recruitment to the 5 side of RPA 
would orientate the ZnF upstream of the AEP domain, with initial binding occurring in a 
closed conformation. In the article presented in Chapter 2 we proposed a model 
whereby PrimPol was recruited to the 3 side of RPA, allowing the enzyme to contact the 
primer-template junction to facilitate TLS. This orientation was necessary to permit the 
ZnF to contact the ssDNA template and the AEP domain to access the primer-template 
junction. However, since this publication, increasing evidence suggests PrimPol primarily 
functions as a repriming enzyme, rather than a TLS polymerase (Kobayashi et al., 2016; 
Pilzecker et al., 2016; Rechkoblit et al., 2016; Schiavone et al., 2016; Vallerga et al., 
2015). Importantly, during repriming the ZnF can contact ssDNA on either side of the 
AEP domain. 
As previously discussed, RPA binds to DNA in a manner which positions the PrimPol-
recruiting RPA70N domain 5 relative to the rest of the protein. This would suggest that 
PrimPol is recruited to the 5 side of RPA. However, RPA70N and PrimPols RBD are 
attached to the rest of their respective proteins by flexible linkers which may allow 
PrimPol recruitment to the 3 side of RPA. RPA binds to polypyrimidine sequences with 
~50-fold higher affinity that polypurine sequences, specifically, in order of decreasing 
affinity RPA binds to dC > dT > mixed ssDNA > dA/dG (Kim et al., 1992). As an initial 
investigation into the polarity of PrimPol recruitment to RPA during repriming, mixed 
sequence DNA templates (96 nt in length) containing a 30 nt polydC or polydT tract at 
their 5 or 3 end were synthesised (Figure 5.16.A.). These templates were used for 
standard fluorescence-based primase assays to analyse the primase activity of PrimPol 
in the presence of increasing concentrations of RPA. 
Here, it would be expected that if PrimPol is recruited to the 5 side of RPA, a 
polypyrimidine tract at the 3 end of the template, and therefore RPA binding to the 3 
end of the template, should stimulate primase activity as the concentration of RPA is 
increased. Moreover, priming should be initiated immediately after the RPA molecule, 
producing reaction products of ~66 nt in its presence. With templates containing a 5 
polypyrimidine tract, RPA would not recruit PrimPol and longer products should be 
observed from primer synthesis and extension from the 3 end of the template. 
Alternatively, if PrimPol is recruited to the 3 side of RPA, templates with a 3 
polypyrimidine tract should not stimulate primase activity and may sequester PrimPol 
away from the ssDNA template, causing inhibition. In this situation, templates with a 5 
polypyriminde tract should produce short reaction products of around 30-40 nt due to 
recruitment of PrimPol to the ssDNA on the 3 side of the RPA molecule bound at the 5 
end of the template. 
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The results of these assays show that when the polypyrimidine tract (both polydC and 
polydT) is located at the 3 end of the template, PrimPols primase activity is stimulated 
as the concentration of RPA is increased. At the highest concentration, inhibition occurs 
due to saturation of the template, as previously determined (Figure 5.16.B.). In each 
case, products of ~60-70 nt are produced, indicative of priming immediately after the 
polypyrimdine tract. Notably, similar size products were produced in the absence of RPA,
likely due to the inability of PrimPol to prime in the polypyrimidine tract. Nevertheless, in 
the presence of RPA a more consistent 60-70 nt product is observable, compared to 
reactions lacking RPA. Interestingly, on the 3 polydC template, a second predominant 
product of ~30-40 nt is produced at higher RPA concentrations. This is consistent with 
PrimPol binding downstream (on the 5 side) of a second RPA molecule (Figure 5.16.B.
indicated by red asterisk). The stimulation of primase activity, coupled with the size of 
reaction products, observed with increasing RPA on these templates suggests that 
PrimPol can be efficiently recruited to the 5 side of RPA to reprime (Figure 5.16.C.).
Interestingly, when the polypyrimidine tract is located at the 5 end of the template, 
reaction products are much longer, equivalent to the size of the full template (Figure 
5.16.B.). This is indicative of priming at the very 3 end of the template and not at the 
polypyrimdine tract where RPA is expected to be bound. As the concentration of RPA is 
increased, more full-length reaction products are produced and stalling of PrimPol at the 
start of the polypyrimidine tract is reduced. Intriguingly, this suggests that PrimPol is 
priming at the 3 end of the template and extending the primer to the polypyrimidine tract
(Figure 5.16.C.). In the absence of RPA PrimPol stalls here, producing ~60-70 nt 
products. However, in the presence of RPA synthesis continues to the end of the 
template. This suggests that RPA is binding to the polypyrimdine tract and aiding primer 
extension through this region, potentially by relaxing any DNA secondary structures, 
which it has previously been reported to do (Chen et al., 2013; Safa et al., 2016). This 
allows inference that RPA is binding where expected and PrimPol is priming at the 
opposite end of the template, in contrast to what is seen on 3 polypyrimidine templates
(Figure 5.16.C.). This further supports recruitment of PrimPol to the 5, rather than 3, 
side of RPA during primer synthesis. 
These preliminary results support the model suggested in the article presented above, 
whereby PrimPol binds and primes downstream of RPA on 5 side (Figure 5.16.C.). 
Indeed, this is consistent with the polarity of RPA when bound to ssDNA. In light of this, 
the inhibitory effect of RPA on PrimPol during primer-extension assays, as shown in 
Chapter 2, may be partially explained by recruitment of the enzyme to the 5 side of the 
protein, consequently preventing access to the primer. It is not inconceivable that this 
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Figure 5.16. Preliminary investigations into the polarity of RPA-mediated PrimPol 
recruitment. 
(A) Sequences of the ssDNA templates used for the primase assays presented in B. 
Templates contained a 30 nt Poly(dC) or Poly(dT) region at either the 3 or 5 end (indicated 
in red) and a 3 biotin tag. (B) Analysis of PrimPols primase activity on the templates listed in 
A in the presence of increasing concentrations of RPA (0, 0.5, 1, 2, 3, 4, 8 µM). PrimPol (1 
µM) was incubated with the respective template (1 µM) and RPA for a single 10 min time-
point. C indicates the no PrimPol control, -RPA indicates reactions containing PrimPol only, 
the red asterisk indicates the location of a second predominant reaction product at higher RPA 
concentrations on the 3-Poly(dC) template, presumably a result of priming on the 5 side of a 
second RPA molecule. Nucleotide size markers (Nt) are shown on the left of the gels. (C)
Schematic showing the location of PrimPol (blue) priming on both 3 and 5 polypyrimidine 
templates based upon the size of the reaction products produced in each case. The reactions 
products produced in B allow inference that RPA (green) is binding to the polypyrimidine tract 
of each template and suggests PrimPol is recruited to the 5 side of RPA during primer 
synthesis. 
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could prevent PrimPol from performing TLS in vivo and instead promote a repriming role. 
Nevertheless, these studies are in the early stages and further experiments and controls 
are required to confirm or negate this model. 
5.6.2. Studies to Identify Additonal PrimPol Interacting Partners
As shown in Figure 5.15.C. PrimPols RBM-B displays a high level of homology with the 
previously identified And-1/Ctf4-interacting motifs of Pol  and the Sld5 subunit of GINS
(Simon et al., 2014). Ctf4 forms a homotrimer which has been suggested to tether Pol  
to the CMG complex, however in reconstitution experiments Pol  functioned 
distributively in the presence of Ctf4 (Yeeles et al., 2017). Alternatively, it has also been 
suggested that Pol  is tethered to the replication fork by shared interactions with FACT 
and nucleosomes, rather than by Ctf4 (Kurat et al., 2017). Nevertheless, the similarity 
between RBM-B and the Ctf4 interacting motif of Pol , coupled with the dispensability 
of RBM-B in binding RPA in vivo, raise the possibility that RBM-B instead interacts with 
Ctf4 during replication. In this section, efforts to identify additional PrimPol interacting 
partners, including Ctf4, will be described. These investigations have focused on 
identifying binding partners through co-immunoprecipitation and MS analysis with 
western blot validation, using a number of FLAG-tagged PrimPol constructs. 
5.6.2.1. Materials and Methods 
5.6.2.1.1. Co-Immunoprecipitation and MS Analysis 
Large-scale immunoprecipitation experiments for MS analysis were performed using 
HEK293 Flp-In T-REx cells engineered for inducible expression of FLAG-PrimPol (WT, 
480-560, and full-length (FL) RBM-B-K.O.). The methodology used was identical to that 
described in section 5.3.10. except five 175 cm2 flasks of confluent HEK293 cells, grown 
in the presence or absence of 10 ng/mL of doxycycline for 24 hrs, were used. Following 
immunoprecipitation, elutions were pooled and processed in-solution for MS. Samples 
were concentrated to 40 µL and supplemented with 160 µL of 8 M urea, 100 mM Tris, 
10 mM CaCl2, and 5mM DTT, before incubation at 37°C for 1 hr. Following incubation, 
16 µL of 200 mM iodoactemide (final concentration 15 mM) was added and samples 
incubated for a further 20 mins in the dark at room temperature. Samples were then 
diluted 7x using 100 mM Tris and 10 mM CaCl2. Digestion was performed using 3 µg of 
sequencing grade modified trypsin (Promega) at 37°C overnight. Subsequently, samples 
were concentrated to 100 µL using a SpeedVac concentrator and pH adjusted using 
trifluoroacetic acid to a final concentration of 1%. Samples were then desalted using 
Pierce C18 tips (ThermoFisher) according to the manufacturers protocol before 
concentrating to 10 µL using a SpeedVac. 
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Prepared samples were analysed by MS using a nano-LC-MS (ThermoFisher U3000 
nanoLC and Orbitrap XL mass spectrometer) (performed by Dr. Peter Kolesar) as 
previously described (Hatimy et al., 2015). Data were analysed and quantified by 
MaxQuant using standard settings to determine label-free quantification (LFQ) 
intensities. Four independent FLAG-PrimPol480-560 experiments were performed, whilst 
the results presented for WT and FL B-RA are each from a single analysis. For 
experiments using HU, cells were treated for 3 hrs with 1 mM HU prior to harvesting. 
Small-scale immunoprecipitation and western blot experiments were performed as 
described in section 5.3.10.
5.6.2.1.2. Isolation of Mitochondria from HEK293 Cells 
HEK293 Flp-In T-REx cells engineered for inducible expression of FL WT and RBM-A-
K.O. FLAG-PrimPol were induced with 10 ng/mL doxycycline 24 hrs prior to harvesting. 
Mitochondria were isolated using a mitochondria isolation kit (ThermoFisher) following 
the manufacturers instructions. Nuclear and cytoplasmic samples were kept and 
analysed alongside isolated mitochondria by western blot using anti-FLAG, anti-RPA2, 
and anti-mtSSB antibodies. 
5.6.2.2. MS Analysis of PrimPol CTD Interacting Partners
In order to identify additional PrimPol CTD interacting partners, potentially including
Ctf4/And1, large-scale co-immunoprecipitation and MS experiments were performed 
using HEK293 cells engineered for inducible expression of N-terminal FLAG-tagged 
PrimPol480-560. Previous pull-down and MS screens of PrimPol interacting partners used 
C-terminal Strep-tagged full-length PrimPol (Rudd, 2013). Importantly, as RBM-B is 
located at the C-terminus of PrimPol, tagging of the enzyme at this region may prevent 
binding of RBM-B interacting partners. Use of FLAG-PrimPol480-560 has the additional 
benefit of removing the DNA-binding AEP and ZnF domains, potentially helping to reduce 
background from DNA bridging between proteins. Despite lacking the functional domains 
required for activity, Figure 5.12.B. demonstrates that PrimPol480-560 is still recruited to 
chromatin, validating its use in these studies. 
A summary of the results of four independent FLAG-PrimPol480-560 co-
immunoprecipitations are highlighted in Table 5.3. In addition to all three RPA subunits, 
mtSSB was enriched 2.2-fold in induced cells, over those grown without doxycycline. 
This suggests that mtSSB, like RPA, interacts with the CTD of PrimPol. Aside from these 
previously identified binding partners, a number of potential novel PrimPol-interacting 
partners, involved in DNA replication and repair, were identified. Perhaps most significant
was the 104-fold enrichment of DNA ligase 3 (LIG3) and 13-fold enrichment of PARP1
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Table 5.3. Mass spectrometry analysis of PrimPol480-560 co-immunoprecipitation experiment elutions.
The results presented are a summary of four independent co-immunoprecipitation analyses. Label-free quantification (LFQ) intensities were determined by 
MaxQuant and represent the means of the four analyses. For proteins identified in both + Dox and  Dox samples, the fold enrichment was calculated by 
dividing LFQ + Dox intensities by LFQ  Dox intensities. 
Protein 
Name
LFQ 
+Dox
LFQ
-Dox
Fold 
Enrichment
Only in
+Dox
In all 
expts. Functional Group
LIG3 2.38 x 109 2.28 x 107 104.4 N N DNA Repair
BANF1 1.06 x 109 6.81 x 107 15.6 N Y DDR
PARP1 1.36 x 1010 1.03 x 109 13.2 N Y DNA Repair
Histone H2A 4.37 x 108 6.03 x 107 7.2 N Y Chromatin Component
RPA14 1.70 x 109 3.20 x 108 5 N Y DNA Replication
RPA70 3.37 x 1010 7.6 x 109 4.4 N Y DNA Replication
FACT subunit 
SSRP1 2.42 x 10
8 5.55 x 107 4.4 N N Chromatin Processing
RPA32 1.00 x 1010 2.82 x 109 3.6 N Y DNA Replication
mtSSB 2.67 x 109 1.20 x 109 2.2 N Y mtDNA Replication
DNA-PKcs 8.62 x 108 0 N/A Y N DNA Repair
XRCC1 6.50 x 108 0 N/A Y N DNA Repair
Histone H2B 1.93 x 108 0 N/A Y N Chromatin Component
XRCC5 1.08 x 108 0 N/A Y Y DNA Repair
Histone H4 6.95 x 107 0 N/A Y N Chromatin Component
PCNA 4.20 x 107 0 N/A Y N DNA Replication
RuvB-like 2 3.20 x 107 0 N/A Y N Chromatin Remodelling
XRCC6 3.07 x 107 0 N/A Y Y DNA Repair
APTX 2.72 x 107 0 N/A Y N DNA Repair
PrimPol 2.66 x 107 0 N/A Y Y DNA Replication / DDT
PNKP 2.06 x 107 0 N/A Y N DNA Repair
hNRP 1.73 x 107 0 N/A Y N Chromatin Formation
DDB1 1.47 x 107 0 N/A Y N DNA Repair
PARP2 3.30 x 106 0 N/A Y N DNA Repair
RBBP4 2.58 x 106 0 N/A Y N Chromatin Remodelling
TFAM 2.51 x 106 0 N/A Y N mtDNA Replication
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in samples from induced cells. Likewise, DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs), Bifunctional polynucleotide/kinase (PNKP), Aprataxin (APTX), DNA 
damage-binding protein 1 (DDB1), PARP2, and X-ray repair cross-complementing 
protein (XRCC) 1, 5, and 6, were all only identified from cells expressing PrimPol480-560. 
All of these proteins play a role in DNA repair, specifically XRCC5/6, DNA-PKcs, and 
APTX are involved in NHEJ, whilst PARP1, XRCC1, and LIG3, are thought to function in 
MMEJ (Ceccaldi et al., 2016). PNKP assists in each pathway by processing DNA termini 
for extension or ligation, while DDB1 functions in the recognition of DNA damage and 
PARP2 is implicated in a number of DNA repair processes including BER/SSBR and 
NHEJ. Given the role of AEPs in prokaryotic DSBR, it is an alluring possibility that 
PrimPol plays an analogous role in eukaryotes. Indeed, in section 4.3. it was observed 
that PrimPol displays a degree of catalytic versatility which might lend itself to such a 
process. However, many of the DNA repair proteins identified here have previously been 
found in pull-down and MS studies of RPA, these include PARP1, LIG3, DNA-PKcs, 
XRCC1, XRCC5/6, PNKP, and DDB1 (Maréchal et al., 2014). In light of this, it seems 
likely that these interactions are simply mediated by RPA, rather than a direct interaction 
with PrimPol. Likewise, to date, no in vivo studies support a role for PrimPol in either 
NHEJ or MMEJ. Nevertheless, PARP1, DNA-PKcs, and XRCC1, have recently been 
implicated in the restart of stalled replication forks, suggesting that PrimPol could 
coordinate with these proteins in a novel restart pathway, rather than a DSBR process 
(Ying et al., 2016).
In addition to the DNA repair proteins described above, the co-immunoprecipitation 
studies of FLAG-PrimPol480-560 also identified a number of chromatin constituents and 
remodeling factors including, FACT subunit SSRP1, Histone H2A, H2B, and H4, RuvB-
like 2, Nucleosome assembly protein 1-like 1 (hNRP), and Histone-binding protein 
RBBP4 (Table 5.3.). This observation is intriguing given that functional interactions 
between FACT, Pol , and nucleosomes, have recently been suggested to regulate 
priming of Okazaki fragments during lagging strand synthesis (Kurat et al., 2017). 
Similarly, TFAM, which has roles in both DNA packaging and replication in the 
mitochondria was also identified. However, further work is required to assess the affect 
of chromatin and DNA packaging factors on priming by PrimPol.
Notably, although known interacting partners including RPA and mtSSB were identified 
in these studies, Ctf4/AND1 was not detected in any of the analyses. This suggests that 
RBM-B is not involved in binding to Ctf4 in vivo, further supporting the previous 
suggestion that it instead functions to bind a second RPA molecule following recruitment 
by RBM-A. 
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5.6.2.3. mtSSB, but not AND-1, Co-Purifies with PrimPols CTD
A rather surprising observation from the MS analyses presented in Table 5.3. was the 
detection of PCNA only in samples from induced cells. This is at odds with the previously 
described Strep-PrimPol pull-down MS analysis which failed to identify PCNA as an 
interacting partner (section 2.4.2.). In order to further investigate this and confirm the 
observed interaction with mtSSB, western blot analysis of elutions from
immunoprecipitation of FL WT, RBM-A-K.O., RBM-B-K.O. and RBM-A+B-K.O. FLAG-
PrimPol, in addition to PrimPol480-560 (CTD), was performed (Figure 5.17.).
Here, analysis of WT FLAG-PrimPol elutions with anti-PCNA, identified the protein in 
both + and  Dox samples at similar levels, despite the absence of any detectable 
PrimPol in  Dox elutions (Figure 5.17.A.). This suggests that PCNA binds to the anti-
FLAG antibodies used in the immunoprecipitation studies, supporting previous 
observations that the protein does not interact with PrimPol. Blots were also analysed 
with anti-AND1. Consistent, with the MS results shown in Table 5.3., AND-1 was not 
detectable in any elutions from the PrimPol variants used, further suggesting that the 
proteins do not share an interaction in vivo (Figure 5.17.A-E.). 
In contrast, mtSSB was indentified in elutions from both WT and PrimPol480-560-
expressing cells and did not appear in elutions from uninduced cells (Figure 5.17.A. and 
B.). Moreover, mtSSB did not co-elute with PrimPol when RBM-A alone, or in 
combination with RBM-B, was mutated (Figure 5.17.C. and E.). When RBM-B was 
mutated alone, mtSSB binding was significantly reduced, however the protein was 
detectable when using longer exposure times (Figure 5.17.D.). This is very similar to the 
results observed with RPA in Figure 5.10., potentially revealing that the mtSSB 
interaction, like the RPA interaction, is mediated by PrimPols RBM-A, with a secondary 
contribution from RBM-B. This would not be surprising given the analogous function of 
mtSSB in the mitochondria. However, unlike RPA, we have failed to identify an 
interaction between PrimPol and mtSSB in SEC analysis (data not shown). Similarly,
mtSSB does not stimulate the primase activity of PrimPol in vitro (Figure 5.18.A.). These
results are also consistent with the mtSSB-interaction potentially being mediated by RPA
and/or ssDNA upon cell lysis during pull-down studies. Nevertheless, it is likely that 
mitochondrially-localised PrimPol is modified in comparison to nuclear PrimPol and 
these modifications may be required to observe an interaction in vitro. One possibility is 
that an intact RBM-A is required for localisation of PrimPol to the mitochondria. To test 
this, mitochondria were isolated from WT FLAG-PrimPol and A-RA FLAG-PrimPol 
expressing HEK293 cells and analysed by western blot (Figure 5.18.B.). Here, there was 
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Figure 5.17. mtSSB co-purifies with PrimPol480-560.
(A-E) Flp-In T-Rex-293 cells transfected with FLAG-tagged wild-type (WT) (A), 480-560 (CTD) (B), RBM-A-K.O. (C), RBM-B-K.O. (D), and RBM-A+B-K.O. 
(E) PrimPol were grown in the presence or absence of doxycycline (10 ngmL-1, 24 hrs), FLAG-PrimPol was immunoprecipitated from the soluble cell lysate 
using anti-FLAG antibodies and western blotted for PrimPol (anti-FLAG), mtSSB (anti-mtSSB), AND1 (anti-AND1) and PCNA (anti-PCNA, A only). The 
presence and absence of doxycycline is indicated by +/- Dox, In indicates the input, E1, E2, and E3, indicate elutions 1, 2, and 3, respectively.
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Figure 5.18. mtSSB does not stimulate PrimPols primase activity in vitro and is not required for localisation of PrimPol to mitochondria in vivo. 
(A) Primer synthesis by WT hPrimPol (400 nM) on M13 ssDNA templates (20 ng
L-1) in the presence of increasing concentrations of mtSSB (0.0625, 0.125, 
0.25, 0.5, 1, 2, 4, and 8 µM). Reactions containing PrimPol only are indicated by no SSB, a positive control containing 1 µM RPA in place of mtSSB is 
indicated by + RPA. C indicates the no enzyme control, oligonucleotide (Nt) length markers are shown on the left of the gel. (B) Flp-In T-Rex-293 cells 
transfected with FLAG-tagged wild-type (WT) and RBM-A-K.O. PrimPol were grown in the presence of doxycycline (10 ngmL-1, 24 hrs) prior to isolation of 
mitochondria. Nuclear (Nuc.), cytoplasmic (Cyto.) and mitochondrial (Mito.) samples were retained and analysed by western blot using anti-FLAG, anti-RPA2, 
and anti-mtSSB antibodies. Enrichment of mtSSB but not RPA in Mito. samples confirms the appropriate isolation of mitochondria. 
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no observable difference in the level of PrimPol in the mitochondria following mutation of 
RBM-A. This demonstrates that RBM-A is not required for localisation of PrimPol to the 
mitochondria. 
5.6.2.4. MS Analysis of Full-length PrimPol Interacting Partners 
In order to identify if the potential CTD-interacting partners observed in the MS analysis 
are relevant in the context of the full-length protein, co-immunoprecipitation and MS 
studies were repeated using WT FLAG-PrimPol-expressing HEK293 cells (Table 5.4.). 
PrimPol has previously been shown to form foci in HEK293 cells in response to HU 
treatment (Bianchi et al., 2013). To identify potential new interactions induced upon fork 
stalling, analysis was also performed on cells treated with HU for 3 hrs (Table 5.5.). 
Additionally, analysis using cells expressing full-length RBM-B-K.O. PrimPol was also 
performed to identify any differences in comparison to the WT (Table 5.6.).
In each case RPA and mtSSB were only identified in elutions from induced cells (Table 
5.4., 5.5. and 5.6.). This is in agreement with the results observed in Figure 5.10. and 
5.17. showing that RBM-B, unlike RBM-A, is not critical for PrimPols interaction with 
RPA or mtSSB in vivo. Analysis of elutions from WT FLAG-PrimPol cells treated with 
HU, and untreated RBM-B-K.O. FLAG-PrimPol cells, also identified a number of repair 
factors found in the CTD analyses, these include PARP1, XRCC6, DNA-PKcs, and LIG3
(Table 5.5. and 5.6.). Likewise a number of chromatin constituents and remodeling 
factors were identified in all three full-length PrimPol analyses, including hNRP, Histone 
H2A and H2B, and RuvB-like 1 and 2 (Table 5.4., 5.5. and 5.6.). Although FACT was not 
detected in any of the elutions. 
Aside from factors already identified in the CTD analyses, a number of extra proteins 
were identified when using full-length PrimPol, including MCM 4, 6, and 7, and CDK1, 
suggesting that any potential interaction with these proteins is not mediated by the CTD
(Table 5.4., 5.5. and 5.6.). Following treatment of WT FLAG-PrimPol cells with HU,
additional proteins were detected, such as High mobility group protein (HMG) B1 and 
B2, and MMR protein MSH2 (Table 5.5.). Further work is required to confirm or negate 
these potential interacting partners. 
5.6.2.4. Western Blot Analysis of Full-length PrimPol Interacting Partners 
In order to validate some of the interactions observed in the MS analysis, small scale 
immunoprecipitations of full-length WT, RBM-A-K.O., RBM-B-K.O. and RBM-A+B-K.O. 
PrimPol, in addition to PrimPol480-560 (CTD), were performed and analysed by western 
blot using anti-PARP1, anti-XRCC1, and anti-MCM4 antibodies (Figure 5.19.). PARP1
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Table 5.4. Mass spectrometry analysis of WT PrimPol co-immunoprecipitation experiment elutions.
Label-free quantification (LFQ) intensities were determined by MaxQuant. For proteins identified in both + Dox and  Dox samples, the fold enrichment was 
calculated by dividing LFQ + Dox intensities by LFQ  Dox intensities. 
Protein 
Name
LFQ
+Dox
LFQ
-Dox
Fold 
Enrichment
Only in
+Dox Functional Group
PrimPol 1.05 x 109 1.19 x 107 88 N DNA Replication / DDR
XRN1 2.16 x 107 0 N/A Y RNA/DNA Processing
RPA70 1.38 x 107 0 N/A Y DNA Replication
mtSSB 1.18 x 107 0 N/A Y mtDNA Replication
MCM4 1.01 x 107 0 N/A Y DNA Replication
RuvB-like 1 7.37 x 106 0 N/A Y Chromatin Remodelling
MCM7 7.31 x 106 0 N/A Y Replication
RuvB-like 2 6.54 x 106 0 N/A Y Chromatin Remodelling
hNRP 5.93 x 106 0 N/A Y Chromatin Formation
RPA14 4.95 x 106 0 N/A Y DNA Replication
RPA32 4.90 x 106 0 N/A Y DNA Replication
MCM6 2.56 x 106 0 N/A Y DNA Replication
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Table 5.5. Mass spectrometry analysis of WT PrimPol co-immunoprecipitation experiment elutions following hydroxyurea treatment.
Cells were treated with 1 mM HU for 3 hrs prior to harvesting and immunoprecipitation. Label-free quantification (LFQ) intensities were determined by 
MaxQuant. For proteins identified in both + Dox and  Dox samples, the fold enrichment was calculated by dividing LFQ + Dox intensities by LFQ  Dox 
intensities. 
Protein 
Name
LFQ
+Dox
LFQ
-Dox
Fold 
Enrichment
Only in
+Dox Functional Group
PrimPol 5.46 x 108 1.15 x 107 48 N DNA Replication / DDT
PARP1 1.68 x 107 5.44 x 106 3 N DNA Repair
MCM7 1.07 x 107 0 N/A Y DNA Replication
mtSSB 7.17 x 106 0 N/A Y mtDNA Replication
RPA14 6.14 x 106 0 N/A Y DNA Replication
XRCC6 6.03 x 106 0 N/A Y DNA Repair
HMGB2 5.30 x 106 0 N/A Y DNA Replication / Repair
RuvB-like 1 5.12 x 106 0 N/A Y Chromatin Remodelling
Histone H2A 5.05 x 106 0 N/A Y Chromatin Constituent
HMGB1 5.04 x 106 0 N/A Y DNA Replication / Repair
Histone H2B 4.76 x 106 0 N/A Y Chromatin Constituent
RPA70 4.39 x 106 0 N/A Y DNA Replication
PCNA 2.47 x 106 0 N/A Y DNA Replication
CDK1 8.25 x 105 0 N/A Y Cell-Cycle Regulation
DNA-PKcs 4.93 x 105 0 N/A Y DNA Repair
MSH2 2.94 x 105 0 N/A Y DNA Repair
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Table 5.6. Mass spectrometry analysis of full-length RBM-B-K.O. PrimPol co-immunoprecipitation experiment elutions.
Label-free quantification (LFQ) intensities were determined by MaxQuant. For proteins identified in both + Dox and  Dox samples, the fold 
enrichment was calculated by dividing LFQ + Dox intensities by LFQ  Dox intensities. 
Protein 
Name
LFQ
+Dox
LFQ
-Dox
Fold 
Enrichment
Only in
+Dox Functional Group
PrimPol 5.90 x 108 4.08 x 106 145 N DNA Replication / DDT
PARP1 3.00 x 107 1.49 x 107 2 N DNA Repair
XRCC6 7.04 x 106 5.38 x 106 1.3 N DNA Repair
RPA70 3.00 x 107 0 N/A Y DNA Replication
RPA32 1.32 x 107 0 N/A Y DNA Replication
RPA14 9.47 x 106 0 N/A Y DNA Replication
MCM7 8.33 x 106 0 N/A Y DNA Replication
BANF1 7.11 x 106 0 N/A Y DDR
mtSSB 7.05 x 106 0 N/A Y mtDNA Replication
Histone H2A 4.20 x 106 0 N/A Y Chromatin Constituent
LIG3 1.56 x 106 0 N/A Y DNA Repair
CDK1 7.36 x 105 0 N/A Y Cell-Cycle Regulation 
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Figure 5.19. Western blot analysis of PARP1, MCM4, and XRCC1 interactions. 
(A-E) Flp-In T-Rex-293 cells transfected with FLAG-tagged wild-type (WT) (A), RBM-A-K.O. (B), RBM-B-K.O. (C), RBM-A+B-K.O. (D), and 480-560 (CTD) 
(E) PrimPol, were grown in the presence or absence of doxycycline (10 ngmL-1, 24 hrs), FLAG-PrimPol was immunoprecipitated from the soluble cell lysate 
using anti-FLAG antibodies and western blotted for PrimPol (anti-FLAG), PARP1 (anti-PARP1), MCM4 (anti-MCM4) and XRCC1 (anti-XRCC1). The presence 
and absence of doxycycline is indicated by +/- Dox, In indicates the input, E indicates elution.
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was enriched in elutions from WT and CTD expressing cells (Figure 5.19.A. and E). 
However, this interaction was significantly reduced upon mutation of RBM-A or RBM-B 
in isolation and together (Figure 5.19.B-D.). Although notably, PARP1 was enriched 2-
fold in the MS analysis of RBM-K.O. elutions (Table 5.6.). Likewise, XRCC1 was 
detected in CTD and WT elutions, but was lost upon mutation of either RBM.  Analysis 
using anti-MCM4 identified the protein in both + and  Dox elutions, suggesting that MCM 
like PCNA, may bind the anti-FLAG beads used for the experiment. However, there was 
a slight enrichment of the protein in + Dox elutions of the FL PrimPol constructs (Figure 
5.19.A-D.), which was not observed in the CTD samples (Figure 5.19.E.). This is 
potentially consistent with the MS results which identified MCM subunits in the FL 
PrimPol, but not CTD, elutions. Further work is required to examine if this is a genuine 
interaction. 
These results give further credence to the possibility that many of the interactions 
identified in these analyses are mediated by RPA. Given that mutation of RBM-A 
prevents recruitment of PrimPol to chromatin and a loss of the RPA-interaction, it is 
difficult to distinguish if potential interactions with other partners are lost due to PrimPol
not being recruited to chromatin, or because the interactions are mediated by RPA. The 
observation that many of the factors identified in the MS analyses have also been 
identified in RPA pull-down studies, suggests that the latter is more likely (Maréchal et 
al., 2014). Nevertheless, interactions mediated by RPA might still be functionally relevant 
in vivo by localising PrimPol to other DNA replication and repair factors. Importantly, the 
interaction studies presented here are in the preliminary stages and further work is 
required to rule out or confirm a direct interaction between PrimPol and the identified 
proteins. However, the repeated observation that many of these interactions are lost 
upon mutation of PrimPols RBMs further highlights the importance of the RPA-
interaction for the enzymes role in vivo. The identification of RPA in all of the MS 
analyses strengthens the work presented earlier in this Chapter and supports RPA as 
the primary PrimPol-interacting partner. 
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Chapter 6
The Role, Recruitment, and Regulation 
of PrimPol During DNA Replication
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6.1. Abstract 
The complex molecular machines responsible for genome replication encounter many 
obstacles during their progression along DNA. Tolerance of these obstructions is critical 
for efficient and timely genome duplication. In recent years, PrimPol has emerged as a 
new player involved in maintaining eukaryotic replication fork progression. This versatile 
replicative enzyme, a member of the AEP superfamily, has the capacity to perform a 
range of template-dependent and independent synthesis activities. However, 
accumulating evidence suggests that PrimPols primary role is to reprime and restart 
DNA replication downstream of a range of replicase-stalling impediments. The following 
Chapter is a modified version of a review of the current PrimPol literature which was 
recently published in Genes (Guilliam and Doherty, 2017). Here, the insights into the 
role, recruitment, and regulation of PrimPol, garnered in part from the work presented in 
this thesis, are discussed in the context of the wider literature. This review provides an 
overview of the complete body of PrimPol studies performed to date, allowing new 
interpretations of some of the data presented in the preceding Chapters. In this respect, 
there is some repetition in the themes and topics presented, however this is necessary 
to consider the initial PrimPol reports in light of more recent studies. The review begins 
with an overview of the evolutionary history of PrimPol, before proceeding to discuss 
recent advances in our understanding of the enzymes role, recruitment, and regulation,
as well as highlighting unanswered questions and potential future avenues of 
investigation.
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6.2. The Discovery and Evolutionary History of PrimPol
As discussed in Chapter 1, the AEP superfamily is evolutionarily and structurally distinct 
from the bacterial DnaG-type primases which, like AEPs in archaea and eukarya, are 
absolutely required for DNA replication initiation in bacteria (Guilliam et al., 2015b). 
Nevertheless, DnaG-like primases are also present in archaea, and likewise, AEPs have 
been identified in bacteria (Aravind et al., 1998b). In each case, these enzymes have 
diverged to fulfil alternative roles, for example in bacteria a member of the AEP 
superfamily is employed, together with  Ku and DNA ligase homologues, in an NHEJ
DNA break repair pathway (Della et al., 2004; Koonin et al., 2000). It is likely that the 
presence of AEPs in bacteria is a result of HGT, with the enzymes originally being 
recruited for replication initiation by the archaeo-eukaryotic lineage following their 
divergence from bacteria (Guilliam et al., 2015b; Iyer et al., 2005). The catalytic core of 
AEPs is defined by two structural modules; an N-terminal module with an ()2 unit, and 
a C-terminal RRM-like fold. These two modules pack together, with the active site 
residues located in between them (Iyer et al., 2005).  
In 2005, detailed in silico analyses divided the AEP superfamily into 13 major families 
which were further organised into three higher order clades; the AEP proper clade, the 
NCLDV-herpesvirus primase clade, and the primpol clade (Iyer et al., 2005). These 
analyses also identified PrimPol and assigned it to the NCLDV-herpesvirus clade, whose 
members are only present in eukaryotes and their viruses. This clade encompasses the 
iridovirus primase and herpes-pox primase families, PrimPol belonging to the latter. 
Members of the herpes-pox primase family possess a conserved C-terminal -strand-
rich region, which replaces the PriCT domains of the iridovirus primase family (Iyer et al., 
2005). The NCLDV-herpesvirus primase clade is suggested to have originated from 
bacteriophage or bacterial proteins possessing a fused AEP and PriCT-2 domain. 
Herpes viruses likely acquired their primase from the NCLDV class, before replacing the 
C-terminal PriCT domain with the characteristic -strand-rich region (Iyer et al., 2005). 
PrimPol orthologues are conserved across vertebrates, plants, and primitive eukaryotes 
including species of fungi, algae, and protists, such as apicomplexans and the slime 
mold Dictyostelium. PrimPol is, however, notably absent from prokaryotes and a number 
of fungi and animal species, including Caenorhabditis elegans and Drosophila (Bianchi 
et al., 2013; García-Gómez et al., 2013; Iyer et al., 2005). This interrupted distribution of 
PrimPol, coupled with the diversity of AEPs observed in mobile elements, such as 
viruses and plasmids (Guilliam et al., 2015b), suggests that PrimPol was originally 
obtained through HGT by an early eukaryote and then lost on multiple separate 
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occasions. Importantly, PrimPol is not closely related to the eukaryotic replicative DNA 
primase small subunit, Prim1, a member of the AEP-proper clade, and is dispensable for 
DNA replication in higher eukaryotes (Bianchi et al., 2013; Iyer et al., 2005). It has been 
speculated that PrimPol may have originated as a DNA repair enzyme in NCLDVs, 
potentially required due to their large genome size and lack of access to cellular DNA 
repair enzymes during replication (Iyer et al., 2005). Likewise, PrimPol may have played 
a role in DNA replication initiation in these viruses. 
6.3. What can PrimPol do? The Domain Architecture and 
Catalytic Activities of PrimPol 
Since the initial identification of PrimPol in 2005 (Iyer et al., 2005), a number of groups 
have purified and characterised the recombinant protein, permitting insight into the 
architectural and biochemical properties of the enzyme (Bianchi et al., 2013; García-
Gómez et al., 2013; Wan et al., 2013). These studies revealed PrimPols impressive 
range of nucleotidyl transferase activities, suggesting a number of potential roles in vivo. 
In this section, we will describe these activities and the domain architecture of the protein, 
which underpins its catalytic flexibility (summarised in Figure 6.1.).
6.3.1. Domain Architecture and Structure 
Previously, an alignment of PrimPol homologues identified 14 conserved regions within 
the protein, including three characteristic AEP catalytic motifs (motifs I, II, and III) towards 
the N-terminus, forming the AEP domain (Iyer et al., 2005). Interestingly, motif I displays 
the variant DxE, rather than the typical DxD motif possessed by most AEPs. Motif I and 
motif III (xD) together form the divalent metal ion binding site and are essential for the 
catalytic activity of the enzyme. Motif II (SxH) was predicted to form part of the nucleotide 
binding site, and is again required for all catalytic activity (Bianchi et al., 2013; García-
Gómez et al., 2013; Keen et al., 2014b; Rudd et al., 2013). Recently, the crystal structure 
of the AEP domain of PrimPol (residues 1-354) in ternary complex with a DNA template-
primer and incoming nucleotide was solved, confirming the existence and role of these 
motifs and two additional motifs, Ia (RQ) and Ib (QRhY/F), which interact with the 
template DNA strand (Rechkoblit et al., 2016). The structure reveals that PrimPols 
catalytic core encloses the 3-end of the primer with two / modules, ModN and ModC, 
lining the cavity. ModN primarily interacts with the template strand, whilst ModC contains 
the catalytic residues and interacts with the incoming nucleotide, as well as the template 
strand. Intriguingly, the structure of PrimPols AEP domain does not resemble a typical 
polymerase fold in any way. There is no thumb domain to hold the primer-template, in 
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Translesion Synthesis
Pseudo-TLS
 Can use both NTPs and dNTPs
 Prefers dNTPs
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 Dependent on ZnF
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 Incorporates ~ 4 nt per binding 
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Figure 6.1. Domain architecture and catalytic activities of PrimPol.
The domain architecture of PrimPol is depicted in the top panel. A helix (purple) located at the 
N-terminus is connected to ModN by a flexible linker and contacts the DNA major groove. 
ModN (blue) and ModC (orange) comprise the archaeo-eukaryotic primase (AEP) domain and 
contain motifs Ia, Ib, I, II, and III, required for template binding and catalytic activity. The zinc 
finger (ZnF) (green) contains three conserved cysteines and a histidine which coordinate a 
zinc ion and are required for primase, but not polymerase, activity. The RPA binding domain 
(RBD) (red) containing RPA binding motif-A (RBM-A) and RBM-B (grey) is located at the C-
terminus. A 100 amino acid (aa) scale bar is shown to the right. The catalytic activities of 
PrimPol are displayed below.
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fact the primer DNA strand almost completely lacks protein contacts, and ModC was 
shown to function as both the finger and palm domains (Rechkoblit et al., 2016). 
PrimPols second conserved domain, the C-terminal UL52-like ZnF contains three 
conserved cysteines and a histidine, as is typical for herpes-pox primase family members 
(Iyer et al., 2005). The first conserved cysteine and histidine residues of this domain 
coordinate a zinc ion and are critical for the primase, but not polymerase, activity of the 
enzyme (Keen et al., 2014b; Mourón et al., 2013). 
6.3.2. Primase Activity
As predicted by the initial in silico identification, PrimPol is an active primase, able to 
utilise both NTPs and dNTPs for primer synthesis, a unique ability amongst eukaryotic 
enzymes (Bianchi et al., 2013; García-Gómez et al., 2013; Wan et al., 2013). 
Surprisingly, PrimPol actually displays a preference for dNTPs over NTPs during primer 
synthesis, a feature more typically associated with archaeal primases (Bianchi et al., 
2013). This primase activity is dependent upon an intact ZnF domain, which is consistent 
with previous studies on the Herpes Simplex Virus Type 1 (HSV1) helicase/primase 
complex. Here, primase activity was lost when key residues in the UL52 zinc-binding 
domain were mutated (Biswas and Weller, 1999; Chen et al., 2005). Interestingly, the 
ZnF domain of PrimPol has been shown to bind ssDNA but not dsDNA, suggesting that 
this module may be important for stabilising PrimPol on ssDNA templates to allow 
synthesis of the initial dinucleotide (Keen et al., 2014b). The ability of PrimPol to 
synthesise DNA primers de novo gives it the potential to reprime and restart replication 
downstream of DNA damage lesions and fork-stalling obstacles in vivo.
6.3.3. Polymerase and Lesion Bypass Activities 
In addition to its DNA and RNA primase activity, PrimPol is also a template-dependent 
DNA polymerase, with an ability to bypass a number of DNA damage lesions. Notably, 
PrimPol can bypass both oxidative and UV-induced lesions, including 8-oxo-dG, and 6-
4PPs (Bianchi et al., 2013; García-Gómez et al., 2013). A recent study analysing the 
kinetics of 8-oxo-dG bypass by PrimPol found that the enzyme incorporates dC (error 
free) opposite the lesion with 6-fold higher efficiency than dA (error prone). Incorporation 
of dC opposite 8-oxo-dG occurred at ~25% efficiency compared to an unmodified 
templating dG, suggesting that PrimPol has the potential to function as an efficient TLS 
polymerase in vivo (Zafar et al., 2014). However, the accuracy of bypass differs in other 
reports, in some instances being only 50% error-free (Bianchi et al., 2013; Guilliam et 
al., 2016; Keen et al., 2014b; Stojkovi et al., 2016). In the case of 6-4PPs, PrimPol 
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bypasses the lesion in an error-prone manner (Bianchi et al., 2013). Although unable to 
directly traverse a CPD, PrimPol can extend from mis-matched bases opposite a CPD 
(Bianchi et al., 2013). Additionally, a truncated form of PrimPol, lacking the ZnF domain, 
can facilitate TLS past a CPD (Keen et al., 2014b). In contrast, in the presence of 
manganese, PrimPols TLS activity is altered allowing the full-length enzyme to extend 
past CPDs and Ap sites, in addition to 6-4PPs and 8-oxo-dG lesions (Mourón et al., 
2013). However, the usage of either magnesium or manganese as the primary cofactor 
for PrimPol in vivo remains unclear. 
6.3.4. Lesion Skipping and Template Independent Extension 
Despite displaying the ability to directly read through some damaged nucleobases, such 
as 8-oxo-dG, it appears that PrimPols bypass of more bulky or distorting lesions is 
facilitated through a pseudo-TLS mechanism. Here, PrimPol is able to re-anneal the 
primer to a new position downstream of the lesion prior to extension, thus looping out 
the templating lesion and generating a shorter extension product than would be produced 
from strict template-dependent extension (García-Gómez et al., 2013; Martínez-Jiménez 
et al., 2015; Mourón et al., 2013). This activity is enhanced in the presence of 
manganese, permitting bypass of 6-4PPs, CPDs, and Ap sites by pseudo-TLS (García-
Gómez et al., 2013; Mourón et al., 2013). Intriguingly, this characteristic is reminiscent 
of the Ap site bypass strategy employed by PolDom (Pitcher et al., 2007; Yakovleva and 
Shuman, 2006). The ability of manganese to stimulate primer-realignment and template 
scrunching by PrimPol offers a clear explanation for the altered TLS ability of the enzyme 
in the presence of this metal ion. It has also been reported that manganese increases 
both PrimPols polymerase activity and affinity for DNA, when compared to magnesium 
(Zafar et al., 2014). 
Notably however, manganese also promotes promiscuous template-independent 
extension by PrimPol, resulting in the generation of non-complementary homopolymeric 
strands (Keen et al., 2014b). The mutagenic effect of manganese on polymerase activity, 
through increased reactivity and promotion of non-template-directed nucleotidyl transfer, 
has been clear for several decades (El-Deiry et al., 1984; Goodman et al., 1983; Pelletier 
et al., 1996; Vaisman et al., 2005; Wang et al., 1977). Moreover, the bypass of lesions 
via template scrunching is potentially more detrimental than beneficial to genomic 
integrity, due to the high risk of generating frame-shift mutations. Therefore, it seems 
likely that more low-risk mechanisms would be employed in vivo where available. 
The lower affinity of PrimPol for DNA and incoming nucleotides in the presence of 
magnesium is often taken as support for manganese as the enzymes primary metal ion 
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cofactor in vivo (Zafar et al., 2014). However, PrimPols inherent low affinity for DNA and 
dNTPs, when using magnesium as a cofactor, may actually act as an important 
mechanism to regulate its activity. In support of this, it has previously been shown that 
dNTP levels in yeast are increased 6-8 fold in the presence of DNA damage (Chabes et 
al., 2003). Importantly, TLS polymerases often require ~10 times greater dNTP 
concentrations for nucleotide binding opposite a lesion, compared to a replicative 
polymerase at an undamaged site (Minko et al., 2003; Shimizu et al., 2002). Increased 
intracellular dNTP concentrations have been found to correlate with an increase in 
damage tolerance, but also increased mutation rates, potentially due to the unregulated 
participation of TLS polymerases in normal replication (Chabes et al., 2003). Thus, in 
yeast it appears that the in vivo activity of TLS polymerases is partly regulated by dNTP 
levels, which increase after DNA damage, consequently restricting the contribution of 
these polymerases to normal DNA replication. Intriguingly, ribonucleotide reductase 
has been found to be up-regulated in response to DNA damage in all studied organisms, 
suggesting that increased dNTP synthesis in response to damage may be a conserved 
mechanism across all domains of life (Sabouri et al., 2008). Similarly, PrimPols relatively 
poor affinity for DNA may be overcome in vivo by association with other factors, such as 
RPA and PolDIP2, again acting to regulate the enzyme by only recruiting it to loci where 
it is actually required (Guilliam et al., 2015a, 2016, 2017; Wan et al., 2013). 
Additionally, it is not clear whether the relatively low intracellular concentrations of 
manganese (0.1 to 40 µM) (Ash and Schramm, 1982; Markesbery et al., 1984; Versieck 
and McCall, 1985), compared to magnesium (0.21 to 0.24 mM) (Gee II et al., 2001; 
Goldschmidt et al., 2006), are sufficient to support the manganese-dependent TLS 
activities of PrimPol in vivo. Indeed, PrimPol required manganese concentrations of 200-
1000 µM to facilitate pseudo-TLS bypass of an abasic site in vitro, whilst 100 µM did not 
permit any observable bypass (Martínez-Jiménez et al., 2015). Thus, the cellular 
relevance of these activities is not immediately clear. One intriguing possibility is that 
PrimPol utilises manganese in the mitochondria only (Zafar et al., 2014). Here, dNTP 
concentrations are lower than those in the cytosol, there is a dearth of TLS polymerases, 
manganese uptake is increased in response to oxidative stress, and the high copy 
number nature of mtDNA may allow more promiscuous lesion bypass mechanisms to be 
employed (Rampazzo et al., 2004; Zafar et al., 2014). Although, more recent in vitro 
reconstitution experiments argue against a TLS-like role for PrimPol in oxidative damage 
bypass during mitochondrial DNA replication (Stojkovi et al., 2016). 
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6.3.5. Fidelity, Mutagenic Signature, and Processivity
Typically, the price paid by polymerases for DNA damage tolerance is a significant 
decrease in both fidelity and processivity. Whilst the structural features of replicative 
polymerases confer extremely efficient and high fidelity DNA synthesis, TLS 
polymerases possess more spacious active sites, altered finger and thumb domains, and 
lack proofreading exonuclease capabilities. These characteristics permit bypass of bulky 
lesions, but result in greatly decreased fidelity and processivity on undamaged DNA 
templates (Sale et al., 2012). Likewise, the eukaryotic replicative primase exhibits poor 
fidelity compared to replicative polymerases (Cotterill et al., 1987; Sheaff and Kuchta, 
1994; Zhang and Grosse, 1990). Rather unsurprisingly, PrimPol, which combines both 
TLS and primase capabilities, exhibits high error rates of ~ 1 x 10-4, comparable with Y 
and X-family polymerases, in assays described in Chapter 2 (Guilliam et al., 2015a). 
Unlike these polymerases however, PrimPol generates indel errors at a much higher 
frequency than substitution mutations, which may be a result of its template scrunching 
ability (Guilliam et al., 2015a). Manganese acts to further decrease PrimPols fidelity on 
undamaged DNA and even more so on 8-oxo-dG containing templates (Zafar et al., 
2014). In addition to poor fidelity, PrimPol shares the characteristic of low processivity 
with canonical TLS polymerases, incorporating only 1-4 nucleotides per binding event 
(Keen et al., 2014b). Intriguingly, the enzymes processivity was found to be negatively 
regulated by its ZnF domain, which may act to stabilise DNA binding and allow primer 
synthesis, whilst additionally limiting primer extension. Removal of the ZnF domain has 
also been found to lower PrimPols fidelity, suggesting the domain acts to regulate 
processivity and fidelity, as well as enabling primase activity (Keen et al., 2014b). 
6.4. What does PrimPol do? The Role of PrimPol in DNA 
Replication
The biochemical classification of PrimPol as both an RNA/DNA primase and a TLS 
polymerase clearly suggests a role in DNA replication and damage tolerance. Moreover, 
these two characteristics give PrimPol the potential to assist the replisome in two 
different ways; through TLS or repriming. In this section, the in vivo characterisation of 
the enzyme, as well as the consequences of its deletion on the cell, are described. Using 
this information, recent advances in our understanding of the cellular roles of PrimPol, 
including work presented in the preceding chapters of this thesis, will be discussed. 
These emerging roles for the enzyme are outlined in Figure 6.2.).
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Figure 6.2. Repriming roles of PrimPol in nuclear DNA replication.
PrimPol is able to reprime and reinitiate leading strand replication downstream of a range of replicase stalling obstacles. Here, the ability of PrimPol to reprime 
downstream of DNA lesions, G4 secondary structures, and chain-terminating nucleotide analogues, is highlighted. Following repriming, replication can 
proceed and the resulting ssDNA gap is filled through TLS or template switching mechanisms, permitting subsequent repair or removal of the obstacle. Only 
the CMG complex, Pol , PrimPol, and RPA, are shown for simplicity. A key for identifying each factor is shown below.
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6.4.1. PrimPol  a DNA Damage Tolerance Enzyme
DDT is critical to support continued replisome progression in the presence of unrepaired 
DNA damage. An inability to tolerate this damage can lead to prolonged fork stalling, 
collapse and, ultimately, genome instability and/or cell death. The importance of DDT in 
preserving genomic integrity is highlighted by the consequences on human health of 
dysfunction in these mechanisms. An obvious example is the variant form of xeroderma 
pigmentosum (XPV). Here, mutation of Pol  causes increased sensitivity to sunlight and 
a predisposition to skin cancer (Sale et al., 2012). This is thought to occur due to 
mutagenic bypass of UV-induced CPDs by alternative TLS polymerases. 
Interestingly, loss of PrimPol in human XPV cells leads to a synergistic increase in UV 
sensitivity, with the enzyme performing a distinct role from Pol  during this process 
(Bianchi et al., 2013). In line with this, PrimPol forms sub-nuclear foci, and is recruited to 
chromatin, in response to UV irradiation (Bianchi et al., 2013; Mourón et al., 2013). Both 
human MRC5 and avian DT40 cells lacking PrimPol (PrimPol-/-) also accumulate an 
increased number of stalled forks, or a reduced ability to restart stalled forks, following 
UV damage (Bianchi et al., 2013; Guilliam et al., 2016; Mourón et al., 2013; Wan et al., 
2013). Unlike human cells, DT40 cells are hypersensitive to UV irradiation in the absence 
of PrimPol only, potentially due to the faster doubling times and increased S-phase 
population of these cells (Bianchi et al., 2013; Kobayashi et al., 2016). Interestingly, it 
has recently been shown that PrimPol-/- DT40 cells are even more sensitive to UV 
damage than previously appreciated (Bailey et al., 2016). In fact, these cells were found 
to be more sensitive than those lacking Pol  when analysed by colony formation assays. 
This effect was determined to be due to an extended G2 arrest, which prevented cell 
cycle progression, rather than an increase in apoptosis (Bailey et al., 2016). These 
reports clearly implicate PrimPol in the maintenance of replisome progression, or restart 
of stalled replication forks, in the presence of UV damage lesions. 
However, PrimPol is also involved in the tolerance of other types of DNA damage. As 
discussed in Chapter 4, PrimPol-/- DT40 cells are hypersensitivity to MMS, cisplatin, and 
HU (Kobayashi et al., 2016). Further deletion of Pols 	 and  in these cells leads to an 
additional increase in damage sensitivity to a similar extent as in wild-type cells, again 
indicating an independent role for PrimPol in DNA damage tolerance (Kobayashi et al., 
2016). PrimPol is also required for recovery of stalled replication forks following HU 
treatment in HeLa cells (Mourón et al., 2013; Wan et al., 2013). Notably, each of these 
DNA damaging agents acts to stall the progression of replication fork. In contrast, loss 
of PrimPol does not sensitise cells to ICRF193, camptothecin, or -rays, agents which 
262
lead to DNA strand breaks. This is suggestive of a broad role for the enzyme in damage 
tolerance, but not in break repair (Kobayashi et al., 2016). PrimPol associates with 
chromatin during G1 and S-phase and PrimPol-/- mouse embryonic fibroblasts (MEFs) 
present chromosome aberrations indicative of S-phase defects, which are enhanced 
after aphidicolin treatment (Bianchi et al., 2013; Mourón et al., 2013). Collectively, these 
findings place PrimPol at the replication fork during S-phase and indicate a role in the 
tolerance of replicase-stalling DNA damage.
6.4.2. PrimPol Reprimes and Restarts Stalled Replication Forks 
The DDT defects observed in the absence of PrimPol are potentially indicative of both a 
role as a TLS polymerase and a repriming enzyme. However, more recent reports clearly 
support the latter (Keen et al., 2014b; Kobayashi et al., 2016; Mourón et al., 2013; 
Pilzecker et al., 2016; Schiavone et al., 2016). Although PrimPol is described as a TLS 
polymerase, the spectrum of DNA damage types it can traverse by true TLS is actually 
rather limited. Discounting pseudo-TLS bypass, which may or may not be relevant in 
vivo, PrimPol is essentially only able to directly bypass 8-oxo-dG lesions (Bianchi et al., 
2013; García-Gómez et al., 2013; Keen et al., 2014b; Mourón et al., 2013). Moreover, a 
number of other polymerases are also able to efficiently and accurately bypass these 
lesions (Haracska et al., 2000; Maga et al., 2013; Zahn et al., 2011). If PrimPols primary 
role were as a TLS polymerase, this observation would be at odds with the range of 
replicase-stalling DNA damaging agents it is involved in tolerating (Kobayashi et al., 
2016). This implies that PrimPol most likely acts as a repriming enzyme for the tolerance 
of DNA damage and this is supported by the study of separation of function mutants 
(Keen et al., 2014b; Kobayashi et al., 2016; Mourón et al., 2013; Schiavone et al., 2016).
Mutation of PrimPols ZnF domain abolishes primase, but actually enhances polymerase
activity (Keen et al., 2014b; Mourón et al., 2013). This important observation has 
permitted investigation into the requirement of primase activity for the enzymes role in 
DNA replication. In each case, when PrimPol-/- cells are complemented with the primase-
deficient / polymerase-proficient ZnF mutant, it is unable to rescue any of the observed 
damage tolerance defects (Keen et al., 2014b; Kobayashi et al., 2016; Mourón et al., 
2013). In contrast, complementation with a primase-proficient / reduced-polymerase 
mutant of PrimPol restored DNA damage tolerance to wild-type levels (Keen et al., 
2014a; Kobayashi et al., 2016). In agreement with this, in Chapter 4 it was shown that 
PrimPol is able to facilitate close-coupled repriming downstream of lesions which it 
cannot bypass by TLS in vitro (Kobayashi et al., 2016). Aside from increased sensitivity 
to DNA damaging agents and decreased replication fork rates, PrimPol-/- and knockdown 
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cells exhibit persistent RPA foci and increased phosphorylation of Chk1 (Mourón et al., 
2013; Wan et al., 2013). Both of these stress response markers are indicative of the 
generation of ssDNA stretches (Choi et al., 2010; Lopes et al., 2006). This would be an 
expected consequence of a lack of repriming by PrimPol, resulting in the uncoupling of 
leading / lagging strand replication and excessive strand-specific unwinding by MCM 
(Lopes et al., 2006). In agreement, cells compensate for the loss of PrimPol by increasing 
both HR mediated fork rescue and dormant origin firing (Bianchi et al., 2013; Mourón et 
al., 2013). These compensatory back-up mechanisms, in addition to redundancy 
between PrimPol and TLS polymerases, may explain why PrimPol is dispensable for 
viability in human cells and mouse models (García-Gómez et al., 2013). These 
observations give further credibility to a place for PrimPol at the progressing replication 
fork during S-phase, which might not necessarily be the case if a TLS-like role was being 
performed. 
As previously mentioned, TLS can potentially occur both at the replication fork, as well 
as post-replicatively, to fill in gaps left opposite lesions following repriming or dormant 
origin firing (Sale et al., 2012). Each of these possibilities are not mutually exclusive, but 
a number of studies point to post-replicative gap-filling as the predominant role for TLS. 
In yeast, DDT mechanisms, including TLS, have been found to operate effectively in a 
post-replicative manner, and ssDNA gaps, indicative of repriming, accumulate following 
UV-damage (Daigaku et al., 2010; Karras and Jentsch, 2010; Lopes et al., 2006). 
Likewise, in human cells DNA replication fork progression in the presence of UV damage 
was found to be independent of TLS and ssDNA gaps opposite UV lesions were 
identified. It was concluded that these gaps were likely a result of repriming downstream 
of lesions rather than dormant origin firing (Elvers et al., 2011). Importantly, mutation of 
Pol  or other TLS factors does not appear to significantly alter replication fork rates in 
the presence of damage (Edmunds et al., 2008; Elvers et al., 2011). This is in stark 
contrast to the effect of loss of PrimPol on replication fork progression following damage, 
further supporting a repriming, rather than TLS, role for this enzyme in vivo. 
6.4.3. PrimPol Bypasses Non-Canonical Replication Impediments 
Whilst DNA damage lesions are some of the best characterised replication impediments, 
they are not the only obstacles replication forks must overcome during their progression. 
In addition to the right-handed B-form of dsDNA, we have become familiar with since 
Watson and Cricks famous model (Watson and Crick, 1953), genomic DNA can also 
adopt a number of other secondary structures as a result of specific sequence motifs 
and protein interactions (Bochman et al., 2012). One alternative DNA secondary 
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structure, which has received increasing attention as evidence for its formation in vivo 
grows, is the G-quadruplex (Murat and Balasubramanian, 2014). As previously 
mentioned, G-quadruplexes are produced by the stacking of G-quartets, which form 
through alternative Hoogsten base-pairing between guanine bases. These structures 
may potentially play an important role in transcription and DNA replication in the cell, but 
they can also pose as major impediments to replisome progression (Cheung et al., 2002; 
Maizels and Gray, 2013; Ribeyre et al., 2009; Sarkies et al., 2010). Consequently, cells 
possess a number of specialised helicases and polymerases to replicate past G-
quadruplexes (León-Ortiz et al., 2014). 
Previously, cells lacking FANCJ or Rev1 were found to stochastically lose Bu-1a protein 
expression (Sarkies et al., 2011; Schiavone et al., 2014). Importantly, the BU-1A locus 
contains a G-quadruplex, which was determined to stall replication in these cells. This 
stalling causes uncoupling of replication from histone recycling at the BU-1A locus and 
consequently leads to the deletion of epigenetic marks, manifesting in loss of Bu-1a 
expression. As described in Chapter 4, it was recently identified using Bu-1a read-out 
assays that PrimPol also plays a critical role in the bypass of these structures during 
DNA replication (Schiavone et al., 2016). Consistent with PrimPols behaviour at most 
DNA damage lesions, in vitro analysis shown in Chapter 4 revealed that the enzyme is 
unable to directly read through G-quadruplexes, but can bind to and facilitate close-
coupled repriming downstream of these structures. Vitally, close-coupled repriming 
ahead of the G-quadruplex would permit the appropriate recycling of histones, and thus 
maintain epigenetic marks and Bu-1a expression. Bypass of G-quadruplex structures 
through repriming by PrimPol was confirmed in vivo using the ZnF primase-deficient 
mutant discussed previously. Here, complementation of PrimPol-/- cells with the ZnF 
mutant failed to prevent instability of Bu-1a expression, in contrast to the wild-type 
protein, confirming that PrimPols primase activity is critical for G-quadruplex bypass 
(Schiavone et al., 2016). Intriguingly, PrimPol was found to only be required for G-
quadruplex bypass during leading strand replication. Presumably, this is because 
primers are constantly generated on the lagging strand anyway, due to the discontinuous 
nature of DNA synthesis there. 
Further evidence of a general role for PrimPol in repriming replication downstream of 
fork-stalling obstacles is provided by studies of CTNAs which are detailed in Chapter 4
(Kobayashi et al., 2016). CTNAs cause replication to stall by being incorporated into the 
3-termini of growing DNA polymers and preventing further extension, as they lack the 3 
hydroxyl required for phosphodiester bond formation (Berdis, 2008; De Clercq and Field, 
2006). Loss of PrimPol has been shown to cause hypersensitivity to a wide range of 
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CTNAs (Kobayashi et al., 2016). Critically, the inability of polymerases to extend from 
CTNAs rules out bypass by direct extension. PrimPol was found to be important for the 
tolerance of CTNAs by repriming downstream. This role was confirmed by both in vivo 
characterisation of the ZnF mutant and in vitro analysis of repriming after CTNAs using 
the primase assay described in Chapter 4 (Kobayashi et al., 2016). 
These critical findings not only identify that PrimPol bypasses G-quadruplexes and 
CTNAs in a similar manner to DNA damage lesions, through repriming. They point to the 
possibility that PrimPol is able to bypass a wide range of leading-strand obstacles during 
normal and perturbed replication. This is in contrast to canonical TLS polymerases which 
are typically highly specialised in the lesions they can bypass. Consequently, it is likely 
that PrimPol is broadly employed as a general mechanism to reprime and restart 
replication ahead of many different leading strand replication impediments. 
6.4.4. A Role for PrimPol in Mitochondrial DNA Replication?
The majority of genetic information in mammalian cells is stored in the nucleus. However, 
a small proportion of DNA is also located in the mitochondria. Despite being only ~16.6 
kb long and encoding just 13 polypeptides, mutation of the mitochondrial genome is 
responsible for a number of mitochondriopathies and is implicated in various other 
pathologies including cancer, cardiovascular diseases, and neurodegenerative disorders 
(Alexeyev et al., 2013). Unlike nuclear DNA, cells possess many copies of mtDNA 
making it highly redundant. In line with this, the rate of mutagenesis is ~10-fold greater 
in the mitochondria than the nucleus (Alexeyev et al., 2013). A major function of 
mitochondria is the generation of ATP through OXPHOS. This process produces reactive 
ROS which can induce damage lesions, including 8-oxo-dG and Ap sites, in mtDNA 
(Alexeyev et al., 2013).
A significant proportion of PrimPol has been found to localise to the mitochondria where 
it interacts with mtSSB, suggesting a potential role in the tolerance of mtDNA damage 
(Bianchi, 2013; Bianchi et al., 2013; García-Gómez et al., 2013; Guilliam et al., 2015a). 
This is supported by defects in mtDNA replication and copy number observed in cells 
lacking PrimPol (Bianchi, 2013; García-Gómez et al., 2013).  However, the ability to 
generate viable PrimPol-/- mice demonstrates that this role is redundant. Indeed, PolRMT
is likely responsible for generating the initial primers essential for mtDNA replication 
(Falkenberg et al., 2007). These primers are then extended by Pol , which until recently 
was thought to be the only mitochondrial DNA polymerase (Loeb and Monnat, 2008). In 
addition to PrimPol, more recent reports indicate that Pol  and Pol 	 also function in 
human mtDNA replication (Singh et al., 2015; Wisnovsky et al., 2016).
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Given that few TLS polymerases appear to localise to the mitochondria, in addition to 
the high levels of ROS there, it was speculated that PrimPol may be involved in TLS 
bypass of mitochondrial 8-oxo-dG lesions and Ap sites (García-Gómez et al., 2013). In 
order to investigate this, a recent study analysed the ability of PrimPol to assist the 
mitochondrial replisome in oxidative damage bypass by TLS (Stojkovi et al., 2016). 
Here, it was found that the mitochondrial replisome is completely stalled by Ap sites and 
pauses significantly at 8-oxo-dG lesions. PrimPol did not enhance the bypass of either 
of these lesions, disagreeing with a TLS role in oxidative damage bypass in the 
mitochondria (Stojkovi et al., 2016). Thus, it seems more likely that PrimPol functions 
to reprime mtDNA replication downstream of blocking lesions, similar to its role in the 
nucleus. In addition to oxidative damage, mtDNA is also subject to deletions. Intriguingly, 
these deletions map in close proximity to G4-forming sequences (Bharti et al., 2014). In 
light of the role of PrimPol in repriming after G-quadruplexes in nuclear DNA replication, 
it would not be surprising if the enzyme fulfilled the same role in the mitochondria. 
However, further work is required to confirm a repriming role for PrimPol here.
6.4.5. Is PrimPol Involved in Somatic Hypermutation?
Generally, mutagenesis during DNA replication is avoided at all costs in order to preserve 
genomic stability. However, an exception to this is during the development of the immune 
system. Here, mutagenesis occurs in immunoglobulin (Ig) genes to enable variation in 
the generated antibodies. This programmed mutagenesis is driven by activation-induced 
deaminase (AID), which deaminates dC to dU (Noia and Neuberger, 2007). Replication 
of dU facilitates C>T transitions. Additionally, dU may be further processed by uracil DNA 
glycosylase (UNG) to generate Ap sites. TLS bypass of these Ap sites can alternatively 
create C>A/G/T mutations due to the non-instructive nature of the lesion (Sale et al., 
2009). 
The involvement of TLS polymerases in somatic hypermutation (SHM) at Ap sites led to 
speculation that, if PrimPol functions as a TLS Pol in vivo, it might also modulate this 
mutagenesis. Analysis of DT40 cells found that hypermutation and gene-conversion 
events are similar in wild-type and PrimPol-/- cells. Moreover, loss of PrimPol in wild-type 
and Pol -/-/Pol 	-/- cells did not significantly alter the mutation spectrum of the studied Ig 
gene (Kobayashi et al., 2016). Intriguingly, another report, which analysed large 
mutational data sets in mice, identified that PrimPol does have a subtle effect on SHM 
outcome (Pilzecker et al., 2016). In this analysis, loss of PrimPol was found to selectively 
increase C>G transversions, but did not affect other G/C or A/T mutations. Interestingly, 
PrimPol was found to specifically prevent the generation of C>G transversions in the 
267
leading strand, potentially explaining the G>C over C>G strand bias of somatically 
mutated Igh loci (Pilzecker et al., 2016). However, this anti-mutagenic activity of PrimPol 
was attributed to the enzymes primase, rather than TLS polymerase, activity. It was 
concluded that PrimPol preferentially reprimes downstream of Ap sites on the leading 
strand, therefore maintaining fork progression and preventing error-prone TLS. The 
resulting ssDNA gap opposite the Ap site could then be filled in by error-free homology 
directed repair. Fascinatingly, in the same report, studies of invasive breast cancers 
suggested that this leading strand anti-mutagenic activity of PrimPol may be genome 
wide. 
Together, these reports establish that PrimPol does not act as a canonical TLS 
polymerase during SHM. Rather, PrimPol affects the mutational outcome of SHM by 
repriming downstream of Ap sites on the leading strand and thus preventing C>G 
transversions. These findings, therefore, further support mounting evidence that 
PrimPols primary role in DNA damage tolerance is to reprime leading strand replication 
and not to perform TLS. 
6.4.6. Why Doesnt Pol -Primase Reprime Leading Strand Replication?
The emerging role for PrimPol in repriming leading strand replication begs the question; 
why doesnt the replicative Pol -primase complex fulfil this role? In E. coli, DnaG, the 
replicative primase, efficiently reprimes replication ahead of replicase stalling DNA 
damage lesions, permitting bypass of the damage without dissociation of the replisome 
(Yeeles and Marians, 2011, 2013). Likewise in yeast, which lack PrimPol, leading strand 
repriming is presumably facilitated by Pol -primase, suggesting that, at least in these 
organisms, the replicative primase has the capacity to fulfil this role. 
Whilst the answer to this question is not completely clear, PrimPol does have one 
advantage over Pol -primase; it preferentially primes using dNTPs. This minimises the 
amount of RNA processing required on the leading strand. Although ribonucleotides are 
routinely incorporated during the initiation of each Okazaki fragment on the lagging 
strand and at replication origins on the leading strand, their persistent presence in DNA
can lead to genomic instability (Williams et al., 2016). Ribonucleotides incorporated 
during primer synthesis are routinely removed through Okazaki fragment maturation 
(Williams and Kunkel, 2014). However, it is not clear how a DNA secondary structure or 
lesion requiring bypass upstream of the primer would affect this process. 
Ribonucleotides incorporated by the replicative polymerases are removed by 
ribonucleotide excision repair (RER). Intriguingly, in RER deficient yeast, leading strand 
ribonucleotides are removed through a Top1 mediated mechanism, which likely also 
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removes a subset of ribonucleotides in RER proficient cells (Williams et al., 2015; 
Williams and Kunkel, 2014). This mechanism of ribonucleotide removal, which doesnt 
appear to occur on the lagging strand, is susceptible to causing genome instability. This 
makes ribonucleotides present in the leading strand potentially more detrimental than 
those in the lagging strand. This is supported by observations that loss of RER and 
increased ribonucleotide incorporation by Pol , but not Pol  or Pol , is lethal (Williams 
et al., 2015).
Although RER deficient yeast are viable, loss of this pathway in mice results in embryonic 
lethality (Reijns et al., 2012). Thus, the greater pressure on higher eukaryotes to 
minimise ribonucleotide presence in the genome may explain why PrimPol is utilised for 
leading strand repriming with dNTPs in these organisms, but has been lost in some lower 
eukaryotes such as yeast. 
6.4.7. Why is PrimPol Damage Tolerant In Vitro?
If PrimPols primary role in vivo is to reprime DNA replication, why does the enzyme 
display TLS-like activity in vitro? Although it is possible that PrimPols TLS-like activity is 
important in the cell, recent studies suggest that the enzymes primase activity is more 
relevant for its in vivo role, as discussed previously. This opens up the possibility that 
this TLS activity is a side effect of being a primase and this is supported by a number 
of observations. 
Recent studies of the RNA primase domains of human Pol -primase provide insight into 
the unique way primases interact with their DNA template and primer (Baranovskiy et 
al., 2016a, 2016b). The RNA primase associated with Pol  is a heterodimer composed 
of a small catalytic subunit, Prim1, and a large regulatory subunit, Prim2. These reports 
identify that the CTD of Prim2 binds to the DNA/RNA junction at the 5-end of the RNA 
primer, whereas Prim1 binds and extends the 3 end of the primer moving away from 
Prim2. Prim1 makes few contacts with the DNA/RNA, resulting in distributive activity. By 
only contacting the primer at the 5 and 3 ends, the primase is unable to sense modified 
nucleotides in the RNA strand, potentially explaining the propensity of primases to 
perform TLS-like extension (Baranovskiy et al., 2016a, 2016b). The authors suggest that 
this binding mechanism is broadly applicable to most primases. In the context of PrimPol, 
the ZnF is likely functionally equivalent of Prim2. Indeed, both are flexibly tethered to 
their respective catalytic domains and required for template recognition during priming, 
although PrimPols ZnF has only been shown to bind ssDNA (Keen et al., 2014b; Liu and 
Huang, 2015). Nevertheless, the ZnF domain may bind the ssDNA immediately 
upstream of the 5 end of the primer. 
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The crystal structure of PrimPols AEP domain potentially supports this model 
(Rechkoblit et al., 2016). Here, only the templating base is held in the active-site cleft, 
with the rest of the 5 template strand directed out of the active site. Additionally, PrimPol 
lacks a thumb domain and makes few contacts with the primer strand. This potentially 
prevents the enzyme from sensing damaged bases in the template and allows them to 
be looped out. Furthermore, unlike TLS polymerases, PrimPol does not possess an 
open active-site cleft and is unable to accommodate bulky lesions such as CPDs and 
6-4PPs (Rechkoblit et al., 2016). This adds further evidence that PrimPol is not a true
TLS polymerase, rather it loops out bulky lesions during bypass, resulting in a propensity 
to generate indels as identified in Chapter 2.  
The ability of primase-polymerases to perform TLS-like extension is well documented 
(Guilliam et al., 2015b). Some AEPs have co-opted this inherent catalytic versatility for 
use in other processes such as NHEJ, becoming specialised and in some instances, 
losing their ability to prime (Guilliam et al., 2015b). However, PrimPols primase activity 
is critical for its role in vivo and thus it is possible that the TLS-like activities observed in 
vitro simply arise as a by-product of the structural features necessary for priming.   
6.5. How does PrimPol get to Where its Needed? The 
Recruitment of PrimPol to Stalled Replication Forks
The studies outlined above and presented in Chapter 4 strongly indicate that PrimPols 
main role in DNA replication is to reprime ahead of impediments on the leading strand. 
In order to fulfil this role, PrimPol must be efficiently recruited to ssDNA downstream of 
stalled replication forks. In this section, we will describe recent advances in our 
understanding of the interactions and mechanisms governing the recruitment of PrimPol. 
6.5.1. PrimPol Interacts with Single-Strand Binding Proteins
Replication fork stalling can cause uncoupling of leading and lagging strand synthesis, 
consequently generating ssDNA stretches on either strand due to continued unwinding 
by the replicative helicase (Lopes et al., 2006). The impact of this on the lagging stand 
is likely limited by the generation of new Okazaki fragments. However, in the absence of 
leading strand fork restart, extended uncoupling can produce stretches of ssDNA. In 
nuclear DNA replication, the resulting ssDNA is bound by RPA, which in turn can trigger 
the S phase checkpoint response (Zou and Elledge, 2003). 
Work described in Chapter 2 reveals that unlike TLS polymerases, PrimPol does not 
interact with PCNA (Guilliam et al., 2015a). However, it does interact with both RPA and 
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mtSSB (Guilliam et al., 2015a; Wan et al., 2013). PrimPols interaction with RPA is 
mediated by its CTD, which binds to the N-terminus of RPA70, the largest subunit of the 
RPA heterotrimer (Guilliam et al., 2015a). In Chapter 5 the structural basis for PrimPols 
interaction with RPA was elucidated (Guilliam et al., 2017), identifying that PrimPol 
possesses two RBMs in its CTD (RBM-A and RBM-B), both of which bind to the basic 
cleft of RPA70N independently of each other. Interestingly, this cleft has previously been 
shown to interact with, and recruit, a number of different DNA damage response proteins, 
including RAD9, MRE11, ATRIP, and p53 (Xu et al., 2008). 
Together, these studies suggest that PrimPol may also be recruited to stalled replication 
forks through its interaction with RPA; with mtSSB potentially playing an analogous role 
in mitochondria.
6.5.2. RPA Recruits PrimPol to Stalled Replication Forks 
Previously, it was identified that PrimPols CTD is required for its function and co-
localisation with RPA in vivo (Wan et al., 2013). However, interpretation of these results 
is limited as removal of the whole CTD has been shown to reduce primase activity in 
vitro, and may abrogate interactions with other binding partners (Keen et al., 2014b). 
Structural studies of the PrimPol-RPA complex, presented in Chapter 5, enabled the in 
vivo analysis of point mutants which disrupt this interaction. 
This work identified that PrimPols RBM-A is the primary mediator of the RPA interaction 
in vivo, whilst RBM-B appears to play a secondary role. RBM-A mutants were unable to 
restore replication fork rates following UV-damage, in comparison to the wild-type or 
RBM-B mutant protein (Guilliam et al., 2017). These findings revealed that PrimPols 
interaction with RPA is required for its cellular role. Moreover, this study also showed 
that this interaction is responsible for the recruitment of PrimPol to chromatin, 
demonstrating that the enzyme is indeed recruited to stalled replication forks by RPA 
(Guilliam et al., 2017). Intriguingly, mutations of key residues at each RBM have been 
identified in cancer patient cell lines, these mutations are sufficient to abrogate binding 
of the affected RBM, adding further support that these motifs are important for PrimPols 
function in vivo (Guilliam et al., 2017). The observation that RBM-A is required for binding 
of PrimPol to chromatin and its interaction with RPA in vivo, suggests that this motif 
mediates the initial recruitment of PrimPol. An intriguing possibility, consistent with the 
observations in Chapter 5, is that RBM-B then binds a second RPA molecule upstream 
of the first to further stabilise the enzyme and promote repriming. 
Aside, from identifying the mechanism by which PrimPol is recruited to stalled replication 
forks; these studies also add to the growing evidence supporting a role for PrimPol as a 
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repriming enzyme. PrimPols recruitment to RPA, and lack of interaction with PCNA, 
suggests it binds to ssDNA downstream of a stalled replicase on the leading strand, the 
ideal place to facilitate repriming following initial leading/lagging strand uncoupling to 
prevent excessive ssDNA generation. A recent report investigating the role of Rad51 
recombinase in aiding replication across UV lesions supports this (Vallerga et al., 2015, 
p. 51). Here, Rad51 and Mre11 depletion was found to favour ssDNA accumulation at 
replication obstacles and subsequent PrimPol-dependent repriming. This also supports 
previous suggestions that excessive unwinding of DNA following stalling of the replicase 
is sufficient to promote ssDNA generation and repriming at replication impediments 
(Elvers et al., 2011). 
Further work is required to elucidate the exact mechanisms controlling PrimPols 
recruitment by RPA to ssDNA. Interestingly, binding of MRE11 and RAD9 to RPA is 
enhanced upon RPA32C phosphorylation (Robison et al., 2004; Wu et al., 2005). Thus, 
phosphorylation of RPA may act as a way to signal recruitment of DNA damage response 
proteins, potentially including PrimPol (Oakley and Patrick, 2010).
6.6. The Regulation of PrimPol During DNA Replication
Work presented in this thesis and elsewhere, strongly indicates that PrimPol is recruited 
by RPA to the leading strand, following replicase stalling, in order to reprime replication 
and prevent genome instability (Guilliam et al., 2015a, 2017; Wan et al., 2013). However,
as shown in Chapter 2, PrimPol is an error-prone enzyme and unscheduled or 
dysregulated activity could lead to mutagenesis (Guilliam et al., 2015a). In this section, 
the proposed mechanisms which act to limit PrimPols contribution to DNA synthesis 
during replication will be discussed (outlined in Figure 6.3.).
6.6.1. Regulation of the Cellular Concentration of PrimPol 
The simplest way to regulate the activity of a protein is by controlling its intracellular 
concentration. This is especially true for proteins which are only required in response to 
specific stressors, for example DNA damage response proteins. This approach is utilised 
during the SOS response in E. coli. Here, ~40 DNA damage response genes are 
upregulated in response to DNA damage (Michel, 2005). 
In comparison to Prim1, PrimPol is expressed at very low levels in human U2OS cells (< 
500 protein copies per cell compared to ~ 13,300) (Beck et al., 2011). This is, however, 
similar to the expression level of TLS Polymerases, including Pols  and . PrimPol 
mRNA expression peaks in G1-S phase, although the total protein levels remain roughly 
constant throughout the cell cycle (Mourón et al., 2013). Thus, the increased association 
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Figure 6.3. Regulation of PrimPol by its ZnF domain and interacting partners.
Top panel: PrimPol is inherently self-regulatory due to the restraining effect of its ZnF domain. 
The AEP and ZnF domains of PrimPol form a hinge-like structure, connected by a flexible 
linker. Binding of PrimPol to ssDNA is mediated by the ZnF domain which binds 3 relative to 
the AEP domain on the template strand. Binding of the ZnF stabilises the AEP domain, 
permitting primer synthesis. The AEP then extends the primer, but is restricted by the 
maximum distance it can move away from the ZnF. The enzyme subsequently dissociates 
leaving behind a short primer. This mechanism limits the processivity of the PrimPol. Middle 
panel: PrimPol is regulated by single-strand binding proteins (SSBs). At sub-saturating 
concentrations of RPA, the protein acts to recruit PrimPol to the ssDNA template, 
consequently stimulating primer synthesis. In vivo this interaction is primarily mediated by 
PrimPols RBM-A which binds to the basic cleft of RPA70N. At saturating RPA concentrations, 
when the ssDNA template is fully coated, PrimPol cannot gain access and primer synthesis is 
inhibited. This serves to limit where PrimPol can prime. Bottom panel: PolDIP2 enhances 
PrimPols primer extension activity by binding the AEP domain and stabilising it on the DNA.  
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of PrimPol with chromatin during the G1 and S phases of the cell cycle in unperturbed 
cells is a result of finer mechanisms controlling recruitment to DNA, rather than increased 
expression. This may also be the case with the increased recruitment of the enzyme to 
chromatin in response to DNA damage. Nevertheless, the low level of PrimPol 
expression, in comparison to the replicative primase, acts as the primary mechanism to 
restrict its contribution to normal replication. 
6.6.2. PrimPol is Self-Regulating 
The structural features afforded to PrimPol by virtue of being a primase also act as 
inherent regulatory mechanisms. As mentioned previously, PrimPol displays very low 
processivity. This distributive nature appears to be due to two key features. Firstly, the 
AEP catalytic domain has a much smaller footprint than most polymerases, potentially 
explaining why the enzyme binds DNA so poorly (Rechkoblit et al., 2016). Secondly, the 
ZnF domain acts to negatively regulate PrimPols processivity (Keen et al., 2014b). 
It has been suggested that the Prim2 subunit of the replicative eukaryotic primase 
enforces a strict counting mechanism on the enzyme (Kuchta and Stengel, 2010b). Here, 
the Prim2 and Prim1 subunits form a hinge-like structure. The enzyme binds to ssDNA 
in a closed conformation, with Prim2 facilitating template recognition. The Prim1 subunit 
then initiates primer synthesis, moving away from Prim2 which binds the 5 end of the 
primer (Baranovskiy et al., 2016b; Kuchta and Stengel, 2010b). Thus, an inherent 
counting mechanism is conferred by the maximum distance Prim1 can elongate the 
primer away from Prim2. The ZnF domain of PrimPol likely act in a similar manner
(Guilliam et al., 2017). In this scenario, the AEP domain and ZnF form a hinge structure, 
connected by a flexible linker. The enzyme binds to DNA in a closed conformation 
assisted by the ZnF domain, which binds on the 3 side relative to the AEP domain on 
the template strand. The AEP domain can then synthesise and elongate the primer until 
further extension is restricted by the ZnF domain. PrimPol is, therefore, self-regulating. 
The supervisory effect of the ZnF domain, which permits priming but limits elongation, 
coupled with the AEPs poor affinity for DNA, restricts the ability of PrimPol to partake in 
significant unregulated DNA synthesis during DNA replication.
6.6.3. Regulation by Single-Strand Binding Proteins 
The ability of primases to bind and prime on ssDNA gives them the potential to facilitate 
un-scheduled priming in vivo, wherever ssDNA is available. Despite limiting the synthesis 
of long DNA tracts, PrimPols self-regulatory mechanisms do not restrict where it can 
prime. Dysregulated priming is potentially highly detrimental to the cell, as these primers 
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could be extended by other polymerases. To prevent this, PrimPol is also regulated by 
RPA and mtSSB. Both of these SSBs stimulate the activity of their respective replicative 
polymerases,  and  (Oliveira and Kaguni, 2010; Tsurimoto and Stillman, 1989). In 
contrast, as shown in Chapter 2, both RPA and mtSSB severely restrict the polymerase 
activity of PrimPol (Guilliam et al., 2015a). Additionally, these SSBs can also inhibit 
primase activity, as is the case with Pol -primase (Collins and Kelly, 1991; Guilliam et 
al., 2015a). However, as demonstrated in Chapter 5, RPAs effect on PrimPols primase 
activity is highly concentration-dependent. In fact, sub-saturating concentrations of RPA 
dramatically stimulate primer synthesis, but as the concentration increases inhibition 
occurs (Guilliam et al., 2017). It is likely that both RPA and mtSSB act to prevent un-
scheduled priming events by blocking access to the ssDNA template. Thus, PrimPol 
requires a free ssDNA interface adjacent to the SSB in order to be recruited. This 
recruitment likely acts to enhance PrimPols poor affinity for DNA, providing a platform 
for primer synthesis. 
As previously mentioned, RPA binds ssDNA with a defined polarity (Fan and Pavletich, 
2012; Iftode and Borowiec, 2000; Kolpashchikov et al., 2001; Laat et al., 1998). Initially, 
the DBD-A and DBD-B OB folds of RPA70 bind ssDNA in a tandem manner, forming an 
8-nt binding complex. The interface in contact with DNA is then extended to 20-30 nts 
by the binding of DBD-C and DBD-D, which occurs in a defined 5-3 direction on the 
template strand (Brosey et al., 2013). This would position the RPA70N domain, which 
recruits PrimPol, 5 relative to rest of the RPA molecule on the template strand. This 
suggests that PrimPol binds ahead of RPA in vivo, with the ZnF contacting ssDNA 
adjacent to RPA and the AEP bound downstream on the 5 side. Indeed, the binding of 
PrimPol in this manner is supported by preliminary investigations described in Chapter 
5.
The orientation of PrimPols interaction with RPA may explain the inhibition observed in 
primer extension assays in Chapter 2. By preferentially binding on the 5 side of RPA, 
PrimPol would not be able to access the primer strand at the 3 end of the template. This 
may also limit PrimPols access of free 3 termini in vivo, therefore preventing pseudo-
TLS bypass and mutagenesis. Additionally, replicative polymerases are thought to be 
able to easily displace RPA as they approach the protein from the 3 side, encountering 
the weakly bound DBD-D and DBD-C domains, before DBD-B and DBD-A (Iftode et al., 
1999). This in turn shifts the equilibrium from the 20-30-nt RPA complex, to the more 
weakly bound 8-nt mode, thus permitting displacement. In contrast, if PrimPol binds to 
the 5 side of RPA, it would move away from the protein, preventing displacement in the
same way. In support of this, primase assays presented in Chapter 5 reveal that PrimPol 
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can displace a single RPA molecule bound at the 5 end of a ssDNA template, when 
approaching from the 3 side (see section 5.4.10.). Presumably, in this scenario, PrimPol 
cannot be recruited to 5 side of RPA due to the lack of a ssDNA interface there. It is 
possible that the interaction between PrimPol and RPA also further enhances the 
regulation of the enzymes processivity by holding the ZnF domain and preventing 
continued extension by the AEP domain. 
6.6.4. What Generates the ssDNA Interface Required for PrimPol 
Recruitment?
The requirement of a ssDNA interface downstream of RPA for efficient PrimPol 
recruitment begs the question: how is this free ssDNA interface generated in vivo? 
Although the answer to this question is currently unknown, one obvious solution would 
be through the action of the replicative helicase. Following stalling of the leading strand 
replicase, leading and lagging strand replication can become uncoupled. Here, the 
replisome progresses in the absence of DNA synthesis on the leading strand. Continued 
unwinding of duplex parental DNA by MCM generates ssDNA on the leading strand, 
which is bound by RPA. Consequently, an RPA/ssDNA interface for PrimPol binding 
could be generated directly behind the progressing MCM. Subsequent repriming by 
PrimPol would prevent extended leading/lagging strand uncoupling, allowing leading 
strand replication to resume at the progressing replisome. The short RPA-bound ssDNA 
gap left behind could then be filled by TLS or template switching mechanisms. 
In support of this, it has recently been shown that the mitochondrial replicative helicase, 
Twinkle, can stimulate DNA synthesis by PrimPol, indicating that replicative helicases 
can potentially facilitate PrimPol activity in vivo (Stojkovi et al., 2016). It is interesting to 
note that many DNA primases interact with replicative helicases, with some even 
possessing their own helicase domains (Kuchta and Stengel, 2010b).
6.6.5. Regulation by PolDIP2
PolDIP2 was originally identified as a binding partner of the p50 subunit of Pol , in 
addition to PCNA (Liu et al., 2003). More recently, PolDIP2 was shown to interact with 
Pols , 	, , and Rev1 (Maga et al., 2013; Tissier et al., 2010). In vitro, the protein 
stimulates the polymerase activity of Pol  by increasing its affinity for PCNA, as well as 
enhancing TLS by Pols  and  (Maga et al., 2013). These observations have led to 
suggestions that PolDIP2 may play an important role in the switch between Pol  and 
TLS polymerases during DNA replication (Maga et al., 2013; Tissier et al., 2010). 
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As reported in Chapter 3, PolDIP2 also significantly enhances the DNA binding and 
processivity of PrimPols AEP domain (Guilliam et al., 2016). Additionally, PolDIP2 
appears to be important for PrimPols function in vivo, suggesting it may act as a way to 
positively regulate the enzymes activity. Notably, however, this was not sufficient to 
relieve the negative effect of RPA or mtSSB on PrimPols polymerase activity. PolDIP2 
was found to stimulate PrimPols bypass of 8-oxo-dG lesions, however unlike previous 
studies of Pols  and , this stimulation was not greater than that seen on undamaged 
templates (Guilliam et al., 2016; Maga et al., 2013). Here, the increased bypass was a 
result of an overall increase in the efficiency of the enzyme, rather than an 8-oxo-dG 
specific effect, although fidelity opposite the lesion was improved. Given that PrimPol 
appears to primarily function in repriming, PolDIP2 is likely required for the enhancement
of primer extension by PrimPols AEP domain, following synthesis of the initial di-
nucleotide. Interestingly, PolDIP2 binds to PrimPol at a region in close proximity to motifs 
Ia and Ib, identified in the recent crystal structure (Guilliam et al., 2016; Rechkoblit et al., 
2016). These motifs harbour the majority of the residues responsible for mediating 
binding of the AEP domain to the DNA template. PolDIP2, therefore, potentially changes 
the conformation of this region to enhance PrimPols affinity for the DNA template, 
resulting in the increased DNA binding and processivity described in Chapter 3. 
PrimPols inherent low processivity only permits incorporation of 1-4 nt before 
dissociation, however it is unlikely that a primer this short would be stable or sufficient to 
facilitate restart by the replicative polymerases. As PrimPol lacks an equivalent of Pol 
in the Pol -primase complex, it must elongate its own primers to a viable length. This is 
likely the reason PrimPol displays both primase and polymerase activities, and suggests 
it requires a further processivity factor, such as PolDIP2, to function efficiently in vivo.
Aside from enhancing PrimPols primer extension activity, another intriguing role for 
PolDIP2 is in the hand-off of the nascent primer strand from PrimPol to Pol . As 
mentioned in Chapter 1, recent biochemical and cellular studies have revealed that Pol 
 initially extends primers synthesised by Pol -primase on the leading strand during 
DNA replication in yeast (Daigaku et al., 2015; Yeeles et al., 2017). Assuming that this 
mechanism is conserved in higher eukaryotes, it is likely that primers generated by 
PrimPol during leading-strand repriming would be initially extended by Pol , before 
continued extension by Pol . Previous reports that PolDIP2 functions in the polymerase 
switch during TLS, coupled with the shared interaction of PrimPol, Pol , and PCNA, with 
the protein, raise the possibility that PolDIP2 may promote a switch from PrimPol to Pol 
 following primer synthesis and extension (Maga et al., 2013) (Figure 6.4.). 
Nevertheless, more work is required to explore this potential mechanism. 
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6.7. Conclusions and Perspectives
Nearly half a century ago, Rupp and Howard-Flanders identified the presence of ssDNA 
gaps left opposite UV photoproducts following DNA replication in NER deficient E. coli 
(Rupp and Howard-Flanders, 1968). A model was proposed which envisaged reinitiation 
of replication downstream of the damage on both leading and lagging-strand templates; 
the first suggestion of repriming. The idea of leading strand reinitiation remained 
controversial until almost four decades later when origin-independent leading strand 
reinitiation was observed (Heller and Marians, 2006). Follow-up studies confirmed that 
the replicative primase, DnaG, could reprime leading strand replication downstream of a 
lesion, whilst the replisome remained associated with the template (Yeeles and Marians, 
2011, 2013). Over recent years, evidence has accumulated to support leading strand 
repriming as a conserved mechanism for dealing with replisome-stalling impediments in 
eukaryotes (Elvers et al., 2011; Karras and Jentsch, 2010; Lopes et al., 2006). It now 
seems clear that PrimPol is employed in this mechanism in eukaryotic organisms for the 
bypass of a wide range of leading strand obstacles (Figure 6.4.) (Guilliam et al., 2017; 
Keen et al., 2014b; Kobayashi et al., 2016; Mourón et al., 2013; Pilzecker et al., 2016; 
Schiavone et al., 2016; Vallerga et al., 2015).
Since the initial reports describing PrimPol only four years ago, studies from a number 
of laboratories have greatly increased our understanding of the role, recruitment, and 
regulation of the enzyme during DNA replication (Bianchi et al., 2013; García-Gómez et 
al., 2013; Wan et al., 2013). However, we are only just beginning to appreciate the novel 
roles that PrimPol plays in DNA replication and damage tolerance. The exact interplay 
between leading strand repriming by PrimPol and other DDT mechanisms, such as TLS, 
is still not yet clear. It is possible that DDT mechanisms work to complement repriming 
by filling in the resulting ssDNA gaps. Alternatively, repriming could occur when TLS at 
the replication fork fails, in order to prevent extended leading/lagging strand replication 
uncoupling. The redundancy between Pol -primase and PrimPol in vivo is also an 
interesting avenue of future study. The reason for the apparent requirement of PrimPol 
for leading strand repriming in higher eukaryotes, but not other organisms, is not yet 
completely clear. Although leading strand repriming is emerging as the primary role for 
PrimPol during DNA replication, the catalytic versatility of the enzyme may lend itself to 
disparate roles in other processes, such as transcription (Martínez-Jiménez et al., 2015). 
We now know that RPA serves to recruit PrimPol to stalled replication forks in the nucleus 
(Guilliam et al., 2017). However, mtSSB has not yet been shown to play an analogous 
role in the mitochondria, although an interaction between the proteins in vivo is 
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Leading strand stalled by 
lesion / G4 / CTNA
RPA recruitment of PrimPol
& primer synthesis
Primer elongation 
& hand-off
CMG
Pol 
Lesion/G4/
CTNA
RPA
PrimPol
PolDIP2
Pol 
Figure 6.4. The role, recruitment, and regulation of PrimPol in DNA replication.
Top panel: Pol  is stalled on the leading strand by a lesion, secondary structure, or CTNA. Lagging strand replication continues, subsequently generating 
ssDNA on the leading strand. This ssDNA is bound by RPA as the CMG complex progresses. Middle panel: The generation of an RPA / ssDNA interface 
provides a platform for PrimPol recruitment. PrimPol requires a free ssDNA region adjacent to RPA and thus is recruited to the exposed ssDNA behind the 
CMG complex. This recruitment is facilitated by the interaction between PrimPols RBMs and RPA70N. Following recruitment, PrimPol reprimes the leading 
strand. Bottom panel: PrimPol elongates its primer, assisted by PolDIP2, before further extension is restricted by its ZnF and RPA interaction. The primer 
is then handed-off to the replicative polymerase, possibly Pol , mediated by each proteins interaction with PolDIP2. 
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documented (Guilliam et al., 2015a). Additionally, it is possible that post-translational 
modifications, as well as interactions with the replicative helicases, play a role in this 
process (Stojkovi et al., 2016). The necessity of appropriate recruitment and regulation 
of PrimPol in the cell is highlighted by the mutations of PrimPols RBMs identified in 
cancer patient cell lines, which likely adversely affect recruitment of the enzyme (Guilliam 
et al., 2017). The regulation of PrimPol appears to walk a fine line between preventing 
and causing genetic instability, as PrimPol is inherently error-prone and also been found 
to be over-expressed in some cancers, such as glioma (Guilliam et al., 2015a; Yan et 
al., 2011). Although we have highlighted some of the known mechanisms regulating 
PrimPols activity here, it is likely that additional layers of regulation remain to be 
discovered. 
The hypersensitivity to DNA damaging agents observed in the absence of PrimPol 
legitimises the enzyme as a potential target for inhibition in combination with other DDT 
factors and DNA damaging chemotherapeutics (Bianchi et al., 2013; Kobayashi et al., 
2016; Mourón et al., 2013). Similarly, PrimPol homologues in trypanosomes have been 
identified as essential for survival and thus PrimPol-like proteins in other species may 
also be potential targets for anti-parasitic drugs (Rudd et al., 2013). Further studies will 
be important in determining the viability and usefulness of manipulating PrimPol in 
treating cancer and other diseases. 
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